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Summary 
Members of the Pneumoviridae virus family are responsible for severe respiratory tract 
disease in their hosts. Human respiratory syncytial virus (hRSV) is responsible for over 
200,000 deaths worldwide each year and bovine respiratory syncytial virus (bRSV) causes 
major economic loss to the cattle industry worldwide. The current model for all non-
segmented negative-sense single stranded RNA virus gene expression, is that mRNA is 
generated in a polar gradient, with decreasing levels of mRNA transcribed from genes 
further along the genome from the 3´ end. With the exception of translation of ORF-2 
located on the bicistronic M2 mRNA, translation of Pneumoviridae mRNAs is thought to be 
regulated through the levels of mRNA abundance. Translation of M2 ORF-2 has been 
characterised as being regulated by the non-canonical mechanism of coupled translation 
termination/initiation in pneumonia virus of mice (PVM), hRSV and avian metapneumovirus 
(APV). This mechanism is reliant on a proportion of the elongating ribosome translating the 
upstream M2 ORF-1, terminating and reinitiating translation of M2 ORF-2. Although the 
initiation site for M2 ORF-2 is similar in bRSV to other members of this family that use the 
mechanism of coupled translation, the mechanism has not been characterised. 
 
Using the technique of ribosomal profiling to analyse steady state viral mRNA abundance 
and viral translation in both hRSV and bRSV-infected cells, it was observed that for certain 
viral mRNAs, levels of mRNA abundance did not follow the standard polar transcription 
model. This was characterised by an increase in the levels of mRNA abundance between the 
mRNA’s respective gene and its upstream neighbour. The increase was observed in the same 
group of mRNAs in both viruses suggesting that factors other than the transcription polar 
gradient influence levels of viral mRNA abundance. It was also observed that levels of 
proportional translation did not match the respective proportional levels of mRNA 
abundance for certain viral mRNAs in both viruses. This would suggest that translation of 
viral genomes is not primarily controlled by mRNA abundance and instead other 
translational regulatory factors influence levels of translation.   
 
The mechanism of bRSV M2 ORF-2 translation was also characterised using reporter 
plasmids assays. It was identified that the mechanism of initiation of translation of M2 ORF-
2 used, was not that of coupled translation termination/initiation used by other members of 
this family. Instead it was observed that translation of M2 ORF-2 used an internal initiation 
mechanism located inside M2 ORF-1 to initiate translation. 
 
The mechanism of coupled translation termination/initiation used for translation of PVM M2 
ORF-2 was also further characterised. It was observed that translation of M2 ORF-2 was 
reliant on upstream sequence in the M2 ORF-1 sequence. A predicted mRNA secondary 
structure was identified in this region and when disrupted, inhibited translation of M2 ORF-
2. This was similar to the mechanism of coupled translation used in hRSV, suggesting that 
the mechanism used by this family is reliant on a mRNA secondary structure located 
upstream of the initiation site.  
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1.1.1. The Pneumoviridae family  
Respiratory diseases have been a major cause of mortality among both human and 
animal populations throughout history. One of the main agents behind these diseases 
are viruses. Of these viruses, the Pneumoviridae family is a major cause of 
respiratory diseases in a large range of animals: which include birds, rodents, 
livestock and humans. These viruses tend to have a high morbidity and in certain 
situations a high mortality.  
 
The Pneumoviridae family is part of the order Mononegavirales. This order 
comprises of a non-segmented single stranded negative-sense RNA genome viruses 
which consist of 10 genes. The Pneumoviridae family can be further divided into the 
Orthopneumovirus and Metapneumovirus genera (Alvarez et al., 2003; 2016; 
McCarthy and Goodman, 2010). 
 
As seen in table 1, the genus Metapneumovirus contains two species of virus and the  
Orthopneumovirus genus contains three. All of these viruses cause acute respiratory 
illness in their host species. This thesis will focus on the Orthopneumovirus genus. 
 
 
Table 1: Members of the Pneumoviridae family 
Species of virus that are found in the two genera of the Pneumoviridae family. List according to the 
International Committee on Taxonomy of Viruses (ICTV 2016) 
 
1.1.2. Human Respiratory Syncytial Virus 
Human respiratory syncytial virus (hRSV) was first isolated in chimpanzees in the 
1950s (Blount et al., 1956). The virus can be separated into two subgroups (A and B) 
based on antigenic differences (Fletcher et al., 1997). Both subgroups are responsible 
for causing lower respiratory tract diseases, such as bronchiolitis and pneumonia in 
humans, and are capable of causing disease in all age groups. It is estimated that 
160,000 people a year die worldwide from hRSV related diseases (Cowton et al., 
2006) -of those 60,000 are children (Nair et al., 2010). By the age of three, it is 
estimated that almost all children have been infected with hRSV (Simoes, 1999). The 
Orthopneumovirus Metapneumovirus 
Human respiratory syncytial virus Avian metapneumovirus 
Bovine respiratory syncytial virus  Human metapneumovirus 
Pneumonia virus of mice  
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symptoms caused by hRSV tend to be mild with symptoms such as cough and 
rhinitis/coryza. In general, children, the elderly and the immunodeficient have a 
higher probability of the infection becoming more severe (McNamara and Smyth, 
2002). Most infections tend to show mild upper respiratory symptoms. An infection 
however may become more severe and progress to the lower respiratory tract causing 
the associated diseases mentioned above. Cases of mortality tend to occur in infants 
with other mitigating factors such as immunodeficiency, premature birth and cystic 
fibrosis (Borchers et al., 2013; Cowton et al., 2006; Fleming et al., 2005; Guvenel et 
al., 2014; Lee et al., 2012; McNamara and Smyth, 2002). 
 
hRSV infects epithelial cells that are found in both the respiratory and nasal tracts. 
There are generally no major cytopathological effects caused by hRSV during 
infection, with the virus tending to supress and delay apoptosis in the cell. In severe 
infection, the virus causes an increase in fluid extravasation into the air spaces found 
in the lung. Animal models in mice have also shown that the virus decreases sodium 
transport across epithelial cells leading to a decrease in fluid clearance in the lungs. 
Severe infection can also lead to a loss in plasma membrane integrity in bronchial 
cells (Oshansky et al., 2009). 
 
Currently, there is no vaccine for hRSV. Initial attempts at producing an inactivated 
viral vaccine ended disastrously in the 1960s. The inactivated vaccine used increased 
the severity of viral infections once a child was immunized leading to higher rates of 
hospitalization and mortality among the recipients. This was thought to be due to the 
vaccine increasing the activity of the T-helper 2 cells, which lead to pulmonary 
eosinophilia (Borchers et al., 2013). As a result over the next few decades, a sharp 
decrease in research into a suitable vaccine was seen. Recently there has been an 
increased level of research into an alternative vaccine. These include using both 
attenuated and recombinant antigen methods to produce a viable vaccine. Research 
into an attenuated vaccine has focussed on using hRSV mutants, where individual 
mutated sites and deletions target the Non Structural 2 (Section 1.2.2), Small 
hydrophobic (Section 1.2.6) and M2 (Section 1.2.10) viral genes (Guvenel et al., 
2014). This combination of knockouts has produced an attenuated vaccine that has 
reached clinical trials. There has also been initial success in the development of 
recombinant adjuvant vaccines. All surface proteins (fusion (Section 1.2.8), 
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glycoprotein (Section 1.2.7) and small hydrophobic protein (Section 1.2.6)) have 
been used to produce antigens which can induce immunity against hRSV (Borchers 
et al., 2013; Guvenel et al., 2014; Rudraraju et al., 2013).  
 
One of the most effective treatments for hRSV is the use of the humanized 
monoclonal antibody Palivizumab (Medimmune). This antibody binds to the fusion 
glycoprotein that protrudes externally from the viral membrane. The antibody is 
effective at reducing the viral titre, however this does not in turn completely halt the 
viral infection and monthly doses must be given as a result in order to stop viral 
dissemination. As a result of this and due to the high cost (~$14K per dose), this 
treatment is mainly used as a prophylaxis for young children and only given to 
children that are at high risk of developing a severe infection from the virus. 
Ribavirin (a nucleoside analogue) is currently the only antiviral molecule that is 
allowed for human use. However, due to the fear of side effects and the cost to 
benefit ratio, the drug is not commonly used. There are currently other drugs that are 
being tested that have not been approved for human use that target viral pathways. 
This includes research into new prophylaxis treatment for neonates, that provides 
protection against several viruses in the Pneumoviridae family that infect humans 
(Corti et al., 2013; Gomez et al., 2014).  
 
1.1.3. Bovine Respiratory Syncytial Virus 
Bovine respiratory syncytial virus (bRSV) like all members of the Orthopneumovirus 
genus (McCarthy and Goodman, 2010) has the same 10 genes that code for the same 
11 proteins. bRSV causes both upper and lower respiratory infections in cattle, with 
calves under 6 months being most vulnerable. The symptoms caused by this virus 
can range from dyspnea, tachypnea, ocular secretions, dry muzzle, reduced activity 
and anorexia. This in turn leads to a loss of activity, which has a huge economic cost. 
Death from the virus is also not uncommon among cases. The viral infection also 
makes cattle more susceptible to bacterial infections such as Mycoplasma bovis 
which is the leading cause of cattle mortality in the US (Sacco et al., 2014). 
 
As in hRSV infection, the virus infects epithelial cells found in the respiratory tract. 
Many of the viral symptoms are caused by the immune response. Factors released 
from the innate immune response can lead to fever and anorexia due to the release of 
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proinflammatory cytokines. Inflammation in the lung can also be linked to a T-helper 
2 response. Both the innate and adaptive immune responses are linked to the cause of 
the more severe symptoms in bRSV (Gershwin, 2012). 
 
There are multiple vaccines that are used for bRSV. These usually include a mixture 
of both inactivated and live attenuated virus. As with the inactivated vaccine for 
hRSV, some inactivated vaccines for bRSV have also shown to cause an increase in 
severity of the disease caused by bRSV (Sacco et al., 2014). Current vaccines that 
are used in the market today are far from perfect as their efficacy is far from ideal. 
New research has focussed on the use of adjuvant and attenuated vaccines, which 
have shown better efficacy and also a decrease in vaccine-enhanced disease. 
Currently there is no effective treatment for bRSV in cattle (Blodörn et al., 2014; 
Sacco et al., 2014). 
 
1.1.4. Pneumonia Virus of Mice  
Pneumonia virus of mice (PVM) is responsible for causing respiratory disease in 
mice, with symptoms similar to that of severe disease in hRSV. Death of mice tends 
to follow quickly after infection. In neonatal mice, there is virtually no inflammation 
during infection (Rosenberg and Domachowske, 2008). Current research suggests 
that the virus is not a pathogen to other animals including humans, as the levels of 
replication are so low. Although there is evidence of neutralizing antibodies found in 
humans during exposure, it is suggested that this is due to polyreactive neutral 
antibodies. The virus has been used extensively as a model for the inflammatory 
response of all viruses in the Orthopneumovirus genus. PVM causes a similar 
inflammatory response compared to that in severe disease in hRSV. Both viral 
infections cause the release of macrophage inflammatory protein 1α and 2 (MIP-1α 
and MIP-2) and monocyte chemoattractant protein 1 (MCP-1). The release of these 
proteins leads to the stimulation and activation of the innate immune cells. During 
infection some of the viral proteins including NS1 and NS2 are responsible for 
inhibiting the cellular interferon response to the viral infection (Brock et al., 2012; 
Dyer et al., 2012; Rosenberg and Domachowske, 2008).  
	 6	
1.2.1. Genome of the Orthopneumovirus genus  
All three members that belong to this genus have a single negative-sense RNA 
genome that is ~15kb long. The genome comprises of 10 genes from which 11 
proteins are translated. As seen in Fig. 1.1B, all three members of the genus have the 
same 10 genes in the genome arranged in the same sequential order (Buchholz et al., 
1999; Collins et al., 1987; Krempl et al., 2005). The genome is also flanked by a 3´ 
leader sequence and a 5´ trailer sequence. In hRSV the leader sequence has been 
reported to be 44 nts in size and the trailer sequence to be 144 nts in size (Mink et al., 
1991). In this genus, the largest amount of research has been performed on hRSV. 
Therefore, when reviewing the genome and its replication cycle the review will 
mainly focus on hRSV.  
A 
 
B 
 
Fig. 1.1: Virion and genome of members of Orthopneumovirus family 
(A) Virion of members of the Orthopneumovirus genus. The ribonucleoprotein (RNP) complex 
consists of the viral genome encapsidated by the N protein, P protein and L protein. (B) Genome of 
hRSV including M2 gene transcript transcribed from the M2 gene. Diagram includes both AUG and 
stop codons of both open reading frames (ORFs) in the M2 gene transcript. 
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1.2.2. Non structural protein 1 (NS1) and Non structural protein 2 (NS2) 
The first two genes from the 3´ end of the Orthopneumovirus genome are the non 
structural 1 NS1 and non structural protein (NS2) genes. These two genes are 
translated into 139 and 124 amino acid proteins respectively (Johnson and Collins, 
1989). The two proteins are not packaged into infectious virion particles and are only 
present during infection. They are not involved in the replication of the virus, but are 
however involved in suppressing the host cell response to the virus. The two proteins 
are involved in blocking type I and type II interferon signalling pathways (Hastie et 
al., 2012; Lo et al., 2005; Spann et al., 2004). These proteins are also involved in 
preventing premature apoptosis of the infected cell (Bitko et al., 2007). There is also 
evidence of involvement of NS1 in suppressing regulatory T cells. These cells are 
thought to be involved in maintaining self tolerance for the immune system (Yang et 
al., 2015).  
 
1.2.3. Nucleoprotein (N) 
The nucleoprotein (N) encapsidates the RNA genome in the packaged viral particle 
and encapsidates both genome and antigenome inside the cell during infection. 
Encapsidation of the genome forms the nucleocapsid, which protects the viral 
genome during infection from cellular factors such as RNAses. The nucleocapsid 
also comprises of P and L proteins with the M2-1 protein also associated, which 
forms the RNP complex. The N protein forms the nucleocapsid into a helix-like 
structure with variable numbers of N proteins encapsidating the viral RNA in each 
turn. The N protein also allows for transcription and replication by the L protein by 
allowing the L protein to bind through interactions with the P protein (Bakker et al., 
2013; El Omari et al., 2011; Maclellan et al., 2007). 
 
1.2.4. Phosphoprotein (P) 
The phosphoprotein (P) is a 241 amino acid protein that is also associated with the 
RNP complex. The protein is phosphorylated at multiple positions along the length 
(Lu et al., 2002) and also forms homotetramer complexes with other P proteins to 
form a modular structure (Llorente et al., 2006). The protein is known to associate 
with the N, L and M2-1 proteins (Galloux et al., 2012; Mason et al., 2003). The P 
protein is essential for successful encapsidation of the viral RNA. It also has been 
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suggested that the P protein acts as chaperone for the N protein when not associated 
with the viral genome. This is to prevent the N protein from binding to other cellular 
RNAs. The protein is an essential co-factor for the L protein in its function as a RNA 
dependent RNA polymerase (RdRP) (Galloux et al., 2012). This is achieved by 
specific interactions between the P and N proteins (Lu et al., 2002). The P protein is 
also known to regulate the M2-2 protein in its function by facilitating the viral 
polymerase in its switch from transcription to replication (Asenjo and Villanueva, 
2016).  
 
1.2.5. Matrix protein (M) 
The matrix protein (M) is a non-glycosylated structural protein that is 256 amino 
acids in size, which is involved in the assembly of the viral complex (Ghildyal et al., 
2006). In an infectious virion, the M protein is found as a partial layer between the 
viral membrane and the ribonucleoprotein (Liljeroos et al., 2013). Its role in 
assembly has not been well characterized and is thought to aid in preventing L 
polymerase activity during assembly. The protein forms a bridge between the new 
viral envelope and the ribonucleoprotein (Ghildyal et al., 2006). It is also a key factor 
in the formation of viral filaments formed during infection (Mitra et al., 2012).  
 
1.2.6. Small Hydrophobic protein (SH) 
The small hydrophobic protein (SH) is a type II membrane protein that is 64 amino 
acids in size. During infection, there are up to 4 structurally different isomers of the 
protein expressed (Collins and Mottet, 1993). It is currently not known what fraction 
of each specific isomer of this protein is expressed during infection. It has been 
suggested that the protein acts to aid the virus in immune evasion and to aid the virus 
in virus-mediated cell fusion. It also has been reported that the protein associates 
with the Golgi apparatus and the plasma membrane (Rixon et al., 2005). The 
structure has been solved when binding to lipid bilayers with the protein forming a 
pentameric oligomer (Collins and Mottet, 1993). It also has been found to associate 
with proteins in antiapoptotic pathways (Li et al., 2015b). 
 
1.2.7. Glycoprotein (G) 
The glycoprotein (G) is a type II glycosylated surface membrane protein and varies 
between 292 and 299 amino acids in size (Teng and Collins, 2002). The G protein 
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varies highly between strains of virus as it is one of the two viral proteins that induce 
neutralizing antibodies. The G protein is thought to enable viral-mediated cell fusion 
by initially binding to glycosaminoglycans and negatively charged carbohydrates. 
This allows the fusion protein to bind to cellular receptors thereby facilitating virus-
mediated cell fusion (Kwilas et al., 2009; Techaarpornkul et al., 2002). The G protein 
is also released from the cell during the replication cycle where it is thought to act as 
an immunomodulatory factor (Hendricks et al., 1987).  
 
1.2.8. Fusion protein (F) 
The fusion protein (F) is a type I surface membrane protein. The protein is 574 
amino acids in size and enables the viral particle to fuse its membrane to the cellular 
membrane. Upon coming into close proximity to the cell membrane, the fusion 
protein will insert a number of hydrophobic residues into the cellular membrane. By 
a process of refolding, the fusion protein brings the cell and viral membranes into 
close proximity allowing fusion of the membranes. This forms a fusion pore 
allowing entry of the nucleocapsid into the cytoplasm of the cell. The F protein does 
not play a significant role in replication inside the cell (González-Reyes et al., 2001; 
Krzyzaniak et al., 2013; Low et al., 2008; McLellan et al., 2013b; Melero and Mas, 
2015; Tayyari et al., 2011).  
 
1.2.9. M2-1 protein 
The M2-1 protein is translated from the first open reading frame (ORF) located on 
the M2 gene transcript. The role of the 194 amino acid protein has been primarily 
investigated through the use of minigenomes. These studies have elucidated that the 
M2-1 protein acts as an antitermination factor during transcription of the viral 
genome (Collins et al., 1996; Fearns and Collins, 1999b; Hardy and Wertz, 1998). 
The protein prevents termination of the transcribing viral polymerase at both 
intergenic regions (Collins et al., 1996), as well as at gene stop (GE) sites in the 
genome (Fearns and Collins, 1999b; Hardy and Wertz, 1998). It has also been found 
that transcription of longer mRNAs, as well as polycistronic read-through mRNAs 
are highly dependent on the presence of M2-1 protein. For the transcription of the 
viral genome, the protein is especially critical in the transcription of gene transcripts 
past the NS1 and NS2 genes of hRSV. The M2-1 protein however, does not have any 
specific role in the replication of the viral genome (Fearns and Collins, 1999b). The 
	 10	
M2-1 protein associates itself with the RNP complex during infection, with reported 
interactions with the N and P proteins. It has also been reported to interact with the 
M protein although the precise role in the interaction is still unclear (García et al., 
1993). 
 
1.2.10. M2-2 protein 
The M2-2 protein is translated from the second ORF located on the M2 gene 
transcript. The role of the 83 amino acid protein is in the switch from transcription to 
replication of the viral genome. Although the mechanism for this role is unknown, 
knockout mutants of the M2-2 protein have shown a significant reduction in the 
levels of genomic viral RNA and also a significant decrease in the levels of viral 
yield during infection, with as much as a 1000-fold reduction observed. It is 
unknown whether the switch is due to the M2-2 protein directing synthesis of 
antigenomic or genomic RNA. However, it has been found that the protein 
accumulates during hRSV infection and peaks after 12-15 hours post infection and 
continues to remain constant after this time (Bermingham and Collins, 1999). 
 
1.2.11. Large protein (L) 
The large protein (L) is a 2165 amino acid protein and is the final gene in the viral 
genome (Collins et al., 2013). The L protein acts as an RNA dependent RNA 
polymerase (RdRP) for the virus and is associated with the RNP complex in the cell 
and in the virion. The protein during infection will initially individually transcribe 
viral genes in the viral genome (Noton et al., 2012). The L protein will also cap and 
polyadenylate the viral mRNA during transcription (Barik, 1993; Liuzzi et al., 2005). 
During later stages of infection, the L protein switches from transcription to 
replication by transcribing an antigenome. This acts a template for the L protein to 
produce multiple copies of the negative-sense genome (Morin et al., 2013). As 
described in Section 1.2.4, the L protein is reliant on the P protein, which acts as a 
critical cofactor by interacting with N protein thereby bringing the L protein into 
contact with the genome (Lu et al., 2002). The N protein must encapsidate both the 
genome and antigenome throughout the entire replication cycle, therefore the P 
protein is essential as a cofactor for the L protein for both transcription and 
replication (Morin et al., 2013). During transcription the local N protein 
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encapsidating the region that is transcribed must be removed in order for the L 
protein to access the genome.  
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1.3.1. Replication cycle  
 
Fig. 1.2 Life cycle of viruses in the Orthopneumovirus genus 
Life cycle of viruses in the Othropneumovirus genus. Transcription, replication, translation and packaging of the viral genome occur in the cytoplasm of the cell. (A) Viral 
entry. (B) Transcription of viral mRNAs by the RdRP. (C) Replication of the viral genome through the synthesis of an antigenome by the RdRP. The RdRP will use the 
antigenome as a template to synthesize multiple copies of the genome. (D) Translation of viral mRNAs. (E) Assembly of viral proteins and genome. (F) Budding and release.  
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1.3.1.1 Host cell entry 
For Orthopneumoviruses host cell entry (Fig. 1.2A), the G protein initially binds to 
epithelium cells in order to bring the virus into contact with the cellular membrane. It 
is generally accepted that the G protein binds to negatively charged carbohydrates 
such as glycosaminoglycans (Kwilas et al., 2009; Techaarpornkul et al., 2002). There 
are several reported glycosaminoglycans such as heparan sulphate and chondroitin 
sulphate that have been reported to bind to the G protein. However with certain 
examples such as a herapan sulphate, the protein is not present on human airway 
epithelium cells (Krzyzaniak et al., 2013). It has also been shown that in vitro, hRSV 
can enter the cell without the use of the G protein and also without binding to any 
glycosaminoglycans using only the F protein (Techaarpornkul et al., 2001). 
 
Upon successful binding of the virus, the F protein is responsible for cell-mediated 
viral fusion of the viral membrane to the cellular plasma membrane. In the viral 
membrane the F protein forms a trimeric complex linked by disulphide bonds. This 
trimeric complex is formed in a conformation called a prefusion complex. When the 
F protein comes into to close proximity to the membrane, the protein will then insert 
a stretch of hydrophobic residues into the membrane. This results in a 
conformational change to form the post fusion complex, which brings the two 
membranes into close proximity with each other. It is currently thought that in 
hRSV, there is a trigger that causes the F protein to insert its hydrophobic residues 
into the membrane (Mastrangelo and Hegele, 2013; McLellan et al., 2013a; 
McLellan et al., 2013b; Melero and Mas, 2015). It has been suggested that the virus 
can also bind to intracellular adhesion molecules (ICAM). However, there is 
increasing evidence that the cellular protein nucleolin acts as a trigger (Behera et al., 
2001; Tayyari et al., 2011; Techaarpornkul et al., 2001). The virus uses an 
endocytotic method called macropinocytosis to insert its genetic material in the form 
of the RNP into the cell (Krzyzaniak et al., 2013). By bringing the two membranes 
together, the membranes will then fuse and form a fusion pore that allows the virus 
to insert its RNP into the cytoplasm of the cell. The exact method of entry into the 
cell however, is still debated (Melero and Mas, 2015).  
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1.3.2. Transcription of the Orthopneumovirus genome 
Once the RNP of the virus is inside the cell, transcription of the genome commences 
within the cytoplasm in inclusion bodies (Fig. 1.2B) (García et al., 1993). Initiation 
of transcription occurs at the promoter site in the 44nt leader region which flanks the 
3¢ end of the viral genome. The site of the promoter at the 3¢ end has been suggested 
to be either at position +1 or +3 in the leader sequence. There are two suggested 
models on how the L protein initiates transcription at the first gene start (GS) signal 
of NS1 based on the location of the promoter at either one of the two positions. Once 
bound to either position +1 or +3, the RdRP will begin to transcribe the leader 
sequence. In both of these models, there is a checkpoint at position +25 in the leader 
sequence which causes the termination of transcription of the leader mRNA and 
dissociation of the nascent mRNA from the polymerase. This allows the RdRP to 
initiate transcription at the gene start signal for NS1 (Tremaglio et al., 2013). There 
is also evidence that for successful elongation of transcription, the transcribed 
mRNA must be guanylated by the polymerase. This is thought to occur when the 
newly transcribed mRNA is 45 to 50 nucleotides long. Inhibitors used to target this 
function of polymerase resulted in no full length mRNAs transcribed and instead 
shorter truncated mRNAs were created that were not guanylated suggesting the 
importance of guanylation for successful transcription (Liuzzi et al., 2005).  
 
As seen in Fig. 1.3, the L protein transcribes individual mRNAs from each gene 
beginning at each gene start signal, with synthesis continuing until a gene stop signal 
is reached. The nascent mRNA is capped during transcription and is polyadenylated 
and released once the polymerase reaches the gene stop signal. The efficiency of 
polyadenylation and termination is not 100% efficient. Instead it has been reported 
that read-through can occur between two genes, with as many as 10% of viral 
mRNAs transcribed are polycistronic mRNAs caused by readthrough (Tran et al., 
2004). For the terminating polymerase reaching the gene stop signal, there are one of 
two options, the polymerase can either dissociate from the genomic RNA or begin 
synthesis of the mRNA for the next gene following recognition of the gene start 
sequence. The dissociated polymerase in order to reinitiate transcription, must bind 
to the promoter located at the leader sequence found at the 3¢ end of the genome or 
can reinitiate directly at the first gene start signal for the genome at NS1 (Cattaneo et 
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al., 1987; Collins and Wertz, 1983; Krempl et al., 2002; Plumet et al., 2005; Tran et 
al., 2004; Tremaglio et al., 2013). This process repeats itself after the termination of 
transcription at each gene stop signal thereby forming a transcription polar gradient. 
Larger quantities of mRNAs are therefore synthesized for genes found closer to the 
3¢ end. This method allows the virus to control the amounts of proteins produced 
(Cowton et al., 2006). Although transcription can occur in vitro without any co-
factors, both actin and profilin have been found to act as cellular co-factors for viral 
transcription (Burke et al., 1998; Burke et al., 2000). 
 
Fig. 1.3: Polar gradient transcription model 
Schematic of the polar gradient transcription model. Diagram illustrates possible options for the 
terminating viral polymerase at each gene stop signal along the genome. The polymerase can either 
disassociate from the genomic RNA strand and reinitiate transcription at the promoter at 3¢ end of the 
genome or begin transcription of the next gene through the next gene start signal. As a result, a 
gradient of mRNAs are generated with a larger quantity transcribed for genes closer to the promoter. 
Genes in the schematic are coloured separately.  
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Originally evidence for a transcription polar gradient was reported in other 
Mononegavirales. The first example of transcription initiation at the 3¢ end of the 
genome was reported in vesicular stomatitis virus (VSV) using UV irradiation 
studies (Abraham and Banerjee, 1976). Further evidence of a transcription polar 
gradient in VSV was reported in Hodges et al., 2012. Before the reclassification of 
Orthopneumoviruses from the Paramyxoviridae family, a transcription gradient was 
reported using UV irradiation in Sendai virus. Similar to VSV, it was reported there 
was only a single promoter for the polymerase located at the 3¢ end of the genome 
(Glazier et al., 1977). Further evidence for this polar gradient came from the measles 
virus, which is also a member of the Paramyxoviridae family. Contrary to the 
previous two studies, northern blot analysis was used to quantify the levels of mRNA 
produced for measles virus (Cattaneo et al., 1987). For hRSV, partial transcription 
maps have been generated through the use of hybridisation probes (Collins and 
Wertz, 1983) and minigneomes (Fearns and Collins, 1999b). These provided 
evidence of the polar gradient model of transcription. However in both examples, the 
transcription maps were created using only partial number of genes at the 3¢ end of 
the genome (Fearns and Collins, 1999b;,Collins and Wertz, 1983). Further evidence 
for a polar gradient also exists due to a single promoter being used by viruses in this 
family (Liuzzi et al., 2005).  
 
There is however growing evidence that suggests that the polar gradient model of 
transcription is not accurate and the gene order of the genome is the not the sole 
factor controlling the levels of viral mRNA abundance. Transcriptome sequencing of 
cells infected with hRSV has revealed that certain genes in the genome have higher 
levels of mRNA abundance than ones further upstream. These data contradicted the 
polar gradient model, where the level of mRNA abundance is dependent on the 
position of the gene from the promoter. Contrary to the model, it was reported that 
the G mRNA had the highest levels of mRNA abundance in the hRSV genome. This 
gene is located in the centre of the genome and if the polar gradient model were 
accurate, it would be expected that the NS1 mRNA (closest gene to the promoter) 
would have the highest mRNA levels. It was also reported that the M mRNA, which 
is transcribed from the 5th gene from the promoter, also had higher levels than any of 
the four mRNAs whose genes were located upstream (Aljabr et al., 2016). A 
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divergence from the polar gradient model has also been reported in quantification of 
viral mRNA levels (with the exception of the SH gene transcript) in hRSV using 
Northern Blot analysis. The virus was harvested at a similar time to the previous 
report between 16-20 hpi. It was reported that mRNA levels did not follow levels 
predicted by the polar gradient model. However, unlike data acquired from 
transcriptome sequencing, levels of mRNA abundance from the genes located in the 
centre of the genome did not significantly alter. If there was an increase in mRNA 
abundance compared to the upstream gene, it was significantly smaller to what was 
reported in transcriptome sequencing. There was one large increase in the levels of 
mRNA abundance reported between the F and M2 genes (Krempl et al., 2002). 
Further evidence for this model being inaccurate was reported in the transcriptome 
sequencing of cells infected with hendra virus (Paramyxoviridae family). Similar to 
hRSV, it was reported that the G mRNA had higher mRNA levels than the upstream 
F mRNA. This difference was not as significant as observed in hRSV (Wynne et al., 
2014). Although these data do suggest that the model is inaccurate, the sequential 
order of the genome still appears to be the defining factor in dictating viral mRNA 
abundance (Aljabr et al., 2016; Krempl et al., 2002; Wynne et al., 2014). 
 
It could be possible that the transcription polar gradient model may still be accurate 
even with the data mentioned above. This is due to transcriptome sequencing not 
accounting for viral mRNA half-life. It could be possible that the levels of mRNA 
transcribed are relative to the position of the gene in the genome. However different 
mRNA half-lives could distort the levels of mRNA in the cell when transcriptome 
sequencing was performed. There is currently no data on mRNA half-lives for 
members of the Pneumoviridae family. It has been reported that in VSV, the half-
lives of all viral gene transcripts are similar to the point where they are 
indistinguishable (Pennica et al., 1979).  
 
The M2-1 protein is also involved in the transcription of the hRSV genome. This 
protein acts as a factor to inhibit premature termination by associating itself with the 
P, L and N proteins in inclusion bodies where transcription and replication occur. 
The precise mechanism in which the M2-1 protein acts as an anti-termination factor 
is unknown. There are three suggested mechanisms that have been proposed. 1: The 
protein prevents rehybridisation or secondary structure formation, thereby allowing 
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elongation to continue (Cartee and Wertz, 2001). 2: By increasing the affinity of the 
L:RNA interaction. 3: By stopping the release of the L protein once a GE sequence 
has been reached, therefore allowing the L protein to reinitiate transcription at the 
next GS signal. (Blondot et al., 2012) NMR and RNA disassociation experiments 
have revealed that M2-1 protein must initially bind to the P protein in order to bind 
to the viral RNA. However, once in proximity of the L protein and RNA, the M2-1 
protein disassociates from the P protein and associates itself with the L protein. The 
M2-1 protein also has a high binding affinity to the 3¢ end of the leader RNA 
suggesting that the protein could associate itself with the L protein during initiation. 
The M2-1 protein is also partially phosphorylated which is thought to aid its 
function; although the precise role of phosphorylation remains unclear (Blondot et 
al., 2012; Mason et al., 2003; Tran et al., 2009). 
 
1.3.3. Viral replication 
Following transcription, the L protein transcribes a positive-sense copy of the 
genome known as the antigenome (Fig. 1.4 red strand). This is also encapsidated by 
the nucleoprotein and subsequently acts as a template for replication, resulting in the 
production of new negative-sense viral genomes (Fig. 1.4 blue strand). The L protein 
will also synthesise additional nucleotides to 3¢ end of the antigenome. Although the 
precise function of the addition of these nucleotides is unknown, it is thought that 
these may act to protect the leader sequence of the genome from RNases. 
 
Fig. 1.4: Schematic of Pneumoviridae genome replication 
Schematic of Pneumoviridae genome replication. Viral polymerase will transcribe an antigenome 
(red) from the genome (blue). The viral polymerase will then transcribe multiple copies of the genome 
(blue) from the antigenome 
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The switch between transcription and replication is thought to occur between 12-15 
hours post infection, with the majority of RdRPs after this point transcribing an 
antigenome (Bermingham and Collins, 1999). Initiation of replication by the L 
protein begins with the L protein initiating synthesis at the 3¢ promoter found in the 
leader sequence of the antigenome. Inside the leader sequence, nucleotides 1-13 are 
the key nucleotides that act to recruit the L protein to initiate RNA synthesis (Noton 
et al., 2010). Replication is thought to occur in the cytoplasm within inclusion 
bodies, which consists of the ribonucleoprotein complex (N and P proteins), the L 
protein and M protein (Grosfeld et al., 1995). Multiple copies of the genome are 
transcribed from the antigenome which are then encapsidated by the N protein.  
 
The M2-2 protein is thought to aid in the change from transcription to replication. 
Although there is little research on this process, it has been shown that the level of 
M2-2 protein has a direct effect on the amounts of viral mRNA produced. The M2-2 
protein is expressed in relatively small quantities compared to that of other viral 
proteins in the genome. Overexpression of the M2-2 protein leads to a large decrease 
in viral replication (Cheng et al., 2005). It is also important to note that the deletion 
of the M2-2 gene from the genome does not lead to a halt in replication of the virus 
but does greatly reduce the ability for the virus to replicate, with the yield of the 
virus decreasing up to 1000-fold (Bermingham and Collins, 1999; Cheng et al., 
2005).  
 
1.3.4. Assembly and budding 
Upon termination of replication, inclusion bodies travel to the cell membrane where 
they join with viral glycoproteins that are bound to the cell membrane (Fig. 1.2E and 
1.2F). From here, these proteins assemble into viral filaments, which lead to the 
formation of the virion. The matrix protein is thought to aid in the maturation of 
filaments in the late stages of maturation (Mitra et al., 2012; Shaikh et al., 2012). The 
viral filaments will form when the viral proteins deform the host cell membrane. The 
M protein is thought to interact with the phospholipids in the plasma membrane in 
order to achieve this (Money et al., 2009; Shaikh and Crowe, 2013). Following 
assembly of the viral genome and proteins, the virus will bud from the plasma 
membrane, this involves a scission event which is directed by cellular proteins (Mitra 
et al., 2012). The exact mechanism of budding for hRSV is unknown, however Vps-
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4 and other proteins such as FIP2, which are commonly used by many other viruses 
for budding are not used (Utley et al., 2008). This budding event allows the release 
of newly infectious particles (Bermingham and Collins, 1999; Collins and Graham, 
2008; Cowton et al., 2006; Mitra et al., 2012).  
 
1.4.1. Translation of Orthopneumovirus viral gene transcripts 
All gene transcripts transcribed by the L protein in all members of the 
Orthopneumovirus genus are capped and polyadenylated. With the exception of 
translation of the M2-2 protein from M2 ORF-2, all gene transcripts initiate 
translation through the canonical cap-dependent initiation pathway that is used by 
cellular mRNAs for initiation of translation. This pathway uses the m7G cap located 
on the 5¢ end of each gene transcript to bind eukaryotic initiation factors (eIF) to the 
mRNA. The binding of eIFs to the m7G cap initiates a cascade of recruitment of 
initiation factors which ultimately leads to the recruitment of the 40S ribosomal 
complex to the mRNA strand forming the 43S scanning complex. This 43S scanning 
complex will then scan down the 5¢ untranslated region (UTR) until the complex 
reaches an AUG codon with an optimal Kozak sequence (GCCACCAUGG) (Kozak, 
1986, 1997). The 43S scanning subunit will bind to the AUG codon through the Met-
tRNAMeti bound in the subunit. This will then set off a further cascade which will 
recruit the 60S subunit to the complex and cause the release of bound eIFs to form 
the 80S subunit. The ribosomes will then begin the elongation phase of translation 
and synthesize the nascent polypeptide with aid from eukaryotic elongation factors 
(eEF) to deliver aminoacyl-tRNAs, aid in peptide formation and aid in translocation 
of the ribosome. Upon reaching a terminating stop codon (UGA,UAA or UAG), the 
ribosome will release the nascent polypeptide and use eukaryotic release factors 
(eRF) to initiate the dissociation of the 80S complex and release from the mRNA 
strand. The elongation and termination phases of translation are thought to be used 
by all gene transcripts with the exception of termination of translation in M2 ORF-1. 
A detailed review covering these mechanisms can be found for initiation (Jackson et 
al., 2010) and elongation/termination (Dever and Green, 2012). In the 
Orthopneumovirus genus, levels of translation with the exception of the M2 ORF-2 
are controlled by mRNA abundance, which is dictated by the polar gradient model of 
transcription.  
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Regulation of translation in viruses tend to occur in order to maximise the use of 
their small viral genomes. This can include using polycistronic gene transcripts to 
translate multiple proteins from a single gene transcript. Viruses access multiple 
ORFs through employing non-canonical initiation mechanisms. These mechanisms 
as well as allowing access to multiple ORFs on a gene transcript, allow a virus to 
tightly regulate levels of translation of specific proteins that may be required at 
different levels during the entire or specific stages of infection.  
 
Viruses are also capable of disrupting host cell translation by regulating canonical 
initiation of translation. This allows the virus to maximise viral translation in the cell 
by utilizing non-canonical initiation mechanisms to continue viral translation, whilst 
limiting initiation of translation cellular mRNAs. Viruses tend to specifically target 
translational initiation factors involved with the initiation of the 80S ribosome 
through the cap-dependent canonical initiation pathway. For example, both 
adenovirus (Yueh and Schneider, 2000) and vesicular stomatitis virus (VSV) 
(Connor and Lyles, 2002) reduce the levels of phosphorylated eIF4E through the 
dephosphorylation of the initiation factor. Phosphorylation of eIF4E increases the 
binding affinity to the m7G cap allowing the eIF4F complex to bind to the mRNA. A 
decrease in the level of phosphorylated eIF4E results in a reduction of eIF4F 
complexes bound to the mRNA cap, which further prevents the 43S ribosomes from 
binding to the mRNA.  
 
Other members of the eIF4F complex are also targeted by viruses. During infection 
in cells by poliovirus, eIF4G is cleaved by the poliovirus 2A protein. eIF4G acts as a 
scaffold protein in the eIF4F complex by binding to eIF4E and eIF4A. The initiation 
factor also binds to initiation factors in the 43S complex thereby allowing the 
ribosome to bind to the mRNA and begin scanning the 5¢ UTR. Cleavage of this 
protein prevents the formation of the eIF4F complex and therefore prevents the 43S 
ribosome complex from binding to the mRNA (Gradi et al., 1998).  
 
Other viruses also target the tertiary complex. Measles virus reduces canonical 
initiation by phosphorylating the eIF2a subunit of the eIF2 protein. Although this 
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only partially inhibits canonical initiation, phosphorylation of eIF2a prevents the 
exchange of GDP with GTP with the eIF2B protein. The eIF2-GTP complex 
increases the binding affinity of the initiation factor to Met-tRNAMeti. Failure to 
replace GDP with GTP significantly reduces the affinity, which in turn reduces the 
levels of tertiary complexes capable of providing Met-tRNAMeti for initiating 
ribosomes  (Sato et al., 2007). Viruses may also reduce the levels of host cellular 
eIF2a phosphorylation in order to limit the host cell response to infection. hRSV 
prevents host cellular phosphorylation of eIF2a by using the viral N protein to bind 
to the protein kinase R which is responsible for host cellular phosphorylation of 
eIF2a (Groskreutz et al., 2010).  
 
A non-canonical initiation mechanism has been reported in the Pneumoviridae for 
the translation of the M2-2 protein from the second ORF in the M2 gene transcript 
through the use of coupled translation termination/initiation. This mechanism is used 
to both access the ORF inside a bicistronic gene transcript and to control the levels of 
translation for a protein which is required at very precise levels during infection 
(Ahmadian et al., 2000; Gould and Easton, 2005).  
 
1.4.2. Translation of M2 ORF-2 
In all members of the Pneumoviridae family, the M2 ORF-2 is located on the 
bicistronic M2 gene transcript. This gene transcript contains two overlapping open 
reading frames, with the first (M2 ORF-1) being translated into the M2-1 protein and 
the second (M2 ORF-2) being translated into the M2-2 protein (Fig. 1.5A). In this 
family, the open reading frames overlap with varying distances and in different 
frames to each other. The size and frame depends on the virus in question. In current 
literature, only three members of the Pneumoviridae family (hRSV (Ahmadian et al., 
2000), APV (Gould and Easton, 2007) and PVM (Gould and Easton, 2007) have had 
the initiation mechanism for translation of M2 ORF-2 characterised. For all three 
members, the non-canonical mechanism of coupled translation termination/initiation 
has been identified as the mechanism used for the initiation of translation of the M2 
ORF-2 on the M2 bicistronic gene transcript. The mechanism is reliant on the 
translation of the preceding ORF, M2 ORF-1 and relies on the terminating ribosome 
of the first ORF (M2 ORF-1) reinitiating translation for the second ORF (M2 ORF-
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2). The mechanism is not dependent on viral proteins as studies have revealed that 
transfecting uninfected cells with the M2 gene encoded on an expression plasmid 
still results in translation of the second ORF (Ahmadian et al., 2000; Gould and 
Easton, 2007). 
 
 
Fig. 1.5: Schematic of hRSV M2 gene transcript and sequences of the M2 ORF-1/ORF-2 overlap 
regions for members of the Pneumoviridae family that use the mechanism of coupled translation 
(A) Schematic of the hRSV M2 gene transcript. The black line represents the mRNA strand. Boxes 
represent ORFs located on the mRNA strand. Start and terminating codons for M2 ORF-1 (yellow) 
and M2 ORF-2 (blue) are displayed. (B) Sequence of the hRSV M2 ORF-1/ORF-2 overlap region. 
AUG codons used for initiation of ORF-2 are underlined. The terminating stop codon for ORF-1 is in 
bold. (C) Sequence of the PVM M2 ORF-1/ORF-2 overlap region. AUG codons used for initiation of 
ORF-2 are underlined. The terminating stop codon for ORF-1 is in bold. (D) Sequence of the APV 
M2 ORF-1/ORF-2 overlap region. AUG codons used for initiation of ORF-2 are underlined. The 
terminating stop codon for ORF-1 is in bold. 
 
 
In the current literature there has been no other investigation into the mechanism of 
translation of M2 ORF-2 in bRSV, ovine RSV, caprine RSV and human 
metapneumovirus (Ahmadian et al., 2000; Gould and Easton, 2007). Ovine RSV and 
caprine RSV although closely related to hRSV, have yet to be classified into the 
Orthopneumovirus genus by ICTV (ICTV, 2016). Out of the three members that 
have had the initiation mechanism of M2 ORF-2 translation identified, hRSV is the 
best characterised mechanism. In hRSV (Fig. 1.5B), M2 ORF-2 is in the second (+1 
to M2 ORF-1) reading frame. M2 ORF-1 and M2 ORF-2 overlap each other by 32 
nts, this is between the first viable AUG codon that can be used for initiation of 
translation of M2 ORF-2 and the terminating stop codon of M2 ORF-1. There are 
three start codons for M2 ORF-2, all of which can be used to initiate translation, with 
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a slight preference for initiation occurring at the two start codons at the 5¢ end of the 
M2 ORF-1/ORF-2 overlap region (Ahmadian et al., 2000). 
 
The M2 ORF-1/ORF-2 overlap region in PVM (Fig. 1.5C) is significantly larger than 
hRSV at 67 nts in size. In PVM, M2 ORF-2 is in the third (+2 to M2 ORF-1) reading 
frame. The overlap region contains two start codons located at either end of the 
overlap region. Both of these start codons can be used for initiation of M2 ORF-2. 
Although there is a slight preference for initiation at the AUG start codon at the 5´ 
end of the overlap. There have been no further studies to characterise the mechanism 
in PVM (Gould and Easton, 2007). APV, a member of the Metapneumovirus genus 
has an overlap region of 34 nucleotides and like PVM, the M2 ORF-2 is the third 
reading frame (Fig. 1.5C). APV has two start codons, both located towards the 5´ end 
of the overlap region. Both of these are used for initiation of M2 ORF-2, although 
there is a preference for initiation of translation at the AUG located at the 5´ end of 
the overlap region (Gould and Easton, 2007).  
 
As seen in Fig. 1.6, the mechanism of coupled translation is reliant on the 
termination of a ribosome that is translating the upstream M2 ORF-1 (Fig. 1.6B). 
Upon termination of the ribosome (Fig. 1.6C), the nascent M2-1 polypeptide will be 
released and the majority of ribosomes will disassemble and disengage from the 
mRNA. However, a small proportion of ribosomes (~3%) (P. Gould and A. Easton, 
personal communication) will remain attached to the mRNA. These remaining 
ribosomes will translocate upstream (Fig. 1.6D) until reaching be one of start codons 
found in the M2 ORF-1/ORF-2 overlap region and reinitiating translation (Fig. 
1.6E). Removing the stop codon of M2 ORF-1 completely inhibits the translation of 
the M2 ORF-2, as the ribosome is unable to terminate translation of M2 ORF-1 and 
translocate upstream. The mechanism is also distance dependent on the stop codon. 
Removing the M2 ORF-1 stop codon and reintroducing a stop codon in the same 
frame as M2 ORF-1 further downstream but still in close proximity to the original 
M2-1 stop codon, completely inhibits translation of M2 ORF-2 (Ahmadian et al., 
2000; Gould and Easton, 2005). 
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Fig. 1.6: Mechanism of coupled translation termination/initiation for the hRSV M2 ORF-2 
(A) Schematic of the hRSV M2 gene transcript, which displays the initiation sites for M2 ORF-2 and 
terminating stop codon for M2 ORF-1. (B) Translation by ribosome of M2 ORF-1. (C) Termination of 
translation at the M2 ORF-1 stop codon and release of the M2-1 polypeptide chain by the ribosome. 
(D) Translocation upstream by the terminating ribosome. (E) Initiation of translation of M2 ORF-2 by 
the translocating ribosome at one of the three initiation codons located in the M2 ORF-1/ORF-2 
overlap region. A representation of the mRNA secondary structure critical for initiation of M2 ORF-2 
that is located between position 396 and 511 in the M2 ORF-1 is presented in all panels. The 
secondary structure is thought to pause elongating ribosomes translating M2 ORF-1 allowing for 
successful reinitiation of translation for M2 ORF-2 (P.Gould and A.Easton, personal communication)  
  
The sequence of the M2 gene transcript is also significant to the mechanism of 
coupled translation. For hRSV, sequence 5´ of the M2 ORF-1/ORF-2 overlap region 
in the M2 ORF-1 is vital for the mechanism. There is however, no vital sequence for 
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this mechanism 3´ of the overlap region. The M2 ORF-2 sequence 3´ of the M2 
ORF-1/ORF-2 overlap region can be replaced or removed and not affect initiation of 
translation of the second ORF. This characteristic has enabled reporter plasmids to 
be created that were specifically designed to investigate the mechanism of coupled 
translation termination/initiation. These reporter plasmids contained an altered M2 
gene that would still be transcribed in the same format as the bicistronic M2 gene 
transcript. In this gene, the M2 ORF-2 sequence past the M2 ORF-1/ORF-2 overlap 
region was replaced by a reporter gene that codes for the CAT protein. Upon 
transfection of plasmids into cells and transcription of the gene, the reporter protein 
was expressed from the second ORF. This was then quantified using an enzyme-
linked immunosorbent assay (ELISA) specific for the reporter protein. This enabled 
quantification of translation of the second ORF and was the primary method used to 
investigate and characterise this particular mechanism (Ahmadian et al., 2000). 
 
Gould and Easton, 2005 further characterized the role of the M2 ORF-1 sequence 
upstream of the M2 ORF-1/ORF-2 overlap region by creating chimeric plasmids 
where increasing proportions of M2 ORF-1 from the 5´ end of gene transcript were 
deleted and replaced with eGFP coding sequence. These chimeric plasmids used the 
same reporter system as mentioned above to quantify the expression of M2 ORF-2. 
Removal of the first 320 nts of the M2 ORF-1 sequence from the 5´ end of the gene 
transcript slightly affected the efficiency of coupled translation. However, this region 
was not critical, as removal did not directly inhibit the mechanism. Removal of the 
next 100 nucleotides markedly lowered translation to 10% in comparison to 
expression of ORF-2 for plasmids that contained the full length M2 ORF-1 sequence. 
A removal of a further 20 nucleotides caused complete inhibition of translation of the 
second ORF. Using this data, primer extension and toe printing assays revealed a 
large secondary structure found in the region that was critical for the translation of 
M2 ORF-2 between position 414 and 594 (Gould and Easton, 2005). 
 
This secondary structure was fully identified with use of selective 2´-hydroxyl 
acylation and primer extension (SHAPE) mapping and was found to consist of four 
stemloops, which contained three A-rich blocks inside the structure (P. Gould and A. 
Easton, personal communication). The secondary structure was found to be the 
primary cause of inhibition of translation of ORF-2 observed in Gould and Easton, 
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2005. Mutations altering the entire secondary structure completely inhibited the 
translation of the second ORF. Further mutations revealed that two of the three A-
rich blocks had a direct inhibitory effect on the translation of second ORF (P. Gould 
and A. Easton, personal communication). It was reported that the cellular protein 
DDX3X (P. Gould and A. Easton, personal communication), an RNA helicase 
(Garbelli et al., 2011) bound to the A rich blocks. The protein was found to be of 
crucial importance to the mechanism. Inhibiting the ATPase activity of DDX3X 
caused complete inhibition of the translation of M2 ORF-2. Although DDX3X is 
vital for this mechanism, it is still unknown how this protein contributes to this 
mechanism (P. Gould and A. Easton, personal communication).  
 
Although the significance of the M2 ORF-1 sequence on the initiation of M2 ORF-2 
has been well documented, the effect that this sequence has on elongating ribosomes 
has not. Ribosomal profiling was used to investigate the role of the secondary 
structure in M2 ORF-1. This technique uses next generation sequencing to map the 
position of all elongating ribosomes in a cellular population. Using this technique, it 
was reported that throughout the entire M2 ORF-1 sequence there were regions of 
sequence where a high frequency of elongating ribosomes were stalling that could be 
attributed to structured regions slowing down the elongating ribosomes. A significant 
peak comprising of over 5% of all elongating ribosomes translating M2 ORF-1 were 
identified pausing on a single nucleotide on stemloop II in the highly structured 
region critical for initiation of M2 ORF-2 (P. Gould and A. Easton, personal 
communication).  
 
Combined with these previous data (Ahmadian et al., 2000; Gould and Easton, 
2005), it has been suggested that the secondary structure is critical for the mechanism 
of coupled translation by pausing elongating ribosomes translating M2 ORF-1 for a 
significant amount of time, which allows terminating ribosomes further downstream 
to translocate upstream to reinitiate at one of the M2 ORF-2 start codons in the M2 
ORF-1/ORF-2 overlap region. Without this secondary structure, elongating 
ribosomes translating the M2 ORF-1 would prevent the initiating ribosome from 
translocating upstream. Whether this pause is caused by an interaction with DDX3X 
is not known. However, the protein may act in a complementary way by unwinding 
the structure thereby allowing the ribosome to continue translating the first ORF. 
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DDX3X is known to act as a initiation factor for translation in certain cellular and 
viral mRNAs and has been suggested that the protein aids eIF4A in unwinding 
certain secondary structures in the 5´UTR (Soto-Rifo et al., 2012). It is therefore 
conceivable that DDX3X also is able to unwind certain region in the M2-1 ORF. 
Further studies are needed to clarify the role of this protein (P. Gould and A. Easton, 
personal communication).  
 
1.5.1. The mechanism of coupled translation termination/initiation used in other 
organisms 
This translational mechanism of coupled translation has also been documented in 
other viral, eukaryotic and prokaryotic organisms (Gould et al., 2014; Gould and 
Easton, 2005; Oppenheim and Yanofsky, 1980). In the majority of cases except some 
prokaryotic examples (Thomas et al., 1987), the organization of the ORF’s tend to 
follow a similar pattern (Fig. 1.7) (Gould et al., 2014; Gould and Easton, 2005; 
Oppenheim and Yanofsky, 1980). The ORF using the mechanism tends to be found 
downstream of the ORF that it is reliant on. In many viral cases the two ORFs will 
overlap each other from a few nucleotides to tens of nucleotides (nts) (Ahmadian et 
al., 2000). This is also the case in many prokaryotic examples (Aksoy et al., 1984; 
Oppenheim and Yanofsky, 1980). However in prokaryotes, the two ORFs may also 
be separated by a small distance ranging up to tens of nucleotides away from each 
other (Hellmuth et al., 1991). In all cases the mechanism is reliant on the termination 
of the ribosome translating the upstream ORF. 
 
 
Fig. 1.7: Typical structure of gene transcript, where the mechanism of coupled translation is 
used for translation of ORF-2  
Typical structure of gene transcript, where coupled translation is used for initiation of translation of 
ORF-2. The black line represents the mRNA strand. Boxes represent ORFs located on the mRNA 
strand. Translation of ORF-1 is required for successful initiation of translation of ORF-2. Both ORFs 
usually overlap by a number of nucleotides. 
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Initially the mechanism of coupled translation was first discovered in phage viruses 
in the 1960s (Gussin, 1966; Horiuchi et al., 1966). A well characterised example 
found in phages is the translation of the MS2 bacteriophage replicase ORF. The 
replicase ORF is reliant on the translation of the coat ORF. The translation of the 
coat ORF disrupts two long range interactions between the two ORFs, which allows 
reinitiating ribosomes access to the initiation site of the replicase gene for translation 
(Licis et al., 1998). 
 
Coupled translation was first characterized in prokaryotes in the E.coli tryptophan 
operon. This polycistronic mRNA contains five ORFs that once translated to proteins 
are responsible for tryptophan synthesis. As seen in Fig. 1.8, two ORF pairs in the 
gene transcript are found to be translationally coupled (trpE/trpD and trpB/trpA, with 
trpA (Aksoy et al., 1984) and trpD (Oppenheim and Yanofsky, 1980) using the 
mechanism). The two ORF pairs both have overlapping regions of 1 nucleotide 
(UGAUG). Similar to other examples, coupled translation of both trpD and trpA are 
reliant on terminating stop codon of trpE and trpB being in the vicinity of initiation 
codons for trpD and trpA (Das and Yanofsky, 1989). There are three suggested 
mechanisms by which coupled translation is used both in the tryptophan operon and 
in other prokaryotic examples. The first mechanism involves ribosomes that are 
translating the upstream ORF of the ORF pair removing secondary structures. These 
secondary structures in the mRNA sequence sequester initiation of the second ORF 
by either blocking the Shine Dalgarno (SD)/ribosome binding site (RBS) or start 
codon. This removal also increases the concentration of ribosomes around the RBS 
or SD sequence, that allows efficient translation of the second ORF to commence 
(Oppenheim and Yanofsky, 1980). The second mechanism suggests that the removal 
of the secondary structure by the elongating ribosome allows de-novo ribosomes to 
bind to the RBS site of the second ORF and initiate translation (Oppenheim and 
Yanofsky, 1980). The third mechanism involves the translating ribosome not 
disassociating once it has reached the stop codon of the first ORF. It will instead 
translocate upstream in search of a start codon of the second ORF. This will 
generally be under the circumstances where both ORFs overlap each other 
(Oppenheim and Yanofsky, 1980). As well as the tryptophan operon, coupled 
translation has been characterised in other prokaryotic mRNAs. This includes the 
E.coli galK ORF located in the galactose operon (reliant on translation of the galT 
	 30	
ORF) (Schümperli et al., 1982) and the E.coli atpA ORF, which is reliant on 
translation of the upstream atpH ORF (Rex et al., 1994). Unlike other organisms that 
use coupled translation, prokaryotic examples tend to use coupled translation to 
translate an ORF in 1:1 ratios in relation to the upstream ORF which the mechanism 
is reliant on (Oppenheim and Yanofsky, 1980; Rex et al., 1994; Schümperli et al., 
1982). 
 
 
Fig. 1.8: Structure of E.coli tryptophan operon 
Structure of the polycistronic E.coliI tryptophan operon. The black line represents the mRNA strand. 
Boxes represent ORFs located on the mRNA strand. Sequences for the stop and start codons of the 
ORF pairs trpE/trpD and trpB/trpA. The mechanism of coupled translation termination/initiation is 
used for initiation of translation of trpD and trpA ORFs. These two ORFs are reliant on the translation 
and termination of the trpE and trpB ORFs respectively.  
 
Coupled translation has also been reported in polycistronic mRNAs in human cells. 
Although the majority of human mRNAs transcribed are monocistronic, it has been 
reported that there are examples of polycistronic mRNAs. The mechanism identified 
for initiation of translation of the second ORF in some of these polycistronic mRNAs 
is that of coupled translation termination/initiation. However in comparison to both 
prokaryotic and viral examples, the mechanism differs significantly (Gould et al., 
2014).  
 
The mechanism has been reported in five gene transcripts, where removal of the 
terminating stop codon for the first ORF inhibited translation of the second ORF. In 
all examples, the two ORFs overlap each other but vary in size. All five gene 
transcripts are in the second reading frame in relationship to the first ORF. Unlike 
examples in other organisms, the overlap regions are rich in multiple AUG codons 
that are in the frame of the second ORF (average of 7 AUG codons). It was reported 
however, that not all of the AUGs in the overlaps were used for initiation of the 
second ORF (Gould et al., 2014).  
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Out of the 5 examples identified that use the mechanism of coupled translation, the 
mechanism for the translation of CASQ2 ORF-2 is the most characterised. It was 
reported that the overlap region was the only factor necessary for successful 
initiation of translation. In the CASQ2 gene transcript, the overlap region (81 nts) is 
rich in aspartate residue (Asp) (GAU) repeats that are in the ORF-1 reading frame 
(Fig. 1.9). Initiation can occur at AUG codons at both ends of the overlap, with a 
slight preference for initiation at AUG codons located at the 3¢ end of the overlap 
region. The GAU repeats are critical for the initiation of the second ORF in CASQ2. 
It has been suggested that instead of the repeated GAU sequence directing initiation 
of the second ORF, the Asp amino acids are responsible for successful initiation. It 
has been suggested that the Asp amino acids at the carboxyl terminus may cause 
interactions in the exit tunnel of the ribosome leading to stalling. This stalling may 
allow terminating ribosomes to reinitiate translation of the second ORF without 
encountering elongating ribosomes translating the first ORF. Replacing the Asp 
codons with other codons inhibited the mechanism. The other 4 examples that have 
been identified as using mechanism of coupled translation are also reliant on Asp 
residue repeats in the overlapping region. These Asp residue repeats are thought to 
have the same effect on the reinitiating ribosome as suggested during initiation of 
CASQ2 ORF-2. Although only five polycistronic mRNAs were identified as using 
this mechanism, bioinformatic analysis has identified many more potential 
polycistronic mRNA that may use this mechanism (Gould et al., 2014). 
 
 
 
Fig. 1.9: Sequence of CASQ2 bicistronic gene transcript 
Sequence of the CASQ2 gene transcript ORF-1/ORF-2 overlap region and the translated amino acid 
sequence for each ORF is shown above and below the mRNA sequence. Aspartic acid residues that 
have been identified as being critical to initiation mechanism of translation of ORF-2 are highlighted 
in green. AUG codons in the ORF-1/ORF-2 overlap region in ORF-2 are highlighted in bold.  
 
The mechanism of coupled translation is also used in other viruses that infect 
eukaryotic organisms. There are six families of viruses which belong to groups III, 
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IV and V that are known to use this mechanism (Ahmadian et al., 2000; Fütterer and 
Hohn, 1991; Guo et al., 2009; Horvath et al., 1990; Li et al., 2011; Meyers, 2003). 
The majority of viruses that use this mechanism are reliant on the RNA sequences 
surrounding the initiation site of the ORF that uses this mechanism. Viruses that use 
this mechanism in the cauliflower mosaic virus (Caulimoviridae family) are not 
reliant on the sequence, but are reliant on the expression of a viral protein (Fütterer 
and Hohn, 1991).  
 
A number of viruses in the Caliciviridae family (group IV) have been identified as 
using coupled translation to initiate translation of ORFs located on bicistronic 
subgenomic (sg) RNAs. As in all other examples, this mechanism is dependent on 
termination of elongating ribosomes translating the upstream ORF. Coupled 
translation has been reported in five members of this positive-sense single stranded 
RNA genome family (feline calicivirus (Luttermann and Meyers, 2007), murine 
norovirus (Napthine et al., 2009), human norovirus (Luttermann and Meyers, 2014), 
rabbit haemorrhagic disease virus (RHDV) (Meyers, 2003) and bovine norovirus 
(McCormick et al., 2008)). These are positive-sense single stranded RNA viruses 
that contain no viral envelope. The genome is approximately 7 to 8 kb long, which 
comprises of either two or three ORFs. As well as using the genome strand for 
translation, the virus will transcribe a subgenomic RNA strand that consists of ORF-
2 and ORF-3 of the virus’s three ORFs (Fig. 1.10). For the majority of viruses that 
use this mechanism (except bovine norovirus (McCormick et al., 2008)), coupled 
translation is used for the translation of ORF-3 on the subgenomic bicistronic RNA 
(Luttermann and Meyers, 2007) (Napthine et al., 2009) (Meyers, 2003). These ORFs 
are translated to produce the capsid proteins VP1 and VP2 (Luttermann and Meyers, 
2007) (Napthine et al., 2009) (VP60 and VP10 in RHDV (Meyers, 2003)) for ORF-2 
and ORF-3 respectively. The two ORFs found in the subgenomic RNA overlap each 
other by varying lengths; with human and murine norovirus both overlapping by one 
nucleotide (UAAUG) (Napthine et al., 2009; Luttermann and Meyers, 2014), feline 
calicivirus (FCV) overlapping by 4 nucleotides (AUGA) (Luttermann and Meyers, 
2007) and RHDV by eight nucleotides (AUGUCUGA) (Meyers, 2003). For all these 
viruses, translation of the ORF-3 is reliant on the translation of ORF-2 (Luttermann 
and Meyers, 2007) (Napthine et al., 2009) (Meyers, 2003). The levels of protein 
translated from the third ORF are much lower than levels translated in the second 
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ORF, with the feline calicivirus producing VP1 and VP2 in a molar ratio of 18:1 
(Luttermann and Meyers, 2007). 
 
 
 
Fig. 1.10: Structure of the bicistronic calicivirus subgenomic RNA 
Schematic of calicivirus subgenomic RNA. The black line represents the subgenomic RNA strand. 
ORF-2 is highlighted in yellow and ORF-3 is highlighted in blue.  
 
However, unlike the other three examples that use coupled translation, bovine 
norovirus differs by using this mechanism to translate the capsid protein from ORF-2 
via the genomic RNA. The translation of ORF-2 is reliant on the translation of ORF-
1. Other viruses in this family usually translate ORF-2 from the subgenomic RNA. 
Although this still occurs in bovine norovirus as the capsid protein is translated from 
both genomic and subgenomic mRNA, it has been suggested that the capsid protein 
in bovine norovirus may also be involved in the earlier stages of the viral life cycle 
and therefore is required to be translated earlier from the genomic RNA (McCormick 
et al., 2008).  
 
Although bovine norovirus uses the same mechanism for coupled translation for 
ORF-2 as other members use for ORF-3, the rest of this review will refer to the 
translation of ORF-3 in the subgenomic mRNA using the mechanism of coupled 
translation. 
 
All caliciviruses that use this mechanism are reliant on a region of sequence that is 
located approximately 70 nucleotides upstream from the terminating stop codon of 
ORF-3 (Fig. 1.11A). This region is referred to as the termination upstream ribosomal 
binding site (TURBS). The region consists of three sequence motifs one of which 
(Motif 1) contains a five nucleotide sequence (UGGGA), which is conserved 
between all members of this family that use this mechanism (Fig. 1.11B) 
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(Luttermann and Meyers, 2007; Meyers, 2007). The size of the motif varies between 
different viruses, for example, feline calicivirus (6 nts) and RHDV (15 nts). Motif 2 
in the TURBS sequence is non-conserved throughout this viral family. The sequence 
of Motif 2 differs significantly between different viruses. For example, FCV Motif 2 
sequence is AGGAGU (Luttermann and Meyers, 2007). Whereas CUGGGG 
(Meyers, 2007) is RHDV’s Motif 2 sequence. The third motif (2*) is found directly 
upstream of Motif 1. It is similar in composition to Motif 2 in that it is not conserved 
throughout this family of viruses. Between the motifs are spacer sequences and 
whilst are not essential, have been suggested to determine the difference in efficiency 
of this mechanism between different members of this family (Luttermann and 
Meyers, 2009; Meyers, 2007).  
 
Fig. 1.11: TURBS used for initiation of ORF-3 in human norovirus subgenomic RNA 
 (A) Location of TURBS motifs located in ORF-2 of human norovirus subgenomic RNA. The black 
line represents the subgenomic RNA strand. Motif 1 is highlighted in blue, Motif 2 is highlighted in 
green and Motif 2* is highlighted in red. (B) Sequence of TURBS and ORF-2/ORF-3 overlap region 
of the subgenomic human norovirus. The initiation codon used for ORF-3 is underlined. The 
terminating stop codon for ORF-2 is in bold. For the TURBS sequence, the sequence for Motif 1 is 
highlighted in blue. The sequence for Motif 2 is highlighted in green. The sequence for Motif 2* is 
highlighted in red.  
 
It has been shown that Motif 1 binds to helix 26 (h26) in the 18S rRNA sequence 
found in the 40S ribosomal subunit (Luttermann and Meyers, 2009; Meyers, 2007; 
Pöyry et al., 2007). Motif 2* is thought to form a secondary structure with Motif 2 
and is thought to place Motif 1 into an optimal position which efficiently binds to 
h26. Mutations altering the structure cause a dramatic decrease in translation 
efficiency of ORF-3. It is thought, that by binding to h26, the interaction brings the 
18S rRNA into an optimal position to the viral RNA. This allows certain residues 
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located on the 18S rRNA that are associated with canonical initiation of translation, 
to be brought into their optimal positions on the viral RNA strand (Martin et al., 
2016). This in turn is thought to position the ribosome so that the start site for ORF-3 
is positioned in the P site of the ribosome (Luttermann and Meyers, 2009) . 
 
There have been three proposed models that may be used by ribosome to reinitiate 
translation at the ORF-3 initiation site. Two of these use the 40S subunit and one the 
80S subunit. It is thought that all three models can be used by the ribosome for 
initiation of translation of ORF-3.  
 
For the first model, the mechanism uses eIF3 for successful initiation through 
interactions between the TURBS sequence and eIF3. It was initially suggested that 
by binding the 40S subunit and eIF3, the TURBS sequence binds to the 40S subunit 
long enough to encourage initiation factors to bind and aid in the recruitment of the 
60S subunit (Pöyry et al., 2007). Although little is known about the interaction 
between the mRNA and eIF3, it has been shown that mutagenesis of Motif 1 has 
little effect on the binding of eIF3 (Luttermann and Meyers, 2009). 
 
A second and more recent model, has suggested that initiation of ORF-3 is eIF3 
independent. For this model, the 40S subunit following termination is capable of 
reinitiating translation using either eIF2/1/1A or Ligatin as cofactors with the 
TURBS sequence to stabilise the subunit allowing the recruitment of the 60S 
subunit. However, in this model eIF3 was found to still hold importance in the 
mechanism under conditions where there was a lack of alternate initiation factors 
(Zinoviev et al., 2015).  
 
For the third model, reinitiation is achieved without the separation of the ribosomal 
complex. 80S ribosomal subunits have been found to be also capable of reinitiating 
translation due to the stabilizing effect that the TURBS sequence provides (Zinoviev 
et al., 2015).  
 
All three ribosomal mechanisms (80S and both 40S methods) that are used for 
reinitiation use either the native or near cognate start codons for initiation, with the 
mechanism using eIF2/1/1A being the most tolerant to deviation from the start codon 
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(Zinoviev et al., 2015). The start codons used for initiation of translation of ORF-3 
are not essential for reinitiation. In some members of the calicivirus family, replacing 
one, two or even three nucleotides in the AUG codon used for initiation of ORF-3 
still leads to successful initiation of translation of ORF-3. In FCV, these mutations 
reduced the levels of ORF-3 expression by 40%, 70% and 88% respectively. This is 
slightly lower in RHDV with the replacement of one nucleotide reducing expression 
by 30% and replacement of the entire start codon completely inhibiting translation of 
ORF-3. The context of the Kozak sequence surrounding the AUG codon also has no 
bearing on the efficiency of reinitiation of ORF-3 in all viruses in this family 
(Luttermann and Meyers, 2014).  
 
It has been discovered that in human norovirus and FCV, initiation of ORF-3 can 
also occur downstream of the ORF-2/ORF-3 overlap region when the native 
initiation codon for ORF-3 is mutated. Initiation using the start codons located 
downstream is also dependent on the Kozak sequence surrounding the start codon 
(Luttermann and Meyers, 2014). It has been suggested that a fraction of the 
ribosomes used for initiation of ORF-3 are capable of scanning downstream if the 
ribosome is unable to use the start codons associated with coupled translation. This 
fraction of terminating ribosomes is thought to use a classical scanning-like 
mechanism post termination to reinitiate at this downstream start codon. 40S 
subunits are likely to be involved in this mechanism in conjunction with eIF4F to 
scan for the downstream start codons. This alternative model is not used in RHDV 
where as mentioned, removal of the main start codons leads to complete inhibition of 
translation for the second ORF (Luttermann and Meyers, 2014; Zinoviev et al., 
2015). Under standard conditions the ribosome will almost always prefer to use the 
native start codon. This start site is preferred by all three separate mechanisms 
(Zinoviev et al., 2015). It has been reported that sequence directly downstream of the 
ORF-2 terminating stop codon is of importance for the mechanism. Although the 
specific purpose of this sequence is unknown, it is thought to modulate the 
mechanism. This regulation is believed to be both reliant on the location of sequence 
in relation to the initiation site and also the specific sequence. It has been suggested 
that this acts through some form of secondary structure although mutational studies 
could not confirm a predicted structure in this region (Haβ et al., 2014). 
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Depending on whether the codon is non-cognate or cognate, elongator tRNAs have 
been found to be used in reinitiation instead of Met-tRNAMeti. However it is 
suggested that fewer elongator tRNAs will be used in the presence of a native AUG 
as Met-tRNAMeti and so will always have a higher affinity. The tRNA found in the P 
site during termination has also been found to have an impact on the levels of 
reinitiation which may be due to the affinity in the P/E hybrid state. Examples such 
tRNAVal and tRNAArg reduced the efficiency for translation. This therefore may have 
been due to sensitivity of the tRNA to Mg2+ (Zinoviev et al., 2015). 
 
The mechanism of coupled translation using a TURBS sequence to reinitiate 
translation in the second ORF of a bicistronic mRNA has also been reported in the 
influenza B virus for translation of the protein BM2. The negative-sense single 
stranded genome virus influenza B is a member of the Orthomyxoviridae family 
(Powell et al., 2008). The gene for the BM2 protein is located on the seventh 
genomic segment, which is transcribed into a bicistronic mRNA strand with the first 
ORF being translated to the M1 protein and the second ORF translated to the BM2 
protein. The two ORFs overlap by 1 nucleotide UAAUG. It has been reported that 
translation of BM2 is reliant on the termination of translation of M1. Removal or 
changing the location of the M1 terminating stop codon inhibits the initiation of 
translation of BM2 (Horvath et al., 1990). It also been reported that similar to 
members that use this mechanism in the Caliciviridae, translation of the BM2 ORF is 
reliant on a 45nts sequence directly upstream of the AUG codon. This sequence is 
similar to the TURBS Motif 1 sequence observed in caliciviruses (Fig. 1.12). Unlike 
TURBS sequences in caliciviruses, the TURBS sequence is unstructured, this is 
likely due to the lack of Motif 2 and Motif2*. Motif 1 of influenza B similar to 
caliciviruses, has been shown to interact with the h26 helix on the 18S rRNA (Powell 
et al., 2011; Powell et al., 2008). The 40S ribosomal subunit is thought to be 
responsible for reinitiation of translation. eIF3 has also been suggested to aid in the 
process of reintiation. It also has been suggested that the distance between the stop 
codon and the TURBS sequence is more important to the mechanism than the 
distance between the AUG and the stop codon. Initiation can still occur albeit at a 
significantly lower level if the AUG located in the overlap is removed and the next 
viable start codon is located up to 63 nucleotides downstream. However the 
ribosome will reinitiate at the start codon in the overlap region if given a choice 
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between the AUG codon in the overlap and an alternate AUG codon in close 
proximity (Powell et al., 2011).  
 
 
 
Fig. 1.12: Sequence of the influenza B segment 7 M1 ORF/ BM2 ORF overlap region and 
TURBS like Motif 1.  
Sequence of the influenza B segment 7 M1 ORF/ BM2 ORF overlap region. The AUG codon used for 
initiation of translation of BM2 ORF is underlined. The terminating stop codon for the M1 ORF is in 
bold. The sequence for Motif 1 used for initiation of translation of BM2 ORF through the mechanism 
of coupled translation termination/initiation is highlighted in red.  
 
 
Whilst the majority of viruses that use coupled translation tend to infect animal hosts, 
coupled translation has been identified in the fungal-infecting Helminthosporium 
victoriae virus 190S from the Totiviridae subfamily. This double stranded RNA virus 
is a non-segmented virus comprising of two ORFs that code the capsid protein and 
the RNA polymerase protein (RdRP). These two ORFs overlap each other with the 
following sequence AUGA. A second AUG codon can be used for reinitiation of the 
second ORF, which is located 90 nucleotides downstream of the overlap region. 
However, initiation is preferred at the start codon located in the overlap region (Li et 
al., 2011).  
 
Translation of the RdRP ORF is reliant on the stop codon. Studies have also 
identified a predicted pseudoknot like structure located within 13 nucleotides 
upstream of the overlapping region. This predicted secondary structure has been 
found to be of importance in the translation of the second ORF, however the precise 
role of this structure is still unknown. There is evidence to suggest that the structure 
may be similar to a TURBS sequence found in caliciviruses and influenza B. This is 
due to the predicted structure having a complementary sequence (CUGAUCG) to the 
18S rRNA of the infected host cell (helminthosporium savius) ribosome. However, 
this potential function has been deemed improbable, as this complementary sequence 
is not in the same region of the 18S rRNA that TURBS motifs bind to. Structural 
predictions also suggest that this sequence is also located in the stem of the structure, 
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which might mean that it may be impossible for this sequence to bind to the rRNA. It 
has also been suggested this predicted structure may act as barrier to prevent the 
ribosome from translocating too far upstream from the overlap region which allows 
the ribosome to reinitiate in the vicinity of the start codon for the RdRP (Li et al., 
2011, 2015a). 
 
Another possibility that has not been discussed is that it still is feasible that the 
unwinding of this stem loop structure by elongating ribosomes or other cellular 
factors, allows an interaction between the mRNA strand and the 18S RNA to occur 
similar to examples of coupled translation observed in prokaryotes (Oppenheim and 
Yanofsky, 1980). Although it is noted that this sequence of complementarity is not 
located in the same vicinity in the 18S rRNA sequence used by influenza B and 
caliciviruses for its TURBS Motif 1 sequence. The interaction may still allow the 
ribosome to be tethered in the correct position allowing reinitiation to occur.  
 
Another fungus infecting virus associated with the picorna-like super family has 
been documented as using coupled translation. Cryphonectria hypovirus 1 (CHV1), a 
double stranded RNA genome virus that infects chestnut blight fungus, has been 
found to use the coupled translation mechanism to translate its second ORF. The 
viral genome contains two ORFs. The first ORF contains the p69 polyprotein, which 
is further cleaved into the p29 and p40 proteins. The second ORF contains another 
large polyprotein, which contains the multifunctional protein p48 (an RdRP and a 
RNA helicase) (Guo et al., 2009).  
 
The two ORFs overlap by one nucleotide UAAUG, which is also an identical overlap 
to the coupled gene of BM2 in influenza B. Studies have shown that the translation 
of the first ORF is essential for the translation of the second ORF and the terminating 
stop codon of the first ORF is also required. Removing or moving the terminating 
stop codon further upstream as to prevent or cause premature termination of 
translation of the first ORF prevents translation of the second ORF. Similar to other 
viruses that use this mechanism the levels of the second ORF translated are about 4-
5% compared to the levels of the first ORF. Upstream sequences found in the p40 
coding sequence in the first ORF have been found to also play a role in translation, 
although the precise role is not known. It is possible that there may be structural 
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elements in this region as closely related viruses have structural regions in the p40 
ORF which have sequences complementary to the 18S rRNA. These regions are 
however a significant distance from the h26 sequence that binds to TURBS 
sequences at the 3´ end of the 18S rRNA. This sequence at the 3´ end of the 18S 
rRNA is not conserved in this host organism, which may explain why no 
complementarity to the viral mRNA is found here. It is still not known how this 
complementary sequence to the 18S rRNA aids in the mechanism. Finally, it has also 
been suggested that the actual viral protein of p40 may also be involved. Further 
mutational studies in regions that are of great distance from the overlap caused a 
reduction in translation efficiency suggesting that the protein p40 itself may be 
involved in translation. This distance is considered too far from the ORF-2 initiation 
site to influence the mechanism of coupled translation. Therefore it is expected that 
these mutations disrupt the function of the p40 protein which may aid in translation 
of ORF-2 (Guo et al., 2009).   
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1.6.1. Other non-canonical mechanisms for initiation of translation 
The mechanism of coupled translation for the initiation of M2 ORF-2 has been well 
documented in members of the Pneumoviridae family, which includes both the 
Orthopneumovirus (hRSV (Ahmadian et al., 2000), PVM (Gould and Easton, 2007)) 
and the Metapneumovirus (APV (Gould and Easton, 2007)) genera. These data 
would suggest that as the sequence of M2 ORF-1 differs in members that use the 
mechanism coupled translation; it is feasible that the mechanism of coupled 
translation is used for the initiation of M2 ORF-2 by all members of this family. 
 
There is however evidence from a single report, that another member of the 
Metapneumovirus genus (human metapneumovirus) does not use this mechanism. 
The human metapneumovirus (HMPV) M2 ORF-2 is located on the bicistronic M2 
gene transcript and similar to APV, contains the two ORFs of M2 ORF-1 and M2 
ORF-2. These two ORFs overlap each other by 53nts. The mechanism of initiation of 
translation of M2 ORF-2 in the second ORF is yet to be identified, however it has 
been reported that translation of M2 ORF-2 is not reliant on the translation of the 
first ORF M2 ORF-1. In this study, plasmids for reverse genetics for the M2 gene 
were created, where full M2 ORF-1 translation was inhibited through the 
introduction of premature terminating stop codons for M2 ORF-1 and the removal of 
the M2 ORF-1 start codon. The inhibition of translation of M2 ORF-1 did not affect 
translation of M2 ORF-2 (Buchholz et al., 2005). In members of this family that use 
the mechanism of coupled translation, inhibition of translation of M2 ORF-1 would 
lead to inhibited translation of M2 ORF-2 (Ahmadian et al., 2000; Gould and Easton, 
2007). This is a prerequisite of coupled translation, where successful translation of 
the first ORF is required (Buchholz et al., 2005). As it is unlikely that a canonical 
initiation mechanism is not used due to the presence of the first ORF, it is possible 
that mechanism used for initiation of M2 ORF-2 is another non-canonical 
mechanism. The data also suggest the possibility that not all viruses in this family 
use the mechanism of coupled translation for the initiation of translation of M2 ORF-
2 (Buchholz et al., 2005).   
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1.6.2. Leaky scanning 
Of all alternate non-canonical mechanisms that could be used for initiation of M2 
ORF-2 in pneumoviruses with the mechanism uncharacterised, leaky scanning is the 
closest related mechanism to canonical cap-dependent translation. Leaky scanning, is 
a cap-dependent mechanism where the scanning 48S ribosome bypasses the first 
AUG and continues scanning further downstream and initiates translation at an 
alternate start codon. In some cases, the scanning 48S ribosome may initiate at 
multiple AUG codons and may also bypass multiple AUG codons to initiate at a 
downstream site.  
 
The underlying mechanism is connected to the strength of the context of the Kozak 
sequence surrounding the AUG. As mentioned in Section 1.4.2, initiation is reliant 
on the scanning ribosome recognising an AUG codon with an optimal context of 
GCCACCAUGG  (Kozak, 1986). With the most vital nucleotide at position -3 from 
the A in the AUG codon required to be a purine with a slight preference for an A 
nucleotide. The second most vital nucleotide is at position +4, which is required to be 
a purine nucleotide with a slight preference for a G nucleotide. The Kozak sequence 
surrounding these two vital nucleotides as well the AUG codon can vary between 
different species (Kozak, 1986, 1997). However, the requirement for the nucleotides 
at position -3 and +4 is consistent for all species (Grzegorski et al., 2014; Nakagawa 
et al., 2008). This Kozak sequence is required to ensure binding fidelity by the Met-
tRNAMeti anticodon to prevent the anticodon binding to other codons. Under some 
circumstances where this context is weak or non-existent a small proportion of the 
scanning ribosomes will initiate at this AUG codon. The remainder of the scanning 
ribosomes are capable of scanning further downstream and will initiate at an AUG 
with a better context. It is also important to note that there are examples where an 
AUG with a poor context at the 5´ terminal of the mRNA will be capable of binding 
to the majority of the scanning 43S ribosomes and initiate translation at that site. 
This is thought to be due to the presence of highly structured AUGs which may slow 
the scanning ribosome down sufficiently to bind effectively at AUGs with a poor 
surrounding Kozak sequence (Kozak, 2002; Lin and Lo, 1992).  
 
Leaky scanning is a relatively common occurrence in viruses that transcribe 
polycistronic mRNAs and has been reported in examples involving a wide range of 
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infected host organisms including plants. In cases of leaky scanning used to bypass 
the first ORF, the context of the Kozak sequence of the first AUG codon may be 
weak allowing scanning ribosomes to scan past the first AUG. This is used in 
examples such as initiation for the p17 cistron in segment S1 in Avian reovirus 
where the consensus sequence for the bypassed AUG codon is UCGAUGC (Racine 
et al., 2007) or segment 2 of influenza A virus for the initiation of PB1-F2 and N40 
cistrons where the consensus sequence for the bypassed AUG codon is UGAAUGG 
(Wise et al., 2009). Another possibility is that the start codon for the first ORF is a 
non AUG codon, this is the case in such examples as the pre-genomic RNA of rice 
tungro bacilliform virus (AUU) (Fütterer et al., 1997) and in the eukaryotic example 
of c-myc (CUG) (Spotts et al., 1997). However in all these cases the first ORF is still 
translated at significantly lower rates compared to downstream ORFs in polycistronic 
mRNAs. 
 
There is no defined pattern between different examples of viruses in relationship to 
the outcome of the scanning ribosome once it passes the first AUG codon. The 
ribosome is capable of still bypassing multiple AUGs in order reach one with an 
optimal Kozak sequence such as in the expression of PB1-F2 in segment 2 of the 
influenza virus, which scans past 3 AUG codons to reach the initiation codon for 
PB1-F2 (Wise et al., 2009).  
 
The ribosome is also capable of initiating translation at the next available codon such 
as for the NSs protein that is expressed on viral small mRNA from the Andes 
hantavirus. The ribosome is capable of scanning past the N initiation codon and 
initiating translation at the initiation codon for the NSs ORF even if the sequence of 
the N initiation codon is mutated to have an optimal Kozak sequence (Vera-Otarola 
et al., 2012).  
 
In polycistronic mRNAs where multiple ORFs are translated through leaky scanning, 
a proportion of the ribosomes that have bypassed the first AUG codon can initiate at 
the second ORF. However, the majority of ribosomes will bypass the AUG codon 
used for initiation of the second ORF and initiate at an AUG codon further along. 
This again is due to the context of the Kozak sequence. Rice tungro bacilliform virus 
pregenomic RNA is a polycistronic RNA containing three ORFs (Fig. 1.13). The 
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first ORF initiates translation through ribosomal shunting, and the second and third 
ORFs initiate translation through leaky scanning. The first two ORFs have poor start 
codons (first ORF with a non AUG codon and the second containing neither optimal 
nucleotide at -3 or +4 UACAUGAGC), however the initiation codon for the third 
ORF has a much stronger Kozak sequence (AGCAUGA). As result a small 
proportion of ribosomes initiate translation through leaky scanning at the AUG 
codon of ORF-2 and the remaining scanning ribosomes will continue scanning and 
initiate at the AUG codon for ORF-3. There is also one AUG codon of poor context 
(UUUAUGUGC) that is bypassed by the scanning ribosome between ORF-2 and 
ORF-3. This is also the longest distance reported where initiation has occurred 
through leaky scanning at a distance of 894nts (Fütterer et al., 1997). There are also 
examples where the both the second and third ORFs have equally optimal Kozak 
sequences. This is observed in segment 2 of the influenza A virus, where the AUG 
codons PB1-F2 and N40 have equally optimal Kozak sequences (Wise et al., 2009). 
The reason why a proportion of scanning ribosomes pass by the second ORF is still 
unknown. 
 
 
Fig. 1.13: Schematic of the rice tungro bacilliform virus polycistronic pregenomic RNA and 
mechanisms used for initiation of translation of the three ORFs 
Schematic of the rice tungro bacilliform virus polycistronic pregenomic RNA. The black line 
represents the mRNA strand. Boxes represent ORFs located on the mRNA strand. Ribosomal 
shunting is used for translation of ORF-1 (yellow). Ribosomal shunting is further described in Section 
1.6.4. Leaky scanning is used for translation of ORF-2 (blue) and ORF-3 (green). 
 
The frame of the AUG that the bypassing 43S ribosome will initiate at varies from 
example to example. For instance in the rice tungro bacilliform virus, all three ORFs 
are in the same reading frame (Fütterer et al., 1997). However in other cases such as 
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the pelargonium line pattern virus, the polycistronic sgRNA contains three ORFs, all 
of which are reliant on initiation of translation through leaky scanning and are all in 
different reading frames (Castaño et al., 2009). There are also examples of viruses 
that use a mixture of frames such as segment 2 of the influenza A virus which is 
mentioned earlier (Wise et al., 2009). This however, is unsurprising as scanning 
ribosomes are not influenced by frame. There are also cases on bicistronic mRNAs 
where the two reading frames overlap such as in Andes hantavirus where NSs ORF 
overlaps the N ORF by 18nts (Fuller et al., 1983; Vera-Otarola et al., 2012). It is also 
possible for leaky scanning to be used in conjunction with other non-canonical 
mechanisms. For example in the tricistronic S1 mRNA of avian reovirus, leaky 
scanning is used for the initiation of translation of the p17 ORF which is the second 
ORF on the mRNA strand. However the third ORF which is translated to the σC 
protein, uses the mechanism of leaky scanning for initiation of translation but uses it 
in conjunction with the mechanism of ribosomal shunting (Racine et al., 2007; 
Racine and Duncan, 2010). 
 
In the majority of cases mentioned previously, a lower level of expression of the first 
ORF is observed in relationship to a downstream ORF where the preferential 
ribosome initiation site is. This however is not the case in all examples of leaky 
scanning. For instance in VSV, two truncated versions of the Matrix or M protein (33 
and 51 amino acids away from the methionine) are translated by leaky scanning. 
These two truncated versions of the protein are produced in lower quantities 
compared to the first ORF. The context of the Kozak sequence surrounding the 
matrix protein AUG codon is suitably strong (AUCAUGA). It is unknown what 
causes a small proportion of the ribosomes to bypass the initial AUG even though it 
has a strong Kozak sequence (Jayakar and Whitt, 2002). 
 
1.6.3 Programmed ribosomal frameshifting 
Programmed ribosomal frameshifting (PRF) is a mechanism used by the same 
elongating ribosome to translate two separate ORFs in different reading frames to 
generate a fusion protein. In this process the elongating ribosome translating the first 
ORF will shift the frame in which the mRNA is being read without terminating or 
reinitiating translation. This shift will cause the elongating ribosome to translate the 
second ORF without disrupting the process of elongation and as a result two separate 
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proteins are translated in the form of a fusion protein which may later be cleaved to 
two separate proteins.  
 
In the vast majority of examples of PRF, there is a shift by the elongating ribosome 
to the -1 frame in relationship to the frame of the first ORF. There are however 
examples where PRF occurs in +1/-2 direction, these examples are less common and 
the mechanism is less well defined. PRF has been most commonly documented as a 
mechanism of translation of viral mRNAs. There also been documented cases in both 
eukaryotic (Dinman, 2012) and prokaryotic organisms (Flower and McHenry, 1990). 
This also includes the mechanism being used in mammalian mRNAs (Dinman, 
2012).  
 
For programmed -1 ribosomal frameshifting, all examples documented are reliant on 
two factors for successful frameshifting of the ribosome. Firstly the site of the 
frameshift must be in a specific location and within a certain sequence called a 
slippery sequence. Secondly, this slippery sequence must be in close vicinity to a 
structured region downstream of the slippery sequence (Caliskan et al., 2015). The 
slippery sequence can vary in sequence, but must have the same format of 
XXXYYYZ where X can be any nucleotide, Y can be either A or U and Z can be 
any nucleotide except for G. As seen in Fig. 1.14, for the elongating ribosome 
translating the first ORF, the slippery sequence must be in the format X_XXY_YYZ 
(where _signifies the break between each codon). Therefore a shift in the -1 frame 
would lead to this slippery sequence being read as XXX_YYY_Z (Howard et al., 
2004; Plant and Dinman, 2006; Yu et al., 2014).  
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Fig. 1.14: Sequence of slippery sequence used for the mechanism of programmed ribosomal 
frameshifting used by infectious bronchitis virus (IBV) for the initiation of translation of the 
1a/1b polyprotein ORF. 
Figure displays the slippery sequence used by IBV for programmed -1 ribosomal frameshifting used 
for initiation of translation of the 1a/1b polyprotein. Figure also displays the critical secondary 
structure for PRF located 6 nts downstream of the slippery sequence (Brierley et al., 1989). 
 
The secondary structure varies between examples, but is always within several 
nucleotides of the slippery sequence. These structures tend to form pseudoknots 
where the stem loop structures bind with distant sequences downstream leading to 
the formation of large loops between stems (Namy et al., 2006). The exact process of 
how the slippage occurs is still debated.  
 
There are currently three suggested models of how the slippage occurs based on the 
point in time during elongation when the slippage occurs. These three models are all 
reliant on GTP hydrolysis. The first model suggests that the slippage occurs when the 
XXY codon is in the process of being translocated to the P site and the energy 
required for frameshifting is derived from the eEF2 GTP hydrolysis. Upon the 
ribosome reaching the structured region, a pause in translocation is caused. This 
pause causes the ribosome to slip by one nucleotide in the -1 direction so the P site 
instead of having XXY in the codon, now has XXX. The anticodon of the sequence 
can still bind to positions 1 and 2 in the codon and the third nucleotide in the codon 
may bind putatively due to wobble base pairing (Namy et al., 2006).  
 
Another model of slippage has been suggested to occur during the delivery and 
binding of the aminoacyl-tRNA to the A site but before the peptidyl transfer. The 
energy for this reaction comes from the hydrolysis of GTP from eEF1A. The model 
suggests that before the accommodation of aminoacyl-tRNA and during 
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translocation, the structural element causes a significant level of pressure for the 
ribosome during translocation. Once the aminoacyl-tRNA binds in the A site, the 
pressure is relieved by the release of tRNA from the mRNA and the movement of the 
ribosome in the -1 direction. This again leads to wobble base pairing for position 3 in 
both codons due to the nature of the slippery sequence (Plant et al., 2003).  
 
The third model is similar to the second where the pressure is built before 
translocation but before peptidyl transfer to the A site. However this model is 
thought to occur when the ribosome contains tRNAs in all three sites. When the 
slippage occurs, the XXY in the P site changes to XXX and the A codon changes to 
YYY (where N is any nucleotide). The energy is also derived from the hydrolysis of 
GTP from eEF2 (Léger et al., 2007). The debate continues which model is used, 
however there is growing evidence that the second model is used for (-1) 
frameshifting. 
 
The first documented case of -1 frameshifting was reported in rous sarcoma virus for 
the translation of the Gag-Pol polyprotein located on the unspliced viral mRNA 
(Jacks et al., 1988a; Jacks and Varmus, 1985). Frameshifting is also used in a similar 
mechanism for the translation of the human immunodeficiency virus (HIV) Gag-Pol 
polyprotein (Jacks et al., 1988b). For both viruses, the unspliced viral mRNA 
contains two ORFs, with the Gag polyprotein translated from the first ORF and the 
Pol polyprotein translated from the second ORF (Jacks et al., 1988b). The Gag-Pol 
fusion polyprotein once translated is cleaved into the respective proteins found in 
each ORF. For HIV, the levels of translation of Gag-Pol polyprotein are not 
produced in equal amounts compared to the levels of Gag polyprotein translated. 
Frameshifting only occurs in a small proportion of cases (5% (Jacks et al., 1988b)). 
The majority of ribosomes will continue past the slippery sequence and terminate 
translation at the Gag ORF terminating stop codon (Biswas et al., 2004; Jacks et al., 
1988b; Nikolaitchik and Hu, 2014). Many retro viruses and positive-sense RNA 
genome viruses use frameshifting for the expression of the viruses’ RdRP. In 
positive-sense single stranded RNA viruses such as coronaviruses (Fig. 1.14), 
programmed -1 ribosomal frameshifting is used for the translation of the ORF1b 
polyprotein. This mechanism allows the virus to tightly control the levels of the 
replicase protein produced (Brierley et al., 1987).  
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It has been suggested that the downstream structured regions used for PRF in viruses, 
play a key role in controlling the levels of frameshifting. It is also of note that these 
structures differ in different members of the same family that use PRF. They do 
however lead to roughly similar levels of frameshifting (Plant et al., 2010; Thiel et 
al., 2003).  
 
There have also been examples of frameshifting in negative-sense single stranded 
RNA genome viruses such as the measles virus (a member of Paramyxoviridae 
family). In measles virus, frameshifting occurs in the P gene transcript for the 
synthesis of the R protein. As seen in Fig. 1.15A, the P polycistronic gene transcript 
contains 4 ORFs (P, C, V and R). The R ORF is translated to the R protein which is a 
fusion product consisting of 294 amino acids (aa) translated from the P ORF and 5 aa 
translated from the V ORF. The site of the frameshift occurs in between the 
overlapping region between the P and V ORFs. The -1 shift during translation of the 
P ORF results in the elongating ribosome translating the final 18nts of the V ORF 
and terminating translation at the V terminating stop codon. Evidence suggests that 
the slippery sequence may slightly differ to the consensus sequence (Fig. 1.15B). It is 
also ambiguous whether a structural region is involved. The study’s conclusions 
were unclear whether a structural region downstream of this alleged slippery 
sequence was present due to the limitations in modelling software (Liston and 
Briedis, 1995).  
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Fig. 1.15: Structure of the polycistronic P gene transcript in measles virus and site of frameshift 
for the R protein 
 (A) Structure of the polycistronic P gene transcript in measles virus containing the P (blue), C 
(yellow), V (green) and R (blue/green). The black line represents the mRNA strand. Boxes represent 
ORFs located on the mRNA strand. All three ORFs are in separate reading frames. The R ORF (blue 
and green) is displayed in two separate colours to represent the combined two frames which originate 
from the P and V ORFs. The site of the frameshift is shown through an arrow. (B) Site of -1 slippage 
for the R protein. The codon in the first ORF is underlined and codon after the slippage is highlighted 
in bold 
 
The less well defined example of programmed +1 ribosomal frameshifting has been 
observed in both eukaryotes and prokaryotes. In eukaryotes, the yeast gene OAZ1 
and its mammalian homologue have been identified as using +1 frameshifting. In 
both eukaryotes and prokaryotes the slippery sequence used in +1 frameshifting 
appears to be case specific. In eukaryotes the mechanism is still reliant on a highly 
structured region downstream of the slippery sequence. The slippery sequence, for 
example in OAZ1, is UCCUGAU with the UGA codon located in the A site during 
frameshifting. A feedback loop is thought to also control whether frameshifting 
occurs (Ivanov and Atkins, 2007; Matsufuji et al., 1996; Palanimurugan et al., 2004). 
There have also been examples of +1 frameshifting in viruses. Lake Sinai viruses 1 
and 2 use +1 frameshifting for the translation of the RdRP (Olivier et al., 2008). +1 
frameshifting has also been identified as the mechanism to translate the fusion 
protein PA-X in influenza A. The fusion protein is thought to be used for host gene 
shut off. The slippery sequence again differs with the sequence for influenza A being 
UCCUUUCGU (Firth et al., 2012). There have also been examples of -2 
frameshifting in viruses, such as the trichomonas vaginalis virus 1 using 
frameshifting for the production Pol protein (Ai, 2016; Goodman et al., 2011).  
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1.6.4. Ribosomal Shunting 
Ribosomal shunting is a cap-dependent mechanism that is partly reliant on scanning. 
The premise of ribosomal shunting is the 40S ribosomal subunit bypassing (through 
a jump) large structured elements typically in the 5´ UTR and resuming scanning 
post jump (Fig. 1.16). The ribosome is thought to achieve this by retaining certain 
initiation factors pre-jump through the translation of a short ORF (sORF) before 
reaching the structure, which enables the ribosome to jump/bypass the secondary 
structure and bind to the mRNA on the other end of the structure and continue 
scanning. In general it is thought that shunting is used to bypass long 5´ UTRs that 
contain multiple AUGs, which in some cases have as good a context Kozak sequence 
as the AUG used for translation of the desired ORF. The majority of ribosomal 
shunting examples have been characterised in viruses and only a small number of 
examples have been reported in eukaryotic organisms (Ogawa, 2013).  
 
 
Fig. 1.16: Schematic of the site and mechanism of ribosomal shunting 
Schematic of the site and mechanism of ribosomal shunting. Ribosomal shunting will initially 
translate a sORF (red) in the 5´ UTR. Upon termination, the ribosome will retain some of it’s 
initiation factors and will bypass a large structured region of sequence by jumping from the donor site 
to the acceptor site (blue). The ribosome will then continue scanning until it reaches the AUG codon. 
 
It appears that throughout all examples of shunting, the exact mechanics behind the 
mechanism differ significantly from one example to the other. One of the first and 
most well characterized examples of the mechanism of ribosomal shunting is from 
the cauliflower mosaic virus, which is a member of the Caulimoviridae family. The 
mechanism is used to bypass a large 5´UTR on the 35S mRNA and translate ORF 
VII. In this example, the scanning 43S ribosome will initiate translation at a short  
	 52	
sORF located in the 5´ UTR, which is in the vicinity of a large stem loop structure. 
Upon termination the vast majority of ribosomes will dissociate from the mRNA. 
However in a small number of cases, some of the 40S ribosomal subunits retain 
some key initiation factors that do not include any factors that can act as a RNA 
helicase. The ribosome will move several nucleotides upstream to the beginning of 
the stem loop structure called the donor site. The ribosome however, due to not 
having the ability to unwind the stem loop, will instead jump/bypass the structured 
region (around 480nts in length), where it will bind to the mRNA acceptor site and 
continue scanning downstream and initiate translation of ORF VII (Ryabova and 
Hohn, 2000). This has also been documented in the rice tungro bacilliform virus 
(RTBV), another member of the Caulimoviridae family. This virus also uses a 
similar mechanism to bypass a large stem loop structure. Although both the stem 
loop and translated sORF differ from the cauliflower mosaic virus example. In both 
of these cases the acceptor and donor sites where the ribosome jumps and lands are 
found within the vicinity of the stem loop structure (Pooggin et al., 2012; Pooggin et 
al., 2006).  
 
Other viruses use shunting to access ORFs using complementary sequences to the 
18S rRNA. Adenovirus uses ribosomal shunting to translate ORFs in late mRNAs. 
During this point in the infection eIF4E is dephosphorylated which prevents the 
initiation eIF4F complex from efficiently binding to the m7G cap. As a result the 
majority of capped mRNAs are not translated as ribosomes are unable to scan 
through the 5´ UTR and initiate translation due to lack of the eIF4F complex 
containing an RNA helicase (eIF4A) in the scanning ribosomal complex. Ribosomal 
shunting is therefore employed by the virus to translate ORFs during this point of 
infection. This shunt allows the ribosome to bypass the 5´ UTR which is highly 
structured and would otherwise be unable to be bypassed. Analysis of the 5´ UTR 
has revealed that shunting is directed by three conserved regions that are 
complementary to the 3´ region of the 18S rRNA. These complementary sequences 
are separated from each other by ~30nts and are labelled C1 to C3. The three regions 
are thought to bind to a stem loop structure found at the 3´ end of the 18S rRNA in 
40S subunits, which in turn allows the recruitment of initiation factors. The precise 
mechanism by which the C1 to C3 regions direct shunting is unknown (Yueh and 
Schneider, 2000). However, unlike members who use shunting in the Caulimoviridae 
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family, the adenovirus does not rely on the translation of a sORF. This shunting 
mechanism for translation has also been reported in the hsp70-1 gene transcript in 
human cells (Chappell et al., 2006).  
 
Another mechanism of shunting has been reported in the translation of the Sendai 
virus Y1 and Y2 proteins. The two ORF belong to a polycistronic mRNA, in which 
multiple mechanisms are used to translate each of the residing ORFs. Shunting has 
been identified as the mechanism of translation for two of these ORFs (Fig. 1.17A). 
This shunting mechanism differs from others as no donor site has been identified. As 
seen in Fig. 1.17B, it was reported that critical sequences directly upstream of the Y2 
initiation site may act as an acceptor site for both Y1 and Y2 ORFs. It is thought that 
this acceptor site is presented to the ribosome inside a secondary structure (de 
Breyne et al., 2003; Latorre et al., 1998).  
 
 
Fig. 1.17: Structure of the polycistronic P gene transcript of Sendai virus and site of initiation 
for the Y1 and Y2 proteins 
(A) Structure of the polycistronic P gene transcript in Sendai virus containing the P, C’, C, Y1 and Y2 
ORFs. The black line represents the mRNA strand. Boxes represent ORFs located on the mRNA 
strand. The colour of the ORF represents the reading frame of the ORF (blue +1 and yellow +2). (B) 
Initiation sites (in bold) for translation of Y1 and Y2 ORFs. The arrow below identifies sequence 
critical for the mechanism of ribosomal shunting that is thought to act as an acceptor site.  
 
Shunting can be used in conjunction with other mechanisms to initiate translation of 
ORFs on a polycistronic mRNA. As mentioned in Section 1.6.2, avian reovirus uses 
leaky scanning for the translation of all three ORFs in the S1 mRNA. However, the 
σC ORF also uses a shunting mechanism as well as leaky scanning (70/30 leaky 
scanning/shunting). The S1 mRNA has a short 5´ UTR, which is highly unusual for a 
virus using the shunting mechanism. There is no room for sORF to be translated as 
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described in the cauliflower mosaic virus. It has been suggested that the shunting 
occurs after the termination of one of the upstream ORFs to that of σC. As only a 
small number of proteins are present in the virus due to leaky scanning being used, 
the efficiency of this shunting mechanism can afford not to be highly efficient 
(Racine and Duncan, 2010). 
 
1.6.5. Internal Ribosome entry site 
Internal ribosome entry sites (IRES) are capable of initiating translation in a cap- 
independent manner in almost any location along an mRNA strand. These IRESs are 
either capable of assembling the 80S ribosomal complex and initiating translation 
with few or no initiation factors by assembling the 80S complex entirely through 
interactions with the mRNA. They tend to be used in conditions where the m7G cap 
is not accessible/doesn’t exist or in conditions where initiation factors are not 
available. IRESs are highly structured regions of mRNA either located at the 5´ UTR 
or found within cistrons. These highly structured regions tend to form high affinity 
complexes with the ribosomal subunits. In turn manipulating the ribosomal subunits 
in order to assemble the 80S subunit and initiate translation in the vicinity of the 
IRES, usually at an AUG codon. IRESs tend to have an incredibly high degree of 
variability with very little sequence or structural homology between different 
examples (Balvay et al., 2009). First discovered in picornaviruses (Jang et al., 1988; 
Pelletier and Sonenberg, 1988), IRESs are primarily found as examples of internal 
cap-independent initiation in viral mRNAs. However, there are an increasing 
numbers of examples being discovered in eukaryotic mRNAs (Spriggs et al., 2009). 
IRESs as initiation systems can be easily adopted to be used by other mRNAs and 
placed in alternate examples of cellular environments and still successfully initiate 
translation.  
 
Attempts to classify viral IRES have resulted in a large quantity of well defined 
IRESs being divided into 4 distinctive groups. However there are many other 
examples that do not fit into these four groups, which is testament to the high 
diversity of IRESs found on viral mRNAs alone (Kieft, 2008). 
 
Group 1 are the simplest group both in size and mechanism. These IRESs do not 
require any eIFs to assemble the 80S ribosomal complex and instead assemble the 
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ribosomal subunit through mRNA interaction alone. They also tend to be smallest in 
size of the four major groups, with one of the two cricket paralysis virus (CrPV) 
IRESs only being 190nts in size. The majority of the viruses that use group 1 IRESs 
belong to the Dicistroviridae family. This includes the mentioned CrPV (Wilson et 
al., 2000b), plautia stali intestine virus (Sasaki and Nakashima, 1999), Israeli acute 
paralysis virus (Ren et al., 2012) and the shrimp tuara syndrome virus (Mari et al., 
2002). With the most well characterised IRES in this family being the CrPV IRES 
used for initiation of ORF-2. This IRES is located in an intergenic region between 
two cistrons on a bicistronic mRNA. The IRES directs initiation of translation at a 
non-AUG codon. For CrPV, the IRES consists of three pseudoknots. Initially the 
sole mechanism thought to be used by CrPV IRES involved the pseudoknots binding 
to the 40S ribosomal subunit, resulting in the recruitment of the 60S ribosome for the 
formation of the 80S ribosomal subunit (Wilson et al., 2000a). There is however 
evidence that the IRES can also directly recruit the 80S subunit and multiple 
mechanisms are thought to be used by the IRES in order to maximise translational 
efficiency (Petrov et al., 2016). As the initiation site is not an AUG, the first tRNA 
that is delivered to the ribosome is by eEF1A. It is believed that one of the 
pseudoknots, by forming a similar confirmation to tRNA, binds in the A site and then 
is moved to the P site by eEF2. This thereby allows the ribosome to form a correct 
conformational shape reminiscent of the ribosome in elongation phase more similar 
to a pretranslocation state (Fernández et al., 2014).  
 
Group 2 IRESs are reliant on eIFs to successfully initiate translation. These IRESs 
are also reliant on an AUG site for initiation. Unlike group 1 IRESs, these viral 
IRESs originate from more than one family, examples include: classical swine fever 
virus (Rijnbrand et al., 1997), porcine teschovirus 1 (Pisarev et al., 2004) and the 
most well characterised member of this group, hepatitis C virus (HCV) (Tsukiyama-
Kohara et al., 1992). For the HCV, the IRES is located in the 5´ UTR of the positive-
sense RNA genome. The IRES is responsible for initiating translation of the entire 
polycistronic RNA which is translated into a polyprotein that is later cleaved into the 
individual HCV proteins. Compared to the structure of the CrPV, the structure is 
more complex. The structure is 340 nts in size and comprises of 4 domains of which 
II,III and IV independently fold. The mechanism used by the HCV IRES for 
initiation of translation occurs over several steps. The first step is the recruitment of 
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the 40S complex to the IRES. The 40S complex is bound to domain III of the IRES 
which mediates further interactions with other domains. The second step is 
recruitment of eIF3 and the ternary complex, which also binds to domain III. Certain 
eIF3 subunits are involved in aiding the process of 80S ribosomal assembly. The 
AUG codon used for initiation is located on domain IV is thought to fold into the 
40S decoding groove, thereby allowing binding with Met-tRNAMeti in the P site. The 
final step is the association of the 60S subunit to form the 80S subunit, this is 
mediated by eIF5 and eIF5B to hydrolyse the GTP on eIF2, which leads to the 
release of eIF2-GDP and the joining of the 60S subunit to the 40S complex. This is 
orchestrated by the domain II in the IRES. eEF1A will then bring the aminoacyl-
tRNA into the A site to initiate elongation. Under certain conditions this initiation 
process may vary in examples such as ion concentration variation or inactivation of 
eIFs. The IRES is still capable of initiating translation even when certain initiation 
factors are not available or if the Mg2+ ion concentration changes from optimal levels 
leading to change in structure (Jaafar et al., 2016; Pérard et al., 2013).  
 
Groups 3 and 4 are derived from the Picornaviridae family. This family has multiple 
members that use IRESs for cap-independent translation. Although this family has 
members belonging to both groups 3 and 4, all IRESs belonging to this family have 
also been separately classified into five separate types. Types 1 and 2 in this family 
can also be classified into Groups 4 and 3 respectively. Types 3 to 5 are not 
classified into the 4 IRES groups but do share similar characteristics to both group 3 
and 4 IRESs (Martínez-Salas et al., 2015).   
 
Group 3 and 4 IRESs are also reliant on eIFs, the ternary complex and other cellular 
cofactors called IRES-transacting factors (ITAFs) for successful initiation of 
translation (Pestova et al., 1996). For group 3 IRESs, the AUG codon is located in 
the direct vicinity of the IRES and the 40S ribosomal complex is loaded directly onto 
the AUG in a Yn-Xm-AUG motif (Kolupaeva et al., 2003). This group comprises of 
such example as the encephalomyocarditis virus (EMCV) IRES (Ghattas et al., 1991) 
and the foot and mouth disease virus (FMDV) IRES from the Picornaviridae family 
(Martínez-Azorín et al., 2008). In group 4, the 40S complex is loaded onto the same 
motif, however the ribosome will not use the AUG as the initiation site and instead 
will use an AUG 150 nts downstream of the IRES. The ribosome may scan or shunt 
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itself over 100-15 0nts to the initiation codon. Group 4 IRESs comprise of such 
examples as the polio virus IRES (Pelletier and Sonenberg, 1988)  
 
Almost the entire group of eIFs is required for successful initiation of both groups 3 
and 4 IRESs with the exception of eIF4E. The IRESs of both groups are reliant on 
other cellular cofactor named ITAFs. These tend to be nuclear based proteins that 
migrate to cytoplasm, which include polypyrimidine-tract binding protein PTB. 
There is also evidence of interactions between the poly-A tail and the IRES during 
initiation (Sweeney et al., 2014).  
 
Although this review covers the 4 major group of IRESs, it is important to note that 
there are constantly new IRESs being discovered that do not fit into the 4 groups of 
IRESs. There are also multiple examples in eukaryotic mRNAs that are not 
mentioned in this review. 
 
1.7. Aims 
The aim of this project was to identify and investigate the use of regulatory 
mechanisms used by the Pneumoviridae family to control viral gene expression. The 
technique of ribosomal profiling was used to create transcriptional and translational 
profiles of both the hRSV and bRSV viral genomes. Transcriptional profiles were 
used to identify if the levels of viral mRNA abundance followed the levels predicted 
by the polar gradient model and therefore identify if this model primarily controlled 
viral gene expression. Translational profiles were used to investigate whether any 
viral mRNAs other than the M2 mRNA used translational regulation.  
 
The only translational regulation mechanism identified in this family is for initiation 
of translation of M2 ORF-2, which has been identified in several members of this 
family. This mechanism is currently uncharacterised in bRSV. Therefore reporter 
plasmid assays were used to investigate the mechanism used for translation of bRSV 
M2 ORF-2. Reporter plasmid assays were also used to further characterise the 
regulatory mechanism of coupled translation termination/initiation used for initiation 
of translation of PVM M2 ORF-2.  
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Chapter 2 
Materials and Methods 
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2.1. Tissue culture and virus propagation 
2.1.1. Tissue culture media 
All cells lines were cultured in Glasgow Modification of Eagle’s Medium (GMEM). 
All media contained 0.2 mM of L-glutamine, 100 µg/ml of penicillin and 
streptomycin and 10% (v/v) foetal bovine serum (FBS). Under conditions where 
virus was used which included plaque assays, transfections and growth of viral 
stocks, GMEM media would contain 2% FBS instead of 10%. For the remaining 
chapter the percentage at the beginning of GMEM refers to the concentration (v/v) of 
FBS supplemented in the media. 
 
2.1.2. Phosphate buffered saline (PBS)  
2.5mM KCl, 0.15 M NaCl 1.5 mM KH2PO4, 6.5 mM Na2HPO4, pH7.4 
 
2.1.3. Cell lines 
Human epithelial type 2 (HEp-2) cells, epithelial cells of African green monkey 
origin (BSC-1) cells and Madin-Darby bovine kidney (MDBK) cells were all 
acquired from Dr Phillip Gould and Prof. Andrew Easton.  
 
2.1.4. Maintenance of cell lines  
All cell lines were grown at 37oC at 5% CO2 in FalconTM T-175 175 cm2 flasks. Cells 
were grown in 50 ml of 10% GMEM in T-175 flasks. Cells typically doubled in 
number between every 12 and 24 hours. Once cells had reached 100% confluency, 
cells would be passaged to reduce the confluency of the cells. The 10% GMEM 
media would be removed from the flask and versene (0.02% (w/v) EDTA and 
0.002% (w/v) phenol red in PBS, pH 7.4) was used to wash the cells. The cells 
would be disassociated by adding 5 ml of trypsin EDTA (0.02% (w/v) EDTA and 
0.25% (w/v) trypsin in PBS, pH 7.4) and incubating at room temperature until all 
cells had disassociated from the flask’s surface. 5 ml of 10% GMEM would be added 
to the disassociated cells to neutralize the trypsin EDTA. A proportion of cells would 
then be removed for the requirements of the experiments and the remaining media 
containing cells were made up to 50 ml using 10% GMEM. Cells would then be 
incubated back at 37oC. The concentration of cells after a passage were never 
reduced to lower than 12.5% and were never passaged more than 20 times. All media 
used for cell culture unless otherwise stated was heated to 37oC before use. 
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2.1.5. Storage of cell lines in Liquid N2 
All cells were stored in liquid N2 for long-term storage. Cells destined for storage 
were passaged so that all cells were disassociated from the flask’s surface and 
pelleted at 2000 rpm for 4 min. The supernatant was removed and cells would be 
suspended in 40% (v/v) of 10% GMEM, 50% (v/v) FBS and 10% (v/v) Dimethyl 
sulfoxide (DMSO). The newly suspended cells were placed in cryotubes, the cells 
were then frozen by storing the cryotubes in isopropanol at -70oC over a period of 24 
hours. The frozen cells were then transferred to liquid N2 for long-term storage.  
 
Cells that were removed from liquid N2 were thawed at 37oC and added to 10 ml of 
10% GMEM. The cells were pelleted at 2000 rpm for 4 minutes and resuspended in 
10 ml 10% GMEM. The cells were then seeded into FalconTM T-75 flasks and left to 
grow until confluent and then transferred to a T-175 flask as described in Section 
2.1.4. 
 
2.1.6. bRSV 
Stocks of bRSV (Snook strain) were acquired from Prof. Andrew Easton. This strain 
was used for isolation of the M2 gene sequence and for ribosomal profiling. Stocks 
of bRSV were grown in MDBK cells. MDBK cells were grown in NUNCTM Cell 
Culture Treated TripleFlasks with standard cell culture techniques described in 
Section 2.1.4. Cells were supplemented with 100 ml 10% GMEM media whilst 
reaching 100% confluency. Upon cells reaching 100% confluency, the 10% GMEM 
media was removed and 90 ml of 2% GMEM was added to the flask. Virus was then 
added at a multiplicity of infection (MOI) of 0.01. Cells were incubated at 31oC and 
incubated until all cells were showing signs of infection, the time frame of this 
ranged from 5 to 8 days. Cells were harvested by adding glass beads to the flask and 
gently rocking the flask until all cells attached to the flask surface were removed. All 
media was then removed from the flask and was centrifuged at 3200g for 20 minutes. 
The supernatant was either frozen at -70oC or precipitated using the protocol 
described in Section 2.1.8. Plaque assays as described in Section 2.1.9 were 
performed using MDBK cells. 
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2.1.7. Vaccinia virus  
Stocks of the vaccinia virus (VTF7-3) strain were acquired from Prof. Andrew 
Easton. Stocks were replaced by infecting BSC-1 cells with vaccinia virus at a MOI 
of 0.01 when cells were 90% confluent. The cells were incubated at 37oC for 4-5 
days and harvested once all cells showed extensive cytopathic effect. Cells were 
harvested by adding glass beads to the flask and gently rocking the flask until all 
cells attached to the flask surface were removed. All media was then removed from 
the flask and was centrifuged at 3200g for 20 minutes. The supernatant containing 
the virus was stored at -70oC. Plaque assays as described in Section 2.1.9 were 
performed using BSC-1 cells 
 
2.1.8. Concentrating Virus 
In order to increase the titre of viral stocks, media containing harvested virus was 
mixed with 50% PEG 6000 in NTE buffer (w/v) ratio (0.15 M NaCl, 0.05 M Tris-
HCl, 0.001 M EDTA pH7.5) to give a final concentration of 10% (v/v) PEG. The 
mixture was mixed for 90 minutes at 4oC with low stirring. The sample was pelleted 
by centrifuging at 3200g for 5 minutes at 4oC and then resuspended in the desired 
volume to acquire the desired titre. 
 
2.1.9. Quantifying virus 
Virus titres were quantified using plaque assays. Serial dilutions were made by 
diluting the virus in PBS in 10 fold increments ranging up 10-7. Cells were grown in 
12 well plates in 10% media until they reached 90% confluency. The cell media was 
then removed and 250µl of a diluted virus was added to each well and incubated with 
intermediate rocking at 37oC. Two wells were used as repeats for each dilution. The 
PBS containing virus was removed from the wells after the hour incubation and 1ml 
of CMC overlay (1% (w/v) carboxymethyl cellulose in 2% GMEM) was added to 
each well. The cells were be incubated at 37oC until visible plaques formed. The 
infected cells were fixed using 4% glutaraldehyde solution (4% (v/v) glutaraldehyde 
in PBS) and left in solution for 2 hours. The plates were then washed and crystal 
violet solution (0.5% (w/v) crystal violet, 20% (v/v) methanol in H2O) was added 
and incubated at room temperature for 40 minutes. The crystal violet solution was 
washed off the plates and the plates dried. Plaques were then counted and the titre 
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(Plaque forming units (Pfu/ml of stock virus) calculated from the number of plaques 
present.  
 
2.2. Protein techniques 
SDS-PAGE and western blot analysis of proteins to determine the presence of fusion 
proteins. 
 
2.2.1. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
Prior to western blot analysis, proteins were separated using SDS-PAGE. Each gel 
comprised of both a running and stacking gel. All running gels were 10% gels which 
comprised of 2.8 ml H2O, 3ml 30% acrylamide mix, 4 ml 0.5 M Tris-HCl (pH8.8), 
0.15 ml 10% SDS 0.1 ml, 10% ammonium persulfate and 4µl TEMED. Stacking gels 
comprised of 8.45 ml H20, 30% acrylamide mix, 3.75 ml 0.5 M Tris-HCl (pH6.8), 
0.15 ml 10% SDS, 0.15 ml 10% ammonium persulfate, 4 µl TEMED. 
 
Prior to loading samples on the gel, protein samples were mixed with 4x loading dye, 
which contained beta-mercaptoethanol. The quantity of lysate required was either 
dependent on well volume or concentration of protein required for western blot 
analysis. A PageRuler Prestained protein ladder 10 to 180 kDa (ThermoFisher 
Scientific) was used to determine protein size. 5 µl of the ladder was added to one 
well in the gel. Samples were then incubated for 5 minutes at 95oC to denature the 
protein. Samples once loaded were run at 125V for 2 hours in 1x running buffer (15 
g/l Tris, 72 g/l glycine, 5 g/l SDS pH 8.2 for a 5X concentration).  
 
After the gel had sufficiently separated, the gel was then washed in double-distilled 
water for 5 minutes. For western blot analysis, preparation of the gel continued as 
described in Section 2.2.2. For non-specific protein analysis, the gel was stained 
using Coomassie stain (Bio-Rad). 50 ml of stain was added to the gel and left 
rocking for 30 minutes. The gel was then washed in destain (20% methanol, 10% 
acetic acid, 70% H2O) until bands became visible. A protein ladder was used to 
identify the size of the protein bands in the gel. Bands were visualized on an 
illuminator box. 
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2.2.2. Protein detection using western blot analysis 
The gel from Section 2.2.1 once washed was rewashed in transfer buffer (10% 10x 
tris glycine, 20% methanol, 70% water) for 5 minutes. The gel was then placed on a 
nitrocellulose membrane and run in a gel electrophoresis tank using transfer buffer 
for 1 hour at 200 mA. Upon completion of transfer of proteins onto a nitrocellulose 
membrane, the membrane was then washed in TBS tween (50mM Tris, 150 mM 
NaCl and 0.05% tween 20) for 5 minutes. The membrane was then immersed in 2% 
bovine serum albumin (BSA) in TBS tween for 1 hour to act as a blocking agent. 
The membrane was then incubated with 25ml of primary antibody overnight at 4 oC. 
The primary antibody (Goat Anti-CAT IgG Fc Abcam) was diluted 1 in 3000 in PBS 
solution (1% w/v BSA and 0.08% v/v sodium azide). The membrane was then 
washed for 1 hour in TBS tween. 10ml of secondary antibody for the specific 
primary antibody (Rabbit Anti-Goat IgG H&L (HRP) Abcam) was incubated for 2 
hours with the membrane. The antibody was dissolved in powdered milk in 5% w/v 
ratio in TBS tween at a dilution of 1 in 3000. The membrane was then washed for 1 
hour in TBS tween. ECL western blotting substrate (Pierce) was added to develop 
the membrane as described by manufacturers protocol. The membrane was then 
placed onto X-ray film and kept in a developer cassette for a set period of time. 
Films were developed in a X-ray film developer machine. 
 
2.2.3. Bicinchoninic acid protein assay 
A bicinchoninic acid protein assay (BCA) was performed using a Pierce BCA 
protein Assay Kit from ThermoFisher Scientific. Assay was performed according to 
manufactuers instructions. 
 
2.3. Cloning  
All constructs were created using the following methods below. For an in depth 
cloning strategy see relevant results section. Primer sequences can be found in 
Appendix C. 
 
2.3.1. PCR 
For all PCR reactions, the proof reading polymerase Pfu DNA polymerase 
(Promega) was used. A total reaction mixture of 50 µl in 500 µl PCR tubes was used 
for each reaction. Primers were added to make a final concentration of 0.2pmol/µl. 
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Primers were acquired from IDT and were resuspended at concentration of 10 
pmol/ul. dNTPs were added to make a final concentration of 200 µM for each dNTP. 
A maximum of 50 ng of template was added. Pfu DNA polymerase reaction buffer 
(Promega) was added to the reaction mixture from a from 10x solution to create a 
final 1x concentration (200mM Tris-HCl (pH 8.8 at 25°C), 100 mM KCl, 100 mM 
(NH4)2SO4, 20 mM MgSO4, 1.0% Triton X-100 and 1mg/ml nuclease-free BSA). 
1.25 units of Pfu DNA polymerase were used for each reaction. A typical reaction 
mixture is shown in Table 2.1. Reactions were performed in an Eppendorf 
Mastercycler Gradient PCR machine. The reaction cycle is shown in Table 2.2. PCR 
products were purified using a QIAGEN Gel extraction kit (Section 2.3.14) once 
correct band was identified on a 1% agarose gel (Section 2.3.2). 
 
 
Reagent  Quantity  Final Concentration 
Pfu DNA Polymerase 
buffer 10x 
5 µl 1x 
dNTP Solution 10mM of 
each dNTP  
1 µl 200 µM each dNTP 
Forward Primer 
10pmol/µl 
1 µl 0.2 pmol/µl 
Reverse Primer 10pmol/µl 1 µl 0.2 pmol/µl 
DNA template ≈1 µl 50 ng 
Pfu DNA polymerase 1 µl  1.25 units 
Water To total volume of 50µl NA 
Table 2.1: PCR reaction mix used for all PCR reactions 
PCR reagent mixture for Pfu DNA polymerase. 
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Table 2.2: PCR reaction conditions used for all PCR reactions 
PCR cycle program used for PCR reaction using the Pfu DNA polymerase 
 
2.3.2. Agarose gel electrophoresis 
Agarose gels were used to quantify and visualize DNA. Gels were made to 1% w/v 
agarose in TBE buffer (45 mM Tris-Borate, 1 mM EDTA) and 1 µl of Midori Green 
staining solution was added. Gels were set and run in TBE buffer. DNA samples 
were mixed in 6x xylene cyanol or 6x bromophenol blue. A HighRanger plus 100 bp 
DNA ladder was used in all experiments. Gels were run at 120V for 40 minutes and 
visualized using a UV box.  
 
2.3.3. Quantification of DNA and RNA  
DNA and RNA was quantified using a Implen NP80 Nanophotometer. Both DNA 
and RNA quantification was performed at a wavelength of 260nm. The 
Nanophotometer was initially blanked with the 1 µl of solution that the nucleic acid 
was dissolved in. 1 µl of sample was then used to quantify the levels of nucleic acid. 
 
2.3.4. Restriction digest  
Restriction digests were performed using FAST DIGEST restriction enzymes from 
Thermoscientific. 5 units (1 µl) of enzyme was used to digest 1 µg of DNA 
(quantified as described in Section 2.3.3) in a total reaction mixture of 20 µl. A Fast 
Digest buffer was added at 1/10th the volume of the reaction mixture (10 mM Tris-
HCl (pH 7.5 at 37°C), 10 mM MgCl2 0.1 mg/mL BSA). The remainder of the 
reaction mixture was made up to 20 µl with nuclease free water. Reaction samples 
were incubated at 37 oC for 2 hours. For each reaction, a control was used for each 
restriction endonuclease. For a control reaction, each restriction endonuclease was 
Temperature  Time Cycles 
95oC 5 minutes  1 
95oC 30 seconds 30 
58 oC dependent on primer 
TM 
30 seconds  
72 oC 1 minute per kbp 
72 oC 10 minutes 1 
4 oC Indefinite NA 
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used to digest the plasmid pBluescribe. The successful digestion of the plasmid was 
confirmed on a agarose gel with the plasmid being visually linearized compared to 
uncut plasmid run on the same gel.  
 
2.3.5. Digestion of insert and vector samples for cloning 
Inserts and vectors used in cloning underwent the same restriction digest as described 
in Section 2.3.4. Digested insert samples were purified using a QIAGEN PCR 
Purification kit (Section 2.3.15). Digested vectors were purified based on the size of 
the fragments generated. If the unwanted fragment was under 100nts, then the 
sample was purified with a QIAGEN PCR Purification kit (Section 2.3.15). 
However, if the unwanted fragment was over 100 nts in size, then the entire 
restriction digest mixture was run on a 1% agarose gel (Section 2.3.3). The desired 
fragment used for the vector was excised from the gel and purified using QIAGEN 
Gel Extraction Kit (Section 2.3.15). Upon purification, all samples had the levels of 
DNA quantified using an Implen Nanophotometer. 
 
2.3.6. Dephosphorylation of vector 
The digested vector was dephosphorylated in order to prevent self-ligation. 1 unit of 
Antarctic phosphatase was added to the previous digested reaction mixture. Antarctic 
phosphatase buffer was added at 1/10th the volume of the total reaction mixture (50 
mM Bis-Tris-Propane HCl 1 mM MgCl2 0.1 mM ZnCl2 pH 6.0 at 25°C). The 
reaction mixture was then incubated at 1 hour at 37 oC. Samples were then purified 
using a QIAGEN PCR Purification kit (Section 2.3.15). 
  
2.3.7. Ligation 
Digested inserts were mixed at molar ratio of 3:1 with a digested and 
dephosphorylated vector. Quantities required were calculated using NEB clone 
ligation calculator. T4 DNA ligase from Thermoscientific was used for the reaction. 
5 units (1 µl) of enzyme was added to a total reaction volume of 20 µl. T4 DNA 
ligase buffer was added at 1/10th the volume of the total reaction mixture (400 mM 
Tris-HCl, 100 mM MgCl2, 100 mM DTT, 5 mM ATP (pH 7.8 at 25°C)). The 
remaining volume comprised of digested vector and insert DNA. Reaction mixtures 
were incubated for 1 hour at 37oC. Samples were then directly transformed into 
DH5α competent bacteria. 
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2.3.8. Transformation 
Transformations were performed using DH5α competent bacteria. For transformation 
of ligations, ligation mixture (never exceeding 100 ng of DNA) equalling 1/10th the 
volume of competent bacterial cells were mixed with the bacteria on ice. The mixture 
was then incubated on ice for 30 minutes. The transformation mixture was then heat 
shocked at 42oC for 45 seconds. The mixture was then placed on ice and incubated 
for another 2 minutes. All plasmids used contained an ampicillin (AMP) resistance 
gene. The competent bacteria were therefore incubated at 37oC in 10x volume of L-
broth (LB) broth for 45 minutes in order for the bacteria to express the ampicillin 
resistant genes. After the 45 minutes incubation, bacterial cells was plated on 
ampicillin LB agar plates (ampicillin at a concentration of 100 µg/ml). For certain 
ligation mixtures requiring blue white selection, ampicillin LB agar plates was used 
that also contained Isopropyl β-D-1-thiogalactopyranoside (IPTG) and X-Gal (X-Gal 
40 µg/ml, IPTG 100 µg/ml and ampicillin 100 µg/ml). Plated colonies were 
incubated for 48 hours at 30oC before being picked.  
 
2.3.9. Colony selection 
White colonies were selected for bacteria that had been plated on LB agar plates with 
IPTG and X-Gal. This indicated that the lacz gene in the transformed plasmid had 
been disrupted indicating successful ligation. No disruption of the lacz gene would 
lead to a distinctive blue colour in colonies. Multiple colonies were picked if 
ampicillin LB agar plates were used. Selected individual colonies were picked into 5 
ml of LB broth containing ampicillin (concentration 100 µg/ml) and incubated at 
37oC overnight. Plasmids from bacterial colonies were purified using a QIAGEN 
Plasmid Miniprep Kit (Section 2.3.12).  
 
2.3.10. Sequencing of DNA 
For sequencing of plasmids, up to 500 ng of plasmid was added to a total reaction 
mixture of 10 µl in a 1.5 ml microcentrifuge tube. The correct sequencing primer was 
used at a final concentration of 2.5 pmol/µl. Samples were then sent to GATC 
sequencing for sequence analysis.  
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2.3.11. Glycerol stocks  
Successfully cloned plasmids were stored at -70oC in glycerol stocks. Plasmids were 
transformed into DH5α competent bacteria, plated and grown overnight at 37oC on 
ampicillin LB agar plates (Section 2.3.8). Colonies were picked into 5 ml LB with 
ampicillin at a concentration of 100 µg/ml and grown overnight at 37oC. 0.5 ml of 
the bacterial culture was taken and mixed with 50% glycerol solution (50% (v/v) 
glycerol in H2O) at a (v/v) ratio of 50%. The solution was stored in cryotubes and 
stored at -70oC. Stored plasmids in glycerol stocks could then be plated on ampicillin 
LB agar plates when required.  
 
2.3.12. Increasing stocks of plasmid 
To increase stocks of plasmid, colonies were picked from plates inoculated with 
glycerol stocks of the respective plasmid required. A colony was picked into 5 ml LB 
with ampicillin at a concentration of 100 µg/ml and grown overnight at 37oC. 
Bacterial cultures were then purified using QIAGEN Plasmid Miniprep Kits (Section 
2.3.13). Plasmids preps were quantified using an Implen Nanophotometer. 
 
2.3.13. Plasmid purification  
Plasmids were purified using a QIAGEN Plasmid Miniprep kit. Purifications were 
performed to manufacturers instructions. 
 
2.3.14. Gel purification 
DNA fragments separated using agarose gel electrophoresis were purified using a 
QIAGEN Gel Purification Kit. Purifications were performed to manufacturers 
instructions. 
 
2.3.15. PCR purification 
PCR samples were purified using a QIAGEN PCR Purification Kit. Purifications 
were performed to manufacturers instructions. 
 
2.4. Quantification of Coupled translation 
Constructs created to characterise the mechanisms of M2 ORF-2 translation were 
transfected into cells and the levels of reporter gene expressed was measured, 
enabling the efficiency of coupled translation to be measured. 
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2.4.1. Transfections 
Lipofection transfections were used to introduce plasmids into cells. HEp-2 cells 
were used for all transfections. Cells were plated into 12 well plates so at the time of 
transfection each well would be at 50% confluency. TransIT-LT1 transfection 
reagent (Mirus) was used as the vector for transfection. For each well, 500 ng of 
plasmid was added to 1.5 µl of TransIT-LT1 transfection reagent (Mirus) in 100 µl of 
Opti-MEM (Thermoscientific) and incubated for 30 minutes at room temperature. 
Initially cell media was aspirated from each well and vaccinia virus (VTF7-3 strain) 
in 1 ml of 2% GMEM at a MOI of 1 was added. This was to provide a T7 RNA 
polymerase to the cell to aid in successful transcription of the plasmid. The cells 
were then incubated with the virus for 1 hour at 37oC. After the hour the viral 
infected media was aspirated off and the Opti-MEM mixture with the transfection 
reagent and plasmid was added to each well. 1.5 ml of 10% GMEM was then added 
to the cells. The cells were then incubated for 48 hours at 37oC and were then 
harvested. The media was initially aspirated and each well was washed in sterile 
PBS. The PBS was then aspirated and 300 µl of lysis buffer (Roche CAT ELISA kit) 
was added to each well. The lysed cells were left for 30 minutes to ensure all cells 
were completely lysed. Lysed cells were then be removed and centrifuged at 
13000rpm for 7 minutes to separate cell debris. The supernatant was frozen at -20 oC. 
For each experiment, three separate transfections were performed for each plasmid. 
The experiment was repeated a total of three times. This meant that a total of three 
triplicates of transfections were performed for each plasmid tested.  
 
2.4.2. CAT Enzyme-linked immunosorbent assay (ELISA) 
A Roche CAT ELISA kit was used to quantify the levels of CAT protein expressed 
from transfected plasmids in HEp-2 cells. 30 µl of harvested sample was initially 
mixed with sample buffer from ELISA KITS to make up to a total volume of 200 µl. 
The mixture was added to ELISA plates and incubated for 1 hour at 37oC. After the 
incubation the plates were washed in TBS TWEEN four times and the secondary 
antibody Anti-CAT-DIG was added. The antibody from stock solution was diluted to 
1/200 in sample buffer and 200 µl was added to each well. The plate was incubated 
for another hour at 37oC. The plates were then washed with TBS Tween 4 times and 
the tertiary antibody was added (Anti-DIG-POD). This antibody was diluted 1/133 in 
sample buffer from stock solutions and 200 µl was added to each well and incubated 
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for one hour at 37oC. The plates were then washed 4 times after incubation and 200 
µl of peroxidase (POD) substrate would be added and incubated at room temperature 
for 5 minutes. The ELISA plate was placed on plate reader and read at 405nm 
wavelength.  
 
2.4.3. GFP ELISA 
An Abcam GFP ELISA was used to quantify the levels of eGFP protein expressed 
from plasmids transfected in HEp-2 cells. Initially cellular lysate harvested from 
transfected cells was diluted 1 in 100 with PTR buffer and 50 µl of the diluted 
sample was added to each well. 50 µl of antibody mixture (containing detector and 
capture antibodies) was added. The ELISA plate was incubated at room temperature 
for 1 hour on plate shaker set at 450 rpm. After the hour incubation, the wells were 
washed with 350 µl wash buffer 3 times. 100 µl of TMB substrate was added to each 
well and the ELISA plate was incubated whilst covered for 3 minutes on a plate 
shaker set at 400 rpm. 100 µl of Stop solution was then added and the ELISA plate 
was incubated for 1 minute on a plate shaker set at 400 rpm. The ELISA plate was 
then placed in a plate reader and was read at 450 nm wavelength. A standard curve 
was created using GFP recombinant protein using a serial dilution in 3 fold 
increments from a concentration of 4000 pg/ml to 2.7 pg/ml. Creation of the standard 
curve followed the same protocol for the GFP ELISA as descirbed above. 
 
2.5. Competent bacteria production 
DH5α cells were plated on LB agar plates. Colonies were picked in 5 ml LB broth 
and incubated at 37oC overnight. Bacteria grown overnight were added to 100 ml of 
LB broth in a 250 ml conical flask and were grown to an OD600 of 0.39 (measured 
using photometer). Once the correct OD600 was reached the flask was placed on ice 
for 5 minutes. Bacterial colonies were centrifuged at 2000 rpm for 15 minutes at 4oC. 
The pellet would then be resuspended in 40 ml of Tfb I buffer (30 mM KOAc 
acetate, 100 mM RbCl, 10 mM CaCl2, 50 mM MnCl2, 15% v/v glycerol to a pH to 
5.8) and incubated for 1 hour at 4oC for 1 hour. Cells were then centrifuged for 15 
minutes at 3000 rpm at 4oC. The pellet was then resuspended in 4 ml of Tfb II 
(10mM MOPS, 75 mM CaCl2, 10 mM RbCl2, 15% v/v glycerol to a pH to 6.5) and 
incubated for 5 hours at 4oC. Bacteria in Tfb II were aliquoted in 100 µl quantities 
and snap frozen in liquid nitrogen and stored at -80oC. 
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2.6. RNA extraction and reverse transcription (RT)  
The M2 RNA of bRSV was isolated from virus using a QIAGEN Viral RNA 
extraction kit. Reverse transcription was used to create DNA copies of the viral RNA 
that could be used as a template to amplify the M2 Gene through PCR. 
 
2.6.1. RNA extraction  
RNA was extracted from bRSV (Snook strain) using a QIAGEN Viral RNA 
Extraction Kit. The method was completed according to the manufacturers 
instructions. 3x104 Plaque forming units (Pfu) of bRSV were used to extract the viral 
genome. 
 
2.6.2. Reverse transcription  
M-MLV reverse transcriptase (Promega) was used for RT amplification of the viral 
genome using random oligo-nucleotides as primers (500 ng). A maximum reaction 
volume of 50 µl was used. The maximum quantity of RNA that was capable of being 
added to the reaction was added. 5 µl of reaction buffer was added to the reaction 
(250mM Tris-HCl, 15mM MgCl2, 50 mM DTT, 375 mM KCl). dNTPs at a final 
concentration of 200µM for each dNTP were added. 200 units of M-MLV reverse 
transcriptase enzyme and 20 units of ribonuclease inhibitor (Promega) were finally 
added. The reaction mixture was incubated for 60 minutes at 37 oC. cDNA was 
amplied as described in Section 2.3.1.  
 
2.7. In vitro transcription reaction 
A MEGAscript kit from Ambion was used to perform in vitro transcription reactions 
using a T7 RNA polymerase. Amplicons generated by PCR from plasmids used the 
same method and reaction conditions as described in Section 2.3.1. Specific primers 
used to amplify each plasmid are mentioned in respective results chapters. Prior to 
use in the in vitro reaction, PCR products were purified using a QIAGEN PCR 
purification kit as described in Section 2.3.15. For each reaction, 1 µg of purified 
PCR product was added to each reaction. This was added to a reaction master mix (2 
µl ATP solution (75 mM), 2 µl CTP solution (75mM), 2 µl GTP solution (75mM), 2 
µl UTP solution (75mM), 2 µl 10X reaction Buffer and 2 µl of enzyme mix) and 
nuclease free water was used to bring the total volume to 20 µl. The mixture was 
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incubated at 37oC for 2 hours. Samples were run directly on Novex precast 6% TBE 
urea-polyacrylamide gels to perform denaturing polyacrylamide gel electrophoresis 
(PAGE). Samples were mixed with an equal volume Gel loading buffer II (Ambion) 
and incubated at 90oC for 3 minutes. Samples were run at 100V for 1.5 hours in TBE 
buffer. Gels were stained with 50ml SYBR Gold and viewed using a UV box. A 
Geneflow 100bp ladder was used as a size marker and was prepared using the same 
method as described above. 
 
2.8. Statistics 
Standard deviation was calculated for all transfection results using Microsoft excel. 
Analysing whether there was statistical significant difference in CAT protein 
expression between two transfected plasmids was confirmed using the Welch’s T-
test using Microsoft excel. 
 
2.9. Mfold analysis 
Sequences that had suspected mRNA secondary structure were inputted into the 
mRNA secondary structure modelling software Mfold. The constraint information 
was kept at standard settings: RNA sequence, linear; folding temperature, 37oC; 
percent suboptimality number, 5; upper bound on the number of computed foldings, 
50; window parameter, default; maximum interior/ bulge loop size, 30; maximum 
asymmetry of an interior/bulge loop, 30 and maximum distance between paired 
bases, no limit. 
 
2.10. Ribosomal profiling  
An Illumina ARTseq (now TruSeq) ribosomal profiling kit (mammalian) was used to 
prepare and produce sequencing libraries from RNA harvested from MDBK cells 
infected with bRSV for next generation sequencing using a MiSeq Sequencing 
System.  
 
2.10.1. Infection of cells and harvesting of cellular lysate containing RNA 
Both protected and total libraries were created from cellular lysate harvested from 
the same cellular population. MDBK cells were grown in 100 mm cell culture dishes 
as described in Section 2.1.4. Cells were infected with bRSV (Snook strain) at a MOI 
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of 1 when cells were 90% confluent. Initially media was aspirated off the dish and 
5ml of 0% GMEM media containing bRSV was added to the cells. The cells were 
incubated at 37oC for 1 hour. After the incubation, the media was aspirated and 20ml 
of 2% GMEM media was added. Cells were either incubated for a further 3 or 7 
hours at 37oC. The control cell culture dish (MockP/MockT libraries) followed the 
same protocol above except without the 0% GMEM media containing virus. The 
control cell culture dish used to create the control sequencing libraries was also 
harvested after 3 hours of further incubation. After the incubation period, 5 ml of 2% 
GMEM media containing cycloheximide was added that brought the concentration of 
cycloheximide in the cell culture dish to 0.1 mg/ml and was then incubated for 5 
minutes at 37oC. After the incubation, the media was aspirated and cells were 
washed in 10 ml of ice cold PBS that contained cycloheximide at a concentration of 
0.1 mg/ml. Cells were then scraped off with 800µl of lysis buffer (20% 5x 
Mammalian Polysome buffer, 10% Triton X-100, 1% 100mM DTT, 1% DNAase I, 
0.4% 25 mg/ml Cycloheximide, 66.6% Nuclease free water). The lysis buffer 
containing the cellular lysate was passed through 21, 22, 25 gauge needles and was 
then transferred to a microcentrifuge tube. The cellular lysate was placed on ice and 
incubated for 10 minutes. The lysate was centrifuged at 20000xg at 4oC for 10 
minutes. The supernatant was then transferred to a new fresh tube. Each sample was 
aliquoted into 200 µl aliquots. For each time point, 200 µl of the cellular lysate was 
used to create the protected library and the remaining 600 µl was snap frozen in 
liquid N2 and stored at -80oC, where 200 µl would be later used to create the total 
library as described from Section 2.10.2. For the 200 µl of cellular lysate used to 
create the protected libraries at each time point, 1.5 µl of ARTseq nuclease was 
added to the mixture. The cellular lysate was then incubated for 45 minutes at room 
temperature. The reaction was then halted with 15 µl of SUPERase In RNase 
inhibitor. The preparation process then proceeded onto monosome removal.  
 
2.10.2. Monosome purification 
Illustra Microspin S-400 columns were used to purify monosomes from the purified 
protected mRNA. The S-400 columns were initially equilibrated by resuspending the 
resin and draining the buffer from the resin. 3 ml of 1X Mammalian Polysome buffer 
was allowed to pass through the column in 0.5 ml increments. Once all buffer had 
been drained, the columns were centrifuged at 600 g for 2 minutes. 100 µl of 
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protected sample was added to each column and the column was centrifuged at 600 g 
for 2 minutes. This was repeated once more for each sample. The flow through was 
collected in 1.5 ml microcentrifuge tubes. Both total and protected samples had the 
RNA purified from the cellular lysate using Phenol Chloroform RNA purification 
and RNA precipitation as described in Section 2.10.3. RNA was resuspended in 25 
µl of nuclease free water. 1 µl of each sample was quantified using a nanophotometer 
(Section 2.3.3). The samples were then stored on ice ready for rRNA removal. 
 
2.10.3. Phenol chloroform RNA purification and RNA precipitation 
RNA samples were mixed with Acid Phenol:Chloroform at a 1:1 ratio. The mixture 
was vortexed for 30 seconds and then centrifuged at 14000 rpm for 5 minutes at -
20oC. The aqueous phase was then removed from the organic phase. This process 
was repeated two more times. Upon the third extraction the aqueous phase was 
mixed with CHCl3:Isoamyl Alcohol (24:1) at a 1:1 ratio. The mixture was vortexed 
for 30 seconds and then centrifuged at 14000 rpm for 5 minutes at -20oC. The 
aqueous phase was removed and an RNA precipitation was immediately performed. 
 
For an RNA precipitation, each precipitation was performed with 400 µl (if lower, 
made up with nuclease free water) of each sample. If there was more than 400 µl of 
sample, multiple reactions were performed. To the 400µl of sample; 700 µl of 
isopropanol, 40 µl of 5 M ammonium acetate, 2µl of 10% SDS and 2µl of glycogen 
(20mg/ml) were added. The sample was briefly vortexed and stored at -20oC 
overnight. The sample was centrifuged at 14000rpm for 20 minutes at -20oC. The 
supernatant was removed and the pellet was washed twice in 800 µl of ice cold 80% 
ethanol. For each wash the ethanol and pellet were centrifuged at 14000 rpm for 20 
minutes at -20oC. The pellet was then dried and resuspended in nuclease free water. 
 
2.10.4. rRNA removal 
Ribo zero magnetic beads were used to remove rRNA from both protected and total 
RNA samples. 225 µl of magnetic beads were used for each sample. The magnetic 
beads were initially washed by placing the 225 µl magnetic beads in a 1.5ml 
microcentrifuge tube and placing the tube on a magnetic stand for 1 minute. The 
supernatant was removed and 225 µl of RNase free-water was added to the beads and 
resuspended by vortexing. The beads were then placed on a magnetic stand and left 
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for 1 minute. The process was repeated again and the beads were resuspended in 65 
µl of Magnetic Bead Resuspension Solution. The beads were set aside at room 
temperature for later use. 
 
For each total and protected sample, up to 5 µg of RNA (measured on a 
nanophotometer Section 2.3.3) was added to rRNA hybridizing probes in the 
mixture: Ribo-Zero Reaction Buffer, 4 µl; RNA sample, up to 28 µl; Ribo-Zero 
Removal Solution, 10 µl: RNase-free water, amount so sample reaches 40 µl. The 
mixture was incubated at 68oC for 10 minutes and then left to incubate at room 
temperature for 5 minutes. The sample was then added to magnetic bead mixture and 
resuspended using a pipette to mix the sample 10 times and then vortexed for 10 
seconds. The sample was then incubated at room temperature for 5 minutes and 
placed on the magnetic stand for a further minute. The supernatant was then removed 
and placed in a 1.5 ml microcentrifuge tube. The sample was then purified using 
phenol chloroform and precipitated with isopropanol overnight. The Protected 
samples were resuspended in 11 µl of RNase free water. Total RNA samples were 
resuspended in 20 µl of RNase free water. Samples if not used immediately for the 
next stage were stored at -80oC. 
 
2.10.5. Purification of protected samples 
11µl of protected sample was added to 11 µl Gel Loading Buffer II. The ladder for 
the gel was prepared in a mixture of: 20/100 oligo ladder, 4µl; Nuclease-free water, 1 
µl; Gel Loading Buffer II, 5 µl. Both the ladder and protected samples were 
incubated for 5 minutes at 95oC. The samples were then loaded onto Novex 15% 
precast TBE urea-polyacrylamide gels and run at 150 V in TBE buffer until the 
bromophenol blue band had reached the bottom of the gel. The gel was then removed 
and stained in 50 ml SYBR Gold for 15 minutes. The gel was then placed under a 
blue light transilluminator. For each protected sample, the area corresponding to 28 
to 35 nts was excised, this was performed even if no bands were visible. The excised 
gel band was cut up using a razor and placed into a 0.2 ml PCR tube with a hole 
punched in the bottom. This PCR tube was placed into a 0.5 ml microcentrifuge tube 
which also had a hole punched in the bottom by a needle. The tubes were placed in a 
1.5 ml microcentrifuge tube. The tubes and gel were centrifuged at 12000 g for 2 
minutes. The 0.5 and 0.2 ml tubes were removed and the following mixture was 
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added to the gel found in the 1.5 ml micro centrifuge tube: Nuclease-free water, 400 
µl; 5 M ammonium acetate, 40 µl; 10% SDS, 2µl. The mixture was rocked at room 
temperature for 1 hour. A 1 ml pipette tip with its tip cut to increase the bore of the 
tip, was used to transfer the mixture to filter tubes. The whole sample was 
centrifuged at 2000 g for 3 minutes. The sample was precipitated as described in 
Section 2.10.3, samples were resuspended in 20 µl of RNase free water. 
 
2.10.6. Fragmentation of total RNA samples and end repair of total and 
protected samples 
Total RNA samples were fragmented in order to generate correct sized fragments for 
end repair and sequencing. Both protected and total samples had 7.5 µl PNK Buffer 
added to 20 µl of each sample. Protected samples were stored on ice and the total 
RNA samples were incubated at 94oC for 25 minutes. The samples were then placed 
on ice. To both protected and total RNA samples the following reagents were added 
to the samples: Nuclease-free water 44.5 µl and PNK 3 µl. The samples were 
incubated at 37oC for 1 hour. 25 µl of nuclease free water was added to each sample. 
The samples were then purified using Zymo RNA Clean and Concentrator Kit. The 
samples were purified according to manufacturers instructions. For step 1, 200 µl of 
RNA Binding Buffer was used and 450 µl of 100% ethanol was added in step 2. 10 
µl of Nuclease Free water was used to elute the samples from the columns. From this 
point onwards both total and protected samples underwent the same preparation 
methods.  
 
2.10.7. Ligation of 3´ Adapters 
For all samples a ligation master mix was created with the following reagents used 
for each sample: ARTseq Ligation Buffer, 3.5 µl; 100 mM Dithiothreitol (DTT), 1µl; 
ARTseq Ligase, 1.5 µl. The master mix was kept on ice. For each of the samples, 1µl 
of ARTseq 3´ Adapter was added and the sample was incubated at 65oC for 2 
minutes and then held at 4oC. 6 µl of master mix was added to each sample. The 
sample was briefly centrifuged to collate the mixture at the bottom of the tube. The 
sample was incubated at room temperature for 2 hours. 2 µl of ARTseq AR enzyme 
was added to the samples and mixed. The samples were incubated at 30oC for 30 
minutes.    
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2.10.8. Reverse transcription of samples 
A RT master mix was created with the following reagents for each sample: ARTseq 
RT Reaction Mix, 4.5 µl; EpiScript RT, 1 µl; 100 mM Dithiothreitol (DTT), 1.5 µl; 
Nuclease-free water, 6 µl. 13 µl of each reaction mixture was added to both protected 
and total RNA samples and incubated at 50oC for 30 minutes. 1 µl of ARTseq 
Exonuclease was added to each mixture. Each sample was placed in a thermocycler 
and then underwent the following programme: 37oC for 30 minutes, 80oC for 15 
minutes and held at 4oC. 1 µl ARTseq RNase Mix was added to each reaction and 
incubated at 55oC for 5 minutes. Samples were then purified using an RNA Clean 
and Concentrator Kit (Zymo). The samples were purified according to manufacturers 
instructions. All samples were eluted in 10 µl of nuclease free water and stored at -
20oC. 
 
2.10.9. Purification of cDNA  
For both total and protected samples, 10 µl of sample was mixed with 10 µl of Gel 
Loading Buffer II. A 20/100 Oligo ladder was used as the size marker. 4 µl of ladder 
was mixed with 1µl of Nuclease-free water and 5 µl of Gel Loading Buffer II. All 
samples and ladder were incubated at 95oC for 5 minutes and then cooled on ice. All 
samples were loaded onto Novex 10% precast TBE urea-polyacrylamide gels. The 
gel was run at 150 V in TBE buffer until the bromophenol blue had completely run 
off the gel. The gel was then stained in SYBR Gold for 15 minutes. The gel was then 
viewed under a blue light transilluminator. Bands were excised at 80-100 nts and 70-
80 nts for total and protected samples respectively. The excised gel bands were then 
placed into a 0.2 ml PCR tube with a hole punched in the bottom. This PCR tube was 
placed into a 0.5 ml microcentrifuge tube which also had a hole punched in the 
bottom by a needle. The tubes were placed in a 1.5 ml microcentrifuge tube. The 
tubes and gel were centrifuged for 12000 g for 2 minutes. The 0.5 and 0.2ml tubes 
were removed and the following mixture was added to the gel found in the 1.5ml 
micro centrifuge tube: Nuclease-free water, 400 µl; 5M ammonium acetate, 40µl; 
10% SDS, 2 µl. The samples were shaken for 1 hour at 37oC. A 1ml pipette tip with 
its tip cut to increase the bore of the tip, was used to transfer the mixture to filter 
tubes. The whole sample was centrifuged at 2000 g for 3 minutes. The sample was 
precipitated and 2 µl of glycogen (20 mg/ml) and 700 µl of 100% isopropanol was 
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added with the supernatant to a new 1.5 ml microcentrifuge tube. The sample was 
mixed by vortexing and placed at –20oC overnight. The sample was then washed in 
80% ice cold ethanol and resuspended in 10 µl of nuclease free water. 
 
2.10.10. Circularize cDNA  
A master mix was created that contained each of the following reagents for each 
sample: ARTseq CL Reaction Mix, 4 µl; ATP, 2 µl; MnCl2, 2 µl; CircLigase, 2 µl. 
10µl of the master mix was mixed with 10 µl of each sample. The samples were then 
incubated at 4oC for 2 hours.  
 
2.10.11. Amplification of samples using PCR 
For each sample, a master mix was created with the following reagents for each 
sample: Nuclease-free water, 5.33 µl; ARTseq Forward PCR Primer (Table 2.3), 
0.66 µl; Phusion High-Fidelity PCR Master Mix with HF Buffer (NEB), 8.33 µl. 
14.32 µl of the master mix was added to 1.66 µl of sample and 0.66 µl of the specific 
index primer used for each sample (Table 2.3). The sample was amplified using a 
thermocycler as seen in Table 2.4. 
 
Amplified samples were purified by native PAGE. Samples were mixed with 3 µl of 
bromophenol blue. A 10 bp ladder from IDT was used for each gel, 0.5 µl was mixed 
with 4.5 µl of water and 1 µl of bromophenol blue. All samples were run on a precast 
8% Native PAGE TBE gel, 5 µl of xylene cyanol was added to an unused lane. The 
gel was run at 100 V in TBE buffer until the xylene cyanol band had run completely 
of the gel. A band at 140-160 bp in size was excised ensuring not to include the band 
at 113 bp, which was the amplified 3´ adaptor primer. The excised gel bands were 
then placed into a 0.2 ml PCR tube with a hole punched in the bottom. This PCR 
tube was placed into a 0.5 ml microcentrifuge tube which also had a hole punched in 
the bottom by a needle. The tubes were placed in a 1.5 ml microcentrifuge tube. The 
tubes and gel were centrifuged for 12000 g for 2 minutes. The 0.5 ml and 0.2 ml 
tubes were removed and the following mixture was added to the gel found in the 1.5 
ml micro centrifuge tube: Nuclease-free water, 400 µl; 5 M ammonium acetate, 40 
µl; 10% SDS, 2 µl. The samples were shaken for 1 hour at 37oC. A 1 ml pipette tip 
with its tip cut to increase the bore of the tip was used to transfer the mixture to filter 
tubes. The whole sample was centrifuged at 2000 g for 3 minutes. The sample was 
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precipitated and 2 µl of glycogen (20 mg/ml) and 700 µl of 100% isopropanol was 
added with the supernatant to a new 1.5 ml microcentrifuge tube. The sample was 
mixed by vortexing and placed at –20oC overnight. The sample was centrifuged at 
14000 rpm for 15 minutes. The sample was then washed in 80% ice cold ethanol and 
resuspended in 15 µl of nuclease free water. 1µl of the sample was then run on a 8% 
precast polyarcylamide TBE gel with same protocol as mentioned above. The sample 
was used for sequencing if there was no amplified 3´ adapter primer present. If the 
primer was present on the gel, the sample was PCR purified a second time. PCR 
reactions were scaled up by a factor of two in order to increase yield for sequencing 
if necessary. 
Primer Library to amplified Sequence  
Forward All libraries AATGATACGGCGACCACCGAGATCTACACGTTC
AGAGTTCTACAGTCCGACG  
Index 4 bRSV4P CAAGCAGAAGACGGCATACGAGATTGGTCAGT
GACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
Index 7 bRSV4T CAAGCAGAAGACGGCATACGAGATGTAGCCGT
GACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
Index 8 bRSV8P CAAGCAGAAGACGGCATACGAGATTCAAGTGT
GACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
Index 11 bRSV8T CAAGCAGAAGACGGCATACGAGATGATTCGGT
GACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
Index 1 MockP CAAGCAGAAGACGGCATACGAGATCGTGATGT
GACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
Index 2 MockT CAAGCAGAAGACGGCATACGAGATACATCGGT
GACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
Table 2.3: Primers used to amplify sequence libraries 
Index and forward primers used for each sample to create the respective sequencing libraries. Specific 
index sequence for each primer is underlined. 
 
Temperature in oC Time in seconds Cycles 
98 30 1 
94 15 9 
55 5 
64 10 
4 Hold Hold 
Table 2.4: PCR conditions used to amplify sequence libraries 
PCR conditions used to amplify sequence libraries using Phusion High-Fidelity DNA polymerase 
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2.10.12. Sequencing 
Samples were sequenced using MiSeq Next Gen sequencer. Sequencing was 
performed by the University of Warwick Genomics department. For each MiSeq 
sequencing cartridge used, three samples were selected with optimal index primer 
combinations for sequencing. 2 nM of each sample was required for each sequencing 
cartridge. The purity and quantity of the sample was confirmed using Bioanalyser 
and Qubit DNA analyser. Raw next generation sequencing results were then stored 
on Base Space cloud server. For each cartridge, three libraries were sequenced based 
on the optimal combinations of index primers. For one cartridge bRSV4P, bRSV8P 
and MockP libraries were sequenced. The second cartridge contained bRSV4T, 
bRSV8T and MockT libraries. 
 
2.10.13. Processing and analysis of sequencing from ribosomal profiling  
Sequencing was stored on the cloud server BaseSpace. The quality of each sample 
was determined using the software FastQC provided on the Base Space server. 
Samples were downloaded off the server and processed using MAC operating 
system. All further processing was performed on a MAC operating system. All 
further codes that were used for scripts to process data were performed using BASH 
coding. Four different scripts were used to process the sequencing data. Fastx_toolkit 
was an open source software provided by the Hannon lab. The software trimmed the 
adaptor primers off the sequences reads and removed unwanted sequences that were 
artefacts generated through sequencing. Bowtie and SAMtools scripts were open 
source software available from John Hopkins University and were provided by Dr 
Nigel Dyer. Bowtie aligned the reads against each genome. SAMtools processed the 
aligned reads so they could be viewed using the software IGV. The script orfanalyser 
was a program created and provided by Dr Nigel Dyer. This software processed the 
genome that sequencing libraries were aligned to using Bowtie and SAMtools and so 
could be visualised in the software IGV. The results were viewed and analysed on 
the open source software IGV. Examples of scripts used can be seen in Appendix A. 
Calculation for adjust reads and adjusted percentages for both protected and total 
sequencing libraries are shown in Fig. 2.1. 
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Fig. 2.1: Calculation for adjusted reads and adjusted percentage   
(A) Calculation for adjusted reads and adjusted percentages for both protected and total sequencing 
libraries for each mRNA. (B) A working example of the calculation used to acquire the adjusted 
percentage of total viral translation for N mRNA in the library bRSV4P. 
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Chapter 3 
Transcriptional and 
Translational Profiles of 
bRSV and hRSV 
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3.1. Introduction 
Gene expression in members of the Pneumoviridae family is primarily controlled 
through the transcription of mRNAs and it is thought that primarily the levels of 
mRNAs transcribed dictate the level of viral proteins translated. With the exception 
of the mechanism of coupled translation termination/initiation for the initiation of 
translation of M2 ORF-2 (M2-2 ORF), little regulation occurs at the level of 
translation of viral mRNAs for this family. 
 
The RNA dependent RNA polymerase (RdRP) complex is thought to control the 
levels of viral mRNAs through the generation of a transcriptional polar gradient. 
Initiation of transcription by the RdRP can only occur at the promoter located in the 
3´ leader sequence. After binding to the RNA the RdRP is thought to begin 
transcription at the first gene start signal located in the NS1 gene. The RdRP 
continues to transcribe the gene until a gene stop signal is reached and then 
terminates transcription. After release of the nascent mRNA, the RdRP has two 
possible options; it can either dissociate from the genomic RNA after which it is able 
to reinitiate transcription by binding only at the promoter or it can move onto the 
next gene start signal and initiate transcription of the next gene in the genome. This 
occurs at every gene down the entire length of the genome, with a proportion of 
RdRPs disassociating at each gene stop signal. As a result, fewer mRNAs are 
transcribed from genes as the RdRP progresses towards the 5´ end of the genome. 
Evidence for the polar transcription model is reviewed in Section 1.3.2. It has been 
reported that transcriptional read-through also occurs in approximately 10% of 
occasions between genes creating polycistronic mRNAs (Fearns and Collins, 1999b). 
 
Although the primary mechanism of regulation for gene expression in the 
Pneumoviridae family is thought to be through the polar transcription gradient, there 
is growing evidence to suggest that this is the not the sole factor in controlling the 
levels of viral mRNA abundance. As reviewed in Section 1.3.2, through the use of 
transcriptome sequencing, it has been reported that levels of mRNA abundance for 
several mRNAs (NS2, G and M) in the hRSV genome did not follow levels predicted 
by the polar gradient model. Instead these mRNAs had higher levels of mRNA 
abundance than mRNAs transcribed from genes found closer to the 3´ promoter, with 
the G mRNA (7th gene from the 3´ promoter) having the highest levels of mRNA 
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abundance in the viral genome (Aljabr et al., 2016). However, these data do suggest 
that the levels of mRNA abundance for the majority of genes in the hRSV genome 
are controlled by the position of the gene relative to the 3´ promoter in a manner 
consistent with elements of the polar gradient model. Data on the transcription 
efficiency of the hRSV genes was derived from transcriptome sequencing libraries 
constructed from RNA harvested from hRSV infected cells at 24 and 48 hours post 
infection (Aljabr et al., 2016). Two factors are important in assessing these data. The 
first is that the data is determined using steady-state levels of mRNA which may not 
be a true reflection of transcription levels due to differences in mRNA stabilities. 
Secondly, the time points at which samples were taken are at the later stages of 
infections in cells, where cellular resources are likely to be at lower levels than at 
earlier stages of infection. The different metabolisms of the cells at late stage in 
infection may affect transcription levels as well as mRNA stabilities. Transcription at 
earlier time points may reflect a different situation. 
 
The overall levels of mRNAs transcribed are also controlled by the switch from 
transcription to replication by the RdRP, which is orchestrated by the M2-2 protein 
through an unknown process. As the M2-2 protein is not present in packaged virions, 
the switch is dependent on the levels of M2-2 protein translated from the M2 
bicistronic gene transcript and the precise levels of M2-2 protein dictate the ‘switch’, 
with over expression of the M2-2 protein leading to inhibition of viral replication 
(Cheng et al., 2005). While the levels of M2-2 protein translated in hRSV are 
controlled by the non-canonical mechanism of coupled translation 
termination/initiation it is currently not known which mechanism is used for 
initiation of M2 ORF-2 by the closely related bRSV. However, due to the location of 
the M2 ORF-2 (Section 4.1), it is likely that this mechanism will also be a non-
canonical initiation mechanism. No additional non-canonical translation initiation 
mechanisms have been reported to be used by pneumoviruses. 
 
With the advancements in next generation sequencing, it is now possible to build full 
transcriptional and translational profiles of organisms using the technique of 
ribosomal profiling developed by Ingolia et al., 2009. Ribosomal profiling works on 
the principle that all elongating ribosomes translating cellular mRNA cover a region 
of mRNA which is being translated. During elongation, the ribosome covers 9 
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nucleotides (which are positioned in the A, P and E sites of the ribosome), and a 
further 21 nucleotides surrounding this region (Ingolia et al., 2009; Steitz, 1969). 
This can be advantageous as the region covered by the ribosome (referred to as the 
footprint) is protected from degradation by RNAases.  
 
Elongation can be paused using the antibiotic compound cycloheximide, a compound 
originally isolated from the Streptomyces griseus bacteria. It has been suggested that 
this compound binds to the E-site in the 60S ribosomal subunit whilst the E-site 
deacylated tRNA still resides there. This in turn inhibits the release of the E-site 
tRNA and therefore translocation of the ribosome is halted. However as a tRNA 
must be present in the E-site, the ribosome must undergo at least one cycle of 
translocation before translocation is halted meaning that cycloheximide is never 
capable of holding the ribosome on the initiation codon in the P-site (Schneider-
Poetsch et al., 2010).  
 
Cycloheximide is used in ribosomal profiling to pause all elongating ribosome in 
vivo (Section 2.10.1). The region of mRNA that is covered by each elongating 
ribosome is then isolated by lysing cells and digesting all other RNA present in the 
cell using RNases. The region of mRNA that is covered by each ribosome is 
protected from digestion from the RNase and a footprint is therefore created (Ingolia 
et al., 2009). RT-PCR amplification and further processing are then used to produce 
a next generation sequencing library for these footprints (Section 2.10.8-2.10.11).  
 
By using next generation sequencing to sequence these footprints over an entire 
population of cells, it is possible to calculate the elongating ribosomal frequency on 
each mRNA in a cellular population based on the number of footprints aligned to that 
mRNA (Section 2.10.12). This gives valuable information on the levels of 
translation, frame of translation and reveals which genes are being translated and 
under what conditions this occurs (Ingolia et al., 2013; Ingolia et al., 2009). This can 
also be applied to measure viral gene expression during different stages of infection 
in a cell. A necessary control is to prepare an RNA extract in which the ribosomes 
are removed. This RNA is then subjected to limited fragmentation using an alkaline 
buffer followed by RT-PCR amplification prior to sequencing. This provides a 
control for potential bias occurring during the isolation of the short RNA fragments 
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and in the RT-PCR step during preparation of sequencing libraries. This control can 
also be used to establish the abundance of individual mRNAs in the cell. 
 
The aim of this chapter was to use ribosomal profiling to build a transcriptional and 
translational profile of bRSV to investigate transcriptional and translational 
regulation. The data obtained here for bRSV was compared and analysed with hRSV 
transcriptional and translational profiles built and processed from obtained raw 
sequencing data that was generated previously by Dr Phillip Gould.  
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3.2. Ribosomal profile analysis of bRSV and hRSV transcription and 
translation 
A detailed method of the ribosomal profiling technique used to build sequencing 
libraries for next generation sequencing from bRSV (Snook strain) infected MDBK 
cells harvested at 4 and 8 hours post infection (hpi) can be found in Section 2.10. The 
bRSV Snook strain was chosen to be used due to the strain being extensively studied 
in animals (Blodörn et al., 2014; Blodörn et al., 2015; Gaddum et al., 2003). This 
bRSV strain was also one of the only laboratory strains available that was pathogenic 
to cells (Thomas et al., 1998; Thomas et al., 1982). These two early time points of 
infection for both viruses were chosen as it has been reported (Bermingham and 
Collins, 1999) that the switch from transcription to replication of the viral genome 
began between 12-15 hpi. Therefore at the 4hr time point in particular it was 
expected that transcription was likely to be the primary function of the virus RdRP 
rather than replication. As the levels of viral transcription were likely to be near 
maximal, these were also optimal times to investigate whether regulation of 
translation could be detected. 
 
Two libraries were created and sequenced for bRSV at each time point. The first 
(protected) comprised of a sequencing library where the sequences originated from 
the footprints belonging to elongating ribosomes translating mRNA. This sequencing 
library determined the location of all elongating ribosomes at the time point and was 
used to produce a translational profile. The second (total) consisted of sequences that 
originated from total cellular RNA after removal of ribosomes. This was the control 
for the ribosome protected libraries to ensure that there was no bias incorporated in 
later stages of the sequencing protocol and was also used to construct a 
transcriptional profile where the levels of mRNA could be quantified. Additional 
controls derived from total and protected RNAs extracted from mock infected cells 
were also prepared to ensure there was no previous viral contamination. No evidence 
of prior infection was detected and these data are not shown.  
 
Raw next generation sequencing data generated from ribosomal profiling of Hep-2 
cells infected with hRSV A2 strain were acquired from Dr Phillip Gould. Similar to 
bRSV, these hRSV infected cells had been harvested at 4 and 8 hpi and for each time 
point and each time point had the respective protected and total libraries sequenced. 
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Sequencing data from the analysis was stored on the cloud server BaseSpace. Table 
3.1 gives the sequencing library name, the time point cells were harvested and the 
type of sequencing library. For completeness the equivalent data for the hRSV are 
also given (P. Gould and A. Easton, personal communication). BaseSpace was also 
used to test the quality of the raw sequencing data. All raw data was processed on an 
iMAC 2013, on a OS X Yosemite operating system. A workflow diagram of the 
scripts and software used to process the raw next generation sequencing data are 
shown in Fig. 3.1. All scripts were run in terminal, and bash commands were used to 
run the scripts. Full commands and variables used to execute each script are given in 
Appendix A.  
 
Sample Time point 
harvested post 
infection of virus 
Protected/Total Virus used Transcriptional 
or Translational 
profile 
bRSV8T 8 hours Total  bRSV Transcriptional 
bRSV8P 8 hours Protected bRSV Translational 
bRSV4T 4 hours Total bRSV Transcriptional 
bRSV4P 4 hours Protected bRSV Translational 
hRSV8T 8 hours Total  hRSV Transcriptional 
hRSV8P 8 hours Protected hRSV Translational 
hRSV4T 4 hours Total hRSV Transcriptional 
hRSV4P 4 hours Protected hRSV Translational 
 
Table 3.1: List of sequencing libraries used  
Description of sequencing libraries used to create transcriptional and translational profiles  
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Fig. 3.1: Workflow diagram of processing raw next generation sequencing data 
Workflow diagram of processing raw next generation sequencing data created through the technique 
of ribosomal profiling and open source software used to process the data. 
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3.3. Quality control of raw data 
Quality control of raw next generation sequencing data was performed using the 
FastQC software on the cloud server BaseSpace. This software analysed the quality 
of each base along each read. On average, each read was 51nts before trimming. This 
length included the sequencing sample, the adaptor primer and sequencing bar codes. 
The software allocated a score to each base for each nucleotide based on the quality 
of each read. A score below 20 indicated a poor quality nucleotide. A score where 
the median was less than 20 and the lower quartile was less than 10 was considered 
completely unusable. A median score between 20 and 28 was considered to be of 
reasonable quality and could be used. The red line for each nucleotide indicates the 
median value, the yellow box represents the inter-quartile range and the whiskers 
represent the 10% and 90% points. The blue line represents the mean quality. 
 
Fig. 3.2 shows a representative quality control (QC) plot for the library bRSV8P. QC 
plots for all libraries can be found in Appendix B1. All sequencing libraries scored a 
high quality score for each nucleotide in the 51 nucleotide fragment. All nucleotide 
positions had the bottom 10% of reads above a score of 28, considered to be an 
excellent quality of sequence read. The high quality of sequencing meant that it was 
possible to produce transcriptional and translational profiles in the confidence that no 
errors were created during the next generation sequencing of sample libraries due to 
poor quality of reads. 
 
 
Fig. 3.2: QC plot of reads from sequencing library bRSV8P 
QC plot, derived from FastQC software, of reads from bRSV sequencing library bRSV8P. The plot 
shows the quality of each nucleotide along unprocessed reads.  
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3.4.1.1. Identification of a transcription polar gradient during transcription for 
bRSV 
Total sequencing libraries containing sequences originating from total RNA from 
infected cells were used to build a transcriptional profile of bRSV gene expression in 
MDBK cells harvested at 4 and 8 hpi. These samples contained virus genome and 
antigenome RNA as well as mRNAs, with mRNA representing the highest 
proportion of viral RNA present. Although there has been no investigation into the 
mRNA half-life for bRSV, previous studies on other members of the 
Mononegavirales order (VSV) have determined that the half-life of all viral mRNAs 
were the same (Pennica et al., 1979). 
 
Alignment of sequencing libraries bRSV4T and bRSV8T to bRSV mRNAs 
A detailed description of the processing of raw data is given in Section 3.2. The 
minimum read length aligned against each mRNA was 25nts. This was the 
recommended read size suggested by the manufacturer’s protocol for the ARTseq 
Ribosomal Profiling kit used to prepare sequencing libraries. Alignments were 
performed using the Bowtie open source software (Ingolia et al., 2012). As the 
complete genome sequence for the bRSV Snook strain has not yet been reported, the 
sequence of the bRSV strain A51908 (accession: AF092942.1) was used to align the 
sequence library. Each bRSV mRNA sequence from bRSV A51908 strain was 
separately aligned against both sequencing libraries. 
 
The L and M2 genes overlap by 67nts (Zamora and Samal, 1992) and 
unambiguously distinguishing the origin of reads aligned to the overlap region was 
therefore not possible. In addition, it has been shown for hRSV that a short 
polyadenylated RNA representing the overlap region of the M2 and L genes is 
produced as an independent transcript (Collins et al., 1987). For this reason the two 
more separate alignments were performed where the overlap region was not included 
so that transcription from the L and M2 genes could be distinguished (Collins et al., 
1987). 
 
As each mRNA is a different length, the number of reads aligned to each was 
normalised against the length of that mRNA. This was performed by taking the mode 
read length from each sequencing library, which was identified using the software 
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FastQC to plot the frequency of different sized read lengths as shown in Fig. 3.3 (30 
bp for bRSV4T and 30 bp bRSV8T). The adjusted read frequency was then 
calculated by dividing the length of the mRNA by the mode read length. This figure 
was then divided into the number of reads aligned for that specific mRNA. This 
adjusted figure represented the actual number of mRNA strands belonging to each 
mRNA and the results for each mRNA are presented as a percentage of the adjusted 
total number reads aligned to all bRSV mRNAs for each sequencing library. The 
specific calculation can be found in Section 2.10.13. A proportion of all alignments 
originated from genomic and antigenomic RNA. However, these could not be 
separated from the mRNA. However, as replication has not begun at the time points 
chosen, both the genome and antigenome RNA will be present in very low quantities 
and therefore as each contains equimolar amounts of sequence from all genes they 
will not affect the final calculation. 
 
A 
B 
 
Fig. 3.3 Sequence length distribution of reads in libraries bRSV4T and bRSV8T 
Analysis of libraries was performed using FastQC software. Libraries were analysed after the removal 
of sequences from adaptor primers and barcodes before analysis. (A) Sequence length distribution of 
reads in the sequencing library bRSV4T. The mode read length was 30bp. (B) Sequence length 
distribution of reads in the sequencing library bRSV8T. The mode read length was 30bp. 
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3.4.1.2. Transcriptional profile of bRSV at 4hr and 8 hr post infection 
Sequencing libraries derived from RNA extracted at 4 and 8 hpi were used to build 
transcriptional profiles for bRSV. As shown in Table 3.2, there was a total of 
5,548,383 reads and 7,897,845 reads above 25nts in size for the bRSV4T and 
bRSV8T libraries respectively. There were 3104 reads that aligned to all bRSV 
mRNAs for the bRSV4T library representing 0.06% of the total number of reads for 
this library. There were 53325 reads that aligned to all bRSV mRNAs for the 
bRSV8T library representing 0.68% of the total number for the library. This 
indicates a 11-fold increase in the levels of viral mRNA between the 4 and 8 hour 
time points. This may reflect the increasing levels RdRPs produced as the infection 
proceeds. 
 
Fig. 3.4 shows the levels of bRSV viral mRNA abundance expressed as a percentage 
of the total number of adjusted reads aligned to all bRSV viral mRNAs at 4 and 8 hpi 
as described in Section 3.4.1.1. As seen in Fig. 3.4, the relative levels of mRNA for 
the first 6 genes of the viral genome at both time points resemble that of the 
predicted polar transcription gradient model. At 4 hpi, for the first three genes NS1 
(14.5% of total viral mRNA), NS2 (15.4%) and N (14.7%), there was little 
fluctuation between the levels of mRNA. However at 8 hpi, the NS1 (18%) and N 
(17.9%) mRNA levels were higher compared to NS2 (14.1%) which did appear to 
change dramatically with time. This is not consistent with a polar gradient of 
transcription but may reflect the accumulated effects of the different stabilities of the 
mRNAs. Further analysis is required to explore this. 
 
The levels of mRNA at 4 hpi from the N, M, P, SH and G genes decreased from 
14.7% of the total level of viral mRNA for the N gene to 4.9% of the total level of 
viral mRNA for the G gene. However, this was not a linear decrease and there was 
only a very slight decrease observed between the levels of mRNA from the P 
(11.5%), M (10.9%), and SH (10.2%) genes with a much greater decrease of 5.3% 
between the SH and G genes. A similar pattern was observed with these 5 genes at 8 
hpi. However the steepness of the gradient was greater with the levels of N gene 
mRNA at 17.9% of the total and only 0.9% of total mRNAs from the G gene. The 
decrease in the levels of mRNA between the P (15.3%), M (10.8%) and SH (9.4%) 
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genes were also much larger than seen at 4 hpi, with a decrease of 4.5% between the 
P and M mRNAs and a decrease of 1.4% between the M and SH mRNAs. At 8 hpi, 
the levels of the G gene mRNA, as a proportion of total virus mRNA was also 
significantly lower than at 4 hpi. There was also a significantly larger drop in levels 
of mRNA between the SH and G genes with a decrease of 8.5% at this gene junction. 
Unexpectedly, the G gene was also represented by the lowest level of mRNA from 
the entire genome at 8 hpi. This is not consistent with the polar gradient model of 
transcription and may again reflect differences in stability of the different virus 
mRNAs. 
 
An increase in mRNA levels moving from the G gene to the M2 gene was seen for 
both time points. At 4 hpi there was an increase in mRNA levels by 1% between the 
F gene (5.9%) in comparison to the G gene. Although this increase was small, the 
trend of increasing mRNA levels moving further from the 3´ promoter continued 
with an increase of 3.7% between the F and the M2 (9.6%) genes. This trend was 
also observed at 8 hpi, with an increase in mRNA of 4.5% between the G and F 
(5.4%) genes. A smaller increase of 1.6% was also observed between the F and M2 
(7%) genes. This increase in mRNA abundance along the genome is not consistent 
with a polar gradient of transcription. In addition, the levels of M2 mRNA were 
similar to those from genes further upstream, with mRNAs from the M2 gene at 
9.6% and 7.2% for 4 and 8 hpi, respectively. This was similar to the mRNA levels of 
the SH gene (10.2% and 9.4%) seen at 4 and 8 hpi respectively. 
  
The furthest gene from the 3´ promoter is the L gene that encodes the enzyme 
function of the RdRP. There was a 7.2% decrease in mRNA levels from the 
preceding M2 gene. At 4 hpi, L gene mRNA represented 2.4% of the total level of 
viral mRNAs. As well as having the lowest mRNA abundance, the reduction in level 
compared to the preceding gene was the greatest of all. While there was a similar 
drop in mRNA level at 8 hpi and the L gene was represented by 1.3% less mRNA, it 
was not the gene represented by least mRNA nor was it the greatest drop observed in 
comparison to the levels from the neighbouring upstream gene. The reason for the 
apparent difference in relative level of M2 mRNA is not known and, as before, 
further analysis will clarify the implications of these data. 
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The level of mRNA derived from of the 67nt overlap between the M2 and L gene is 
shown in Fig. 3.5. As can be seen, for the M2 gene at 4 hpi a large proportion of 
reads aligned to this overlap region, with 52% of the total aligned solely to the 
remainder of the M2 gene arising from this area. As it was not possible to assign 
these to the M2 or L genes, or to the 67nt polyadenylated RNA that is generated, this 
prevented accurate estimation of the increase in the level of mRNAs between the F 
and M2 genes at 4 hpi. The level was lower (6%) at 8 hpi. This did not affect the 
levels of mRNA abundance for M2 or L genes. Therefore it is possible to accurately 
estimate the level of mRNAs between the F and M2 genes at 8 hpi. 
 
The data from this section would suggest that between certain genes in the genome, 
levels of mRNA abundance did not follow the polar gradient model of transcription 
at one or both time points. This either could be due to the divergence in mRNA half-
life between different gene transcripts or the current model of transcription is not 
accurate.  
 
 
 
Table 3.2: Number of reads in sequencing libraries bRSV4T and bRSV8T  
Number of reads in the sequencing libraries bRSV4T and bRSV8T and total number of reads aligned 
to bRSV mRNAs.  
 bRSV4T bRSV8T 
Total number of reads 25nts 
or above  
 5,548,258  7,897,845 
Number of reads aligned to 
bRSV mRNAs 
 3,104  53,325 
Percentage of reads aligned 
to bRSV mRNAs 
 0.06  0.66 
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Fig. 3.4: Transcriptional profile of all bRSV mRNAs in infected MDBK cells harvested at 4 hpi 
and 8 hpi  
Transcriptional profile of bRSV at 4hpi and 8hpi using the sequencing libraries bRSV4T and bRSV8T 
respectively. Transcriptional profile is displayed as the level of reads aligned to each mRNA as 
percentage of total reads aligned to bRSV viral genome. Reads have been normalised against the size 
of each mRNA. 
 
 
Fig. 3.5: Transcriptional profile showing the levels mRNA abundance of M2 and L mRNAs of 
bRSV at 4 hpi and 8 hpi.  
Transcriptional profile showing the abundance of bRSV M2 and L mRNAs at 4hpi and 8hpi using the 
sequencing libraries bRSV4T and bRSV8T respectively. The transcriptional profile is expressed as 
the level of reads aligned to each mRNA as a percentage of total reads aligned to bRSV. Reads were 
normalised against the size of each mRNA. The figure also shows the adjusted percentage when the 
sequence from M2/L overlap was removed from the alignment of each mRNA sequence. M2-L 
represents the removal of the overlap sequence from M2 mRNA during alignment. L-M2 represents 
the removal of the overlap sequence from L mRNA during alignment.   
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3.4.2.1. Identification of a polar transcription gradient of hRSV genes 
Sequencing libraries derived from total unprotected RNA were used to build 
transcriptional profiles of hRSV strain A2 by Dr Phillip Gould using the approach 
described above. As with bRSV the sequence libraries were created from RNA 
harvested at 4 hpi (hRSV4T) and 8 hpi (hRSV8T). As with bRSV, there is currently 
no data on the half-life of hRSV mRNAs but studies on other members of the 
mononegavirales order (VSV) suggested that the half-life of all viral mRNAs were 
the same (Pennica et al., 1979). All data analysis for the hRSV transcriptional 
profiling was carried out as part of this thesis. 
 
Alignment of sequencing libraries hRSV4T and hRSV8T to hRSV mRNAs 
A detailed description of the processing of raw data is given in Section 3.2. The 
minimum read length aligned against each gene was 25nts and alignments against the 
hRSV A2 genome (accession: KT992094.1) were performed using Bowtie open 
source software. Each hRSV mRNA sequence from the hRSV A2 strain was 
separately aligned against both sequencing libraries. In hRSV the M2 and L genes 
overlap by 68nts (Fearns and Collins, 1999a) and the analysis of this region was as 
before (Section 3.4.1.1). FastQC software was used to plot the read length 
distribution in each library. The mode length of 36 bp for hRSV4T and 34 bp 
hRSV8T is shown in Fig. 3.6. Reads were adjusted for gene transcript length using 
the same method as described in Section 3.4.1.1.  
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A 
B 
 
 
Fig. 3.6 Sequence read length distribution in sequencing libraries hRSV4T and hRSV8T 
Analyses of libraries were performed using FastQC software. Libraries were analysed using the 
FastQC software after removal of adaptor primers and barcode sequences. (A) Sequence read length 
distribution in the sequencing library hRSV4T. The mode read length was 36bp. (B) Sequence read 
length distribution in the sequencing library hRSV8T. The mode read length was 34bp. 
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3.4.2.2. Transcriptional profile of hRSV at 4 and 8 hpi 
The sequencing libraries hRSV4T and hRSV8T were used to create transcriptional 
profiles of hRSV at 4 and 8 hpi. The sequence reads from each library were aligned 
against each hRSV A2 gene. As seen in Table 3.3, there was a total of 3,733,622 
reads in the sequencing library hRSV4T and 6,693,375 reads in the sequencing 
library hRSV8T that were above 25nts in size. At 4 hpi, 6,219 reads (0.17% of the 
total) were aligned to hRSV genes. At 8 hpi 18,713 (0.28% of the total) reads were 
aligned to hRSV genes. The read density suggested that there was a 16-fold increase 
in mRNA levels between 4 and 8 hpi which was a greater increase than was seen 
with bRSV. However, this may simply reflect differences in sample sizes for the two 
virus systems. 
 
Fig. 3.7 shows hRSV viral mRNA abundance as a percentage of the total number of 
adjusted reads aligned to all hRSV viral mRNAs in hRSV infected cells at 4 and 8 
hpi as described in Section 3.4.1.1. As expected the NS1 gene as the first gene in the 
genome was the most represented by mRNA levels of all genes (20.9% and 40.5% of 
total virus mRNAs at 4 and 8 hpi, respectively) and the L gene represented the least 
at both time points (0.6% and 0.4% of all viral mRNAs at 4 and 8 hpi, respectively) 
as the furthest gene from the 3´ promoter in the genome. 
 
At 4 hpi, a decrease in mRNA levels occurred between the NS1 gene (gene 1) and 
the N gene (gene 3) with a decrease of 4.2% in levels of mRNA between the NS1 
(20.9% of total virus mRNAs) and NS2 (16.7%) genes. A similar decrease of 4.3% 
was seen between the NS2 and N (12.4%) genes. However an increase of 2.6% was 
seen in mRNA levels between the N and P genes. A decrease in mRNA levels was 
seen sequentially in the P to G genes with a small decrease of 3% between the P 
(15%) and M (12%) genes, a larger decrease of 7.7% between the M and SH (4.2%) 
genes and a small decrease of 0.7% between the SH and G (3.6%) genes. Levels of 
mRNA increased between the G and M2 genes with an increase of 2.7% between the 
G and F (6.3% of virus mRNAs) genes and 2% increase between the F and M2 
(8.3%) genes. These two increases in mRNA abundance observed between 
neighbouring genes were a divergence from the polar gradient of transcription. 
Finally, a decrease of 7.7% in the levels of mRNA was detected between the M2 and 
L genes. 
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A similar pattern of changing RNA levels was seen at 8 hpi, though the precise levels 
differed and there was no increase in mRNA levels between the N and P genes as 
was seen at 4 hpi. There was an increase that was not consistent with the polar 
gradient model in mRNA levels between the NS2 and N genes. The values obtained 
for the genes were: the NS1 gene expressed 40.5% of total virus mRNAs, the NS2 
gene 10.5%, the N gene 15.3%, the P gene 8.9%, the M gene 8.9%, the SH gene 
1.4%, the G gene 0.5%, the F gene 5.7%, the M2 gene 7.8% and the L gene 0.4%. 
 
As with the bRSV M2/L gene overlap region separate sets of alignments were 
performed in which the overlapping sequence were removed from each gene and the 
remaining sequences aligned against the sequence library. For each mRNA with the 
removed overlap, a new the figure as a percentage of total viral mRNAs was 
calculated. As seen in Fig. 3.8, the proportion of reads found in this overlap is 
extremely small these did not affect the overall transcriptional profile observed for 
hRSV. 
 
The data from this section would suggest that between certain genes in the genome, 
the levels of mRNA abundance did not follow the polar gradient model of 
transcription at one or both time points. This either could be due to the divergence in 
mRNA half-life between different gene transcripts or the current model of 
transcription is not accurate.  
 
Table 3.3: Number of reads in sequencing libraries hRSV4T and hRSV8T  
Number of reads in the sequencing libraries hRSV4T and hRSV8T and total number of reads aligned 
to hRSV mRNAs.  
 hRSV4T hRSV8T 
Total number of reads 
25nts or above  
 3,733,380  6,688,948 
Number of reads aligned 
to hRSV mRNAs 
 6,219  18,713 
Percentage of reads 
aligned to hRSV gene 
transcipts 
0.17   2.8 
	 101	
 
Fig. 3.7 Transcriptional profile of all hRSV mRNAs at 4hpi and 8hpi.  
Transcriptional profile of hRSV at 4hpi and 8hpi using the sequencing libraries hRSV4T and hRSV8T 
respectively. Transcriptional profile is displayed as the level of reads aligned for each mRNA as 
percentage of total reads aligned to the hRSV viral genome. Reads have been normalised against the 
size of each mRNA. 
 
 
Fig. 3.8: Transcriptional profile showing the levels of mRNA abundance of M2 and L mRNAs in 
hRSV at 4 hpi and 8 hpi. 
Transcriptional profile of mRNA abundance for the hRSV M2 and L mRNAs at 4hpi and 8hpi using 
the sequencing libraries hRSV4T and hRSV8T, respectively. The transcriptional profile is expressed 
as the level of aligned for each mRNA as percentage of total reads aligned to hRSV. Reads were 
normalised against the size of each mRNA. The figure also shows the adjusted percentage when the 
sequence from M2/L overlap is removed from the alignment of each mRNA sequence M2-L 
represents the removal of the overlap sequence from the M2  mRNA during alignment. L-M2 
represents the removal of the overlap sequence from the L mRNA during alignment.   
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3.5.1.1. Identifying translational regulation during translation of bRSV viral 
mRNAs 
The current model of regulation of gene expression in pneumoviruses is that the 
majority of the control is exerted through the level of mRNA abundance. There is no 
evidence that regulation of translation influences the level of gene expression, with 
the exception of the M2 ORF-2 in the M2 mRNA. The sequencing libraries bRSV4P 
and bRSV8P contained reads that originated from fragments of mRNA that were 
protected by ribosomes, present a snapshot of the location of all elongating 
ribosomes on virus mRNAs at 4 and 8 hpi, respectively. These data were used to 
build profiles of bRSV mRNA translation which could be interrogated for evidence 
of regulation of translation in bRSV. Regions within mRNA with high or low 
distributions of elongating ribosomes may also indicate areas of interest such as 
highly structural regions or internal initiation sites. With no translation regulation, 
the ribosome distribution for each viral mRNA should be proportionally equal to 
proportional levels of the respective individual mRNAs. Deviation from the expected 
profile would indicate that translational regulation was a factor in viral gene 
expression.  
 
Alignment of sequencing library to bRSV mRNAs 
A detailed description of the processing of raw data is given in Section 3.2. The 
minimum read length aligned against each mRNA was 25nts as recommended by the 
protocol. Alignments were performed using Bowtie open source software. As before, 
the genome sequence of the bRSV strain A51908 was used to align the sequencing 
libraries derived from RNA extracted from cells infected with bRSV (Snook strain). 
The sequencing libraries were aligned against each mRNA sequence from the virus 
genome except for the M2 mRNA. This was due to the presence of two ORFs which 
overlap each other by up to 17nts. To address this, two individual alignments were 
performed. The first used the sequence from the entire M2 ORF-1 including the stop 
codon and the second used the sequence beginning at the AUG at position 554 from 
the start of the M2 mRNA and continued up until the end of the M2 ORF-2. This 
AUG is the 5´ proximal putative start of the M2 ORF-2. As the two ORFs 
overlapped, it was therefore possible that these footprints could align twice in this 
region. The data however showed that there were only very small amount of reads 
aligned to the M2 ORF-2 suggesting that the majority of the reads arose from 
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ribosomes translating the M2 ORF-1. The overlap between the M2 and L genes does 
not present a similar problem, as M2 ORF-2 does not extend into the L mRNA 
sequence. However, a short 67 nt mRNA-like molecule is transcribed from the M2/L 
gene overlap region and as this has the L protein initiation codon and is therefore 
capable of making a short peptide, a proportion of ribosomes at the 5´ end of the L 
mRNA may arise from this RNA rather than the mRNA encoding the entire L 
protein. It was impossible to distinguish the origin of elongating ribosomes in this 
region. Therefore no attempts were made to alter the calculations for this mRNA. 
 
As each mRNA in the viral genome differs in length, the number of reads aligned to 
each mRNA were normalised against the length of the individual mRNAs to provide 
the number of ribosomes per unit length of mRNA. First, the length of each mRNA 
was divided by the mode read length of each sequencing library as shown in Fig. 3.9 
(31 bp for bRSV4P and 28 bp for bRSV8P calculated from the software FastQC). 
This value was the number of fragmented read lengths per mRNA length. The 
mRNA length was divided by the mode read length so levels of translation between 
different libraries could be compared. These values for each mRNA were then 
divided into the number of ribosome protected fragments aligned to the specific 
mRNA to generate the number of full length mRNAs that were completely covered 
in protected fragments (adjusted number of reads). These adjusted reads for each 
mRNA were expressed as a percentage of the adjusted total number of reads aligned 
to all viral mRNAs in each sequencing library. This percentage represented the 
adjusted percentage of total viral translation for each mRNA. The calculation and a 
working example are shown in Section 3.10.3. 
 
Any change in translation compared to mRNA abundance was identified by 
measuring both the change in proportional viral translation to proportional viral 
mRNA abundance and the translational efficiency of each viral mRNA.  
 
Looking at the change in proportional translation to proportional mRNA abundance 
for each viral gene transcript, identified if the respective levels of translation 
matched the levels of mRNA abundance. For each viral mRNA, this was calculated 
by taking the adjusted percentage of total viral translation (as discussed above), and 
comparing this to the adjusted percentage of total viral mRNA abundance (Section 
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3.4.1.2) from the respective total library harvested at that time point. If the 
proportion of viral translation and proportion of mRNA abundance were equal for a 
viral mRNA, then it was unlikely that there was any translation regulation and 
translation was controlled by viral mRNA abundance. However, a change in 
proportional translation to proportional mRNA abundance would suggest that 
translational regulation was influencing the levels of ribosomes translating that viral 
mRNA. 
 
The translational efficiency for each viral mRNA was calculated by dividing the 
adjusted percentage of total viral translation (discussed above) by the adjusted 
percentage of total viral mRNA abundance for each viral mRNA (Section 3.4.1.2). A 
translational efficiency of 1 indicated that there was no translational regulation. A 
translational efficiency between 0 and 1 would indicate that the translation is being 
downregulated. Correspondingly, a translational efficiency value above 1 would 
indicate upregulation to increase translation. In this way a translational efficiency 
value of 1 would indicate that translation of the mRNA is linked to abundance and 
that there is little probability of it being affected by translational regulation. 
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A 
 
B 
 
Fig. 3.9: Sequence length distribution of reads in sequencing libraries hRSV4T and hRSV8T 
Analysis of libraries were performed using FastQC software. Libraries were analysed using FastQC 
software after removal of adaptor primers and barcode sequences. (A) Sequence length distribution of 
reads in the sequencing library bRSV4P. The mode read length was 31 bp. (B) Sequence length 
distribution of reads in the sequencing library bRSV8P. The mode read length was 28 bp. 
 
3.5.1.2. Translational profile of bRSV 
For both sequence libraries bRSV4P and bRSV8P, derived from ribosome-protected 
RNA, reads of 25 nts or longer were aligned against each mRNA (including the M2 
ORF-1 and M2 ORF-2s) from the bRSV strain as before. A total of 6,775,850 reads 
were obtained for the bRSV4P library prepared from RNA extracted at 4 hpi and 
6,665,582 reads for the bRSV8P library for RNA extracted at 8 hpi. Although rRNA 
removal was performed during the preparation of each sequencing library (Section 
3.10.4), 2.5% and 5.2% of reads still aligned to Bos taurus rRNA in the bRSV4P and 
bRSV8P libraries respectively.  
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When aligned to bRSV mRNAs, 0.2% of the reads aligned to the bRSV4P library 
and 1.02% aligned to the bRSV8P library. The increase in level of ribosome-
associated RNAs is likely to be due to the increase in virus mRNA levels detected 
between 4 and 8 hpi described in Section 3.4.1.2. However, the 10-fold increase in 
mRNA levels between 4 and 8 hpi was matched by a 5.1-fold increase in the levels 
of translation. The reason for the difference is not known. Fig. 3.10A and Fig. 3.11A 
shows the change in proportional translation to proportional mRNA abundance for 
each viral mRNA at 4 and 8 hpi, respectively. The translational efficiencies for each 
viral mRNA at 4 and 8 hpi, were displayed in Fig. 3.10B and Fig. 3.11B 
respectively.  
 
M2 ORF-2 was not considered in this analysis due to the unique nature of the M2 
bicistronic mRNA. Translation of this ORF in hRSV is known to use a non-canonical 
mechanism and therefore it is likely that translation of bRSV M2 ORF-2 is regulated 
by factors other than mRNA abundance. The number of reads aligned to this ORF 
were also so small that omission did not affect the calculations. The adjusted 
percentage of total viral translation for the M2 ORF-1 was included and the value for 
ribosome-protected reads aligned to the M2 ORF-1 were adjusted to the size of the 
M2 ORF-1 alone rather than the entire M2 mRNA. For both the translational 
efficiency and the change in proportional translation to mRNA abundance, the 
adjusted percentage of total viral mRNA for the M2 mRNA was used to calculate 
both figures.  
 
Fig. 3.10 shows the data from the RNAs prepared at 4 hpi. Fig. 3.10A shows the 
change in proportional translation to proportional mRNA abundance for each viral 
mRNA and the black line represents the point where the proportion of translation is 
equal to the proportion of mRNA abundance for each mRNA. As no repeats were 
able to be performed for these time points, the mean change in translation against 
mRNA abundance of all mRNAs in the viral genome is shown as the two red lines 
on each figure. This enabled identification of viral mRNAs where the change in 
translation greatly exceeded the mean variation, which would support the possibility 
that the change was not due to random variance and was caused by regulation of 
translation. Fig. 3.10B shows the translational efficiencies for each viral mRNA. 
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At 4 hpi, the NS1, NS2, P and G mRNAs all had higher proportional levels of 
translation than expected from their levels of mRNA abundance, with translational 
efficiencies of 1.22, 1.17, 1.3 and 1.63 respectively. All of these values were higher 
than the average change strongly suggesting that they were subject to translational 
upregulation. 
 
The SH mRNA and M2-1 ORF had lower levels of proportional translation 
compared to the levels of their mRNAs with translational efficiencies of 0.71 and 
0.41, respectively. These changes in translation were also greater than the average 
change, suggesting that both of these mRNAs are translationally downregulated 
 
For the L mRNA, the change in the translation in comparison to mRNA abundance 
was 1.2%, which was below the average change (2.59%). However proportionally, 
this was a 50% drop in translation compared to mRNA abundance and the 
translational efficiency was significantly lower (0.5) than that determined for the SH 
mRNA. This suggests that the decrease in translation was not caused by variation 
and was likely due to downregulation of translation. The low proportional change 
can therefore be accounted for the low levels of translation and mRNA abundance 
instead of a lack of regulation. 
 
For all other viral mRNAs from the N, F and M genes, there was little change in 
translation compared to mRNA abundance. Further replicates of the analysis will be 
required to establish if these small changes are significant.  
  
	 108	
A 
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Fig. 3.10: Comparison of proportional translation against proportional mRNA abundance and 
translational efficiencies of bRSV viral mRNAs harvested at 4 hpi 
 (A)Adjusted levels of translation as a percentage of total reads aligned to all bRSV viral mRNAs 
against adjusted levels of mRNA abundance as a percentage of total reads aligned to bRSV viral 
mRNAs. The black line represents the points where levels of mRNA abundance and translation were 
proportionally equal. The red lines represent the mean change in translation from the levels of mRNA 
abundance. (B). Translational efficiency of viral mRNAs created from libraries where RNA was 
harvested at 4 hpi from sequencing libraries bRSV4P and bRSV4T  
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Fig.3.11A and 3.11B show the comparison between proportional translation to 
proportional mRNA abundance and the translational efficiencies for viral mRNAs 
extracted at 8 hpi. At 8 hpi, the P and G mRNAs had higher levels of proportional 
translation than their proportional levels of mRNA abundance with translational 
efficiencies of 1.27 and 7 respectively. Both of these proportional changes were 
higher than the average change, strongly suggesting that they were subject to 
translational upregulation. 
 
The SH mRNA and M2-1 ORF had lower levels of proportional translation 
compared to the levels of their mRNAs with translational efficiencies of 0.51 and 
0.55, respectively. These changes in translation were also greater than the average, 
suggesting that both of these mRNAs are translationally downregulated at 8 hpi. 
 
As seen at 4 hpi, the L mRNA exhibited a low translational efficiency of 0.27 though 
this proportional change was within the average change. However, given the very 
low translational efficiency value, the data suggests that translation of L mRNA is 
downregulated. 
 
For the other viral mRNAs from the NS1, NS2, N, M and F genes, although all gave 
translational efficiencies greater or lower than 1 they were very close to unity. This 
suggests that these mRNAs are not subject to translational regulation. However, as 
for the equivalent mRNAs at 4 hpi, replicate samples will be required to determine if 
the small changes are significant. 
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Fig. 3.11: Comparison of proportional translation against proportional mRNA abundance and 
translational efficiencies of bRSV viral mRNAs harvested at 8 hpi 
A) Adjusted levels of translation as a percentage of total reads aligned to all bRSV viral mRNAs 
against adjusted levels of mRNA abundance as a percentage of total reads aligned to all bRSV viral 
mRNAs. The black line represents the points where levels of transcription and translation were 
proportionally equal. The red lines represent the mean change in translation from the levels of 
transcription. (B) Translational efficiency of viral mRNAs created from libraries where RNA was 
harvested at 8 hpi from sequencing libraries bRSV8P and bRSV8T  
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3.5.1.3. Comparison of translational profiles between 4 and 8 hpi for bRSV  
In total five viral mRNAs appeared to be upregulated due to translational regulation. 
The P and G mRNA were upregulated at both 4 and 8 hpi. For the P mRNA, the 
increase in translation was similar at both time points. However, in contrast, for the 
G mRNA, there was a 4.4-fold increase in translation efficiency between 4 and 8 hpi. 
 
The SH, L mRNA and M2 ORF-1 were all downregulated at both time points. The 
levels of downregulation appeared to increase for both the L and SH mRNAs, with a 
0.71-fold and 0.54-fold decrease for SH and L mRNAs respectively over both time 
points. For the M2 ORF-1, only a small change in the levels of translation was 
observed between the two time points with downregulation observed in both 
samples. Translation of NS1 and NS2 mRNAs were clearly upregulated at 4 hpi, but 
not regulated at 8 hpi. 
 
3.5.2.1. Translational profile of hRSV 
To investigate potential translational regulation in hRSV gene expression the 
sequencing libraries hRSV4P and hRSV8P (provided by Dr Phillip Gould) were 
analysed as described in Section 3.5.1.1. 
 
Alignment of sequencing library to hRSV mRNAs 
Sequences with a read length of 25 nts or above were used as recommended by the 
protocol and the data were processed as before in Section 3.5.1.1, with alignments 
performed using the Bowtie open source software. The sequence for hRSV strain A2 
genome was used to align each hRSV mRNA sequence (except the M2) against both 
sequencing libraries. The M2 mRNA used the same method as described in Section 
3.5.1.1 to align the separate ORFs and to account for the M2 ORF-1/ORF-2 overlap. 
The mode read length of each sequencing library is shown in Fig. 3.12 and was 29 bp 
for hRSV4P and 29 bp for hRSV8P. The same methods as described in Section 
3.5.1.1, were used to calculate both the translational efficiency and to compare the 
change in proportional translation to the proportional levels of mRNA abundance for 
each viral mRNA.  
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A 
 
B 
 
Fig. 3.12: Sequence length distribution of reads in sequencing libraries hRSV4T and hRSV8T 
Analysis of libraries were performed using FastQC software. Libraries were inputted into FastQC 
software after reads had been trimmed of adaptor primers and barcodes. (A) Sequence length 
distribution of reads in the sequencing library hRSV4P. The mode read length was 29 bp. (B) 
Sequence length distribution of reads in the sequencing library hRSV8P. The mode read length was 
29 bp.  
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3.5.2.2. Translational profile of hRSV from sequencing libraries hRSV4P and 
hRSV8P 
A total of 9,461,174 reads was obtained for the sequencing library hRSV4P and 
10,083,760 for the sequencing library hRSV8P. Although rRNA removal was 
performed during the preparation of each sequencing library (Section 3.10.4), 33% 
and 33.9% of reads still aligned to Homo sapien rRNA in the hRSV4P and hRSV8P 
libraries respectively.  
 
When aligned to hRSV mRNAs, 79,060 (0.84%) and 628,988 (6.24%) reads aligned 
to the hRSV4P and hRSV8P libraries respectively, suggesting a 7.5 fold increase in 
translation of hRSV mRNAs between 4 and 8 hpi. As for the analysis of bRSV 
mRNAs, reads aligned to the levels of translation of M2 ORF-2 were omitted for the 
subsequent analysis. 
 
At 4 hpi, the N and G mRNAs had higher levels of proportional translation than the 
proportional levels of their mRNA abundances with translational efficiencies of 1.5 
and 1.98, respectively (Figs. 3.13A and Fig. 3.13B). Both mRNAs had higher 
changes in translation that the average, suggesting that they were subject to 
translational upregulation. For the SH mRNA, there was an increase in proportional 
translation in comparison to the level of the mRNA. While this was less than the 
average change the translational efficiency was higher than that of the N mRNA 
(1.63) suggesting that translation of SH mRNA was regulated. This proportional 
change being lower than the average change was likely due to the low levels of 
translation and mRNA abundance. As although a large proportional increase was 
observed, suggesting regulation, in real terms this was only a small increase which 
was smaller than the average change.  
 
The NS1 mRNA alone had a reduced level of translational efficiency of 0.69. This 
change in proportional translation was also greater than the average change, 
suggesting that this mRNA was subject to translational control leading to reduced 
translation. 
 
As seen with bRSV, the hRSV L mRNA demonstrated a low translational efficiency 
with a value of 0.68 even though the proportional change was smaller than the 
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average change. This was also similar to the translational efficiency observed in the 
downregulated NS1 mRNA. This suggests that translation of the L mRNA is 
downregulated at 4 hpi. For other viral mRNAs from the NS2, P, M, SH, F and M2 
genes, the values of translational efficiencies did not also significantly differ from 
unity suggesting that their translation was determined by mRNA abundance alone.  
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Fig. 3.13: Comparison of proportional translation against proportional mRNA abundance and 
translational efficiencies of hRSV viral mRNAs harvested at 4 hpi 
 (A) Adjusted levels of translation as a percentage of total reads aligned to all hRSV viral mRNAs 
against adjusted levels of levels of mRNA abundance as a percentage of total reads aligned to all 
hRSV viral mRNAs. The black line represents the points where levels of mRNA abundance and 
translation were proportionally equal. The red lines represent the mean change in translation from the 
levels of mRNA abundance. (B) Translational efficiency of viral mRNAs from the hRSV sequencing 
libraries hRSV4P and hRSV4T.   
0
0.5
1
1.5
2
2.5
NS1 NS2 N P M SH G F M2	ORF-1 L
Tr
an
sl
at
io
na
l	e
ffi
ci
en
cy
mRNA
NS1NS2
N P
MSHG F M2	ORF-1 
L0
5
10
15
20
25
30
0 5 10 15 20 25 30Adj
us
te
d	
pe
rc
en
ta
ge
	o
f	t
ot
al
	v
ir
al
	tr
an
sl
at
io
n	
fr
om
	th
e	
pr
ot
ec
te
d	
se
qu
en
ci
ng
	li
br
ar
y	
hR
SV
4P
	
Adjusted	percentage	of	total	mRNA	abundance	from	the	total	
sequencing	library	hRSV4T	
	 116	
Fig.3.14A and 3.14B display the comparison between proportional translation to 
proportional mRNA abundance and the translational efficiencies for sequencing viral 
mRNA harvested at 8 hpi respectively (libraries hRSV8P and hRSV8T) 
 
At 8 hpi, the NS2 and SH mRNAs had higher proportional changes in translation 
than the average change, with translational efficiencies of 1.83 and 6.57 respectively. 
This indicates that translation of these mRNAs was being upregulated. As observed 
for the SH mRNA at 4hpi, there were high translational efficiencies for the G and P 
mRNAs (1.64 and 13.03, respectively) though neither had a greater proportional 
change than the average change seen with all mRNAs in this sample. These high 
translational efficiencies suggest that translation of both P and G mRNAs were 
upregulated. The G mRNA also had the highest translational efficiency of both time 
points. 
 
The NS1 mRNA was the only mRNA that had significantly reduced translational 
efficiency with a value of 0.29, the proportional change was also greater than the 
average change. This indicates that the NS1 mRNA was translationally 
downregulated. As seen at 4 hpi, there was a decrease in the translational efficiency 
(0.47) for the L mRNA though the change was lower than the average change. As 
described at 4hpi, this low translational efficiency likely means that downregulation 
of translation for the L mRNA was observed. 
 
For the M, F and M2 mRNAs, the values did not exceed the average change and 
were close to unity. This suggests that for these mRNAs at this time point there was 
no translational regulation and the translation was determined primarily by mRNA 
abundance.   
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B 
 
Fig. 3.14: Comparison of proportional translation against proportional mRNA abundance and 
translational efficiencies of hRSV viral mRNAs harvested at 8 hpi  
 (A) Adjusted levels of translation as a percentage of total reads aligned to all hRSV viral mRNAs 
against adjusted levels of mRNA abundance as a percentage of total reads aligned to all hRSV viral 
mRNAs. The black line represents the points where levels of mRNA abundance and translation were 
proportionally equal. The red lines represent the mean change in translation from the levels of mRNA 
abudance. (B) Translational efficiencies of mRNAs from the hRSV sequencing libraries hRSV8P and 
hRSV8T..   
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3.5.2.3. Comparison of translational profiles between 4 and 8 hpi for hRSV  
A 6.6-fold increase in translational efficiency was seen for the G mRNA, which was 
the highest increase for all viral mRNAs between the two points. This suggests that 
there was a significant increase in translation of this mRNA at 8 hpi. There was also 
an increase in translation efficiency for the SH mRNA from 4 to 8 hpi, with a 4.03-
fold increase between the two time points.  
 
The NS1 and the L mRNAs were both poorly translated at both time points and the 
degree of downregulation increased for both the L and NS1 mRNAs, with a 0.42 and 
0.62-fold decrease for NS1 and L mRNA, respectively between 4 and 8 hpi. 
 
It is also interesting that translation of N and NS2 viral mRNAs were clearly 
upregulated at one time point but not regulated at the other with the N mRNA 
regulated at 4 hpi and the NS2 mRNA regulated at 8hpi. For the other viral mRNAs, 
the levels of translational regulation did not exceed the mean change indicating that 
they were not subject to translational regulation.   
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3.6. Conclusions 
A summary of the levels of mRNA detected for each virus at 4 and 8 hpi are shown 
in Table 3.4. The transcriptional profiles of both viruses followed similar trends in 
the levels of mRNA abundance. For genes located between the NS1 and G genes in 
the genome at 4 hpi, there was a decreasing gradient of mRNA abundance. At 8 hpi, 
this trend was also observed in both viruses with the exception of the NS2 mRNA 
abundance which was at lower levels that the adjacent N gene mRNA. This is 
interesting, as the lower NS2 mRNA level was not observed for both viruses at 4 hpi 
and may indicate that factors other than the RdRP or that the mRNA half-life are 
influencing transcription changes for this mRNA at later stages of infection. The 
hRSV SH mRNA had significantly lower levels of mRNA in comparison to levels 
observed for the bRSV SH mRNA which may be due to different transcription levels 
in the two viruses, or that the mRNA half-lives for these two mRNAs differ. 
 
Progressing along the virus genome from the G to M2 genes in both viruses there 
was a sequential increase in the levels of mRNA abundance in the same order from 
the 3´ promoter genome at both time points which is not consistent with the polar 
gradient model of transcription. However, the analysis was based on steady-state 
levels of mRNA and did not take account of mRNA half-lives, which may play a role 
in determining the final levels of each mRNA in infected cells.  
 
The relative abundances of the M2 and L mRNAs were consistent with the model of 
polar transcription. |It was also seen that the abundance of the G mRNA in both 
viruses were extremely low at 8 hpi. Again this is not consistent with the polar 
gradient of transcription but may be due to differential mRNA stability. 
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Table 3.4: Summary of mRNA levels at 4 and 8 hpi for bRSV and hRSV 
The levels of viral mRNA abundance for each gene are expressed as a percentage of the total virus-
specific mRNAs at 4 and 8hpi. Percentage has been adjusted for size of each viral mRNA. 
 
A summary of the translational efficiency of mRNA detected for each virus at 4 and 
8 hpi are shown in Table 3.5. In both viruses there appears to be translational 
regulation occurring for various viral mRNAs. For both bRSV and hRSV 
translational profiles, only the G mRNA appears to be upregulated in both viruses at 
both time points, contrasting with the reduction in observed levels of mRNA. There 
also appears to be upregulation in both viruses throughout the first 8 hr of infection 
for the P mRNA with the exception for translation of the hRSV P mRNA at 4hpi. 
There are also examples of upregulation observed for other viral mRNAs at one time 
point in one virus but not the other. For example this is seen with the NS2 and NS1 
mRNAs at 4 hpi for bRSV and the NS2 mRNA at 8 hpi for hRSV. 
 
The L mRNA is the only mRNA from which translation is reduced in both viruses at 
both time points with this being greater at the later time point. For bRSV, the SH and 
M2-1 mRNAs were poorly translated at both time points as was the situation for the 
hRSV NS1 mRNA. It is interesting to note that the SH mRNA was upregulated at 
both time points for hRSV and downregulated for both time points in bRSV. This 
may suggest that translational regulation is necessary in both viruses to produce the 
required levels of the proteins, which could be attributed to the differences in the 
levels of mRNA abundance between the two viruses. 
 
 
  
 Virus gene 
Virus and time 
point 
NS1 NS2 N P M SH G F M2 L 
bRSV 4 hr 14.5 15.4 14.7 11.5 10.9 10.2 4.9 5.9 9.6 2.4 
8 hr 18.0 14.1 17.9 15.3 10.8 9.4 0.9 5.4 7.0 1.3 
hRSV 4 hr 20.9 16.7 12.4 15.0 12.0 4.3 3.6 6.3 8.3 0.6 
8 hr 40.5 10.5 15.3 8.9 8.9 1.4 0.5 5.7 7.8 0.4 
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 Virus gene 
Virus and time 
point 
NS1 NS2 N P M SH G F M2 
ORF-1 
L 
bRSV 4hr 1.22 1.17 0.94 1.3 0.94 0.71 1.63 0.76 0.42 0.50 
8hr 0.92 1.11 0.94 1.27 1.12 0.51 7 0.76 0.55 0.27 
hRSV 4hr 0.69 0.88 1.5 1.04 0.85 1.63 1.98 0.75 0.89 0.68 
8hr 0.29 1.86 1.06 1.64 1.19 6.57 13.03 0.72 0.89 0.47 
Table 3.5: Summary of translation efficiencies mRNA levels at 4 and 8 hpi for bRSV and hRSV 
Translational efficiencies for viral mRNAs for hRSV and bRSV at 4 and 8hpi.  
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Chapter 4 
Characterisation of 
bRSV M2 ORF-2 
Initiation Mechanism 
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4.1. Introduction  
The method of initiation of translation for ORF-2 of the M2 gene transcript of two 
viruses from the Orthopneumovirus genus has been investigated (Ahmadian et al., 
2000; Gould and Easton, 2007). For both hRSV and PVM the method of initiation 
reported was that of coupled translation termination/initiation. There is currently no 
data on the method of initiation of translation of ORF-2 in the M2 gene transcript of 
bRSV. 
 
The M2 gene of bRSV is the ninth gene from the 3´ end of the viral genome. The 
gene is 960 nts in size and is translated into a bicistronic gene transcript, which 
contains two open reading frames. The two ORFs overlap each other by 17 nts from 
position 554 to 570 on the M2 gene transcript (Fig. 4.1A). The first ORF (M2 ORF-
1) which is 570 nts in size is translated to the protein M2-1. The second ORF (M2 
ORF-2), which is 282 nts in size, is translated to the smaller protein M2-2. M2 ORF-
2 is in the second reading frame relative to the reading frame of M2 ORF-1 (M2-1 
ORF). There are two potential initiation sites located in the M2 ORF-1/ORF-2 
overlap region for the initiation of M2 ORF-2 (M2-2 ORF) (Fig. 4.1B) and these are 
separated by six nucleotides (beginning at positions 554 and 563 from the start of the 
M2 gene transcript). The second start codon at position 563 is 2 nucleotides from the 
ORF-1 stop codon. Neither start codon has a perfect Kozak sequence; with the 5´-
proximal start codon consisting of UGUUAAUGA and the 3´ start codon consisting 
of ACAAAAUGA. Although other viruses within this genus that have been 
investigated can use all of the start codons as potential start codons in their 
overlapping regions, it is not known in bRSV which of these initiation sites is used. 
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A 
 
B 
 
549-UGUUAAUGAACAAAAUGAAUAA-570 
 
Fig. 4.1: Schematic of bRSV gene transcript and the M2 ORF-1/ORF-2 overlap region 
(A) Schematic of the bRSV M2 gene transcript highlighting both ORF-1 (M2 ORF-1) (position 10-
570) and ORF-2 (M2 ORF-2) (position 554-835). (B) Sequence of the 3´ end of M2 ORF-1 from 
position 549-570 of the M2 gene transcript. Sequence includes the M2 ORF-1/ORF-2 overlap region 
from position 554 to 570. Potential AUG sites for initiation of M2 ORF-2 are underlined beginning at 
positions 554 and 563. The terminating stop codon for ORF-1 is highlighted in bold at position 570.  
 
For the Pneumoviridae family, hRSV has been used as the main model for the 
investigation of the function of each gene in the genome. This includes the functions 
of the M2-1 and M2-2 proteins which are involved in the regulation of virus RNA 
synthesis. The role of the M2-1 protein has been primarily investigated through the 
use of minigenomes. These studies have shown that the M2-1 protein acts as an 
antitermination factor during transcription of the viral genome (Collins et al., 1996; 
Fearns and Collins, 1999b; Hardy and Wertz, 1998). Conversely to the M2-1 protein, 
the role of the M2-2 protein is in the switch from transcription to replication. 
 
hRSV is the most closely related virus in the Orthopneumovirus genus to bRSV in 
terms of sequence homology of the M2 gene. hRSV uses the mechanism of coupled 
translation termination/initiation for the initiation of translation of M2 ORF-2 (M2-2 
ORF). The nucleotide sequence homology between the two viruses for the entire M2 
gene is 68.02% and 76.14% for M2 ORF-1 (M2-1 ORF). Although the M2 ORF-
1/ORF-2 overlap regions in both viruses do not share any consensus sequence, there 
is some sequence homology between the overlap region in the bRSV M2 mRNA and 
upstream sequences in the hRSV M2 mRNA.  
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It is unclear what mechanism is used by bRSV for the initiation of translation of the 
M2 ORF-2. It is possible that bRSV uses the mechanism of coupled translation 
termination/initiation similar to that used by hRSV. The nucleotide sequence 
homologies are very high and although the two viruses do not share the same 
sequences within the overlap region, PVM, which also uses coupled translation 
termination/initiation for the initiation of M2 ORF-2 (M2-2 ORF), has a completely 
different overlap region compared to hRSV. This suggests that although the overlap 
sequence is different this mechanism still may be used in bRSV.  
 
It has been shown that hRSV uses a highly structured region within the M2 ORF-1 in 
the M2 mRNA as a necessary component for coupled translation (P. Gould and A. 
Easton, personal communication). Comparison of the sequences has identified a high 
level of sequence homology (78.45%) between hRSV and bRSV in the region 
surrounding the highly structured element that is essential for initiation of translation 
for the hRSV M2 ORF-2 (positions 390-518 in both viruses). This highly 
homologous sequence may suggest that a similar or related structural region may 
exist in the bRSV M2 mRNA. If this is the case, it would strengthen the likelihood 
that bRSV uses a mechanism similar to that used by hRSV to translate the M2 ORF-
2. However, it is also possible that a coupled translation mechanism used for the 
bRSV M2 mRNA may differ from that observed in other members of the 
Orthopneumovirus genus.  
 
The aim of this chapter is to explore the mechanism of initiation of translation of the 
bRSV M2 ORF-2.  
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4.2.1. Construction of a bRSV M2 gene reporter construct 
To analyse the mechanism of translation of the bRSV M2 ORF-2 it was necessary to 
generate a reporter plasmid. For this plasmid, the sequence for the M2 gene 
transcript from bRSV strain Snook was isolated and cloned into a suitable plasmid. 
 
For each different technique used to create reporter plasmids, a detailed methodology 
can be found in Section 2. Sequences for all primers used in all PCR reactions in all 
sections can be found in Appendix C. 
 
Total RNA was isolated from 30 µl of a bRSV virus stock preparation, containing 
1x106 pfu/ml, using a QIAGEN viral RNA extraction kit and samples were purified 
according to the manufacturer’s instructions (Section 2.6.1). The RNA was reverse 
transcribed into DNA by RT PCR using random primers for extension (Section 
2.6.2). The M2 gene transcript was amplified by PCR (Section 2.3.1) using the 
primer pair M2 GTF and M2 GTR. The amplicon generated was 985 nts in size, and 
contained a Kpn I and Sph I site in the 5´ and 3´ ends, respectively. The amplicon 
was then digested with the endonuclease pair Kpn I/Sph I (Section 2.3.4 and Section 
2.3.5) and the isolated DNA fragment was ligated into the vector pBluescribe 
(Section 2.3.7) which had also been digested with the endonuclease pair Kpn I and 
Sph I (Section 2.3.4 to Section 2.3.6). The plasmid was then transformed into E.coli 
DH5α bacteria and plated onto AMP/IPTG/X-Gal LB agar plates (Section 2.3.8). 
The bacteria were grown overnight at 37oC and colonies were selected on the basis 
of blue/white selection. Each selected colony was grown overnight at 37oC (Section 
2.3.9) and small-scale plasmid preparation was carried out (Section 2.3.13). Purified 
plasmids were digested with endonucleases Kpn I and Sph I to confirm the presence 
of the correctly ligated insert (967 nts) (Section 2.3.4). The plasmids were sequenced 
using the primers T7-91 and T3 down to confirm that the sequence was correct 
(Section 2.3.10). Sequencing results from the plasmid, named pbRSVM2, is in 
Appendix B2.  
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4.3.1. Insertion of a reporter gene into the bRSV M2 ORF-2 
To allow measurement of the level of expression from the bRSV M2 ORF-2 a 
reporter gene was inserted into ORF-2, in an analogous way to those used to study 
the hRSV and PVM systems (Ahmadian et al., 2000; Gould and Easton, 2007). This 
approach was based on the premise that translation of M2 ORF-2 was not reliant on 
sequence downstream of the ORF-1/ORF-2 overlap region. Therefore it was possible 
to replace the ORF-2 sequence with a reporter gene that could be quantified when 
expressed.  
 
The reporter plasmid pbRSVWC (Fig. 4.2) was generated to measure bRSV M2 
ORF-2 expression. The reporter plasmid contained a T7 promoter, which allowed a 
T7 RNA polymerase to transcribe the gene in the plasmid. This reporter plasmid 
contained a gene that was transcribed into a bicistronic gene transcript. The gene 
transcript transcribed, was in the same format as the bRSV M2 gene transcript. ORF-
1 of the pbRSVWC gene transcript contained the bRSV M2 ORF-1 sequence. This 
also included the sequence for the bRSV M2 ORF-1/ORF-2 overlap region. This 
overlap region contained the initiation sites used for the translation of ORF-2 in the 
mRNA. The coding sequence of the CAT reporter gene, lacking the CAT AUG 
initiation codon, was fused downstream of the overlap region. This sequence 
replaced the M2 ORF-2 sequence downstream of the overlap region and was in the 
same reading frame as the M2 ORF-2 sequence to create the ORF-2 for the plasmid’s 
bicistronic mRNA. Following transfection of the plasmid into mammalian cells, the 
bicistronic mRNA would be transcribed by a T7 RNA polymerase through initiation 
at the T7 promoter. The T7 RNA polymerase was expressed by infecting the 
mammalian cells with vaccinia VTF7-3 virus that carried the T7 RNA polymerase 
gene.  Initiation of translation of ORF-2 would occur in the ORF-1/ORF-2 overlap 
region and therefore translation of ORF-2 would be controlled by the bRSV M2 gene 
transcript sequence. This led to the reporter CAT protein being translated, which 
could then be quantified using an ELISA assay. The mRNA transcribed from 
pbRSVWC also contained a 30 nt 5´ UTR, of which the last 9 nts were from the 
bRSV M2 5´ UTR; the additional UTR sequence came from the plasmid vector.  
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Fig. 4.2: Schematic of the gene transcript transcribed from the plasmid pbRSVWC 
Schematic representation of the gene transcript transcribed from the plasmid pbRSVWC. Including 
the two ORFs, ORF-1 (M2 ORF-1) and ORF-2 (M2 ORF-2/CAT ORF) which includes the ORF-
1/ORF-2 overlap region. For all diagrams M2-1 represents M2 ORF-1 sequence, M2-2 represents M2 
ORF-2 sequence and CAT represents CAT ORF sequence.   
 
Construction of the plasmid pbRSVWC  
To construct the reporter plasmid pbRSVWC, two fragments were generated by 
PCR. The first fragment (bRSV fragment), was used to create the last 9nts of the 5´ 
UTR and the entire of ORF-1 in the reporter plasmid. This also included the ORF-
1/ORF-2 overlap region .The second fragment (CAT fragment), was used to fuse the 
CAT coding sequence downstream of the ORF-1/ORF-2 overlap region to create 
ORF-2. The two fragments were ligated together to create the insert for the reporter 
plasmid. The bRSV fragment was generated by PCR using the primer pair 
bRSVWTF/bRSVWTR from the plasmid pbRSVM2 (Section 2.3.1). This amplicon 
included the M2 gene transcript sequence from the 5´ end of the M2 gene transcript 
to the 3´ end of the ORF-1/ORF-2 overlap region (residues 1-570 of the bRSV M2 
gene transcript). The 595 nts amplicon contained a Kpn I site and Xba I site at its 5´ 
and 3´ ends, respectively. The CAT fragment was amplified using the primer pair 
CATF/CATR from the plasmid pWildCAT (Section 2.3.1). The amplicon included 
the CAT coding sequence from residue 4-660 from the plasmid pWildCAT. The 
amplicon, which was 678 nts in size contained an Xba I and an Sph I site at its 5´ and 
3´ ends respectively. The bRSV fragment was then digested with the endonuclease 
pair Kpn I/Xba I and the CAT fragment was digested with the endonuclease pair Xba 
I/Sph I (Section 2.3.4 and Section 2.3.5). The two fragments were double ligated into 
the plasmid pBluescribe (Section 2.3.7), which had been digested with 
endonucleases Kpn I and Sph I (Section 2.3.4 to Section 2.3.6). The ligated plasmid 
was then transformed into E.coli DH5α bacteria and plated onto AMP/IPTG/X-Gal 
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LB agar plates (Section 2.3.8). The bacteria were grown overnight at 37oC and 
colonies were selected using blue/white selection (Section 2.3.9). Each picked 
colony was grown overnight at 37oC and small-scale plasmids purification was 
performed as described in Section 2.3.13. Purified plasmids were digested with 
endonucleases Kpn I and Sph I to confirm the presence of the correctly ligated insert 
of 1237 nts. Plasmids were sequenced using the primers T7-91 and T3 down to 
confirm the expected sequence as described in Section 2.3.10. 
 
4.3.2. Expression from the bRSV M2 ORF-2 in HEp-2 cells 
HEp-2 cells were individually transfected with either plasmid pbRSVWC, plasmid 
pWildCAT or empty pBluescribe vector plasmid as described in Section 2.4.1. The 
plasmid pWildCAT contained the hRSV M2 gene with the CAT reporter gene in 
place of the M2 ORF-2 (Ahmadian et al., 2000) and was provided by Dr Phillip 
Gould. This plasmid was the original model for the reporter system for pneumovirus 
coupled translation and was used as a positive control. Cells were infected with the 
vaccinia VTF7-3 virus. This virus expressed the T7 polymerase protein, which was 
used to transcribe gene transcripts from the transfected plasmids. Transfected cells 
were incubated for 48 hours and then lysed and cellular material harvested. An 
ELISA assay was then performed on the cellular lysate to measure the levels of CAT 
protein expression as described in Section 2.4.2. All samples were normalised 
against the assay results from cells transfected with empty vector pBluescribe 
plasmid. This provided the background signal generated in the ELISA. For each 
sample, levels of CAT protein expressed have been visualised as a percentage of the 
levels achieved with the control plasmid pWildCAT. 
 
For all transfected plasmids in this thesis, each transfection for an individual plasmid 
was repeated three times. Each repeat was the mean of three separate transfections of 
each plasmid. Therefore a total of nine separate transfections were performed for 
each plasmid. The mean of all three repeats was calculated and used as the value 
presented for the level of CAT protein expression expressed by each plasmid. The 
standard deviation was calculated from the values of the three repeats.  
 
As shown in Fig. 4.3, plasmid pbRSVWC expressed levels of CAT protein from 
ORF-2 at 19.17% of that of the control plasmid pWildCAT. The expression of CAT 
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protein shows that there was successful initiation of translation of ORF-2 and that the 
reporter system can be successfully used to investigate the mechanism of initiation of 
translation for ORF-2 of the M2 gene transcript in bRSV. The data also indicate that 
in the bRSV M2 gene transcript, sequences within ORF-2 downstream of the ORF-
1/ORF-2 overlap region are not critical for initiation of translation. However, it is 
possible that sequences within ORF-2 may enhance levels of expression.  
 
There was a statistically significant difference in the levels of expression observed 
between the hRSV plasmid pWildCAT and the bRSV plasmid pbRSVWC 
(p=0.013). It has also been observed that PVM expresses lower levels of CAT 
reporter protein in this system than that of hRSV (Gould and Easton, 2007). 
 
 
Fig. 4.3: CAT protein expression from the bRSV M2 ORF-2  
Levels of expression of CAT protein from plasmids pWildCAT and pbRSVWC individually 
transfected into HEp-2 cells. Levels of expression were normalised against the empty vector 
pBluescribe and are expressed as a percentage of the levels detected with the positive control plasmid 
pWildCAT. Error bars indicate standard deviation. 
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4.4.1. Identification of the initiation site for translation of the bRSV M2 ORF-2  
The availability of a reporter system to measure the level of translation for the bRSV 
M2 ORF-2 in Section 4.3, allowed the creation of mutants to investigate the 
mechanism by which M2 ORF-2 is accessed for translation. Two initiation codons 
are located in the ORF-1/ORF-2 overlap region of the M2 mRNA that could be the 
sites of initiation of translation for ORF-2 (beginning at positions 554 and 563 from 
the M2 gene transcript). It is currently unknown if either or both start codons act as 
the initiation codon for initiation of translation of M2 ORF-2. As a first step in 
establishing the mechanism of translation initiation, mutations were introduced into 
the ORF-1/ORF-2 overlap region to mutate each of the potential start codons to 
determine if either or both start codons were used.  
 
The mutations were introduced into the plasmid pbRSVWC, (Fig. 4.4). The plasmid 
pbRSV5´AUG had the AUG beginning at position 554 and located at the 5´ end of 
the ORF-1/ORF-2 overlap region mutated by mutating AUG to CUG. In a similar 
way the plasmid pbRSV3´AUG had the 3´ AUG located at position 563 mutated by 
mutating AUG to CUG. The plasmid pbRSVDouble had both start codons mutated 
by mutating both AUGs in the overlap region to CUG.  
 
bRSV ORF-1/ORF-2 overlap region AUGAACAAAAUGAAUAA       
pbRSV5´AUG                                    CUGAACAAAAUGAAUAA 
pbRSV3´AUG                                    AUGAACAAACUGAAUAA 
pbRSVDouble                                    CUGAACAAACUGAAUAA 
Fig. 4.4: Mutations made to reporter plasmids in the ORF-1/ORF-2 overlap region  
Mutations found in the ORF-1/ORF-2 overlap region for the plasmids pbRSV5´AUG (A to C position 
554), pbRSV3´AUG (A to C position 563) and pbRSVDouble (A to C position 554 and 563). Sites of 
mutations are highlighted in red. Potential AUG sites for initiation of ORF-2 are underlined. The 
terminating stop codon for ORF-1 is highlighted in bold.  
 
Construction of plasmids pbRSV5´AUG, pbRSV3´AUG and pbRSVDouble 
For all three plasmids the method for construction was identical except for the 
reverse primer used to generate the mutations in the bRSV fragment. For each 
plasmid two fragments were generated by PCR that were ligated together as the 
insert into the vector plasmid. The bRSV fragment, which comprised of the bRSV 
M2 5´ UTR and the entire of the bRSV M2 ORF-1 sequence, was amplified from the 
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plasmid pbRSVWC by PCR using the forward primer bRSVWTF and the respective 
reverse primer (Table 4.1), which incorporated the specific mutation (Section 2.3.1). 
For each plasmid, the 594 nts amplicon contained a Kpn I site and a Xba I site at its 
5´ and 3´ ends, respectively. The CAT fragment comprised of the reporter gene CAT 
and was amplified from the plasmid pbRSVWC and using the primer pair CATF and 
CATR (Section 2.3.1). The 678 nts amplicon contained an Xba I and an Sph I site at 
its 5´ and 3´ ends, respectively. The bRSV fragment was digested with the 
endonuclease pair Kpn I and Xba I and the CAT fragment was digested with the 
endonuclease pair Xba I and Sph I (Section 2.3.4 and Section 2.3.5). The two 
fragments were double ligated into the plasmid pBluescribe (Section 2.3.7), which 
had been digested with endonuclease pair Kpn I and Sph I (Section 2.3.4 to Section 
2.3.6). The ligated plasmid was then transformed into E.coli DH5α bacteria and 
plated onto AMP/IPTG/X-Gal LB agar plates (Section 2.3.8). The bacteria were 
grown overnight at 37oC and colonies were selected using blue/white selection 
(Section 2.3.9). Each selected colony was grown overnight at 37oC and small scale 
plasmid preparations were carried out (Section 2.3.13). Purified plasmids were 
digested with endonucleases Kpn I and Sph I to confirm the presence of the correctly 
ligated insert 1237 nts. After confirmation of the correct sized fragments, plasmids 
were sequenced using the primers T7-91 and T3 down to confirm the presence of the 
correct sequence as described in Section 2.3.10. 
 
Table 4.1: Primers used in PCR reaction for bRSV fragment for generating the plasmids 
pbRSV5´AUG, pbRSV3´AUG and pbRSVDouble 
Forward and reverse primers used to generate each bRSV amplicon for the plasmids pbRSV5´AUG, 
pbRSV3´AUG and pbRSVDouble. Sequences for primers are detailed in Appendix C. 
 
4.4.2. Expression of ORF-2 AUG mutations in HEp-2 cells 
The three expression plasmids containing mutated ORF-2 AUG initiation codons 
were individually transfected into HEp-2 cells. Control cells were individually 
transfected into HEp-2 cells with either pbRSVWC or the empty vector pBluescribe. 
Plasmids were transfected into HEp-2 cells as described in Section 2.4.1. The 
Plasmid Forward Primer Reverse Primer  
pbRSV5´AUG bRSVWTF 5´AUGR 
pbRSV3´AUG bRSVWTF 3´AUGR 
pbRSVDouble bRSVWTF DoubleR 
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plasmid pbRSVWC acted as the positive control. As stated before, levels of CAT 
protein expressed were quantified using an ELISA assay as described in Section 
2.4.2. All samples were normalised against the assay results from transfected 
pBluescribe plasmid. This provided the background signal generated in the ELISA. 
For each sample, levels of CAT protein expressed were displayed as a percentage of 
the level obtained with plasmid pbRSVWC. 
 
As shown in Fig. 4.5, mutation of both start codons in the overlap region in the 
plasmid pbRSVDouble reduced levels of CAT protein expression of ORF-2 to 0.17% 
of the control. This significant difference (p=0.003) from the control indicates that 
initiation of translation of the bRSV M2 ORF-2 is completely inhibited and the site 
for initiation is located within the M2 ORF-1/ORF-2 overlap. This is also suggests 
that there is no non-AUG initiation for M2 ORF-2. Mutation of the start codon 
beginning at position 554 in the plasmid pbRSV5´AUG increased levels of CAT 
protein expression from ORF-2 to 104.9% of the control pbRSVWC. Although the 
level of expression was higher compared to the control there was no statistical 
difference between the two (p=0.8). This was likely due to the high standard 
deviation (STD) observed through repeated triplicates. These data indicates that the 
AUG located in the overlap region beginning at the position 554 is not the start 
codon for initiation of translation of the M2 ORF-2. Mutation of the start codon 
beginning at position 563 in the plasmid pbRSV3´AUG reduced levels of CAT 
protein expression to 5.4% of the control. This significant difference compared to the 
control (p=0.003) indicates that this start codon is the primary site for initiation of 
translation of the second ORF. There was also a significant difference between the 
level of expression of pbRSVDouble and pbRSV3´AUG (p=0.002) indicating that 
translation was not fully inhibited by the mutation of the start codon beginning at 
position 563. This may suggest that a small degree of initiation can take place at the 
alternate start codon beginning at position 554. 
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Fig. 4.5: CAT reporter protein expression from ORF-2 AUG initiation codon mutants 
Levels of expression of CAT protein expressed from wild type and mutant plasmids transfected into 
HEp-2 cells. Mutations made to these plasmids are described in Section 4.4.1. Results were 
normalised against the empty vector pBluescribe and are expressed as a percentage of the level 
achieved with the positive control plasmid pbRSVWC. Error bars indicate standard deviation.   
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4.5.1.1. Analysis of translation initiation of the bRSV M2 ORF-2 
The close phylogenetic relationship of the members of Orthopneumovirus genus 
raised the possibility that the mechanism for initiation of the M2 ORF-2 used by 
bRSV was also coupled translation termination/initiation. For hRSV and PVM the 
mechanism is reliant on the termination of elongating ribosomes that are translating 
M2 ORF-1 which then reinitiate translation of the M2 ORF-2 following translocation 
upstream from the M2 ORF-1 stop codon. Mutation of the M2 ORF-1 terminating 
stop codon leading to termination at a point further in the 3´ direction reduces protein 
expression to negligible levels in a length dependent manner (Ahmadian et al., 2000; 
Gould and Easton, 2007).  
 
To determine if translation in the bRSV M2 ORF-2 uses a process of coupled 
translation termination/initiation, the plasmid pbRSVStop was generated. This 
plasmid, which was in the same format as the reporter plasmid pbRSVWC, had the 
ORF-1 (M2 ORF-1) terminating stop codon at position 568 mutated from UAA to 
CAA. The nearest in-frame 3´ stop codon downstream was 42 nts away. This 
increased the size of the ORF-1/ORF-2 overlap region to 50 nts (if overlap region 
began at position 563 at the preferred initiation codon). If coupled translation was 
used as the mechanism for the initiation of M2 ORF-2, then the additional distance 
would have a large negative effect on CAT protein expression. 
 
Construction of the plasmid pbRSVStop  
For the construction of the plasmid bRSVStop, the method for cloning and 
sequencing of the plasmid was the same as used in Section 4.3.1. The bRSV 
fragment for the plasmid was amplified by PCR from the plasmid pbRSVWC using 
the primer pair bRSVWTF/bRSVSTOP. The second fragment CAT fragment was 
also amplified by PCR from the plasmid pbRSVWC, using the primer pair 
CATF/CATR.  
 
4.5.1.2. Expression of plasmid with M2 ORF-1 terminating stop codon mutation 
in HEp-2 cells 
HEp-2 cells were transfected with either plasmid, pbRSVStop pbRSVWC or empty 
pBluescribe vector plasmid as described in Section 2.4.1. The plasmid pbRSVWC 
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acted as the positive control. Levels of CAT protein expressed were quantified using 
a CAT ELISA assay as described in Section 2.4.2. All samples were normalised 
against the assay results from transfected pBluescribe plasmid that provided a 
background signal generated in the ELISA. For each sample, levels of CAT protein 
expressed were displayed as a percentage of the levels of CAT protein expressed 
from the plasmid pbRSVWC. 
 
As shown in Fig. 4.6, mutation of the ORF-1 (M2 ORF-1) termination codon at 
position 568 in the plasmid pbRSVStop reduced levels of CAT protein expression to 
93.3% of the control. There was no significant difference in expression of the CAT 
protein between the plasmid pbRSVStop and the control (p=0.54), indicating that 
mutation of the M2 ORF-1 stop codon had no significant effect on the initiation of 
translation of M2 ORF-2. This indicates that, in contrast to the situation for hRSV 
and PVM, coupled translation termination/initiation is not used for initiation of 
translation of the bRSV M2 ORF-2.  
 
 
Fig. 4.6 CAT protein expression from M2 ORF-1 terminating stop codon mutants 
Levels of expression of the CAT protein from the plasmid pbRSVSTOP transfected into HEp-2 cells. 
Mutations made to this plasmid are described in Section 4.5.1.1. Results were normalised against the 
empty vector pBluescribe and are expressed as a percentage of the level achieved with positive control 
plasmid pbRSVWC. Error bars indicate standard deviation. 
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4.5.2.1. Effect of increasing the length of the M2 ORF-1 on initiation of 
translation of the bRSV M2 ORF-2 
In Section 4.5.1, it was shown that mutation of the M2 ORF-1 terminating stop 
codon that resulted in the length of the M2 ORF-1 increasing by 42nts, did not 
significantly alter the levels of CAT protein expression from ORF-2. This suggests 
that the mechanism used by bRSV is not that of coupled translation 
termination/initiation. However, as the process of coupled translation 
termination/initiation is length dependent and the distance from the M2 ORF-1 
termination codon and the M2 ORF-2 initiation codon is important, it is possible that 
the extension of the ORF-1/ORF-2 overlap region in the plasmid pbRSVStop was 
too short to prevent reinitiation. In the equivalent hRSV and PVM systems used to 
test for coupled translation, the M2 ORF-1 terminating stop codon was mutated and 
the M2 ORF-1 lengths were extended by 40 nts (Ahmadian et al., 2000) and 138 nts 
(Gould and Easton, 2007) respectively. These increased lengths of M2 ORF-1 
prevented ORF-2 expression. Although the M2 ORF-1 in pbRSVStop was extended 
by 42nts, this may have not been a large enough distance for a ribosome to fail to 
reinitiate. This may be due to the close proximity of the preferred start codon to the 
mutated stop codon, resulting in a smaller distance for the reinitiating ribosome to 
scan compared to plasmids used in hRSV and PVM.  
 
In the equivalent study in hRSV (Ahmadian et al., 2000), two expression plasmids 
containing the mutated ORF-1 (M2 ORF-1) stop codon were used to test for coupled 
translation. As mentioned above, both of the plasmids had the ORF-1/ORF-2 overlap 
region extended by 40 nts. In a feature unlike the plasmid pbRSVStop, which had the 
ORF-1/ORF-2 overlap region extended with CAT reporter coding sequence, the two 
plasmids used for hRSV had overlap regions increased with hRSV M2 ORF-2 
sequence that was taken from downstream of the hRSV M2 ORF-1/ORF-2 overlap 
region. For the first plasmid, an additional 44 nts of hRSV M2 ORF-2 sequence was 
added. For the second plasmid an additional 120 nts of hRSV M2 ORF-2 sequence 
was added resulting in an extra 80 nts of hRSV M2 ORF-2 sequence added past the 
plasmids ORF-1 stop codon. Any stop codons in the same frame as ORF-1 in the 
additional sequences were mutated to ensure that the ORF-1/ORF-2 overlap region 
was extended as desired and in both plasmids, no expression of ORF-2 was detected. 
However, it is important to note that no controls were used for either plasmid with 
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the addition of equivalent M2 ORF-2 sequences where the controls would have the 
ORF-1 terminating stop codon present. It is therefore possible that as well as the 
extension of the ORF-1/ORF-2 overlap region being too short to inhibit the potential 
mechanism of coupled translation in the plasmid pbRSVStop, additional M2 ORF-2 
sequence may be required for the mechanism to operate.  
 
4.5.2.2. Analysis of length dependence in the bRSV ORF-1/ORF-2 overlap 
region 
To investigate the importance of length dependence in the bRSV ORF-1/ORF-2 
overlap region and the possible role of the 5´ proximal M2 ORF-2 sequences for 
initiation of translation of M2 ORF-2, four additional plasmids were created. These 
plasmids were in a similar format to the two hRSV plasmids used to test for coupled 
translation of hRSV M2 ORF-2 as described in Section 4.5.2.1. The newly 
synthesised bRSV-based plasmids had additional bRSV M2 ORF-2 sequence added 
between the 3´ end of the ORF-1/ORF-2 overlap region and the 5´ end of the CAT 
reporter coding sequence in ORF-2. The constructs used the CAT reporter system as 
before to measure ORF-2 expression. Two of the newly generated plasmids, 
pbRSVWC42 and pbRSVStop42, had an additional 42 nts of bRSV M2 ORF-2 
(residues 571-612 from the beginning of the bRSV M2 gene transcript) added (Fig. 
4.7A), whilst plasmids pbRSVWC120 and pbRSVStop120 had an additional 120nts 
of bRSV M2 ORF-2 (residues 571-690 from the beginning of the bRSV M2 gene 
transcript) added (Fig. 4.7B). In the plasmid nomenclature, “WC” refers to the 
control in which no mutations were made to the terminating ORF-1 (M2 ORF-1) 
stop codon. “Stop” refers to equivalent plasmids where the ORF-1 stop codon has 
been mutated from UAA to CAA. The number refers to the amount of bRSV M2 
ORF-2 sequence that was added downstream of the ORF-1/ORF-2 overlap region. 
All plasmids had any stop codons present in the additional M2 ORF-2 sequence that 
were in the same frame as ORF-1 mutated out. 
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Fig. 4.7: Schematic of gene transcripts for plasmids used to investigate the effect of increasing 
the size of the M2 ORF-1/ORF-2 overlap region on the translation of ORF-2   
Schematic representation of the gene transcript transcribed from the plasmids pbRSVWC42 and 
pbRSVWC120. Including both ORFs for each plasmid. The second ORF also includes the additional 
ligated M2 ORF-2 sequence. (A) Schematic for the plasmids pbRSVWC42, where 42nts of additional 
M2 ORF-2 sequence was ligated to the 5´ end of the CAT coding sequence. Stop codons in the same 
frame as ORF-1 (M2 ORF-1) in this sequence were removed. (B) Schematic for the plasmid 
pbRSVWC120, where 120nts of additional M2 ORF-2 sequence was ligated to the 5´ end of the CAT 
coding sequence. Stop codons in the same frame as ORF-1 (M2 ORF-1) in this sequence were 
removed.   
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The plasmids pbRSVStop42 and pbRSVStop120 were used to investigate if 
increasing the size of the ORF-1/ORF-2 overlap region by 84 nts and 162 nts 
respectively affected the levels of ORF-2 CAT protein expression. Significant 
reduction or inhibition of CAT protein expression would suggest that the mechanism 
of coupled translation is used.  
 
For each of the plasmids pbRSVStop42 and pbRSVStop120, a control was generated 
that was identical with the exception of the ORF-1 terminating stop codon being 
present in the usual position (plasmids pbRSVWC42 and pbRSVWC120 for the 
plasmids pbRSVStop42 and pbRSV120 respectively). These were used to identify if 
a significant change in expression was registered when the ORF-1 terminating stop 
codon was mutated and the ORF-1/ORF-2 overlap region was extended. These 
plasmids were also used to investigate if additional M2 ORF-2 sequences improved 
the efficiency of initiation of translation in comparison to the reporter plasmid 
pbRSVWC where only the M2 ORF-2 sequence in the ORF-1/ORF-2 overlap region 
was present. 
 
Construction of plasmids pbRSVWC120 and pbRSVStop120 
Inserts for plasmids pbRSVWC120 and pbRSVStop120 were generated by a three-
step PCR. This allowed the introduction of multiple point mutations to mutate stop 
codons in the additional 120 nts M2 ORF-2 region that were in the same frame as 
ORF-1 in the plasmid. Initially two amplicons were generated by PCR from the 
plasmid pbRSVWC for each plasmid. One was a bRSV fragment, which contained 
the bRSV M2 5´ UTR and the entire bRSV M2 ORF-1 sequence. The second was a 
fragment, which contained the CAT reporter coding sequence. For the bRSV 
fragment, the reverse primer that would anneal to the ORF-1/ORF-2 overlap region 
contained an additional 38nts of M2 ORF-2 sequence with the appropriate point 
mutations. For the CAT fragment the same principle was used except the forward 
primer was used to add additional M2 ORF-2 sequence to the 5´ end of the fragment. 
A second PCR step was performed by using each fragment as a template to increase 
the length of the M2 ORF-2 sequence by 42 nts to either the 3´ or 5´ end of the 
bRSV and CAT fragments respectively. By the second PCR step, the two PCR 
fragments contained a region of sequence homology located at the 3´ and 5´ ends for 
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the bRSV and CAT fragments respectively. A third PCR step was performed where 
both fragments were placed in the same reaction. This generated a single amplicon 
where the two fragments were joined due to the region of sequence homology. 
External primers were used to amplify the product.  
 
Each plasmid had a separate bRSV fragment generated with the additional M2 ORF-
2 sequence added to the fragment through the three PCR stages. As well as the 
additional mutations and the addition of the M2 ORF-2 in the first and second PCR 
steps, each of these fragments had either the ORF-1 stop codon retained or mutated 
as necessary. The same CAT fragment was used for both plasmids that would have 
the additional M2 ORF-2 sequence added to the fragment through the first two PCR 
stages.  
 
The primers used for each PCR step for each plasmid can be seen in Table 4.2 and 
the sequences are in Appendix C. For all PCR steps the same PCR protocol was used 
(Section 2.3.1). Products from the previous stage were added in equimolar quantities. 
The template used for each plasmid at each PCR step can be seen in Table 4.3. After 
each stage of PCR, the amplicon was purified using a QIAGEN PCR clean up kit 
before being used for the next PCR step (Section 2.3.15). At the final PCR step for 
each plasmid, the appropriate bRSV fragment generated from the second PCR step 
and the CAT fragment generated in the second PCR step were used as templates to 
join the two fragments together. The primer pair bRSVF/CATR was used to amplify 
the joined fragments for both reactions. Both final joined amplicons generated by 
PCR contained a Kpn I and Sph I sites at the 5´ and 3´ ends respectively. The joined 
fragments for each plasmid were then digested with the endonuclease pair Kpn I/Sph 
I (Section 2.3.4 and Section 2.3.5). The fragments were separately ligated into the 
plasmid pBluescribe (Section 2.3.7) which was digested with endonuclease pair Kpn 
I/Sph I (Section 2.3.4 to Section 2.3.6). The ligated plasmids were then separately 
transformed into E.coli DH5α bacteria and plated onto AMP/IPTG/X-Gal LB agar 
plates (Section 2.3.8). The bacteria were grown overnight at 37oC and colonies were 
selected using blue/white selection (Section 2.3.9). Each picked colony was grown 
overnight at 37oC and small-scale plasmid preparations prepared (Section 
2.3.13).Purified plasmids were digested with endonucleases Kpn I and Sph I to 
confirm the presence of the correctly ligated insert (1457 nts). After confirmation of 
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the correct sized fragments each plasmid was sequenced using primers T7-91 and T3 
down to ensure the mutations had been inserted (Section 2.3.10). 
PCR 
Step 
Primers for bRSV 
fragment for plasmid 
pbRSVWC120 
Primers for bRSV 
fragment for plasmid 
pbRSVStop120 
Primers for CAT 
fragment  
1st  bRSVF/bRSV120R1WC bRSVF/bRSV120R1ST CAT120F1/CATR 
2nd  bRSVF/bRSV120R2 bRSVF/bRSV120R2 CAT120F2/CATR 
3rd  bRSVF bRSVF CATR 
Table 4.2: Primers used for three-step PCR for the construction of plasmids pbRSVWC120 and 
pbRSV120 
Primers used for each round of three-step PCR used to create the final insert for plasmids 
pbRSVWC120 and pbRSVStop120. 
 
PCR Step  Template used for each 
PCR stage for the 
bRSV fragment for the  
plasmid pbRSVWC120 
Template used for  
each PCR stage for 
the bRSV fragment 
plasmid for the 
plasmid 
pbRSVStop120 
Template used 
for each PCR 
stage for CAT 
fragment  
1st  pbRSVWC pbRSVWC pbRSVWC 
2nd   Amplicon generated 
above 
Amplicon generated 
above 
Amplicon 
generated above 
3rd (joining of 
bRSV and CAT 
fragments) 
Amplicon generated 
above + CAT fragment 
generated in 2nd stage 
of PCR 
Amplicon generated 
above + CAT 
fragment generated 
in 2nd stage of PCR 
 
Table 4.3: Templates used for three-step PCR for the construction of the plasmids 
pbRSVWC120 and pbRSV120 
Templates used for each round of three-step PCR used to create the final insert for plasmids 
pbRSVWC120 and pbRSVStop120.  
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Construction of plasmids pbRSVWC42 and pbRSV42 
For each plasmid two fragments were generated by PCR that would act as inserts to 
be ligated into the new vector. The bRSV fragment, containing the entirety of bRSV 
sequence to be ligated into the new plasmids, was amplified by PCR using the primer 
pair bRSVWTF/bRSV42 (Section 2.3.1). This was amplified from either the plasmid 
pbRSVWC120 or pbRSVStop120 as required depending on whether the terminating 
stop codon for ORF-1 needed to be kept or removed. Each amplicon contained a Kpn 
I and Xba I site at the 5´ and 3´ ends, respectively. The CAT fragment used for each 
plasmid contained the CAT reporter coding sequence and was amplified by PCR 
with the primer pair CATF/CATR from the plasmid pbRSVWC120 (Section 2.3.1). 
The amplicon contained an Xba I and a Kpn I site at its 5´ and 3´ ends, respectively. 
The bRSV fragment was then digested with the endonuclease pair Kpn I and Xba I 
and the CAT fragment was digested with the endonuclease pair Xba I and Sph I 
(Section 2.3.4 and Section 2.3.5). The two fragments for each plasmid were 
simultaneously ligated into the plasmid pBluescribe (Section 2.3.7) that had been 
digested with endonuclease pair Kpn I and Sph I (Section 2.3.4 to Section 2.3.6). The 
ligated plasmid were transformed separately into E.coli DH5α bacteria and plated 
onto AMP/IPTG/X-Gal LB agar plates (Section 2.3.8). The bacteria were grown 
overnight at 37oC and colonies were selected through blue white selection (Section 
2.3.9). Each picked colony was grown overnight at 37oC and small-scale plasmid 
preparations were performed (Section 2.3.13). Purified plasmids were digested with 
endonucleases Kpn I and Sph I to confirm the presence of the correctly ligated insert 
(1321nts). Upon confirmation of the correct sized fragments, plasmids were sent off 
for sequencing using the primers T7-91 and T3 down (Section 2.3.10). This allowed 
sufficient coverage for the entire insert sequence to ensure the correct sequence was 
ligated. 
 
4.5.2.3. Expression of plasmids used to investigate the effect of increasing the 
length of the ORF-1/ORF-2 overlap region in HEp-2 cells 
The four expression plasmids described in Section 4.5.2.2 were transfected 
separately into HEp-2 cells as described in Section 2.4.1. Control cells were 
transfected with either pbRSVWC, pbRSVStop or the empty vector pBluescribe. The 
levels of CAT protein expressed were quantified using a specific ELISA assay as 
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described in Section 2.4.2. All data were normalised against the assay results from 
cells transfected with pBluescribe plasmid that provided the background signal 
generated in the ELISA. The plasmids pbRSVWC and pbRSVStop acted as positive 
controls. For each sample levels of CAT protein were expressed as a percentage of 
the levels of CAT protein expressed from the plasmid pbRSVWC. 
 
As seen Fig. 4.8, addition of an extra 42 nts of bRSV M2 ORF-2 (M2-2 ORF) 
sequence downstream of the ORF-1/ORF-2 overlap region in the plasmid 
pbRSVWC42 reduced levels of CAT protein expression to 38% of the control. This 
significant reduction in comparison to the control (p=0.0003) indicated that the M2 
ORF-2 sequence past the M2 ORF-1/ORF-2 overlap region did not enhance 
initiation of translation of the bRSV M2 ORF-2. The reduction in CAT protein 
expression is likely to be due to the addition of the 42 extra nts to ORF-2 creating a 
new basal level of CAT protein expression for this newly generated plasmid. 
 
Mutation of the ORF-1 (M2 ORF-1) stop codon at position 568 and increasing the 
size of the overlap region to 92 nts in size, with the addition of 42 nts of bRSV M2 
ORF-2 sequence downstream of the ORF-1/ORF-2 overlap region in the plasmid 
pbRSVStop42 reduced levels of CAT protein expression to 33.5% of the control. 
Although there was a significant difference between this and the control (p=0.0002), 
expression of CAT protein was not reduced to the very low levels seen in the 
equivalent plasmid constructs for analysis of hRSV and PVM M2 ORF-2 expression. 
The significant reduction in expression however, is not due to a decrease in the ORF-
2 initiation efficiency, as there is no significant reduction between the expression of 
the plasmid pbRSVStop42 and the plasmid pbRSVWC42 (p=0.097); the plasmid 
pbRSVWC42 was the relevant control and expressed CAT protein at basal levels for 
the new format of plasmid. Taken together with the previous results it is therefore 
likely that coupled translation termination/initiation is not the mechanism used for 
initiation of translation of bRSV M2 ORF-2.  
 
Increasing the size of the addition of the bRSV M2 ORF-2 (M2-2 ORF) sequence 
downstream of the ORF-1/ORF-2 overlap region to 120 nts in the plasmid 
pbRSVWC120, reduced levels of CAT protein expression to 0% of the control. This 
was also observed in the plasmid pbRSVStop120, which had ORF-1/ORF-2 overlap 
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region extended to 170 nts through the mutation of the ORF-2 terminating stop 
codon in addition to the addition of 120 nts of M2 ORF-2 sequence downstream of 
the ORF-1/ORF-2 overlap. This indicates that expression of the CAT protein in both 
plasmids was either being inhibited or the expressed reporter protein was failing to 
bind to the antibodies in the ELISA due to the addition of 40 amino acids to the CAT 
protein. This addition may have caused a conformational change that rendered it less 
efficiently detected. It is therefore unlikely that the inhibition of CAT protein 
expression in the plasmid pbRSVStop120 was due to the mechanism of coupled 
translation as expression of CAT protein was not recorded by the ELISA in both 
plasmids.  
 
Fig. 4.8: CAT protein expression from plasmids investigating the effect of an increased M2 
ORF-1/ORF-2 overlap region on the translation of ORF-2 
Levels of expression of CAT protein expressed from plasmids pbRSVWC42, pbRSVStop42, 
pbRSVWC120 and pbRSVStop120 as described in Section 4.5.2.2 were individually transfected into 
HEp-2 cells. Results were normalised against the empty vector pBluescribe and are expressed as a 
percentage of the level achieved with positive control plasmid pbRSVWC. Error bars indicate 
standard deviation.  
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4.6.1. Investigation of the translational profile of the bRSV M2 mRNA using 
ribosomal profiling  
Over recent years the technique of ribosomal profiling have enabled the precise 
definition of positions of ribosomes on mRNA (Ingolia, 2010; Ingolia et al., 2012; 
Ingolia et al., 2009). Ribosomal profiling works on the principle that all elongating 
ribosomes translating cellular mRNA cover a region of mRNA which is being 
translated. As well as covering the 9 nucleotides which are positioned in the A, P and 
E sites of the ribosome an elongating ribosome also extends over a further 21 
nucleotides (Ingolia et al., 2009; Steitz, 1969). The region of mRNA covered by the 
ribosome (referred to as the footprint) is protected from degradation by RNases. The 
elongation phase of translation can be paused using the compound cycloheximide. 
Therefore by digesting all cellular RNA with RNases in lysed cells where translation 
is inhibited with cyclocheximide, only RNA footprints that are protected by paused 
elongating ribosomes are left. These footprints can be sequenced by next generation 
sequencing techniques. The sequence library generated can then be used to map the 
location of all elongating ribosomes in a cellular population at a specific time point. 
This allows the identification of specific regions of interest on a mRNA where high 
or low distributions of elongating ribosomes are present. The frame of each 
elongating ribosome can also be identified allowing the identification of ORFs in 
gene transcripts. 
 
Ribosomal profiling analysis of the hRSV M2 mRNA demonstrated that a high 
frequency of elongating ribosomes were observed around the highly stable secondary 
structure located in the M2 ORF-1 that is essential for the mechanism of coupled 
translation (P. Gould and A. Easton, personal communication). Based on this 
observation it was suggested that the function of the structure is to stall elongating 
ribosomes, creating a ‘gap in ribosomal traffic’ at the 3´ end of ORF-2 and so 
allowing terminating ribosomes to move in a 5´ direction to reinitiate translation at 
one of the ORF-2 start codons. The high number of stalled ribosomes at a specific 
nucleotide position in the vicinity of the structure, a predominant peak was observed 
in the ribosome profile in this region. This peak was the greatest in the M2 mRNA 
and constituted 5.6% of all elongating ribosomes translating ORF-1 (P. Gould and A. 
Easton, personal communication). Taking the hRSV system as a model, ribosomal 
profiling was used to build a translational profile of the bRSV M2 ORF to identify 
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any regions of interest that could help in identifying if the mechanism of initiation of 
translation for the M2 ORF-2 was that of coupled translation. 
 
Two ribosomal profile sequencing libraries were generated from MDBK cells that 
had been infected with bRSV Snook strain. One library was generated using RNA 
extracted at 4 hpi and the other at 8 hpi (sequencing libraries bRSV4P and bRSV8P, 
respectively). These sequence libraries contained data only originating from the 
protected footprints of elongating ribosomes. A detailed description of the 
methodology of ribosomal profiling and the sequencing of these libraries is given in 
Section 2.10. The processing pathway to analyse the raw sequencing data is in 
Section 3.2. All profiles are presented using the software IGV, and the spectra 
represent the distribution of elongating ribosomes on the M2 mRNA. Each point 
represents the nucleotide that each read aligned to the M2 gene transcript begins at. 
 
For the RNA harvested at 4hpi (bRSV4P), a total of 13757 sequence reads out a total 
of 6774318 reads aligned to the bRSV genome. Of the 13757 reads 407 were 
obtained from the M2 mRNA. For the RNA harvested at 8 hpi (bRSV8P), a total of 
67977 reads of a total of 6648581 aligned to the bRSV genome and of these, 1871 
reads were from the M2 mRNA. The bRSV8P sequencing library was used to 
generate a translational profile of the M2 mRNA due to the higher level of reads 
aligned to the gene. 
 
The data presented in Fig. 4.9 shows the distribution of ribosomes along the M2 
mRNA in bRSV infected cells. From this profile, it is possible to identify specific 
regions in which there is a high or low distribution of elongating ribosomes. It is 
clear from this profile, that translation of M2 ORF-1 (M2-1 ORF) is significantly 
higher than that of M2 ORF-2 (M2-2 ORF). The large peaks located at the 5´ end of 
the M2 gene transcript represents the ribosomes surrounding the initiation codon of 
ORF-1. This is a frequent observation in such analyses as there is bias created during 
preparation of such sequencing libraries which favours the amplification of reads at 
the 5´ end of a mRNA. There were no significantly large peaks observed within the 
bRSV M2 mRNA. While there were peaks observed that indicated a higher number 
of reads aligned inside the region of bRSV M2 ORF-1 sequence that shared sequence 
homology to the hRSV critical structure these represented only a small proportion of 
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the total number of ribosomes translating ORF-1 and all were considerably less than 
the 5% observed in the hRSV M2 ribosomal profile data (P. Gould and A. Easton, 
personal communication). This further suggests that a coupled translation process 
analogous to that used by hRSV is not used by the ribosome for initiation of 
translation of the bRSV M2 ORF-2. 
 
 
Fig. 4.9: Translational profile of the bRSV M2 gene transcript from MDBK cells infected with 
bRSV 8hpi. 
Translational profile of the bRSV gene transcript from MDBK cells infected with bRSV 8hpi from the 
sequencing library bRSV8P. Location of all putative start (green) and stop (red) codons in all three 
frames in the M2 gene transcript are found below the spectra. Locations of the preferred start and stop 
codons for the M2 ORF-1 and M2 ORF-2 are identified.   
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4.6.2. Investigation of linked translation of bRSV M2 ORF-1 and ORF-2 using 
ribosomal profiling  
As the initiation of translation of M2 ORF-2 is directly linked to the level of 
translation of M2 ORF-1 in viruses that use coupled translation, it is possible to use 
the method of ribosomal profiling to measure if translation of M2 ORF-2 is directly 
linked to the translation of M2 ORF-1 in bRSV. By measuring the percentage 
increase in translation between two time points for both M2 ORF-1 and M2 ORF-2, 
it is possible to compare the percentage increases from both ORFs in order to 
identify if the translation of the two ORFs are linked. A similar increase or decrease 
between two time points for both ORFs may suggest that translation of M2 ORF-2 is 
linked to translation of M2 ORF-1 therefore providing evidence that coupled 
translation may be used as the mechanism. 
 
The two ribosomal profile sequence libraries bRSV4P and bRSV8P were used to 
measure the percentage increase in translation of both M2 ORFs at 4 and 8 hpi. The 
alignment software Bowtie was used to align the libraries to both ORFs in the bRSV 
M2 gene transcript. In order to calculate the percentage increase in translation for 
both ORFs, the number of reads aligned to each M2 ORF at 8 hpi (library bRSV8P) 
were taken and divided into the number of reads that were aligned to each M2 ORF 
at 4 hpi (library bRSV4P).  
 
As described in Chapter 3, some of the sequences arising from the overlap region 
obtained will align to both ORFs. In the current literature there is a consensus that 
the bRSV ORF-1/ORF-2 overlap region overlaps each other by 17 nts due to the 
assumption that the ribosome initiates translation at the 5´ proximal AUG at position 
554. However, evidence presented here in Section 4.4.2 shows that the AUG at 
position 563 is the preferred site of initiation, which reduces the overlap region to 
8nts. Alignments of both sequencing libraries to this region identified a maximum of 
1.1% (library bRSV8P) of reads aligned to the M2 mRNA sequence located in the 
M2 ORF-1/ORF-2 overlap region. As the percentage of sequences from the overlap 
region were sufficiently small to ignore, the analyses were performed using 
sequences derived from both ORFs that both included the ORF-1/ORF-2 overlap 
region. 
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Fig. 4.10 shows the percentage increase in the levels of translation between 4 and 8 
hpi for the bRSV M2 ORF-1 and bRSV M2 ORF-2. For the M2 ORF-1 there was a 
4.89-fold increase in the levels of translation between 4 hpi and 8 hpi. For the M2 
ORF-2 there was a 1.35-fold increase in translation between 4hpi and 8 hpi. 
Although a statistical analysis was unable to be performed due to ribosomal profiling 
not being repeated for each time point, there was a significantly larger increase in 
translation in M2 ORF-1 compared to M2 ORF-2. This significant difference in the 
percentage increase suggests that the translation of M2 ORF-2 is not linked to the 
levels of translation of M2 ORF-1. This would suggest that as translation is not 
linked, the mechanism of coupled translation is unlikely to be used as the mechanism 
of initiation for translation of M2 ORF-2. 
 
 
Fig. 4.10: Efficiency of translation of the bRSV M2 ORF-1 and M2 ORF-2 at 4 hpi and 8 hpi 
Increase in translation displayed as a percentage increase between 4 hpi and 8hpi for M2 ORF-1 and 
M2 ORF-2. The bRSV M2 ORF-1 and M2 ORF-2 sequence were aligned to the bRSV4P library for 
the levels of translation at 4hpi. The M2 ORF-1 and M2 ORF-2 sequence were aligned to the bRSV8P 
library for the levels of translation at 8hpi.   
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4.7. Conclusions 
Several conclusions could be drawn from the investigation into the initiation 
mechanism of bRSV M2 ORF-2. From these investigations it is clear initiation of the 
bRSV M2 ORF-2 is not reliant on sequence downstream of the M2 ORF-1/ORF-2 
overlapping region. Replacing sequence downstream of the M2 ORF-1/ORF-2 
overlap region with the CAT reporter gene, still lead to successful translation of the 
second ORF. This allowed the generation of a reporter system that was capable of 
measuring ORF-2 expression and thereby allowing the investigation of the 
mechanism used for initiation of translation M2 ORF-2. Furthermore sequence 
downstream of the M2 ORF-1/ORF-2 overlap region had no bearing on the 
efficiency of the mechanism. These observations were all similar characteristics 
observed for the translation of M2 ORF-2 in other members of the Pneumoviridae 
family. 
 
It can also be concluded that initiation of bRSV M2 ORF-2 is reliant on the two 
cognate start codons in the ORF-1/ORF-2 overlap. There was no indication that 
translation of ORF-2 could be initiated from cognate or non-cognate start codons 
located outside of the M2 ORF-1/ORF-2 overlap region as translation was inhibited 
when both cognate start codons in the overlap region were mutated. It was also clear 
that the primary initiation site for M2 ORF-2 was located at position 563. Initiation 
of translation could also occur at the start codon at position 554 but only at a 20-fold 
lower level if the start codon at position 563 was not present. Mutation of the start 
codon at 554 also improved efficiency for initiation for the start codon at 563.  
 
From this chapter it is also apparent that unlike other members in the Pneumoviridae 
family, bRSV does not use the mechanism of coupled translation 
termination/initiation for initiation of translation of M2 ORF-2. Data presented in 
this chapter revealed that translation of M2 ORF-2 was not reliant on termination of 
translation of ORF-1 in the vicinity of the initiation site. Mutating the terminating 
stop codon of M2 ORF-1 so that the M2 ORF-1/ORF-2 overlap was increased in size 
to 92 nts, had no effect on the efficiency of translation of M2 ORF-2. The size that 
the bRSV M2 ORF-1/ORF-2 overlap was increased was significantly larger than the 
size of the increase in the M2 ORF-1/ORF-2 overlap region required to inhibit 
translation of M2 ORF-2 in other members of the Pneumoviridae family (hRSV 
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(Ahmadian et al., 2000) and APV (Gould and Easton, 2007)). This would suggest 
that the mechanism in bRSV is not distance dependent on the M2 ORF-1 terminating 
stop codon, which is a characteristic universal to all examples of coupled translation.  
 
Although there was no detectable expression of the CAT protein when the ORF-
1/ORF-2 was increased to 170 nts with the mutation of the ORF-1 stop codon and 
addition of 120 nts of M2 ORF-2 sequence (pbRSVStop120), the control with the 
ORF-1 terminating stop codon present also had no detectable expression of CAT 
protein. This suggests that the inhibition of ORF-2 translation in the plasmid 
pbRSVStop120 was not due to the mutation of the ORF-1 stop codon and was likely 
due to other unknown circumstances.  
 
Further evidence of an alternate mechanism used by bRSV for initiation of 
translation of M2 ORF-2 came from the use of ribosomal profiling. By building a 
translational profile of the M2 gene transcript, it was clear that there were no 
significant examples of ribosomes stalling in a similar manner observed in hRSV (P. 
Gould and A. Easton, personal communication). As this was essential for translation 
of M2 ORF-2 in hRSV, the lack of a significant peak would suggest a different 
mechanism was used. In bRSV it was also observed that there was no relationship 
between translation of M2 ORF-1 and translation of M2 ORF-2. No proportional 
increase was observed in the translation of M2 ORF-2 when an increase in M2 ORF-
1 translation was observed between 4 hpi and 8 hpi. This indicated that translation of 
M2 ORF-2 was not linked to translation of M2 ORF-1. In hRSV, translation of M2 
ORF-2 is linked to translation M2 ORF-1, with translation of M2 ORF-2 always 
remaining at ~3% of translation of M2 ORF-1. As this was not observed in bRSV, it 
is clear that translation of M2 ORF-2 is not linked to translation of M2 ORF-1 and 
does not use the mechanism of coupled translation. However, these data from this 
chapter does not point to another mechanism.   
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Chapter 5 
Identification of Non-
Canonical Mechanism 
used for Initiation of 
Translation of M2  
ORF-2  
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5.1. Introduction  
Data presented in Chapter 4 demonstrates that initiation of translation of M2 ORF-2 
(M2-2 ORF) in bRSV is not affected by termination of translation of M2 ORF-1 
(M2-1 ORF). This is a defining character of the mechanisms of coupled translation 
termination/initiation that use a TURBS sequence or an upstream structured region, 
and both are reliant on termination of translation of ORF-1. It is therefore unclear 
what mechanism is used for initiation of translation of M2 ORF-2. As the M2 ORF-1 
separates the m7G cap from the M2 ORF-2 initiation site by a distance of 562 nts, it 
is impossible for standard canonical initiation to be used by the ribosome for the 
initiation of M2 ORF-2. Therefore a non-canonical initiation mechanism must be 
used for the initiation of translation of the bRSV M2 ORF-2.  
 
It is possible that a proportion of scanning ribosomes may bypass a number of 
initiation sites to reach the initiation site of M2 ORF-2 using leaky scanning. As 
discussed in Section 1.6.2, leaky scanning is used by ribosomes to initiate translation 
at alternate internal initiation sites that have stronger Kozak sequences than the AUG 
codon with a weak Kozak sequence located closest to the m7G cap. In addition, the 
distance the ribosome can scan through leaky scanning can range from a few 
nucleotides to over 800 nts (Fütterer et al., 1997). However, in most examples, 
ribosomes tend to only bypass two or three AUG codons over a short distance, as the 
efficiency of scanning decreases with distance from the m7G cap. Between the first 
start codon on the M2 mRNA and the first start codon located in the ORF-1/ORF-2 
overlap region, there are 14 alternate start codons that the scanning ribosome could 
initiate at upstream of the ORF-1/ORF-2 overlap region. As seen in table 5.1, these 
14 start codons vary in degrees of strength of their Kozak sequence. In comparison to 
the other AUG codons in M2 ORF-1 (M2-1 ORF), the preferred AUG codon at 
position 564 in the ORF-1/ORF-2 overlap region has a relatively strong Kozak 
sequence. However there are three start codons upstream with similar strength Kozak 
sequences (beginning at position 35, 332 and 335). It would be unusual for the 
ribosome to bypass all 14 codons along a length of 562 nts to initiate translation of 
ORF-2. In viruses where there is a significant distance bypassed by the scanning 
ribosome, such as in the rice tungro bacilliform virus (895 nts), there are only three 
codons between the m7G cap and the initiation site. One of these codons is also used 
for initiation of another ORF through leaky scanning (Fütterer et al., 1997). On the 
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balance of these factors it is therefore unlikely that bRSV uses leaky scanning for 
initiation of ORF-2  
 
Table 5.1: Sites of AUG codons in the bRSV M2 ORF-1 
Sites of AUG codons in the bRSV M2 ORF-1 (M2-1 ORF) including key Kozak nucleotides 
surrounding each AUG.  
 
Position of A in 
Start Codon 
Nucleotide at 
position -3 of 
start codon 
Nucleotide at 
position +4 of 
start codon 
Notes on Start 
codon 
10 A U Start codon for 
ORF-1 (M2-1 
ORF) 
35 A A  
59 U G  
69 A U  
96 U G  
107 C C  
133 U C  
157 U G  
224 A C  
304 G A  
332 A A  
335 A A  
524 U G  
554 U A First start codon 
found in ORF-
1/ORF-2 overlap 
region 
563 A A Preferred start 
codon for M2 
ORF-2 (M2-2 
ORF) 
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Three additional potential non-canonical translation initiation mechanisms are 
options that bRSV may use for the initiation of translation of the M2 ORF-2. 
Programmed ribosomal frameshifting (PRF) involves the use of a slippery sequence 
and a structured element to allow the elongating ribosome to shift frame to translate 
another ORF. The result of PRF is the generation of a fusion protein, although this 
has never been reported in any Pneumoviridae M2 mRNA products making this 
mechanism an unlikely candidate. Ribosomal shunting involves a ribosome 
bypassing large sections of sequence, usually in the 5´ UTR after translating a short 
ORF. Although this mechanism is unlikely to be used in the classical sense as the 
bRSV M2 mRNA 5´ UTR is only 9 nts long, there are examples of shunting that use 
complementary sequences to the 18S rRNA to bypass sections of sequence (Yueh 
and Schneider, 2000). Internal ribosome entry sites (IRES) use structured elements to 
initiate translation in a cap-independent manner. These structured regions are capable 
of directly loading a ribosome onto the mRNA without involvement of the 5´cap. 
This mechanism may be used by bRSV for initiation of translation of M2 ORF-2, as 
there is no data on whether initiation of translation is cap-dependent. A more detailed 
review of these mechanisms can be found in Section 1.6. 
 
The site of initiation of M2 ORF-2 is also of interest. While there are two start 
codons in the ORF-1/ORF-2 overlap region, only the AUG codon closest to the stop 
codon of M2 ORF-1 is the preferred initiation site. It is possible that the Kozak 
sequence is a factor in initiation or the specific position of the AUG in relation to 
some other critical sequence such as a slippery sequence or an IRES. As discussed in 
Section 4.1, the context of the Kozak sequence surrounding the preferred AUG 
codon used for initiation of translation of M2 ORF-2 is not perfect, with an optimal 
A nucleotide located in position -3 in the Kozak sequence but a non-optimal A 
nucleotide in the +4 position. The context of the remaining Kozak sequence is also 
far from perfect (ACAAAAUGA). In comparison to the upstream AUG codon 
(position 554) Kozak sequence (UGUUAAUGA), the preferred AUG codon has 
stronger consensus sequence with a stronger nucleotide located at position -3 (Table 
5.1). Further work identifying the importance of the Kozak sequence and the specific 
position is needed before a conclusion can be drawn.  
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 The aim of this chapter is to explore the mechanism used by bRSV to initiate 
translation of the M2 ORF-2 (M2-2 ORF) and to investigate why the specific site of 
initiation is so important for successful initiation of translation of ORF-2  
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5.2.1. Investigation into whether a programmed ribosomal frameshifting 
mechanism is used by bRSV for the initiation of translation of the M2 ORF-2 
Programmed ribosomal frameshifting (PRF) is a non-canonical mechanism used to 
translate multiple proteins from a polycistronic mRNA strand. As reviewed in 
Section 1.63, PRF allows an elongating ribosome to alter its translating reading 
frame by either slipping backwards or forwards by 1 or 2 nucleotides. Examples of 
PRF are common in many different virus families and many tend to shift the 
elongating ribosome to the -1 reading frame. There are two requirements for PRF; a 
slippery sequence with the consensus sequence of X_XXY_YYZ (where _ separates 
in-frame triplets, X can be any three identical nucleotides, Y can represent a 
triplicate of A or U and Z represents A, C or U) and a hairpin loop which is thought 
to act to slow the elongating ribosome down allowing PRF to occur. As a result of 
this shift, a fusion protein is formed from the combined translated ORFs. A method 
to test for PRF is to use western blot analysis to investigate the presence of fusion 
proteins that are created as result of the frame shift by the elongating ribosome. 
 
Fig. 5.1 shows the sequence surrounding the bRSV M2 ORF-2 initiation codon. As 
shown in Section 4.4.2, mutation of the AUG codon at position 563 to CUG reduced 
ORF-2 expression to negligible levels. Thus, if PRF is used in bRSV M2 ORF-2 
initiation, the site of the slippery sequence is likely to be in close vicinity upstream of 
this codon. As seen in Fig. 5.1, there is no sequence that resembles the consensus 
slippery sequence. However, it is possible for frame shifting to occur even without 
the full slippery sequence, meaning that is possible that this mechanism could still be 
used.  
 
545-UAAUUGUUAAUGAACAAAAUGAAUAA-570 
Fig. 5.1: Sequence surrounding the bRSV M2 ORF-2 initiation site 
Sequence surrounding the ORF-2 (M2 ORF-2) preferred initiation site from position 545-570. 
Preferred AUG codon is underlined and the termination codon for M2 ORF-1 (M2-1 ORF) is 
highlighted in bold. 
 
While western blot analysis of the M2 gene products of hRSV found no evidence for 
a fusion product that would be a natural consequence of PRF (Ahmadian et al., 2000) 
this has never been investigated for bRSV. Currently there is no available antibody 
specific for the bRSV M2-1 or M2-2 proteins. To identify whether a fusion protein 
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was produced western blot analysis was performed using the protein derived from 
cells transfected with the expression plasmids that express CAT protein from ORF-2 
used to investigate bRSV M2 ORF-2 expression as described in Section 4.5.2.3. 
Western blot analysis was performed as described in Section 2.2.1 and Section 2.2.2 
with the antibody Anti-CAT (Goat Anti-CAT IgG Fc (HRP) Abcam) as the primary 
antibody. For each sample a standard amount of protein (100µg) was used, which 
was established by using a bicinchoninic acid assay (BCA) assay to quantify protein 
concentrations in lysed samples as described in Section 2.2.3.   
 
The protein from cells transfected with the plasmid pbRSVWC42 was used to 
investigate if any fusion proteins were present. Protein from cells transfected with 
the plasmids pbRSVWC120, pbRSVStop120 were used as negative controls as these 
plasmids did not express CAT protein (Section 4.5.2). Material from cells transfected 
with plasmid pBluescribe was also used as an additional negative control. Finally, 
the material from cells transfected with the hRSV plasmid pWildCAT was used as a 
positive control for CAT. For all samples except those from cells transfected with 
plasmid pWildCAT, the same quantity of protein was analysed. For the material 
from cells transfected with pWildCAT plasmid, a 1:10 dilution (10 µg) was used in 
view of the significantly higher levels of CAT protein expressed by this plasmid 
when compared to bRSV reporter plasmids.  
 
A theoretical fusion protein of CAT and M2-1 proteins would have a mass of 
approximately 46 kDa. As shown in Fig. 5.2, intense bands with a mass of 
approximately 25 kDa were observed in lanes 1 and 5 which were from cells 
transfected with plasmids pbRSVWC42 and pWildCAT, respectively. These 
products are the expected size for CAT protein that was not fused to the M2-1 
protein. No protein of the size predicted for a fusion protein was seen in any track. 
As expected, no CAT protein was observed in the negative controls from cells 
transfected with plasmids pbRSVWC120 (lane 2), pbRSVStop120 (lane 3) or 
pBluescribe (lane 4). The absence of expressed CAT protein in lanes 2 and 3 for 
pbRSVWC120 and pbRSVStop120, respectively, indicates that there was no 
expression of the CAT protein from the ORF-2 with these constructs as expected. 
 
	 160	
With no reason to assume that a fusion protein would be efficiently cleaved to form 
an intact CAT protein and the absence of a fusion protein product, the data indicates 
that ribosomal frameshifting is not used to initiate translation of M2 ORF-2 in bRSV. 
This is further supported by the evidence in Section 4.4.3, where the AUG located at 
position 563 is essential for efficient initiation of translation for M2 ORF-2. PRF also 
requires a hairpin loop directly downstream of the initiation site, and, for all plasmids 
used in previous chapters, expression from ORF-2 was seen even when the bRSV 
M2 ORF-2 (M2-2 ORF) directly downstream of the ORF-1/ORF-2 overlap region 
was replaced with the CAT gene. 
 
 
 
Fig. 5.2: Western blot analysis of CAT protein from cellular lysates of transfected plasmids  
Western blot analysis of CAT protein from HEp-2 cellular lysates that were individually transfected 
with reporter plasmids. Lane 1: pbRSVWC42, lane 2: pbRSVWC120, lane 3: pbRSVStop120, lane 4: 
pBluescribe and lane 5: pWildCAT. All lanes orginated from the same gel, white gaps indicate lanes 
that were not adjacent to each other.  
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5.3.1.1. Investigation of initiation of the M2 ORF-2 in bRSV at the AUG at 
position 563 
It is unclear why ribosomes have a strong preference to initiate translation at the 
AUG located at position 563 rather than the AUG located at position 554 in the 
ORF-1/ORF-2 overlap region. As indicated above, a possible reason for the 
preference is that the Kozak sequence surrounding the AUG codon plays a role in the 
initiation process with the preferred AUG site at position 563 having a stronger 
upstream consensus sequence as seen in Fig. 5.3 (+4 position for both AUG codons 
is the same). To investigate whether the sequence upstream of the preferred initiation 
codon plays a role in initiation of ORF-2, a plasmid named pbRSVAUGSeqS was 
created. This plasmid was based on the standard reporter system described in 
Chapter 4 to measure ORF-2 expression. The plasmid was designed to direct 
synthesis of a bicistronic mRNA, where the two ORFs overlapped. The bicistronic 
mRNA contained the entire bRSV M2 ORF-1 sequence in ORF-1 and the bRSV M2 
ORF-1/ORF-2 overlap region and the CAT reporter coding sequence in ORF-2. All 
mutations made to create the plasmid pbRSVAUGSeqS were introduced into the 
native bRSV M2 ORF-1 sequence. Mutations in the native bRSV M2 ORF-1 
sequence in ORF-1 for the plasmid pbRSVAUGSeqS are described below. For all 
other plasmids used in this chapter to investigate ORF-2 expression, the same 
reporter system was used. Unless otherwise stated these plasmids were in the same 
format as pbRSVWC and mutations made to investigate ORF-2 expression were 
made to the native bRSV M2 ORF-1 sequence located in ORF-1 of the plasmid’s 
gene. 
 
For the plasmid pbRSVAUGSeqS, the upstream Kozak sequence of the preferred 
AUG at position 563 (residues 557-562) was mutated to the same sequence used for 
the Kozak sequence for the AUG codon at position 554 (residues 548-553) (Fig. 5.3). 
The AUG codon at position 554 in the ORF-1/ORF-2 overlap region that is not used 
for expression of ORF-2 was also mutated. The aim was to determine whether the 
introduction of a weaker Kozak sequence (as used by the AUG codon at position 
554) for the preferred AUG codon at position 563, would alter CAT protein 
expression. A decrease in expression would indicate that the sequence upstream of 
the AUG at position 563 was critical for its use as an initiation site.  
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bRSV M2 Sequence UAAUUGUUAAUGAACAAAAUGAAUAA 
pbRSVAUGSeqS     UAAUUGUUACUGUUGUUAAUGAAUAA 
Fig. 5.3: Mutations introduced into the sequence upstream of AUG (563) for expression of ORF-
2  
The mutations in the M2 ORF-1/ORF-2 overlap region for the plasmids pbRSVAUGSeqS are 
highlighted in red. AUG initiation sites for M2 ORF-2 (M2-2 ORF) inside the ORF-1/ORF-2 overlap 
region are underlined. The stop codon for the ORF-1 (M2-1 ORF) is highlighted in bold. The 
sequence displayed is from position 545 to position 570 
 
Construction of the plasmid pbRSVAUGSeqS  
Two-Step PCR 
For the construction of the plasmid pbRSVAUGSeqS, a two-step PCR method was 
used to create the insert with the mutations that were to be ligated into the vector 
plasmid. Two amplicons were created for the first PCR step. Each amplicon was 
individually amplified by PCR using specific primer pairs. Both amplicons contained 
a region of sequence that was homologous to the other amplicon and this was 
incorporated by either the forward or the reverse primer at the 5´ or 3´ ends 
respectively depending on the primer pair used. This region of overlapping sequence 
contained the mutations that were introduced into the sequence. Both amplicons were 
purified and placed into a PCR reaction. As the two amplicons contained a region of 
sequence homology, the two fragments annealed during the second PCR step. The 
joined amplicons were then amplified with external primers. The resulting joined 
fragment was then ligated into the digested vector plasmid. A detailed methodology 
for each technique used in this chapter can be found in Section 2. Sequences for all 
primers used in all PCR reactions in all sections can be found in the Appendix C. 
 
For the first PCR step, one amplicon (named bRSV) contained the bRSV 5´ UTR 
and the bRSV M2 ORF-1 and the second (named CAT) contained the bRSV M2 
ORF-1/ORF-2 overlap and the CAT reporter coding sequence. The two primer pairs 
used to generate the first two amplicons in the first PCR stage were 
bRSVWTF/AUGSeqSR (bRSV amplicon) and AUGSeqSF/CATR (CAT amplicon). 
Each amplicon was generated by PCR from the plasmid pbRSV5´AUG (Section 
2.3.1), which already had the AUG codon at position 554 mutated to CUG. Before 
the second PCR step, both products were cleaned using a QIAGEN PCR Purification 
Kit as described in Section 2.3.15. The two products were added in equal molar 
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quantities and were ‘fused’ via the second PCR step using the primers 
bRSVWTF/CATR (Section 2.3.1). The final product contained a Kpn I and Sph I site 
at the 5´ and 3´ ends, respectively. The fragment was digested with the endonuclease 
pair Kpn I/Sph I (Section 2.3.4 and Section 2.3.5) and ligated into the plasmid 
pBluescribe (Section 2.3.7) that was previously digested with endonuclease pair Kpn 
I/Sph I (Section 2.3.4 to Section 2.3.6). The ligated plasmid was transformed into 
E.coli DH5α bacteria and plated onto AMP/IPTG/X-Gal LB agar plates (Section 
2.3.8). The bacteria were grown overnight at 37oC and colonies were selected 
through blue white selection (Section 2.3.9). Each picked colony was grown 
overnight at 37oC and small scale plasmid purification was performed as described in 
Section 2.3.13. The purified plasmids were digested with endonucleases Kpn I and 
Sph I to confirm the presence of the correct insert (1237 nts). After confirmation the 
sequence was confirmed using primers T7-91 and T3 down (Section 2.3.10). 
 
5.3.1.2. The role of upstream sequences in expression of the bRSV M2 ORF-2 
from the AUG at position 563 
The plasmid pbRSVAUGSeqS and control plasmids pbRSVWC, pbRSV3´AUG, 
pbRSV5´AUG and pBluescribe were individually transfected into HEp-2 cells as 
described in Section 2.4.1. Plasmids pbRSVWC and pbRSV5´AUG were positive 
controls and pbRSV3´AUG was a negative control for CAT protein expression 
(sequences for plasmids pbRSVWC, pbRSV5¢AUG and pbRSV3¢AUG are found in 
Section 4.4). Levels of CAT protein expressed were quantified using a CAT ELISA 
assay as described in Section 2.4.2. All samples were normalised against levels from 
transfected empty vector pBluescribe plasmid to account for any background signal 
generated in the ELISA. For each sample levels of CAT protein were expressed were 
as a percentage of CAT protein expression from plasmid pbRSVWC. 
 
As seen Fig. 5.4, introducing a weaker Kozak sequence (as used by the AUG codon 
at position 553) for the AUG codon at position 563 and mutating the upstream 
sequence of the AUG codon located at position 554 in the plasmid pbRSVAUGSeqS 
reduced levels of CAT protein expression to 13.1% of that of the control. There was 
a significant reduction in CAT protein expression from the plasmid 
pbRSVAUGSeqS in relationship to both the positive controls pbRSVWC 
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(p=0.000120) and pbRSV5´AUG (p=0.0047). CAT protein expression from the 
plasmid pbRSVAUGSeqS was statistically significantly higher by 9.1% in 
comparison to the negative control pbRVS3´AUG (p=0.0015). These data indicate 
that the upstream sequence of the preferred AUG site beginning at position 563 is 
important for efficient initiation of ORF-2 as mutating this upstream sequence to a 
Kozak sequence of poorer context, significantly reduces levels of expression.  
 
 
  
Fig. 5.4: CAT protein expression of plasmids used to investigate factors leading to initiation of 
translation at the AUG codon at position 563  
Levels of expression of CAT protein expressed from plasmids individually transfected into HEp-2 
cells. Mutations made to these plasmids are described in Section 5.3.1.1. Results were normalised 
against the empty vector pBluescribe and are expressed as a percentage of the positive control plasmid 
pbRSVWC. Error bars indicate standard deviation. 
 
5.3.2.1. The role of the Kozak sequence for translation initiation from the AUG 
codon located at position 563 
The data from Section 5.3.1.2 demonstrated that the sequence within residues 548-
562 upstream of the preferred AUG codon at position 563 plays a role in the 
initiating ribosome choosing this site for initiation of translation of the bRSV M2 
ORF-2. However, the data did not establish whether this is due to the key Kozak 
nucleotides surrounding the AUG codon. In this region the strongest nucleotide of 
the Kozak sequence is an A residue located at position 560 (at position -3 relative to 
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the start codon). The -3 position in the Kozak sequence is one of the key residues and 
the optimal nucleotide for this position is an A nucleotide. Therefore to further 
investigate whether the Kozak sequence is relevant for the initiation of the bRSV M2 
ORF-2, three plasmids (pbRSVΔ560G, pbRSVΔ560C and pbRSVΔ560U) were 
created. These plasmids used the CAT reporter system to measure ORF-2 expression 
as used previously. For the three plasmids the ORF-1 sequence was unaltered while 
the A residue at position 560 was mutated to one of the three other nucleotides (Fig. 
5.5) to determine if translation of CAT protein was reduced with the reduction in 
Kozak sequence strength. For plasmid nomenclature, G, C and U at the end of the 
plasmid name denotes the nucleotide that the A nucleotide at position 560 was 
mutated to.  
 
bRSV M2 Sequence    UAAUUGUUAAUGAACAAAAUGAAUAA 
pbRSVΔ560G          UAAUUGUUAAUGAACGAAAUGAAUAA 
pbRSVΔ560C              UAAUUGUUAAUGAACCAAAUGAAUAA 
pbRSVΔ560U              UAAUUGUUAAUGAACUAAAUGAAUAA 
 
Fig. 5.5: Mutations made to the nucleotide at position 560 in the ORF-1/ORF-2 overlap region 
Mutations in the ORF-1/ORF-2 overlap region for the plasmid pbRSVΔ560G, pbRSVΔ560C and 
pbRSVΔ560U. Sites of mutations are highlighted in red. AUG sites inside the ORF-1/ORF-2 overlap 
region are underlined. The stop codon for ORF-1 is highlighted in bold. The sequences displayed, 
begin at position 545 and end at position 570 from the start of the bRSV mRNA sequence or the 
beginning of bRSV sequence in reporter plasmids. 
 
Construction of the plasmids pbRSVΔ560G, pbRSVΔ560C and pbRSVΔ560U  
The mutation for each plasmid was created using two-step PCR. A detailed 
description of the methodology of the two-step PCR can be seen in Section 5.3.1.1. 
The method for cloning and sequencing of the plasmids was the same as used in 
Section 5.3.1.1. For the first PCR step for each plasmid, the primer pairs used for the 
first PCR step for each plasmid are shown in Table 5.2 and were amplified from the 
plasmid pbRSVWC. For each plasmid, the two amplicons generated in the first PCR 
step were joined in the second PCR step using the primer pair bRSVWTF/CATR.  
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Plasmid Primer pair used for 
bRSV amplicon  
Primer pair used for 
CAT amplicon  
pbRSVΔ560G bRSVWTF/Δ560GR Δ560GF/CATR 
pbRSVΔ560C bRSVWTF/Δ560CR Δ560CF/CATR 
pbRSVΔ560U bRSVWTF/Δ560UR Δ560UF/CATR 
 
Table 5.2: Primer pairs for each amplicon used for the first step in two-step PCR for the 
plasmids pbRSVΔ560G, pbRSVΔ560C and pbRSVΔ560U 
Primer pairs for the bRSV amplicon and CAT amplicon in the first step of two-step PCR for plasmids 
pbRSVΔ560G, pbRSVΔ560C and pbRSVΔ560U. 
 
5.3.2.2. Investigation of the role of Kozak sequence ‘strength’ for translation 
initiation at the AUG codon located at position 563 
The three mutant plasmids pbRSVΔ560G, pbRSVΔ560C and pbRSVΔ560U and two 
control plasmids, pbRSVWC and pBluescribe, were individually transfected into 
HEp-2 cells as described in Section 2.4.1. Levels of CAT protein expressed were 
quantified using a CAT ELISA assay as described in Section 2.4.3 and all data were 
normalised against the assay results from the transfected empty vector pBluescribe 
plasmid as described previously. Levels of CAT protein were expressed as a 
percentage of CAT protein levels obtained from the plasmid pbRSVWC.  
 
As seen in Fig. 5.6 with plasmid pbRSVΔ560G, expression of the CAT protein from 
the second ORF was only slightly reduced to 89.9% of the control which was not 
statistically significantly different to the control (p=0.39). With plasmid 
pbRSVΔ560C expression of the CAT protein was reduced by a significant level to 
75% of the control (p=0.02) and with plasmid pbRSVΔ560U, expression of the CAT 
protein was further reduced to 52% of the control (p=0.0028). These data are entirely 
consistent with the order of nucleotide preference at position -3 in the Kozak 
sequence of A>G>C>U. This strongly suggests that for the AUG codon at position 
563 the Kozak sequence is a significant factor in determining the efficiency of 
translation initiation as is seen in the canonical translation initiation mechanism. 
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Fig. 5.6: CAT protein expression for the plasmids used to investigate the importance of the 
Koazk -3 residue at the AUG codon at position 563 for initiation of translation M2 ORF-2 
Levels of expression of CAT protein expressed from plasmids individually transfected into HEp-2 
cells. Mutations made to these plasmids are described in Section 5.3.2.1. Results were normalised 
against the empty vector pBluescribe and are expressed as a percentage of the positive control plasmid 
pbRSVWC. Error bars indicate standard deviation. 
 
5.3.3.1. Investigation of optimal efficiency for translation initiation using the 
AUG codon at position 563  
While the data described above demonstrates that the nucleotide preference at 
position -3 upstream of the AUG codon at position 563 is consistent with the Kozak 
sequence preference, the remainder of the sequence in this region is suboptimal (Fig. 
4.15). It therefore remains a possibility that the remainder of this sequence plays an 
additional role in the initiation of translation of M2 ORF-2. To further investigate 
whether the Kozak sequence-like function is the primary or sole function for the 
upstream sequence of the AUG codon at position 563, further mutations were made 
to introduce an optimal Kozak sequence surrounding the AUG codon at position 563. 
This was then studied to see if the optimisation led to an increase in ORF-2 
expression which would strengthen the likelihood that the Kozak sequence is a 
primary factor in ORF-2 translation. As shown in Fig. 5.7, the optimal Kozak 
sequence (Kozak, 1987) (GCCGCCACCAUGG) was introduced by mutation into 
both reporter plasmids pbRSVWC and pbRSVStop to create the plasmids 
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pbRSVWCKozak and pbRSVStopKozak, respectively. Plasmid pbRSVStopKozak 
contains an ORF-1/ORF-2 overlap region extended by 42nts compared to the 
wildtype.  
 
Optimal Kozak Sequence         GCCGCCACCAUGG 
bRSV M2               UAAUUGUUAAUGAACAAAAUGAAUAA 
pbSVWCKozak           UAAUUGUUAGCCGCCACCAUGGAUAA 
pbRSVStopKozak        UAAUUGUUAGCCGCCACCAUGGACAA 
 
 
Fig. 5.7: Mutations made to introduce optimal Kozak sequence for the AUG codon at position 
563  
Mutations in the ORF-1/ORF-2 overlap region for the plasmid pbRSVWCKozak and 
pbRSVStopKozak. Sites of mutations are highlighted in red. AUG sites in frame for ORF-2 initiation 
inside the ORF-1/ORF-2 overlap region are underlined. The stop codon for ORF-1 (M2-1 ORF) is 
highlighted in bold. The sequences displayed, begin at position 545 and end at position 570 from the 
start of the bRSV mRNA sequence or the beginning of bRSV sequence in reporter plasmids. 
 
 
Construction of the plasmid pbRSVWCKozak and pbRSVStopKozak  
The mutations were created for the plasmids pbRSVWCKozak and 
pbRSVStopKozak using two-step PCR. A detailed description of the methodology of 
two-step PCR can be seen in Section 5.3.1.1. The method for cloning and sequencing 
of the plasmids was the same as used in Section 5.3.1.1.  For the first PCR step for 
each plasmid, the primer pairs used to generate the two products for the first PCR 
step for the plasmid pbRSVWCKozak were bRSVWTF/KozakR (bRSV amplicon) 
and KozakF/CATR (CAT amplicon) using plasmid pbRSVWC as a template. The 
primer pairs used for the first PCR step for the plasmid pbRSVStopKozak were 
bRSVWTF/KozakStopR (bRSV amplicon) and KozakStopF/CATR (CAT amplicon) 
using the plasmid pbRSVStop as a template. The amplicon pairs generated in the 
first PCR step were joined in the second PCR step using the primer pair 
bRSVWTF/CATR.  
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5.3.3.2. Expression levels directed by the optimised Kozak sequence adjacent to 
the AUG codon at position 563 
The two plasmids, pbRSVWCKozak and pbRSVStopKozak and control plasmids 
pbRSVWC, pbRSVStop and pBluescribe were individually transfected into HEp-2 
cells as described previously (Section 2.4.1). Levels of CAT protein were 
determined, normalized and expressed as a percentage of CAT protein expression 
from the plasmid pbRSVWC, as before. 
 
As seen in Fig. 5.8, introducing an optimal Kozak sequence for the start codon 
located at 563 in the plasmid pbRSVWCKozak significantly reduced levels of CAT 
protein expression to 66% of the control pbRSVWC (p=0.005). Introducing an 
optimal Kozak sequence upstream of position 563 and extending the ORF-1 by 
42nts, by mutating the wild type ORF-1 termination codon in the plasmid 
pbRSVStopKozak had little effect on CAT protein expression; giving 94.5% 
expression of the control pbRSVWC (p=0.55) and only a 0.2% increase compared to 
the control pbRSVStop (p=0.97), which also had the ORF-1 stop codon removed but 
did not have an optimal Kozak sequence for the AUG codon at position 563. 
 
These data strongly suggest that the sequence surrounding the AUG at position 563, 
is already optimal for the ribosome to initiate translation despite differences with the 
optimal Kozak sequence. Changing the sequence to resemble the optimum Kozak 
sequence made no significant difference or reduced translation efficiency. As before, 
removing the ORF-1 termination codon had no effect on translation of ORF-2 even 
when an optimal Kozak sequence was introduced. The data therefore indicates that 
the mechanism used for initiation relies on the surrounding sequence and although 
the nucleotide at position -3 appears to follow the Kozak ‘rules’, does not conform 
completely to the pattern seen with a canonical Kozak sequence. 
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Fig. 5.8: CAT protein expression for plasmids that are used to investigate whether the 
translation of M2 ORF-2 is at optimal efficiency for initiation at the AUG codon at position 563   
Levels of expression of CAT protein expressed from plasmids individually transfected into HEp-2 
cells. Mutations made to these plasmids are described in Section 5.3.3.1. Results were normalised 
against the empty vector pBluescribe and are expressed as a percentage of the positive control plasmid 
pbRSVWC. Error bars indicate standard deviation.  
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5.4.1. Potential alternate start sites for initiation of translation of the bRSV M2 
ORF-2 
It is apparent that the preferred initiation site for M2 ORF-2 (M2-2 ORF) is located 
at the AUG codon beginning at position 563, with the alternate AUG in the ORF-
1/ORF-2 overlap region at position 554 only allowing initiation of translation of 
ORF-2 to occur at significantly lower levels (5.4% of normal ORF-2 translation). 
The sequence surrounding the preferred AUG codon is of importance for initiation in 
regards to the Kozak sequence but also appears to play another role as well as acting 
as the Kozak sequence. It is also apparent that initiation is not reliant on the 
translating ribosome of M2 ORF-1 (M2-1 ORF) terminating in the vicinity of the 
start codon for ORF-2. However it is unclear if the position of the AUG at position 
563 is vital for successful initiation of translation of ORF-2.  
 
As only one AUG codon has been tested as an alternative initiation site for 
translation of ORF-2, it may be possible that start codons at alternate sites may be 
able to act as a suitable alternate initiation site for M2 ORF-2 when the preferred 
initiation site is removed. If initiation was able to take place at an alternate site, it 
would provide evidence of a scanning mechanism used by the ribosome to initiate 
translation of M2 ORF-2. Alternatively, failure to initiate translation at an alternate 
site would indicate that the location of the AUG codon was essential for successful 
translation of M2 ORF-2. 
 
Two plasmids were therefore created to test if translation of ORF-2 could be initiated 
at other sites if the preferred initiation codon was mutated. Both plasmids used the 
same reporter system to measure ORF-2 expression as used in Chapter 4 and were in 
the same format as the reporter plasmid pbRSVWC. The two plasmids, 
pbRSVAUG557 and pbRSVAUG525, introduced two separate alternate AUGs in the 
same frame as ORF-2 in and upstream of the ORF-1/ORF-2 overlap region. Both 
naturally occurring AUGs used for initiation of translation of ORF-2 in the ORF-
1/ORF-2 overlap region were mutated in both plasmids by mutating AUG to CUG. 
As seen in Fig. 5.9, the plasmid pbRSVAUG557 had an artificial AUG codon 
introduced beginning at position 557 by mutating residues AC to UG at residues 
558-559. This AUG codon was introduced between the two mutated AUGs in the 
ORF-1/ORF-2 overlap region. This was created to investigate if AUGs in close 
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proximity to the preferred AUG start site of ORF-2 could act as an alternate start 
codon. The second plasmid, pbRSVAUG524, focused on a native AUG codon 
beginning at position 524 in the same frame as ORF-2, there was however a stop 
codon beginning at position 545 in frame further downstream, which if the AUG at 
position 524 was used for initiation of ORF-2, would lead to premature termination 
of ORF-2 translation. The stop codon beginning at position 545 was therefore 
mutated along with both AUGs in the ORF-1/ORF-2 overlap region by mutating 
UAA to CAA. This was to investigate if AUGs at distance from the preferred start 
codon of ORF-2 would be able to act as an alternate start codon.  
 
bRSV M2 Sequence 
GAAAUAAAUGGUAAUAACCAAGGUGACAUAAUUGUUAAUGAACAAAAUGAAUAA 
pbRSVAUG557 
GAAAUAAAUGGUAAUAACCAAGGUGACAUAAUUGUUACUGAUGAAACUGAAUAA 
pBRSVAUG524 
GAAAUAAAUGGUAAUAACCAAGGUGACACAAUUGUUACUGAACAAACUGAAUAA 
 
Fig. 5.9: Mutations made to alter the potential start site for initiation of translation of ORF-2 
Mutations made to alter the potential start site for initiation of translation of ORF-2 for the plasmid 
pbRSVAUG557 and pbRSVAUG524. Sites of mutations are highlighted in red. AUG sites in frame 
for ORF-2 initiation are underlined. The stop codon for ORF-1 and stop codon preventing initiation of 
ORF-2 upstream of the ORF-1/ORF-2 overlap region beginning at position 545 are highlighted in 
bold. The sequences displayed, begin at position 517 and end at position 570 from the start of the 
bRSV mRNA sequence or the beginning of bRSV sequence in reporter plasmids. 
 
Construction of the plasmids pbRSVAUG557 and pbRSVAUG524 
The plasmids pbRSVAUG557 and pbRSVAUG524 had the relevant mutations 
incorporated by two-step PCR. A detailed description of the method can be seen in 
Section 5.3.1.1. The method for cloning and sequencing of the plasmids was the 
same as used in Section 5.3.1.1.  For the first PCR step for each plasmid, the two 
primer pairs used to generate the first two amplicons for each plasmid were 
bRSVWTF/AUG557R (bRSV amplicon) and AUG557F/CATR (CAT amplicon) for 
the plasmid pbRSVAUG557 and bRSVWTF/AUG524R (bRSV amplicon) and 
AUG524F/CATR (CAT amplicon) for the plasmid pbRSVAUG524. The amplicons 
were amplified from the plasmid pbRSVDouble, which already had the two AUG 
codons used for initiation of ORF-2 in the ORF-1/ORF-2 overlap region mutated. 
For both plasmids, the two amplicons generated in the first PCR step were joined in 
the second PCR step using the primers bRSVWTF/CATR.  
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5.4.2. Expression from alternate AUG start sites for initiation of translation of 
M2 ORF-2 
The two plasmids pbRSVAUG557 and pbRSVAUG524 were individually 
transfected into HEp-2 cells. The control plasmids pbRSVWC and pBluescribe were 
also individually transfected into HEp-2 cells. pbRSVWC acted as the positive 
control. Plasmids were transfected into HEp-2 cells as described in Section 2.4.1. 
Levels of CAT protein expressed were quantified using a CAT ELISA assay as 
described in Section 2.4.2. All samples were normalised against the assay results 
from the transfected empty vector pBluescribe plasmid. This was to account for any 
background signal generated in the ELISA, as the plasmid contained no CAT gene. 
For each sample, levels of CAT protein expressed were displayed as a percentage of 
CAT protein expression from the plasmid pbRSVWC. 
 
As seen in Fig. 5.10, mutating both initiation codons for translation of ORF-2 in the 
ORF-1/ORF-2 overlap region and introducing a start codon beginning at position 
557 in the plasmid pbRSVAUG557, reduced levels of CAT protein expression to 1.2 
% of the control plasmid pbRSVWC. This significant reduction in the expression of 
CAT protein compared to the control (p=0.000096) indicates that translation of the 
second ORF has been reduced to nominal levels. 
 
Mutating both initiation codons for translation of ORF-2 in the ORF-1/ORF-2 
overlap region and removing a stop codon at position 545 allowing translation for the 
second ORF to potentially initiate at the start codon beginning at position 524 in the 
plasmid pbRSVAUG524 reduced levels of CAT protein expression to 0.3% of the 
control. This significant reduction in the expression of CAT protein in comparison to 
the control (p=0.000095) indicates that translation of the second ORF has been 
reduced to nominal levels. 
 
These data indicates that the position of the AUG located at 563 is crucial for 
initiation of translation for the second ORF. The two artificial start codons tested at 
different locations failed to initiate translation of the second ORF above nominal 
levels. The naturally occurring AUG at position 554 had higher levels of CAT 
protein expression (5.4%) compared to the two artificial AUG codons (Section 4.4). 
However this was still an extremely low level of expression compared to the control, 
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which indicates the importance of initiation of ORF-2 at the AUG codon at position 
563. 
 
It could be argued that as these different AUGs trialed had different Kozak 
sequences, the strength of the Kozak sequence could be a mitigating factor for the 
decrease in translation of ORF-2. However, from Section 5.3.3, it was shown that 
optimal Kozak sequences have little effect on the efficiency of translation initiation 
for the second ORF. Both of the AUGs trialed in the sequences had similar strength 
Kozak sequences compared to the preferred AUG, with at least one optimal 
nucleotide present in the key positions either at position -3 or +4 of the start codon. 
This means it is unlikely that the Kozak sequence is the primary factor for the failure 
to initiate translation. Instead it is more likely that the AUG is in a highly specific 
position in relationship to an unknown factor and shifting the AUG even by several 
nucleotides inhibits the ribosome from initiating translation of the second ORF. 
 
 
 
Fig. 5.10: CAT protein expression for the plasmids used to investigate alternate initiation for 
translation of M2 ORF-2   
Levels of expression of CAT protein expressed from plasmids transfected into HEp-2 cells. Mutations 
made to these plasmids are described in Section 5.4.1. Results were normalised against the empty 
vector pBluescribe and are expressed as a percentage of the positive control plasmid pbRSVWC. 
Error bars indicate standard deviation.  
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5.5.1.1. Identification of key structured regions surrounding the start codon for 
ORF-2 located at position 563 
Data from previous subsections strongly suggests that the position of the AUG codon 
used for initiation of translation of M2 ORF-2 is important. Initiation of translation 
of the bRSV M2 ORF-2 does not appear to be improved by improving the Kozak 
sequence surrounding the preferred AUG and this suggests there may be some other 
factor which plays a role in initiation. One possibility is the presence of secondary 
structure in the mRNA adjacent to the M2-ORF-2 initiation codon. As a first step, 
Mfold modeling software was used to predict the presence of potentially structured 
regions in the M2 mRNA. This modeling software has been previously used to 
successfully predict and identify secondary structures located in the M2 gene 
transcript of other members of the Pneumoviridae family (Gould and Easton, 2005). 
 
Using Mfold analysis, the M2 ORF-1 sequence in the vicinity of the overlap region 
was assessed to identify if there was any potential RNA secondary structure present 
in the vicinity of the overlap region. If a structure is present in the region upstream of 
the AUG at position 563, it is likely to be formed by sequences from the local 
vicinity, as there is no evidence that sequences further away are required for 
translation of ORF-2. For this reason a region of 60 nts from position 511 to the M2 
ORF-1 termination codon ending at position 570 was studied. A full description of 
settings for the software can be viewed in Section 2.9. 
 
As seen in Fig. 5.11, the analysis of the 60nt region between residues 511-570 which 
includes the entire M2 ORF-1/ORF-2 overlap region indicated the likely presence of 
two stem loop structures with a good level of stability (minimum free energy ΔG=-
5.10). One of these stem loop structures encompasses the M2 ORF-1/ORF-2 overlap 
region beginning at position 543 and ending at position 565. This region contains the 
preferred AUG codon for ORF-2 and the majority of the surrounding upstream 
sequence which forms base pairs within the stem of the proposed structure. 
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Fig. 5.11 Predicted mRNA structure generated by Mfold sofware 
Predicted of mRNA structure generated by Mfold software using sequence from position 511 to 570 
of the bRSV M2 mRNA. Minimum free energy ΔG=-5.10 
 
 
5.5.1.2 Is secondary structure encompassing the ORF-1/ORF-2 overlap region 
between residues 543 and 565 involved in ORF-2 translation? 
As described in Section 5.5.1.1, the RNA folding software Mfold, predicted a stem 
loop structure encompassing the preferred M2 ORF-2 AUG site at position 563 and 
the immediate upstream sequence. In order to investigate the significance of the 
proposed stem loop structure, the plasmid pbRSVΔ550 was generated into which a 
mutation was inserted to disrupt the predicted structure by mutating the G at position 
550 to an A (Fig. 5.12A). Plasmid pbRSVΔ550 followed the same organization as 
the reporter plasmid pbRSVWC. The mutated sequence (residues 511-570) was 
predicted to lack the stem loop (Fig. 5.12B and Fig. 5.12C). The effect of this on 
translation of ORF-2 was investigated.  
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A 
 
 
 
 
 
 
 
 
 
 
B                                                                                C      
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.12: Location of point mutation to disrupt predicted secondary structure between positions 
553 and 565 in the bRSV M2 mRNA. 
For all figures, the sequence analysed is from position 511 to 570 of the M2 mRNA. The Mfold 
predicted software predicted two alternate structures when mutated sequence was inputted. (A) 
Predicted structure of wild type M2 mRNA RNA (B) Predicted structure of mRNA in which residue 
550 G was mutated to A (C) Alternate predicted structure of mRNA in which residue 550 G was 
mutated to A. All predicted structures were generated using the Mfold program.   
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Construction of the plasmid pbRSVΔ550  
The point mutation for the plasmid pbRSVΔ550 was incorporated using two-step 
PCR and a detailed description of the methodology of the two-step PCR is provided 
in Section 5.3.1.1. The method for cloning and sequencing of the plasmids was the 
same as used in Section 5.3.1.1. For the first PCR step, the primer pairs used for each 
amplicon were bRSVWTF/Δ550R (bRSV amplicon) and Δ550F/CATR (CAT 
amplicon) using the plasmid pbRSVWC as a template. The two amplicons generated 
in the first PCR step were joined in the second PCR step using the primer pair 
bRSVWTF/CATR.  
 
5.5.1.3. The effect of disruption of predicted secondary structure on translation 
of M2 ORF-2 
The plasmid pbRSVΔ550 and control plasmids pbRSVWC and pBluescribe were 
transfected individually into HEp-2 cells as described previously (Section 2.4.1). 
Levels of CAT protein expressed were determined, normalized and expressed as a 
percentage of CAT protein expression from the plasmid pbRSVWC as before. 
Expression of CAT protein from plasmid pbRSVΔ550 was significantly increased to 
223% of the control plasmid pbRSVWC (p=0.000001). The increase in CAT 
expression indicates that the sequence containing the predicted stem loop structure 
significantly inhibits initiation of translation of M2 ORF-2. As shown in Fig. 5.12A, 
the initiating AUG codon is predicted to form part of the base paired structure and 
disruption of the structure may make the codon more accessible thereby improving 
translation. However, it is clear that the stem loop region does not promote ribosome 
access to the initiation codon for expression from ORF-2. 
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Fig. 5.13: CAT protein expression for the plasmid to investigate if disruption of predicted 
secondary structure between position 553 and 565 impacts ORF-2 translation 
Levels of expression of CAT protein expressed from plasmids individually transfected into HEp-2 
cells. Mutations made to this plasmid are described in Section 5.5.1.2. Results were normalised 
against the empty vector pBluescribe and are expressed as a percentage of the positive control plasmid 
pbRSVWC. Error bars indicate standard deviation. 
 
5.5.2.1. Identification of highly structured regions in ORF-1 in the bRSV M2 
mRNA  
From the data in Section 5.5.1.3, it is unlikely expression from the initiation site at 
position 563 requires the upstream predicted structured region identified in the 
previous section. However there is the possibility that a regulatory structured region 
similar to that seen in the hRSV M2 mRNA is present elsewhere. Modelling 
secondary structures using Mfold over such a large sequence is problematic and it is 
preferable to refine the location of such structures using conventional biochemical 
analyses where possible. A feature of the highly structured region in the hRSV M2 
mRNA (Gould and Easton, 2005) was that in vitro transcribed mRNA was a poor 
template for reverse transcription and that significant levels of premature termination 
was seen in hRSV M2 ORF-1. The site of the premature termination coincided with 
the highly structured region essential for translation initiation of the hRSV M2 ORF-
2 (P. Gould and A. Easton, personal communication).  
 
In order to search for a potential structured region in the bRSV M2 ORF-1, an in 
vitro transcription reaction was performed using a template generated by PCR from 
the plasmid pbRSVWC. This plasmid contained the entire bRSV M2 ORF-1 
sequence. An amplicon generated by PCR from the hRSV plasmid pWildCAT 
0
50
100
150
200
250
pbRSVWC	 pbRSVΔ550L
ev
el
s	o
f	C
AT
	e
xp
re
ss
io
n	
as
	a
	
pe
rc
en
ta
ge
	o
f	p
bR
SV
W
C
Plasmid
	 180	
(containing the hRSV M2 ORF-1 sequence) (Appendix B4) was used as a positive 
control (Gould and Easton, 2005) (Section 2.3.1). The primer pair used for both 
plasmids were T7/CATInt (Appendix C). For each plasmid, a product (Fig. 5.14A) 
was generated containing the entirety of the appropriate virus M2 ORF-1 (M2 ORF-
1) plus the M2 ORF-1/ORF-2 overlap region and a portion of the CAT gene. The 
templates also contained a T7 RNA promoter at the 5´ end which was used to 
generate the RNA. The full size RNA products from each reaction were of different 
sizes due to the different sizes of the virus ORF-1 (M2 ORF-1). A detailed 
description of the methodology for T7 in vitro transcription reactions is given in 
Section 2.7. The products of the in vitro transcription reactions were separated using  
denaturing polyacrylamide gel electrophoresis (PAGE) as described in Section 2.7. 
 
Fig. 5.14B shows the products of both in vitro transcription reactions. As seen in lane 
2, the hRSV template generated three RNAs. The largest RNA (1000 nt) represents 
the full length RNA and the band of approximately 900 nt is a premature termination 
product that terminates within the CAT gene sequence. The strong RNA band of 
approximately 400 nt results from premature termination within ORF-1 (M2 ORF-1) 
as described by Gould and Easton, 2005. Lane 3 shows the products of the in vitro 
transcription from the bRSV derived template. The band seen at approximately 950nt 
is the full length RNA product. The absence of other bands in this lane indicates that 
there was no premature termination of transcription. In turn, this suggests that it is 
unlikely that there are any highly structured regions located in the bRSV M2 ORF-1. 
However the possibility of the formation of less stable structures remains. 
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Fig. 5.14: PAGE gel of products of in vitro transcribed RNA from the hRSV and bRSV M2 
ORF-1 
A) Schematic of the hRSV and bRSV templates used in in vitro transcription reactions. Both 
amplicons include a T7 RNA promoter, the entire M2 ORF-1, the M2 ORF-1 / ORF-2 overlap region 
and a partial CAT gene sequence. (B) Products of in vitro transcription were separated on a PAGE 
gel. Lane 1: Geneflow 100 bp ladder. Lane 2: Transcription product from the hRSV template. Lane 3: 
Transcription product from the bRSV template. The sizes of the markers are shown.  
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5.6.1. Identification of critical regions upstream of the ORF-1/ORF-2 overlap 
region for the initiation of translation of the bRSV M2 ORF-2 
The mechanism used to initiate translation of the bRSV M2 ORF-2 remains unclear. 
While analyses described above failed to identify structured regions upstream of the 
M2 ORF-1/ORF-2 overlap region that may play a role in initiation of translation of 
bRSV M2 ORF-2, the possibility remains that other elements are required. In order 
to identify potential critical sequences in the bRSV M2 ORF-1 for translation of 
bRSV M2 ORF-2, an approach based on that described for analysis of hRSV was 
taken (Gould and Easton, 2005). A series of reporter plasmids were constructed 
using the same reporter system to measure ORF-2 expression as used in Chapters 4 
and 5, but in this case the gene encoding eGFP lacking the termination codon was 
inserted in-frame at the 5´ end of the M2-1 ORF-1, in which the M2 ORF-1 initiation 
codon had been deleted. In this way, the 5´ proximal ORF was extended by 722nts 
and expression of the plasmid’s ORF-1 sequence required translation initiation from 
the long eGFP gene. In the plasmid series, increasing proportions of bRSV M2 ORF-
1 sequence were deleted (shown schematically in Fig. 5.15A). Each deletion began at 
the start of the M2-1 coding sequence with the 3´ break point being progressively 
closer to the ORF-1/ORF-2 overlap region. The presence of the entire eGFP coding 
sequence ensured that the ribosomes initiating expression of ORF-1 were significant 
distance from the ORF-1/ORF-2 overlap region. As before, replacement of ORF-2 
with the CAT gene allowed expression to be measured. In total six plasmids were 
created (Fig. 5.15B). For plasmids pbRSV14, pbRSV89, pbRSV209, pbRSV293, 
pbRSV380 and pbRSV527 14 nts, 89 nts, 209 nts, 293 nts, 380 nts and 527 nts were 
removed from ORF-1, respectively.  
 
The plasmid pbRSV14Stop was also generated in which 14 nucleotides were 
removed from the 5´ end of the M2 mRNA in the same format as pbRSV14 and in 
addition, the termination codon for ORF-1 (M2-1 ORF) was mutated from UAA to 
CAA extending the ORF-1/ORF-2 overlap region by 42nts. This was used to explore 
if there was any difference in translation of ORF-2 when the stop codon of ORF-1 
was removed with an additional 722 nts of eGFP sequence added to the 5´ of the 
ORF-1 sequence. 
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Fig. 5.15 Schematic representation of the arrangement of chimeric reporter plasmids used to investigate critical upstream regulatory sequences in ORF-1 for M2 
ORF-2 translation 
(A) Schematic representation of the mRNA transcribed from chimeric reporter plasmids used to investigate critical sequences in the bRSV M2 ORF-1 (M2-1 ORF) for the 
initiation of translation of ORF-2. The diagram shows both ORF-1 (eGFP/M2 ORF-1) and ORF-2 (M2 ORF-2/CAT ORF). (B) Schematic showing the lengths of the M2 
ORF-1 coding sequence in ORF-1 for chimeric plasmids pbRSV14, pbRSVStop14, pbRSV89, pbRSV209, pbRSV293, pbRSV380 and pbRSV526 in comparison to the full 
M2 ORF-1 in the bRSV M2 mRNA (black line). Arrows identify the beginning of the M2 ORF-1 coding sequence for each plasmid. 
A 
B 
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Construction of the plasmids pbRSV14, pbRSV89, pbRSV209, pbRSV293, pbRSV380 
and pbRSV527 
The method for construction for all five plasmids was identical except for the use of 
the forward primer for the amplification of the truncated ORF-1/ORF-2/CAT 
fragments (bRSV fragment). For construction of all plasmids, two amplicons were 
generated which were subsequently ligated together into the vector plasmid. The first 
amplicon (bRSV fragment) consisted of the truncated M2 ORF-1 sequence, the M2 
ORF-1/ORF-2 overlap region and the entire of the CAT coding sequence. This 
amplicon was amplified by PCR using the template plasmid pbRSVWC (Section 
2.3.1). For each PCR reaction, the relevant forward primer used can be seen in Table 
5.3. The reverse primer CAT Hind III, which bound to the 3´ end of the CAT gene, 
was used for every PCR reaction. Each forward primer also contained an Sph I site at 
the 5´ end of the sequence and the reverse primer contained a Hind III site at the 
3´end of the sequence. The predicted lengths of the amplified bRSV fragments can 
be seen in Table 5.3. For all plasmids, the second amplicon was the eGFP fragment. 
This contained the eGFP coding sequence without the termination codon and was 
generated by PCR from the plasmid peGFP using the forward primer T7-91 and the 
reverse primer eGFP Sph I to generate an product of 880bp in size (Section 2.3.1). 
The product contained a Kpn I site at the 5´ end and an Sph I site at the 3´ end of the 
eGFP coding sequence. The bRSV and eGFP fragments for each plasmid were 
digested with the two endonuclease pairs Sph I/Hind III and Kpn I/ Sph I, 
respectively (Section 2.3.4 and Section 2.3.5) and were ligated together into the 
digested empty vector pBluescribe in a single ligation reaction (Section 2.3.7), which 
had been digested with endonuclease pair Kpn I/Hind III (Section 2.3.4 to Section 
2.3.6). Plasmids were then transformed into DH5α bacteria and plated onto 
AMP/IPTG/X-Gal LB agar plates (Section 2.3.8). The bacteria were grown 
overnight at 37oC and colonies were selected through blue white selection (Section 
2.3.9). Small-scale plasmid purification was performed as described in Section 
2.3.13. Purified plasmids were digested with endonucleases Kpn I and Hind III to 
confirm the presence of the expected fragment and the sequence was confirmed as 
before using the primers T7-91 and T3 (Section 2.3.10).  
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Construction of the plasmid pbRSV14Stop 
The plasmid pbRSV14Stop was created using the same approach as above, except 
for the amplification of the bRSV fragment, where the primer pair was 
bRSV14F/CAT Hind III and the template was the plasmid pbRSVStop, which 
contained the mutated ORF-1 termination codon. The size of the final insert was 
1974nts and the sequence was confirmed as before. 
 
 
Plasmid Forward 
Primer 
Reverse 
Primer 
Size of bRSV 
PCR amplicon 
generated (bp) 
Size of 
correctly 
ligated insert 
(bp) 
pbRSV14  pbRSV14F CAT Hind III 1241 1974 
pbRSV89 pbRSV89F CAT Hind III 1165 1898 
pbRSV209 pbRSV209F CAT Hind III 1045 1778 
pbRSV293 pbRSV293F CAT Hind III 961 1694 
pbRSV380 pbRSV380F CAT Hind III 874 1607 
pbRSV527 pbRSV527F CAT Hind III 727 1460 
 
Table 5.3: Primer pairs for each amplicon used for the first step in two-step PCR for generation 
of chimeric plasmids  
Primer pairs used for the bRSV amplicon in the first step of two-step PCR for generation of chimeric 
plasmids. The size of the PCR fragment and the size of the digested insert for each plasmid once 
ligated into the plasmid are also included. 
 
5.6.2. Investigation of the potential role of upstream sequences in expression of 
the bRSV M2 ORF-2  
The plasmids created in Section 5.6.1 were individually transfected into HEp-2 cells 
as described in Section 2.4.1. Cells were also transfected with control plasmids 
pbRSVWC, pbRSVStop and pBluescribe. CAT protein expression was quantified 
using a CAT ELISA assay as described in Section 2.4.2 and data were normalised 
against the assay results from the transfected empty vector pBluescribe plasmid. As 
previously stated, levels of CAT protein expressed were expressed as a percentage of 
CAT protein expression from the plasmid pbRSVWC. 
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As shown in Fig. 5.16, the addition of the eGFP coding sequence to the 5´ end of the 
truncated M2 ORF-1 lacking the first 14 nucleotides of the M2 mRNA sequence in 
the plasmid pbRSV14 reduced CAT protein expression to 72.1% of the control. 
While this reduction was not great it was statistically significant (p=0.0016). Rather 
than reflect a true reduction, this is likely to be due to a general reduction in 
expression caused by the addition of the eGFP ORF in these new chimeric plasmids, 
as it is unlikely that the first 14 nucleotides have such a great effect on the initiation 
of translation of the second ORF. 
 
Mutation of the ORF-1 (M2-1 ORF) termination codon the plasmid pbRSV14Stop 
reduced CAT protein expression to 92.2% of the control. There was no significant 
difference between the plasmid and the control pbRSVWC (p=0.36) and the control 
pbRSVStop (p=0.21). This indicates that the removal of the ORF-1 (M2-1 ORF) 
termination codon and increasing the length of ORF-1/ORF-2 overlap region by 
42nts, had no effect on initiation of translation of the bRSV M2 ORF-2 in the M2 
mRNA, even if the ORF-1 sequence is increased by 717nts. This is consistent with 
previous data suggesting that the ORF-1 termination codon is not a significant factor 
in the initiation of the bRSV M2 ORF-2 (Section 4.5.1.2). Removal of 89nts from the 
5´ end of M2 mRNA in the plasmid pbRSV89, reduced CAT protein expression to 
89.9% of the control (p=0.19) indicating that no essential sequence for initiation of 
translation of ORF-2 lies in that region. Extending the deletion of ORF-1 sequences 
to 209 nts from the 5´ end of M2 mRNA in the plasmid pbRSV209, reduced CAT 
protein expression to 78% of the control. This was significantly different to the 
control (p=0.0076). However, there was no significant difference between this 
plasmid pbRSV209 and the plasmids pbRSV14 (p=0.221) and pbRSV89 (p=0.097) 
which strongly suggests that no essential sequence for the initiation of translation for 
ORF-2 lies in the first 209 nts of the M2 mRNA. 
 
Removal of 293nts from the 5´ end of M2 mRNA in the plasmid pbRSV293 reduced 
levels of CAT protein expression to 57.1% of the control (p=0.000063). In 
comparison to other plasmids in the series there was a significant difference between 
the plasmids pbRSV293 and pbRSV14 (p=0.014) and between the plasmids 
pbRSV293 and pbRSV89 (p=0.00013). The difference between the data from 
plasmids pbRSV293 and pbRSV89 suggests that the sequence between position 210 
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and 293 in the M2 mRNA is of importance to the initiation mechanism M2 ORF-2 
but that loss of this region is not sufficient to completely inhibit initiation of 
translation of M2 ORF-2.  
 
Extending the length of deletion in plasmid pbRSV380 further reduced levels of 
CAT protein expression to 45.7% of the control (p=0.000016). Compared to the 
other plasmids in the series the reduction in expression was significantly different to 
pbRSV14 (p=0.00010), pbRSV89 (p=0.0000062) and pbRSV293 (0.016). Therefore 
since a significant difference was observed between pbRSV380 and both plasmids 
that express CAT protein at basal levels for these new chimeric plasmids and 
between pbRSV380 and pbRSV293, it can be concluded that the sequence in this 
region is of importance to the mechanism of initiation of translation of M2 ORF-2. 
However, this region of sequence is still not critical for the initiation of translation 
for the second ORF.  
 
Removal of 527nts from the 5´ end of M2 mRNA in the plasmid pbRSV527, reduced 
levels of CAT protein expression for the second ORF to 1% of the control 
(p=0.0000067). There was also a significant difference between the data from 
plasmid pbRSV527 and that from plasmids pbRSV14 (p=0.00000012), pbRSV89 
(p=0.00000013), pbRSV293 (p=0.00000017) and pbRSV372 (0.00000073). This 
indicates that between position 381 and position 527, there is a region of sequence 
which is essential for the initiation of translation of bRSV M2 ORF-2. Whether the 
role of this region is linked to other regions further upstream, which also affected 
ORF-2 expression is not known.  
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Fig. 5.16: CAT protein expression from ORF-2 from plasmids containing increasing lengths of 
deletion in M2 ORF-1 
Levels of expression of CAT protein expressed from plasmids used to investigate critical sequences in 
ORF-1 for ORF-2 translation that were individually transfected into HEp-2 cells. As described in 
Section 5.6.1, each plasmid had increasing proportions of sequence deleted from the 5´ end of ORF-1 
and replaced with eGFP. The number in the plasmid name describes the position of the break point 
between M2 ORF-1 and eGFP coding sequence used to replace the deleted upstream M2 ORF-1 
sequence up to this point. Results were normalised against the empty vector pBluescribe and are 
expressed as a percentage of the positive control plasmid pbRSVWC. Error bars indicate standard 
deviation. 
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5.7.1. Investigation of ribosomal shunting as a mechanism for initiation of 
translation for the bRSV M2 ORF-2 (M2-2 ORF) 
Ribosomal shunting is a cap-dependent mechanism used by many viruses to bypass 
stem loop structures that are common in 5´ UTRs to reach a desired AUG codon. 
This mechanism which is discussed in more detail in Section 1.6.4, can be also used 
in conjunction with cap-dependent scanning to initiate translation at a desired AUG 
codon. In some cases the shunting mechanism can bypass large sections of sequence, 
which may include entire ORFs. It has been reported that adenoviruses use shunting 
in conjunction with scanning in late mRNAs in which the shunting process is 
directed by the common tripartite leader sequence (reviewed in Section 1.6.4) (Yueh 
and Schneider, 2000). Inside the tripartite leader region are three sequences which 
are complementary to the 3´end of the 18S rRNA. Removal of these three sequences 
significantly reduces the efficiency of the shunting mechanism although it has been 
speculated that this is only one of the factors that enables the shunting mechanism to 
function (Yueh and Schneider, 2000).  
 
It is unlikely that bRSV uses ribosomal shunting in the classical sense of bypassing 
and translating a short ORF in the 5´ UTR, as the M2 5´ UTR is only 9 nts long and 
does not contain an upstream short ORF. However it is possible that the ribosome 
could use ribosomal shunting to bypass M2 ORF-1 to directly access ORF-2. As seen 
in Fig. 5.17A, significant regions in the vicinity of the bRSV M2 ORF-1/ORF-2 
overlap region aligned with the 3´end of the 18S rRNA. This alignment was in a 
similar location to where the adenovirus tripartite leader complementary sequence 
(referred to as C1) bound to the 3´end of the 18S rRNA (residues 1854-1862 and 
1836-1847 on the 18S rRNA) (Yueh and Schneider, 2000). It was reported that 
removal of the C1 region had only a small effect on the shunting mechanism. 
However, removal of all three regions led to inhibition of the shunting mechanism. 
 
Two plasmids were generated to investigate whether the regions of complementarity 
to the 18S rRNA in the M2 mRNA are involved in the initiation of translation of the 
bRSV M2 ORF-2. Both plasmids followed the same format as the reporter plasmid 
pbRSVWC but each contained specific mutations to alter the sequences that may 
base pair with 18S rRNA. As seen in Fig. 5.17A, the first plasmid pbRSVShuntK, 
was used to investigate the significance of this complementary sequence to the 3´ 
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end of the 18S rRNA by mutating residues at positions 548-554 and 556-558 to 
reduce the complementary between the 3´ end of the 18S rRNA sequence and the M2 
ORF-1 sequence. The second plasmid pbRSVShuntP, was created to investigate if 
increasing the potential interaction with the ribosome would increase the levels of 
translation of ORF-2. This was achieved by mutating residues at positions 554, 557, 
559, 561 and 562 to increase the complementarity between the 3´ end of the 18S 
rRNA and the ORF-1 sequence (Fig. 5.17A).  
 
 
Fig. 5.17: Alignment of 18S rRNA against M2 mRNA and against sites of mutations to either 
disrupt or improve potential binding of the M2 mRNA to 18S rRNA  
 (A) Alignment of 18S rRNA to potential binding sites for M2 mRNA and plasmids pbRSVShuntP 
and pbRSVShuntK. Mutations for both plasmids are highlighted in red. Sequence for 18S rRNA runs 
from the 3´ to 5´ from position 1857-1822. bRSV M2 mRNA sequence runs from 5´ to 3´ from 
position 541-570 (B) Site of bRSV M2 potential binding sites on 18S rRNA. Arrows indicate 
potential binding sites. Red arrows indicate sites mutated to prevent binding in plasmid 
pbRSVShuntK  
 
Construction of the plasmids pbRSVShuntK and pbRSVShuntP  
Mutations were created using two-step PCR as described in Section 5.3.1.1. The 
method for cloning and sequencing of the plasmids was the same as used in Section 
5.3.1.1.  For the first PCR step for each plasmid, the primer pairs used for the first 
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PCR step for the plasmid pbRSVShuntK were bRSVWTF/ShuntKR (bRSV 
amplicon) and ShuntKF/CATR (CAT amplicon). For the plasmid pbRSVShuntP, the 
two primer pairs used for the first PCR step were bRSVWTF/ShuntPR (bRSV 
amplicon) and ShuntPF/CATR (CAT amplicon). For both plasmids, the products 
were amplified from the plasmid pbRSVWC. The two fragments generated in the 
first PCR step for each plasmid, were joined in the second PCR step using the primer 
pair bRSVWTF/CATR.  
 
5.7.2. Expression of the plasmids used to investigate if ribosomal shunting is 
used for initiation of M2 ORF-2 
The two plasmids pbRSVShuntK and pbRSVShuntP and control plasmids 
pbRSVWC and the empty vector pBluescribe were individually transfected into 
HEp-2 cells (Section 2.4.1) and CAT protein expression was measured with a CAT 
ELISA as described in Section 2.4.2. As in previous sections, protein levels were 
expressed as a percentage of CAT protein expression from the control plasmid 
pbRSVWC. 
 
As shown in Fig. 5.18, mutation of the sequence in ORF-1 complementary to the 3´ 
end of the 18S rRNA in the plasmid pbRSVShuntK increased CAT protein 
expression to 133.3% of the control (p=0.0053). This shows clearly that there is no 
requirement for homology to the 18S rRNA for ORF-2. Mutating the sequence in 
ORF-1 to increase the degree of complementarity to the 3´ end of the 18S rRNA in 
the plasmid pbRSVShuntP also increased CAT protein expression from the second 
ORF to 125.3% of the control (p=0.021). There was no significant difference in CAT 
protein expression between the plasmids pbRSVShuntK and pbRSVShuntP 
(p=0.20). Taken together these data show that there is no requirement for base 
pairing between 18S rRNA and bRSV M2 mRNA. This strongly suggests that 
ribosomal shunting is not used for expression of the bRSV M2 ORF-2. 
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Fig. 5.18: CAT protein expression for plasmids used to investigate if ribosomal shunting is used 
for initiation of translation of M2 ORF-2 
Levels of expression of CAT protein expressed from plasmids individually transfected into HEp-2 
cells. Mutations made to these plasmids are described in Section 5.7.1. Results were normalised 
against the empty vector pBluescribe and are expressed as a percentage of the positive control plasmid 
pbRSVWC. Error bars indicate standard deviation. 
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5.8.1. Investigation of internal initiation as a mechanism to initiate translation of 
the bRSV M2 ORF-2 (M2-2 ORF) 
The role of internal ribosome entry sites (IRES) is discussed in Section 1.6.5. IRES 
regions are used in both viral and eukaryotic mRNAs to initiate translation in a cap-
independent manner. The IRES is comprised of a sequence in mRNA that can bind 
the ribosomal 43S complex in close proximity to the desired AUG codon. For some 
IRES regions, this mechanism can occur without the involvement of many of the 
initiation factors required for cap-dependent translation. IRESs tend to be located in 
the 5´ UTR such as in poliovirus (Pelletier and Sonenberg, 1988) and hepatitis C 
virus (Tsukiyama-Kohara et al., 1992). They have also have been located inside 
translated ORFs of polycistronic mRNAs, in which only one of the ORFs uses the 
IRES for initiation (Kang et al., 2009).  
 
A standard method frequently used to test for internal initiation sequences, including 
IRES, is through the use of bicistronic reporter plasmids (Pelletier and Sonenberg, 
1988). This method works on the principle that these plasmids transcribe a 
bicistronic mRNA, which contains two separate ORFs each expressing a different 
reporter protein. The ORFs do not overlap each other and are separated by a spacer 
sequence containing the putative internal initiation sequence that will not be 
translated. A control plasmid is also generated where random sequence is used as the 
spacer sequence. The principle is that the first ORF will initiate translation through a 
cap-dependent process but terminating ribosomes for the first ORF will never initiate 
translation of the second ORF due to the presence of the spacer sequence. Expression 
from the second ORF will only be detected if the test sequence is able to promote 
internal initiation of translation. This approach was used to investigate the bRSV M2 
mRNA. However, as the two ORFs overlap with each other, the sequence potentially 
directing internal initiation would be located within ORF-1 upstream of the initiation 
codon for ORF-2. 
 
A reporter plasmid, pbRSVIRES, was created to test for internal initiation. As seen 
in Fig. 5.19A, the plasmid contained the full eGFP ORF as the first ORF. The spacer 
region and second ORF sequence were taken from the plasmid pbRSVWC. The 
untranslated spacer sequence consisted of the bRSV M2 ORF-1 sequence beginning 
at position 210 and continuing until position 562. The second ORF contained the 
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CAT ORF from the plasmid pbRSVWC (Fig. 5.19C), where the CAT ORF initiation 
codon at 5´ end of the ORF was replaced with 8nts of bRSV M2 mRNA sequence 
between position 563 and 570. The AUG codon from position 563 would be used as 
the initiation codon for the translation of the CAT ORF in this plasmid. The length of 
the spacer sequence was chosen based on the analysis of the role of upstream 
sequences described in Section 5.6.3. A control plasmid pRenLucIRES (Fig. 5.19B) 
was also created. The second ORF in pRenLucIRES consisted of the same CAT ORF 
used in the plasmid pbRSVIRES, but here the CAT ORF AUG start codon was 
replaced with the bRSV M2 ORF-2 AUG codon (residues 554-570). This also 
included the upstream Kozak sequence used for this AUG codon. The Renilla 
luciferase coding sequence (254nts: position 317-570 of the Renilla luciferase coding 
sequence) was used as the control untranslated spacer sequence. 
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Fig. 5.19: Schematic of the mRNAs to investigate potential internal initiation of translation of M2 ORF-2 
(A) Schematic of the mRNA transcribed from the reporter plasmid pbRSVIRES. Figure includes both eGFP and CAT ORFs (black arrows) and untranslated bRSV 
spacer sequence (grey box) derived from residues 210-563 on the bRSV M2 mRNA. (B) Schematic of the mRNA transcribed from the reporter plasmid pRenLucIRES. 
Figure includes both eGFP and CAT ORFs (black arrows) and Renilla luciferase spacer (grey box) derived from residues 317-570-of the Renilla luciferase coding sequence. 
(C) Schematic of ORF-2 of reporter plasmids pbRSVIRES and pRenLucIRES. CAT ORF initiation codon has been replaced with the bRSV M2 ORF-2 5´ codon residues 
(563-570 pbRSVIRES) and (554-570 for pRenLucIRES).  
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Construction of the plasmid pbRSVIRES 
For construction of the plasmid pbRSVIRES, two amplicons were generated by PCR. 
The first was the eGFP fragment containing the eGFP ORF which was amplified by 
PCR using the primer pairs T7-91/eGFPIRESR from the plasmid pbRSV89 (Section 
2.3.1). The primer eGFPIRESR also reintroduced the eGFP termination codon into 
the fragment. The eGFP fragment contained a Kpn I and Sph I site at the 5´ and 3´ 
ends, respectively. The second amplicon was the bRSV fragment, containing the 
bRSV spacer sequence and the CAT reporter coding sequence. The fragment was 
generated by PCR using the primer pairs bRSVIRESF/CATR from the plasmid 
pBRSV89 (Section 2.3.1). The fragment contained a Sph I site and a Hind III site at 
the 5´ and 3´ ends, respectively. The eGFP fragment was digested with the 
endonuclease pair Kpn I/Sph I and the bRSV fragment with the endonuclease pair 
Sph I/ Hind III (Section 2.3.4 and Section 2.3.5). The two fragments were ligated 
simultaneously into the plasmid pBluescribe (Section 2.3.7) previously digested with 
endonuclease pair Kpn I/Hind III (Section 2.3.4 to Section 2.3.6). The ligated 
plasmid was then transformed into E.coli DH5α bacteria and recombinant plasmids 
were identified as before. Purified plasmids were digested with endonucleases Kpn I 
and Sph I to confirm the presence of the desired insert (1785nts) and the sequence 
was confirmed. 
 
Construction of the plasmid pRenLucIRES 
A DNA fragment containing the eGFP ORF was amplified by PCR using the primer 
pairs T7-91/eGFPIRESR from the plasmid pbRSV89 (Section 2.3.1). The primer 
eGFPIRESR also reintroduced the eGFP stop codon into the fragment. The eGFP 
fragment contained a Kpn I and Sph I site at the 5´ and 3´ ends, respectively. A 
second fragment containing the combined Renilla Luciferase spacer sequence and 
the CAT reporter ORF was created using a two-step PCR. A detailed description of 
the methodology of two-step PCR is given in in Section 5.3.1.1. For the first PCR 
step the spacer amplicon, containing the Renilla luciferase sequence, was generated 
using the primer pair RenLucF/RenLucR and was amplified from the plasmid 
pbRSVRen. A fragment containing the CAT ORF was amplified using the primer 
pair bRSVCATF/CATR. The two fragments were joined using the primer pair 
RenLucF/CATR to produce the final reporter gene fragment which contained an Sph 
I and Hind III site at the 5´ and 3´ ends, respectively. The eGFP and CAT fragments 
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were digested with the endonuclease pairs Kpn I/Sph I and Sph I/Hind III as 
appropriate (Section 2.3.4 and Section 2.3.5). The resulting fragments were 
simultaneously ligated into the plasmid pBluescribe (Section 2.3.7) previously 
digested with endonuclease pair Kpn I/Hind III (Section 2.3.4 to Section 2.3.6) and 
the product was transformed into E.coli DH5α bacteria. Recombinant plasmids were 
identified by colour selection, the inserts confirmed by restriction digestion and the 
sequence determined. 
 
5.8.2. Expression of plasmids to investigate a potential internal initiation 
mechanism to initiate translation of M2 ORF-2 
HEp-2 cells were transfected individually with pbRSVIRES, pRenLucIRES or the 
control plasmids pbRSVWC and pBluescribe as described in Section 2.4.1. CAT 
protein expression was quantified using a CAT ELISA assay (as described in Section 
2.4.2) and data were normalised against the assay results from the transfected empty 
vector pBluescribe plasmid. As stated previously, levels of CAT protein expressed 
were expressed as a percentage of CAT protein expression from the plasmid 
pbRSVWC. To control for potential variation in CAT protein expression due to 
differences in transfection efficiencies between individual samples, the levels of 
eGFP expressed from ORF-1 in the plasmids pbRSVIRES and pRENLucIRES were 
determined using a GFP ELISA as described in Section 2.4.3. This was used to 
normalise the levels of eGFP protein between different samples, thereby allowing the 
levels of CAT protein detected to be also adjusted by the same values, which allowed 
comparison of ORF-2 expression from the various samples. The levels of eGFP 
protein expression from each set of transfections for each plasmid are found in 
Appendix (B3) 
 
As seen in Fig. 5.20, expression of the CAT protein in the second ORF with the 
Renilla luciferase spacer sequence in the plasmid pRenLucIRES was only 5.6% of 
the control (p=0.00018). Expression of the CAT protein in the second ORF with the 
bRSV spacer in the plasmid pbRSVIRES was 62% of the control. While this was a 
significant drop in comparison to the control (p=0.003) a significant difference was 
seen between expression from pRenLucIRES and pbRSVIRES (p=0.0000059). This 
increase in expression from pRenLucIRES to pbRSVIRES suggests that an IRES or 
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some form of internal initiation site is present between position 210 and position 570 
that is used for initiation of M2 ORF-2.  
 
 
Fig. 5.20: CAT protein expression for plasmids used to investigate if an internal initiation 
mechanism is used for initiation of translation of M2 ORF-2 
Levels of expression of CAT protein expressed from plasmids individually transfected into HEp-2 
cells. Mutations made to these plasmids are described in Section 5.8.1. Results were normalised 
against the empty vector pBluescribe and are expressed as a percentage of the positive control plasmid 
pbRSVWC. Error bars indicate standard deviation.  
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5.9. Translational profile of the M2 mRNA to identify sites of internal initiation 
for translation of M2 ORF-2 
Ribosomal profiling was used to investigate if there were regions in the bRSV M2 
mRNA with a low distribution of elongating ribosomes, which may indicate the 
presence of an IRES or another form of internal initiation site. A detailed description 
of the technique of ribosomal profiling is given in Section 4.6.1. Analysis of the 
bRSV M2 mRNA would be more complex as any putative internal entry site would 
lie within the M2 ORF-1 which is being actively translated. Two ribosomal profile 
sequence libraries were generated using RNA extracted from MDBK cells that had 
been infected with bRSV Snook strain. One library was generated using RNA 
extracted at 4 hpi and the other at 8 hpi (sequencing libraries bRSV4P and bRSV8P, 
respectively). These sequence libraries contained data only originating from the 
protected footprints of elongating ribosomes. A description of the methodology of 
ribosomal profiling and the sequencing of these libraries is given in Section 2.10. 
The processing pathway to analyse the raw sequencing data is in Section 3.2. All 
profiles were prepared using the IGV software package, and the spectra represent the 
distribution of elongating ribosomes on the M2 mRNA. Each point represents the 
first nucleotide of each sequence read aligned to the M2 mRNA. 
 
For the RNA harvested at 4 hpi (bRSV4P), a total of 6,774,318 reads were obtained 
of which 13757 sequence reads (0.2%) aligned to the bRSV genome. Of the virus-
specific sequences 407 were from the M2 mRNA. For the RNA harvested at 8 hpi 
(bRSV8P), from a total of 6,648,581 reads, 67977 (1.0%) aligned to the bRSV 
genome and of these, 1871 reads were from the M2 mRNA. The bRSV8P 
sequencing library was used to generate a translational profile of the M2 mRNA due 
to the higher level of reads aligned to the gene. All profiles presented in this section 
were created using data from the bRSV8P sequencing library 
 
The data presented in Fig. 5.21 shows the distribution of elongating ribosomes in the 
M2 ORF-1 (M2-1 ORF). The profile has also been separated into segments, which 
represent the locations of the junction points between the eGFP coding sequence and 
M2-1 ORF sequences for the chimeric plasmids discussed in Section 5.6. For each of 
these plasmids the sequence upstream of the appropriate line was deleted and 
replaced by eGFP coding sequence. Fig. 5.22A shows the distribution frequency of 
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elongating ribosomes in the region of the M2 ORF-1 that was used as the spacer 
sequence for the plasmid pbRVIRES. This region, located between nucleotides 210 
and 570 of the bRSV M2 ORF-1 was identified as containing an internal initiation 
site or IRES. Fig. 5.22B shows the frequency distribution of elongating ribosomes in 
the region of the M2 ORF-1 from position 380 to 527. From the results of the 
transfection of the plasmid pbRSV527 in Section 5.6, it was apparent that between 
positions 380 and 527, there was sequence critical for the initiation of translation of 
the bRSV M2 ORF-2 (M2-2 ORF). 
 
As seen in both Fig. 5.22A and Fig. 5.22B between residues 380-428 (area of interest 
highlighted in black box), there are two areas in which very few reads were found 
(residues 380-396 and 419-428). In comparison to the entire M2 ORF-1, there were 
no similar gaps where such low frequencies of reads were aligned to M2 ORF-1. 
Between these two regions of low frequency (residues 409-414), there were several 
nucleotides where a high frequency of reads aligned. For these peaks observed, the 
high frequency of reads aligned in this region were continuous over a 5 nucleotide 
stretch. This was not observed in any other high frequency peaks within the M2 gene 
transcript.  
 
This region of interest is located in the spacer sequence used in pbRSVIRES, the 
majority of this sequence is also in the critical region identified in pbRSV527 
(position 381-528). The sizes of these low frequency regions were much smaller 
(below 20 nts) than observed in translational profiles of cricket paralysis virus IRESs 
(Khong et al., 2016). However, if an IRES was used in bRSV, then elongating 
ribosomes translating the M2 ORF-1 were likely present throughout this sequence. 
Therefore footprints could be aligned across sections of this entire critical structure, 
which would mask a much larger region compared to if the IRES was outside the 
ORF. These two low frequency regions may be the only locations that directly affect 
elongating ribosomes translating the M2 ORF-1 resulting in stacking of ribosomes 
either side of that element. Although this only speculative it could be plausible 
evidence for a site where this internal initiation mechanism is located. 
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Fig. 5.21: Translational profile of the bRSV M2 mRNA showing sites of deletions in plasmids described in Section 5.6 
Translational profile of the bRSV M2-1 ORF. Location of all putative start (green) and stop (red) codons in all three frames in the M2 ORF-1 are found below the spectra. 
Locations of preferred start and stop codons for M2 ORF-1 and M2 ORF-2 are indicated. Lines indicate locations of where eGFP was fused to the M2-1 ORF for the chimeric 
plasmids described in Section 5.6. In these plasmids sequences upstream of the line was deleted for that plasmid and replaced with eGFP.   
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Fig. 5.22: Translational profile of region inside the bRSV M2 ORF-1 that was critical for 
translation of bRSV M2 ORF-2 
(A) Translational profile of the bRSV M2 ORF-1. Location of all putative start (green) and stop (red) 
codons in all three frames in the M2 ORF-1 are found below the spectra. Lines indicate region of 
sequence that was used as a spacer sequence (residues 210-570) for the plasmid pbRSVIRES in 
Section 5.9. Box is used to highlight area of interest discussed in this Section. (B) Translational 
profile of the bRSV M2 ORF-1. Location of all putative start (green) and stop (red) codons in all three 
frames in the M2 ORF-1 are found below spectra. Lines indicate region of sequence that when deleted 
from chimeric plasmid pbRSV527 in Section 5.6, led to an inhibition of translation for the second 
ORF (residues 381-528). Box is used to highlight area of interest discussed in this this section. 
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5.10. Conclusions 
Data acquired in this chapter has further characterised the unknown mechanism used 
by bRSV for initiation of translation of M2-ORF-2. From the data, it can concluded 
that initiation of translation of M2 ORF-2 must occur at the AUG codon located at 
position 563 and both the Kozak sequence and the location of the AUG codon were 
found to influence this preferred site for initiation of M2 ORF-2. 
 
It is clear that the Kozak sequence is a factor in translation of M2 ORF-2. 
Introducing a Kozak sequence of poor context for the AUG codon at position 563, 
significantly reduced protein expression of ORF-2. Furthermore mutating the -3 
position in the Kozak sequence from the optimal nucleotide to less preferable 
nucleotides, also decreased expression in the same order as the preference of each 
nucleotide for that position. However in both experiments, ORF-2 expression was 
never fully inhibited. This suggests that the Kozak sequence was not the defining 
factor that allows initiation of translation to occur at this position. This was further 
supported with the introduction of an optimal Kozak sequence for the preferred AUG 
codon. This new sequence either did not improve or may have slightly lowered CAT 
protein expression from ORF-2. This would suggest that the initiation sequence is 
already optimal in regards to the Kozak sequence and also the Kozak sequence is the 
not the sole factor for initiation.  
 
A possible explanation for the preference for the initiation site being located at 
position 563 is due a secondary structure located in the vicinity of the AUG codon 
which may influence initiation. Inputting the last 60 nts of the M2 ORF-1 into Mfold 
predictive software predicted a secondary structure in which both the AUG codon 
and the surrounding sequence was encompassed in the stem of a predicted structure. 
However it was apparent that this structure was in fact an inhibitory factor on the 
initiation of M2 ORF-2. A single point mutation created to disrupt the predicted 
secondary structure lead to an increase in translation of ORF-2. As the AUG codon 
was base-paired in the stem loop, disruption of the structure may allow an initiating 
ribosome to access the AUG codon without unwinding the structure. This also could 
suggest that this mechanism is reliant on helicases required to unwind this region.  
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As there were limitations to the size of the sequence that could be inputted into the 
Mfold modeling software, in vitro transcription reactions were used to identify the 
presence of large secondary structures through the production of premature 
termination products. It was apparent that there was no large stable secondary 
structure present inside the M2 ORF-1 sequence. This data aided in identifying the 
mechanism used for translation of M2 ORF-2. 
 
Using chimeric reporter plasmids with increasing regions of M2 ORF-1 deleted, it 
was apparent that the sequences between positions 210 and 528 in the M2 ORF-1 
were used by the ribosome to initiate translation of M2 ORF-2 and were essential for 
successful translation. Sequences upstream of this region did not appear to be 
required for ORF-2 translation. The sequences between position 210 and 381 was 
important but not essential for translation of M2 ORF-2, with the removal of this 
region only decreasing translation and not inhibiting it. However, the region between 
382 and 528 was critical for translation with removal inhibiting translation. This 
suggests that the mechanism used for translation of M2 ORF-2 is likely to use this 
region for successful translation.  
 
It is likely that even though bRSV does not use coupled translation for the initiation 
of translation of M2 ORF-2, a non-canonical initiation mechanism is used due to the 
presence of the upstream M2 ORF-1. There are four mechanism which may be used 
(PRF, leaky scanning, shunting and IRES). The data acquired from this chapter has 
ruled out the possibility of at least two of these mechanisms.  
 
It is highly unlikely that the method of initiation for ORF-2 is that of leaky scanning. 
The ribosome has to bypass 14 alternate start codons, with three of these codons 
having similar strength Kozak sequences. It is also unlikely that the mechanism of 
programmed ribosomal frameshifting is used. The lack of a fusion protein present in 
lysed samples would suggest that PRF is not used. It is also unusual for PRF to be 
reliant on a start codon as the site of the frameshift usually occurs at a slippery 
sequence. However evidence from Chapter 4 suggests that the start codon at position 
563 is indeed the location for initiation of ORF-2. There is also the requirement for a 
secondary structure downstream of the frameshift site, this usually begins within 5-6 
nts from the slippery sequence (Namy et al., 2006). However with the replacement of 
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ORF-2 downstream of the ORF-1/ORF-2 overlap region used for these reporter 
plasmids, any structured element that would be used for PRF is removed and 
replaced. It is therefore highly unlikely that a similar structure is formed from the 
new reporter sequence downstream of the ORF-1/ORF-2 overlap region.  
 
The data acquired in this chapter suggests that bRSV does not use a ribosomal 
shunting mechanism similar to that used by Adenovirus in late mRNA translation. 
Regions of sequence surrounding the preferred AUG in bRSV M2 ORF-1 that were 
complementary to the same 3´ 18S RNA sequence used by Adenoviruses (Yueh and 
Schneider, 2000) for shunting were not critical for translation of M2 ORF-2. 
Although this suggests that shunting is not used in this style, it may be possible that a 
differing shunting mechanism may be used. 
 
There is also further evidence that the ribosome does not use a scanning style 
mechanism for translation of M2 ORF-2. Mutations that incorporated artificial AUG 
codons into M2 ORF-1 that could be used for initiation of ORF-2, did not lead to 
successful translation of ORF-1 when the both native initiation codons for ORF-2 
were mutated. This suggests that as translation of ORF-2 was completely inhibited, it 
suggests that mechanism may not use scanning. It also provides further evidence that 
the location of the AUG codon at position 563 is also a factor for successful 
translation. 
 
Creating bicistronic reporter constructs separated by spacer sequences showed that 
there is evidence that an internal initiation mechanism is used. However, identifying 
the precise internal initiation mechanism is difficult. This type of test is only an 
initial test used for internal initiation, with further experiments needing to be 
performed before coming to a conclusion on the type of internal initiation 
mechanism used such as an IRES. Ribosomal profiling has identified regions of 
interest within the sequence where internal initiation may take place, although more 
evidence is needed to conclusively prove these regions of interest are involved in 
initiation of ORF-2.  
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Chapter 6 
Characterisation of the 
Mechanism of Coupled 
Translation 
Termination/Initiation 
used for Translation of 
PVM M2 ORF-2  
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6.1. Introduction 
It has been reported that PVM, a member of the Orthopneumovirus genus in the 
Pneumoviridae family also uses the mechanism of coupled translation termination/ 
initiation for the translation of M2 ORF-2 for the M2-2 protein, found on the 
bicistronic gene transcript of M2, as described for hRSV. For PVM the site of 
initiation differs significantly to that of hRSV. However, PVM is still reliant on the 
termination of translation of the first ORF in order for initiation of translation of the 
second (Gould and Easton, 2007).  
 
As in hRSV, the PVM M2 gene is the ninth gene from the 3´ leader end of the 
genome and is immediately prior to the gene encoding the L polymerase protein. The 
M2 gene of PVM is 869 nts in length and similar to hRSV, contains two ORFs that 
are translated to the M2-1 and M2-2 proteins, respectively. The PVM M2 ORF-1 
(535 nts) is significantly larger than that of M2 ORF-2 (297 nts: Fig. 6.1A). The 
PVM M2 ORF-2 is in reading frame 3, in contrast to the situation for the hRSV M2 
ORF-2 that is in reading frame 2. The two ORFs in the PVM M2 mRNA overlap 
each other by 67 nts, which is significantly longer than seen in the other viruses in 
the family. In PVM, there are two potential initiation sites for M2 ORF-2 which are 
separated by 62 nts (Fig. 6.1B). The second start codon is located at the 3´ of the 
overlap and overlaps the stop codon of M2 ORF-1 by 2 nucleotides. 
 
Gould and Easton, 2007 reported that the initiation of translation of the PVM M2 
ORF-2 was not reliant on M2 ORF-2 sequence downstream of the M2 ORF-1/ORF-2 
overlap region. It was also suggested that both AUG start sites for translation of M2 
ORF-2 in the M2 ORF-1/ORF-2 overlap region are used equally and removal of both 
start codons reduced levels of translation of the second ORF to negligible levels 
(Gould and Easton, 2007). For hRSV (Ahmadian et al., 2000), removal of the 
terminating stop codon of M2 ORF-1 and moving the stop codon downstream from 
the original site of termination has been used to test for coupled translation 
termination/initiation. This leads to inhibition of translation of M2 ORF-2 as the 
mechanism is distance dependent on the site of the stop codon. Gould and Easton, 
2007 reported that for PVM, translation of the M2 ORF-2 was inhibited if the stop 
codon of M2 ORF-2 moved 138 nts downstream (Gould and Easton, 2007). This 
indicates that PVM uses the mechanism of coupled translation termination/initiation 
	 208	
for initiation of M2 ORF-2, as initiation is reliant on translation and termination of 
M2 ORF-1 in the vicinity of the M2 ORF-2 initiation site. 
 
 
 
 
 
Fig. 6.1: Schematic of PVM M2 gene transcript and M2 ORF-1/ORF-2 overlap region 
(A) Schematic of the bicistronic PVM M2 gene transcript including the locations of the two ORFs. 
The line represents the M2 mRNA and the arrows represent the location of the two ORFs. M2 ORF-1 
(535nts long) is translated into the M2-1 protein. M2 ORF-2 (297nts long) is translated into the M2-2 
protein. (B) Sequence of the M2 ORF-1/ORF-2 overlap region. AUG initiation codons for M2 ORF-2 
are underlined. The M2 ORF-1 termination codon is indicated in bold. 
 
It has been shown that in hRSV, a highly structured region 150 nts 5´ of the M2 
ORF-1/ORF-2 overlap region and within M2 ORF-1 is essential for successful 
initiation of translation of M2 ORF-2 (Gould and Easton, 2005). The structured 
region is thought to aid initiating ribosomes for M2 ORF-2 by pausing elongating 
ribosomes translating M2 ORF-1 further upstream, allowing ribosomes to reinitiate 
translation of M2 ORF-2 (P. Gould and A. Easton, personal communication) 
(Section 1.4.2). Other viruses that use the mechanism of coupled translation 
termination/initiation such as members of the Caliciviridae family, utilize a 
termination upstream ribosomal binding site (TURBS) sequence upstream of the 
initiation site for reinitiating ribosomes. The TURBS is thought to bind to the h26 
helix in 18S rRNA to position the reinitiating ribosome in an optimal position for 
reinitiation of translation (Section 1.5.1). For all members of the Caliciviridae family 
that use this mechanism, a short UGGGA sequence is conserved throughout all 
TURBS sequences and is responsible for binding to the h26 helix in 18S rRNA.  
 
While there is evidence that the PVM M2 mRNA utilises coupled translation to 
access M2 ORF-2 (Gould and Easton, 2007), there has been no detailed exploration 
of the mechanism by which the PVM M2-2 protein is translated. In particular there is 
A	
B	
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no information about the potential presence or possible role of sequences within the 
M2 ORF-1 on the translational coupling process in PVM. 
 
The aim of this chapter was to further characterise the mechanisms of coupled 
translation termination/initiation in the PVM M2 mRNA and to search for sequences 
upstream of the M2 ORF-1/ORF-2 overlap region between M2 ORF-1 and M2 ORF-
2 that may be of importance to the process.   
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6.2. Establishing successful expression of ORF-2 in plasmids used to test for 
coupled translation in PVM M2 ORF-2 
Plasmids used to test for coupled translation in PVM from Gould and Easton, 2007 
would be used as templates or as controls for all plasmids used to further investigate 
this mechanism in PVM in this section. Transfection experiments that were used to 
report these findings in Gould and Easton, 2007 were repeated in order to reconfirm 
the vector model for PVM, and that the current plasmids acquired successfully 
expressed the reporter gene CAT. 
 
All plasmids used as templates or controls from Gould and Easton, 2007 in this study 
were acquired from Dr Phillip Gould. A schematic of the reporter plasmid pPVMWC 
which was the template used for all plasmids in this chapter can be seen in Fig. 6.2A. 
The gene transcript transcribed from the reporter plasmid for PVM contained a 5´-
UTR, which was 21 nts in size, of which the final 4 nts originated from the 5´-UTR 
of the M2 gene transcript sequence in PVM. The plasmid contained two ORFs of 
which ORF-1 contained the entirety of the PVM M2 ORF-1. For ORF-2, the PVM 
M2 ORF-2 excluding the overlapping sequence was replaced with the bacterial 
reporter gene CAT and placed in the same reading frame as the M2 ORF-2. 
Therefore initiation of translation of ORF-2 via initiation at the AUG codons in the 
ORF-1/ORF-2 overlapping sequence would lead to the expression of the CAT 
reporter gene. This was then quantified using an ELISA assay. The plasmid 
pPVMStop was used to test for coupled translation by removing the ORF-1 (M2 
ORF-1) stop codon by mutating UGA to UGG. The plasmids pPVMmut1, 
pPVMmut2, pPVMmut3, pPVMmut4 and pPVMmut5 removed both start codons 
(positions 465 and 528 from the start of the M2 gene transcript) for ORF-2 in the 
ORF-1/ORF-2 overlap region in different combinations. The various point mutations 
made in each plasmid in the ORF-1/ORF-2 overlap region for the analyses described 
below can be seen in Fig. 6.2B. 
 
Plasmids were individually transfected into HEp-2 cells as described in Section 
2.4.1. The cells were incubated for 48 hours and then lysed and the protein harvested. 
The level of CAT reporter protein was determined using an ELISA as described in 
Section 2.4.2. All data were normalized against the values obtained from cells 
transfected with empty pBluescribe plasmid. This provided a background signal. For 
	 211	
each sample, levels of CAT protein expressed have been visualized as a percentage 
of CAT protein expression from the plasmid pPVMWC. 
 
Similar levels of CAT reporter gene expression were observed in transfected 
plasmids as reported in Gould and Easton, 2007 (Fig. 6.2C). Removal of ORF-1 (M2 
ORF-1) stop codon in the plasmid pPVMStop reduced CAT protein expression to 
negligible levels (6.5%), confirming that expression of the PVM M2 ORF-2 requires 
translation of ORF-1 and therefore uses the process of coupled translation 
termination/initiation. Removal of both ORF-2 start codons in the ORF-1/ORF-2 
overlap region in plasmids pPVMmut3 (10.8%) and pPVMmut5 (9%) reduced levels 
of CAT protein expression significantly as described in Gould and Easton, 2007. 
This indicated that both AUG codons in the overlapping region are the preferred 
initiation sites for translation of M2 ORF-2. However, there was a visibly lower level 
of expression in the plasmid pPVMmut1 compared to the results in Gould and 
Easton, 2007 (34% decrease). This may suggest that there is a larger preference for 
initiation at the AUG codon located at the 5´ end of the M2 ORF-1/ORF-2 overlap 
than initially reported. It also possible that the quality of the plasmid may have 
caused a lower level of ORF-2 expression than observed in Gould and Easton, 2007. 
A repeat with newly purified pPVMmut1 plasmid would need to performed to 
ascertain if this difference was due to preference or plasmid purity  
	 212	
B	   
 
 
 
Fig. 6.2: Schematic of plasmids and ELISA results measuring CAT expression for constructs 
investigating coupled translation of M2 ORF-2 in PVM 
(A) Schematic of the two ORFs located on the mRNA transcribed from reporter gene plasmid 
pPVMWC used to measure the translation of ORF-2 (M2 ORF-2) in the PVM M2 gene transcript. (B) 
Sequence showing the mutations made to the ORF-1/ORF-2 overlap region for each of the PVM 
reporter plasmids. Potential AUG initiation codons for the M2 ORF-2 are underlined and mutated 
codons are coloured red. The M2 ORF-1 translation termination codon is indicated in bold. (C) Levels 
of CAT protein expressed by each reporter plasmid. Values were normalised against the empty vector 
pBluescribe and are expressed as a percentage of the expression level of the plasmid pPVMWC. Error 
bars are standard deviation.  
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6.3.1. Identification of sequences critical for initiation of PVM M2 ORF-2 
translation upstream of the M2 ORF1/ORF2 overlap region  
Following confirmation of the results of Gould and Easton, 2007, the mechanism of 
coupled translation in PVM was further explored. Using the same approach reported 
for analysis of the hRSV M2 mRNA (Gould and Easton, 2005), a series of reporter 
plasmids were constructed using the same reporter system to measure ORF-2 
expression as used in Section 6.2. But in this case, the gene encoding eGFP lacking 
the termination codon was inserted in-frame at the 5´ end of the M2 ORF-1 in which 
the M2 ORF-1 initiation codon had been deleted. In this way the 5´ proximal ORF 
was extended by 722 nts and expression of the virus ORF-1 sequence required 
translation initiation from the long eGFP gene. In the plasmid series, increasing 
proportions of PVM M2 ORF-1 sequence were deleted (shown schematically in Fig. 
6.3A). Each deletion began at the start of the M2 ORF-1 coding sequence with the 3´ 
break point being progressively closer to the ORF-1/ORF-2 overlap region. The 
presence of the entire eGFP coding sequence ensured that the initiating ribosomes 
were not close to the ORF-1/ORF-2 overlap region, resembling the native PVM M2 
mRNA organisation. As before, replacement of ORF-2 with the CAT gene allowed 
expression to be measured. In total six plasmids were created (Fig. 6.3B). For 
plasmids pPVM6, pPVM84, pPVM204, pPVM370 and pPVM424 had 6, 84, 204, 
370 and 424 nts removed from ORF-1 for each plasmid respectively.  
 
The plasmid pPVM6Stop had 6nts removed from the 5´ end of the M2 gene 
transcript sequence in the same format as pPVM6. The plasmid however also had the 
terminating ORF-1 stop codon mutated (UGA to UGG). This was to ensure that 
coupled translation initiation/termination was still the mechanism of initiation for 
translation of ORF-2.   
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Fig. 6.3: Schematic of chimeric reporter gene plasmids 
(A) Schematic representation of chimeric reporter gene plasmids used to investigate critical sequences in ORF-1 (M2 ORF-1) for the initiation of translation of ORF-2 (M2 
ORF-2). Schematic identifies both the ORF-1 (eGFP/M2 ORF-1) and the ORF-2 (M2 ORF-2/CAT). (B) Schematic displaying the variable lengths of the M2 ORF-1 coding 
sequence in ORF-1 for chimeric plasmids pPVM6, pPVM6Stop, pPVM84, pPVM204, pPVM370 and pPVM424 in comparison to the full length M2 ORF-1 in the M2 gene 
transcript of PVM. The black line represents the M2 gene transcript of PVM. Arrows on this line are used to identify the beginning of the M2 ORF-1 coding sequence for 
each plasmid in relation to the M2 gene transcript. 
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Construction of plasmids pPVM6, pPVM6Stop, pPVM84, pPVM204, pPVM370 and 
pPVM424  
For the plasmids pPVM6, pPVM84, pPVM204, pPVM370 and pPVM424, the 
method for construction of the plasmids was identical except for the use of the 
forward primer for the PCR of the truncated M2 ORF-1/M2 ORF-2/CAT (PVM 
fragment). The method for cloning and sequencing was identical to the protocol used 
in Section 5.6.1. 
 
For these plasmids, the truncated M2 ORF-1/M2 ORF-2/CAT (PVM fragment) 
amplicon was amplified via PCR as described in Section 2.3.1. The template used 
was pPVMWC. For each PCR reaction the relevant forward primer used can be seen 
in Table 6.1. The reverse primer CAT Hind III, was used for every PCR reaction. For 
all plasmids, an eGFP amplicon was generated via PCR from the plasmid peGFP 
using the forward primer T7-91 and the reverse primer eGFP Sph I to generate an 
amplicon of 880 bp in size. The predicted lengths of the resulting PVM inserts can be 
seen in Table 6.1. The size of fragments generated from digestion for each of the 
respective cloned plasmids with the newly ligated inserts can be seen in Table 6.1.  
 
For the plasmid pPVM6Stop, the amplicon of the truncated M2 ORF-1/M2 ORF-
2/CAT fragment was generated using the primers PVM6 F and CAT Hind III from 
the plasmid pPVMStop (plasmid used in Section 6.2, where the terminating ORF-1 
stop codon was removed) to generate an amplicon of 1202 bp. An eGFP amplicon 
was generated via PCR from the plasmid peGFP using the forward primer T7-91 and 
the reverse primer eGFP Sph I to generate an amplicon of 880 bp in size as described 
in Section 2.3.1. The method for cloning and sequencing was identical to the 
protocol used in Section 5.6.1. A correctly digested fragment of 1948 bp was 
observed when the insert was digested from the newly ligated plasmid to confirm 
successful ligation of the insert.  
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Table 6.1: Table of primers used 
Table of primers to used to generate (PVM fragments) amplicons used for each plasmid and size of 
fragments generated for PCR and digest. 
 
6.3.2 Investigation of the potential role of upstream sequences in expression of 
the PVM M2 ORF-2  
The chimeric plasmids described in Section 6.3.1 were individually transfected into 
HEp-2 cells as described in Section 2.4.1. Control cells were transfected with either 
pPVMWC or the empty vector pBluescribe. The levels of CAT protein expressed by 
each transfected plasmid were quantified using a CAT ELISA assay as described in 
Section 2.4.2. All samples were normalized against the results from cells transfected 
with empty pBluescribe plasmid to control for any background signal generated in 
the ELISA. For each sample, levels of CAT protein were expressed as a percentage 
of those obtained from the positive control plasmid pPVMWC. 
 
As seen in Fig. 6.4, the addition of the eGFP coding sequence to the 5´ end of the M2 
ORF-1 lacking the first 6 nucleotides of the M2 gene transcript sequence in the 
plasmid pPVM6 significantly reduced levels of CAT protein expression from ORF-2 
to 29% of that of the control (p=0.00022). A similar reduction of 30% in CAT 
protein expression (p=0.0052) was also seen with plasmid pPVM84 lacking the first 
84 nucleotides of the M2 gene transcript sequence. Such a significant reduction in 
reporter gene expression in a plasmid in which only 6 nucleotides were lacking from 
the 5´ end of the M2 gene transcript was unexpected and this was not seen in 
equivalent plasmids generated by the same method used to investigate hRSV (Gould 
and Easton, 2005). As the expression levels of the two PVM plasmids were 
Plasmid 
Forward 
primer 
Reverse 
Primer 
Size of fragment  
generated (bp) 
Size of correct  
digested insert 
from 
plasmid (bp) 
pPVM6 PVM6 F 
CAT Hind 
III 1202 1948 
 pPVM84 PVM84 F 
CAT Hind 
III 1124 1868 
pPVM204 PVM204 F 
CAT Hind 
III 1015 1750 
pPVM370 PVM370 F 
CAT Hind 
III 839 1584 
pPVM424 PVM424 F 
CAT Hind 
III 785 1530 
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extremely similar (p=0.865), it is likely that the lower level of expression reflects the 
base level of expression for the chimeric plasmids containing the eGPF ORF fused to 
the PVM M2 ORF-1. 
 
The plasmid pPVM6Stop was generated to confirm that expression of ORF-2 M2 
ORF-2/CAT ORF was achieved using coupled translation termination/initiation. In 
pPVM6Stop the ORF-1 stop codon was mutated from UGA to UGG, extending the 
ORF to the next in-frame stop codon located 135nts away. As seen in Fig. 6.4, the 
level of CAT protein expressed by the plasmid pPVM6Stop was 4.6% of that of the 
control plasmid pPVMWC. This was similar to the level of expression observed 
from plasmid pPVMStop (Section 6.2, 6.5%) which contained the entire M2 ORF-1, 
no eGFP sequence and had the M2 ORF-1 stop codon mutated from UGA to UGG 
(see Section 6.2). This 6.3-fold reduction in expression arising from extending the 
first ORF indicates that initiation of translation of the M2 ORF-2 in the plasmids 
containing the eGFP ORF fused to the M2 ORF-1, is achieved by coupled translation 
termination/initiation. 
 
Removal of 204nts from the 5´ end of the M2 gene transcript in the plasmid 
pPVM204 reduced levels of CAT protein expression to 18% of that seen with 
pPVMWC, a 39% reduction in expression in comparison to pPVM6. The expression 
values obtained from pPVM6 and pPVM204 were not statistically significant 
(p=0.21) indicating that no sequences in this region are required for expression of 
ORF-2. 
 
Removal of 370 nts from the 5´ end of M2 mRNA sequence in the plasmid 
pPVM370 reduced levels of CAT protein expression to 3.3% of that of the control. 
This was similar to expression from plasmid pPVM6Stop and there was no 
significant difference between the two plasmids (p=0.71). Thus, removal of the 
sequence between residues 205 and 370 of the PVM M2 mRNA reduced ORF-2 
translation to basal levels indicating that this 165 nts region contains a sequence 
critical for coupled translation termination/initiation to occur. This conclusion was 
further supported by analysis of expression from the plasmid pPVM424 which 
lacked the first 424nts of the M2 mRNA and where the level of CAT protein 
expression was reduced to 5.9% of control levels. This again was similar to levels of 
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expression from pPVM6Stop (p=0.81), indicating that there was no translation of the 
second ORF. 
 
 
 
Fig. 6.4: ELISA results measuring CAT expression for chimeric plasmids investigating critical 
sequences for the mechanism of coupled translation of M2-2 in PVM 
The levels of expression of CAT protein from plasmids transfected into HEp-2 cells. Mutations made 
to these plasmids are described in Section 6.3.1. Levels of CAT expression were normalised against 
the empty vector pBluescribe and are expressed as a percentage of the control plasmid pPVMWC. 
Error bars are standard deviation. 
 
6.4.1 Identification of critical sequence for the initiation of PVM M2 ORF-2 
between 204 nts and 370 nts from the 5´ end of the M2 gene transcript 
Analysis of the region of the PVM M2 mRNA (residues 205-370) that was shown to 
be required for the mechanism of coupled translation of ORF-2 identified a sequence 
identical to the conserved TURBS sequence (UGGGA) at residues 222 to 226. In the 
Caliciviridae family, the TURBS sequence is located 70 nts upstream of the start 
codon of the second ORF (Luttermann and Meyers, 2009; McCormick et al., 2008; 
Meyers, 2003, 2007; Napthine et al., 2009), while in the PVM M2 mRNA this 
sequence is located 242 nts from the first start codon of the M2 ORF-2 in PVM. 
Further analysis was carried out to further define the sequence required for coupled 
translation in PVM and whether the TURBS sequence was also playing a role. 
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A second series of plasmids was created to narrow down the boundaries of the region 
required for coupled translation. Two chimeric plasmids in the same format to those 
used in Section 6.3.3 were created to clarify the upstream 5´ boundary of this region 
to within 80 nucleotides and to analyse the potential role of the TURBS-like 
sequence identified in the PVM M2 ORF-1. eGFP was ligated to the 5´ end of the 
M2 gene transcript as described in Section 6.3.1.  
 
The names of these two plasmids indicate the extent of sequence deletion as 
described in Section 6.3.1. As seen in Fig. 6.5, 228 nts and 306 nts were removed 
from the M2 gene transcript sequence and eGFP coding sequence was ligated to the 
5´ end of the newly shortened M2-1 coding sequence for the plasmids pPVM228 and 
pPVM306. The putative TURBS sequence (residues 222 to 226) was located in the 
M2 ORF-1 coding sequence in the plasmid pPVM228 but not in the plasmid 
pPVM306 (Fig. 6.5 black box). A decrease in expression of the CAT reporter gene 
for the pPVM228 may indicate that putative TURBS sequence may play a role in the 
initiation of translation of M2-2. 
 
 
Fig. 6.5: Schematic of chimeric reporter gene plasmids pPVM228 and pPVM306 
Schematic displaying the variable lengths of the M2 ORF-1 coding sequence in ORF-1 for chimeric 
plasmids pPVM228 and pPVM306 in comparison to the full length M2 ORF-1 in the M2 gene 
transcript of PVM. The black line represents the M2 gene transcript of PVM. Arrows on this line are 
used to identify the beginning of the M2 ORF-1 coding sequence for each plasmid in relation to the 
M2 gene transcript. The black box on this line represents the location of the putative TURBS 
sequence. 
 
Construction of pPVM228 and pPVM306 
For all plasmids, truncated versions of M2-1/M2-2/CAT (PVM fragment) amplicon 
were amplified using PCR as described in Section 2.3.1. The template was the 
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plasmid pPVM204 with the forward primer PVM228 and PVM306 used for the 
plasmids pPVM228 and pPVM306 respectively, and the reverse primer CAT Hind 
III was used for both reactions. This generated fragments of 981bps and 913bps for 
plasmids pPVM228 and pPVM306 respectively. For both plasmids, an eGFP 
amplicon was generated via PCR from the plasmid peGFP using the forward primer 
T7-91 and the reverse primer eGFP Sph I to generate an amplicon of 880bp in size as 
described in Section 2.3.1. The method for cloning and sequencing was identical to 
the protocol used in Section 5.6.1.  
 
6.4.2. Further characterisation into the role of critical sequence for M2 ORF-2 
translation located between positions 204 and 370 
The plasmids pPVM228 and pPVM306 were individually transfected into HEp-2 
cells. Control cells were individually transfected into HEp-2 cells with pPVMWC, 
pPVM6, pPVM84, pPVM370, pPVM424 and pBluescribe as described in 2.4.1. The 
levels of CAT protein expressed were quantified using a CAT ELISA assay as 
described in Section 2.4.2. All samples were normalized against cells transfected 
with the empty vector pBluescribe plasmid. For each sample the levels of CAT 
protein were expressed as a percentage signal obtained from the positive control 
plasmid pPVMWC. pPVM6 and pPVM84 were used as controls for baseline 
expression of these new chimeric plasmids. pPVM370 and pPVM424 were used as 
controls where negligible levels of CAT were expressed, indicating a inhibition of 
translation of the mechanism of coupled translation termination/initiation. 
 
As seen in Fig. 6.6, removal of 228nts from the 5´ end of the M2 gene transcript in 
plasmid pPVM228 reduced levels of reporter expression to 46.7% of that from the 
control plasmid pPVMWC. This was not significantly different (p=0.29) to that seen 
with pPVM6, indicating that pPVM228 was able to direct synthesis from the ORF-2 
normally and that the nucleotide sequence between residues 204 and 228 did not play 
any role in expression of ORF-2. The region between residues 204 to 228 includes 
the putative TURBS sequence and these data therefore confirmed that this did not 
play a role in coupled translation of ORF-2 the PVM M2 mRNA. 
 
Removal of the first 306nts of the M2 gene transcript in plasmid pPVM306 reduced 
reporter expression levels to 3.7% of that seen with the plasmid pPVMWC. This was 
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similar to the expression seen with both pPVM370 and pPVM424, with no 
significant difference between either the control plasmid pPVM370 (p=0.81) and for 
the control plasmid pPVM424 (p=0.71). Taken together these data indicate that the 
sequence lying between 229 nts and 306 nts from the 5´ end of the M2 gene 
transcript plays a critical role in regulating expression of M2 ORF-2 that lies 226 nts 
downstream of this region. This is very similar to the situation with hRSV, in which 
a highly structured region lying approximately 150nts upstream of the 5´ proximal 
ORF-2 initiation codon is essential and plays a key role in the coupled translation 
termination/initiation process. 
 
 
 
Fig. 6.6: ELISA results measuring CAT protein expression from transfection of plasmids into 
HEp-2 cells  
Levels of expression of CAT from chimeric plasmids transfected into HEp-2 cells. Mutations made to 
these plasmids are described in Section 6.4.1. Levels of CAT expression have been normalised against 
the empty vector pBluescribe and are as a percentage of the plasmid pPVMWC. Error bars are 
standard deviation.  
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6.5. Identification of structured regions in the PVM M2 gene transcript 
The data described above indicates that sequences upstream of the M2 ORF-1/ORF-
2 overlap region in PVM are required for initiation of translation of ORF-2. Unlike 
in hRSV (P. Gould and A. Easton, personal communication), it is not known whether 
this region constitutes a highly structured region formed in the M2 gene transcript 
similar to the structure observed in hRSV (Gould and Easton, 2005). In hRSV, this 
structured region is thought to slow elongating ribosomes, allowing terminating 
ribosomes downstream to reinitiate translation for the second ORF.  
 
A feature of the highly structured region in the hRSV M2 mRNA reported in Gould 
and Easton, 2005, was that in in vitro transcribed RNA, significant levels of 
premature termination was seen. The site of the premature termination coincided 
with the highly structured region essential for translation initiation of the hRSV 
ORF-2.  
 
In order to search for a potential structured region in the PVM M2 mRNA, an in 
vitro transcription reaction was performed using amplicons generated by PCR from 
the plasmid pPVMWC to produce RNA (Section 2.7). Amplicons generated by PCR 
from the hRSV plasmid pWildCAT (Appendix B4) was used in an in vitro 
transcription reaction to transcribe mRNA as a positive control (Gould and Easton, 
2005). The products of both reactions were separated using denaturing PAGE 
(Section 2.7). 
 
The primer pair T7/CATInt was used to generate amplicons for both plasmids 
(Section 2.3.1). Both amplicons contained the sequence for a T7 RNA polymerase 
promoter, the entirety of M2 ORF-1, the M2 ORF-1/ORF-2 overlap region and a 
region of the CAT coding sequence (Fig. 6.7A). CATInt was an internal CAT primer 
used to reduce the size of the DNA, in order to increase the quantity of RNA 
transcribed. Due to the difference in the size of both M2 ORF-1s, the amplicon 
generated from the hRSV plasmid pWildCAT was larger than the amplicon 
generated from the PVM plasmid pPVMWC. 
 
The products of the in vitro transcription reactions are shown in Fig. 6.7B. As seen in 
lane 2, in vitro transcription of the amplicon derived from the hRSV pWildCAT 
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plasmid produced three products. The largest band of 1000 nt represents the full 
length RNA transcribed by the T7 polymerase. The strong band found at around 400 
nts represents premature termination within ORF-1 (M2 ORF-1) reported by Gould 
and Easton, 2005. The band of approximately 800 nt in size results from premature 
termination within the CAT ORF.  
 
As seen in Fig. 6.7B lane 3, in vitro transcription of the amplicon derived from the 
PVM pPVMWC plasmid generated two products. The band at 900 nts, represents the 
full length RNA product. A faint band of approximately 300 nts was produced which 
indicates the presence of premature termination during transcription. The premature 
termination product from pPVMWC suggests that a region in the vicinity of 273 nts 
from the start of the M2 gene transcript, prevents extension of some of the 
transcription product. This is likely to be a structured region analogous to that found 
in the hRSV M2 mRNA (Gould and Easton, 2005) and is consistent with the 
presence of an essential region lying between residues 229 and 306 described in 
Section 6.4.3.  
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 Fig. 6.7: PAGE of products of in vitro transcription of plasmids pWildCAT and pPVMWC 
(A) Schematic of amplicons generated from the hRSV plasmid pWildCAT and the PVM plasmid 
pPVMWC. Both amplicons include the T7 RNA promoter, M2 ORF-1, M2 ORF-1/ORF-2 overlap 
region and a partial CAT coding sequence. (B) Products of in vitro transcription were separated on a 
 PAGE gel. Lane 1: Geneflow 100bp ladder. Lane 2: Transcription product of amplicon generated 
from the hRSV plasmid pWildCAT. Lane 3: Transcription product of the amplicon generated from 
the PVM plasmid pPVMWC. The sizes of the markers are shown. Black arrow indicates site of faint 
band in lane 3. All lanes orginated from the same gel, white gaps indicate lanes that were not adjacent 
to each other.  
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6.6.1. Predicting structured regions in PVM M2 ORF-1 using Mfold modelling 
software 
From the data presented in Sections 6.4 and 6.5, an upstream sequence was identified 
that is critical for the initiation of translation for the second ORF in the PVM M2 
gene transcript. Analysis of in vitro transcription products also suggests that this 
region contains some degree of secondary structure. A preliminary analysis was 
carried out using the RNA folding software Mfold to predict potential structures 
within the RNA. This software predicts the most likely stable secondary structure 
within a sequence but is limited in that it bases its predictions on the maximum 
possible base pairing within the target sequence to create the most stable structure. 
For this reason, several different sized sequences were analysed to try to assess the 
most likely potential structure. Studies with eGFP chimeric plasmids indicated that 
no critical sequences required for expression of ORF-2 were located before residue 
229 from the start of the M2 gene transcript and this was taken as the 5´ position of 
the sequences inputted. Three sets of sequences were inputted in the Mfold software 
each with decreasing sizes of sequence inputted from residue 229. Settings used for 
the software are described in Section 2.9. Sequence 1 (Fig. 6.8) extended from 
residue 229 to 535 of the M2 gene transcript representing the essential sequence 
determined above. Sequence 2 (Fig. 6.9) extended from residue 229 to 422 of the M2 
gene transcript and sequence 3 (Fig. 6.10) extended from residue 229 to 322 of the 
M2 gene transcript. 
 
For Fig. 6.8 (residues 229-535) and 6.9 (residues 229-422), the software predicted 
two step loop structures located between residues 231-253 and 304-318 surrounding 
the location identified as containing a putative highly structured region (Section 6.5). 
The majority of the sequence within this location was base paired with sequence at a 
significant distance from this location. It is possible that this could be an accurate 
structure, however it is more likely that this was due to the specific parameters used 
by Mfold software, which attempt to create the stable secondary structure possible 
with the sequence provided. 
 
In Fig. 6.10 (residues 229-322), reducing the input sequence from residue 229-322, 
predicted three stem loops structures at residues 231-253, 254-301 and 303-313. The 
stem loop structure located between residues 254-301 was in location of the putative 
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secondary structure identified in Section 6.5. This is also in the area that was 
identified as being critical for initiation of translation of the M2 ORF-2 from the 
plasmids pPVM228 and pPVM306 (Section 6.4).  
 
A recent analysis using a combination of Mfold informed by biochemical studies has 
generated a 3 dimensional prediction of the structured region within the hRSV M2 
mRNA (Fig. 6.11) (P. Gould and A. Easton, personal communication). Comparison 
of this with the data presented here for the PVM M2 mRNA demonstrates some 
similarities. In particular, stems I, III and IV in the hRSV structure are similar to the 
three stem loops generated by Mfold in Fig. 6.10.  
 
Two predicted structures located between residues 231-253 and 254-301 also contain 
loops that are A-rich, one found on the loop located between residues 240-245 and 
the second loop located between residues 275-282. Recent data has shown that A-
rich regions in the structured region of the hRSV M2 mRNA are essential for 
successful initiation of ORF-2 translation and are thought to allow the essential 
cellular protein DDX3X to bind (P. Gould and A. Easton, personal communication). 
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Fig. 6.8: Predicted mRNA structure generated by Mfold from position 228 to 535 
Predicted mRNA structure generated by Mfold. Sequence inputted from position 228 to 535 from the 
beginning of the M2 gene transcript. ΔG=-56.63 
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Fig. 6.9: Predicted mRNA structure generated by Mfold from position 228 to 422 
Predicted PVM M2 mRNA structure generated by Mfold. The sequence analysed contained 
nucleotides 228 to 422 from the M2 gene transcript. The predicted ΔG=-35.74. 
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Fig. 6.10: Predicted mRNA structure generated by Mfold from position 228 to 322 
Predicted mRNA structure generated by Mfold. Sequence inputted from position 228 to 322 from the 
beginning of the plasmid M2 gene transcript. ΔG=-17.50 
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Fig. 6.11: mRNA secondary structure found in hRSV M2 gene transcript 
mRNA secondary structure identified in hRSV M2 ORF-1 through SHAPE mapping (P. Gould and 
A. Easton, personal communication) Structure is critical for the initiation of translation of M2 ORF-2. 
Stem I (residues 395-421), Stem II (residues 425-511), Stem III (residues 445-478) and Stem IV 
(490-507) 
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6.6.2. Investigation into the involvement of a predicted secondary structure in 
translation of the PVM M2 ORF-2 
The structural predictive software Mfold predicted the presence of a stem loop 
structure from position 254-301 in the PVM M2 gene transcript (Fig. 6.10). As well 
as the predicted structure being in the location of a putative secondary structure 
identified in Section 6.5, this was also located in a region that was identified as being 
critical to the initiation of translation of the M2 ORF-2 in PVM (Section 6.4).  
 
Two plasmids were designed to disrupt this predicted stem loop structure to 
investigate if this affected translation of the PVM M2 ORF-2. Both plasmids were in 
the same format as the plasmid pPVMWC (Fig. 6.12A) and the predicted secondary 
structure was disrupted by mutating three G residues, located at nucleotide positions 
284, 288 and at 298, that base paired in the stem structure. Using Mfold, it was 
predicted that these altered residues when mutated, would disrupt the stem loop 
structure, as shown in Fig. 6.12B. Point mutations were incorporated into the ORF-1 
sequence by mutating these three G residues to C for the plasmid pPVMStructuralC 
(Fig. 6.13A) or U for plasmid pPVMStructuralU (Fig. 6.13.B). A decrease in CAT 
protein expression would suggest that the predicted secondary structure identified is 
likely to be involved in the initiation of translation of ORF-2.  
 
A third plasmid (pPVMStructuralG/C) in the same format as pPVMWC (Fig. 
6.12A), was also created to confirm the presence of the predicted structure generated 
by Mfold. As seen in Fig. 6.13C, the G/C base pairs found at these three sites were 
switched. If this predicted secondary structure was involved in the initiation of 
translation of ORF-2, then CAT expression would not be altered by this new set of 
point mutations as the structure would be retained.  
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Fig. 6.12: Predicted structure of mutated PVM M2 mRNA structure  
 (A) Schematic representing the reporter plasmids pPVMStructuralC, pPVMStructuralU and 
pPVMStructuralG/C. Arrows represent the location for the beginning and the end of the predicted 
stem loop structure located between residues 254-301 on the PVM M2 gene transcript (B) Predicted 
mutated mRNA structure generated by Mfold. The sequence from position 229 to 322 of the PVM M2 
mRNA containing point mutations (G to C) at nucleotide positions 284, 288 and 298 are present. The 
predicted ΔG=-11.35.  
A 
B 
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Fig. 6.13: Sites of point mutations 
to identify the importance of the 
predicted secondary structure at 
residues 254-301 of the PVM M2 
mRNA modelled in Mfold for the 
translation of M2 ORF-2 
 (A) Point mutations at residues 
284, 288 and 298 mutating 
nucleotides G to C in the plasmid 
pPVMStructuralC. (B) Point 
mutations at residues 284, 288 and 
298 mutating nucleotides G to U in 
the plasmid pPVMStructuralU. (C) 
Point mutations reversing the base 
pairs 273-284, 268-288 and 261-
298 in the plasmid 
pPVMStructuralG/C. 
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Construction of plasmids pPVMStructuralC, pPVMStructuralU and 
pPVMStructutalG/C  
 
Two-step PCR.  
The plasmids pPVMStructuralC, pPVMStructuralU and pPVMStructuralG/C had 
their respective point mutations mutated into M2 ORF-1 in the plasmid pPVMWC 
using two-step PCR. A diagram of the process is shown in Fig. 6.14. For each 
plasmid two PCR amplicons were initially generated in two separate PCR reactions 
in the first round of PCR using primers 1 and 3 (amplicon 1) and 2 and 4 (amplicon 
2) (Fig. 6.14). Each amplicon had the mutations incorporated via primers 2 and 3 
into the 5´ or 3´ end of the amplicon. The primers 2 and 3 were the reverse 
complement of the other so both amplicons contained a region of sequence 
homology. A second PCR reaction was performed with both amplicons and the 
external primers (1 and 4) from each of the first step reactions (Fig. 6.14). As the two 
amplicons contained regions of sequence homology they annealed during the 
reaction to generate the desired full length product. The newly generated amplicon 
was further amplified by the two external primers 1 and 4. 
 
Fig. 6.14: Schematic of two-step PCR method to incorporate point mutations into pPVMWC 
Schematic representation of the PCR for the method two-step PCR. For the first step primers 1, and 3 
(Amplicon 1) and 2 and 4 (Amplicon 2) were used to generate two amplicon products that overlapped 
each other. Primers 2 and 3 were used to introduce point mutations into each amplicon. For the second 
step, primers 1 and 4 were used to join the two initial amplicons with overlapping sequences together 
with the newly incorporated point mutations in place. Horizontal lines between primers 2 and 3 
represents the sites of the three point mutations  
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The cloning and sequencing method for all plasmids can be seen in Section 5.3.1.1. 
For the first step of the two-step PCR, two amplicons were generated using PCR 
from the template pPVMWC for each plasmid. The primer pairs used to amplify the 
amplicons are found in Table 6.2. All amplicons were 422 bp in size. After the first 
step, amplicons were purified using a QIAGEN PCR purification kit as described in 
Section 2.3.13. For the second step for each plasmid, the two amplicons were joined 
via a second round of PCR using the primers T7-91/T3-down (Primers 1 and 4 Fig. 
6.14), this generated a fragment of 1354 bp in size.  
 
Plasmid Primer Pairs for each amplicon 
pPVMStructuralG/C T7-91/PstrucGC R 	
and T3-down/ PstrucGC F 	
pPVMStructuralC  T7-91/PstrucC R	
and T3-down/ PstrucC F 	
pPVMStructuralU  T7-91/PstrucT R 	
and T3-down/ PstrucT F 	
Table 6.2: Table of primer pairs used for two-step PCR 
Table of primer pairs used for in the PVM fragment for first step of the two-step PCR used to 
construct the plasmids pPVMStructuralG/C, pPVMStructuralC and pPVMStructuralU. 
 
 
6.6.3. Disruption of a predicted secondary to investigate its involvement in M2 
ORF-2 translation 
The plasmids described in 6.6.2 were individually transfected into HEp-2 cells as 
described in Section 2.4.1. Control cells were individually transfected with either 
pPVMWC or the empty vector pBluescribe. The level of CAT protein expression 
was quantified using a CAT ELISA assay as described in Section 2.4.2. All values 
were normalized against the results from transfected empty pBluescribe plasmid. For 
each sample, the levels of CAT expressed have been expressed as a percentage of the 
positive control plasmid pPVMWC. 
 
As shown in Fig. 6.15, mutating each of the G residues at positions 284, 288 and 298 
to C in plasmid pPVMStructuralC had no significant effect on CAT reporter 
expression with a level of 98% of the positive control plasmid transfection (p=0.82). 
Mutating the G residues at positions 284, 288 and 298 to U in the plasmid 
PVMStructuralU, reduced CAT protein expression to 92% of the control which was 
not significantly different (p=0.27) to the level obtained with pPVMStructuralC 
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(p=0.49). Taken together, these data indicate either that the predicted structure is not 
present, it is present but was unaffected by the mutations or that it is present but 
integrity of the structure is not required for the initiation of translation of the ORF-2. 
 
In the plasmid pPVMStructuralG/C three additional mutations at positions 261, 268 
and 273 were introduced into the mutant pPVMStructuralC. These mutations were 
designed to reinstate the predicted stem structure in the M2 mRNA but with the G 
and C residues now located on the opposite strands of the stem. As seen in Fig. 6.15, 
these additional mutations completely ablated expression of CAT protein (p=0.0005 
compared to the positive control). The dramatic effect of the three additional 
mutations at positions 261, 268 and 273 combined with the mutations at positions 
284, 288 and 298 suggests that the predicted stem structure is unlikely to exist in the 
mRNA. The data show that the region contains critical residues or a critical structure 
that is disrupted in the pPVMStructuralG/C mutant but further mutational analysis 
will be required to clarify the situation.  
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Fig. 6.15: Expression of CAT reporter protein from transfection of mutant plasmids into HEp-2 
cells  
Levels of expression of CAT protein in transfected HEp-2 cells from plasmids containing mutations 
designed to alter the structure of the PVM M2 mRNA as described in Section 6.6.2. Levels of CAT 
protein expression were normalised against the empty vector pBluescribe and are expressed as a 
percentage of the level obtained with the positive control plasmid pPVMWC. Error bars are standard 
deviation.  
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6.7. Conclusions  
Data acquired from this chapter has further characterised the mechanism of coupled 
translation for initiation of translation of PVM M2 ORF-2. Chimeric reporter 
plasmids identified a region of sequence between positions 229 and 339 in the M2 
ORF-1 that was used by the ribosome to initiate translation of M2 ORF-2 and was 
essential for successful translation. Removal of this region of sequence inhibited the 
mechanism of coupled translation.  
 
This reliance on an upstream sequence has also been reported in the mechanism of 
coupled translation used to translate the hRSV M2 ORF-2 (Gould and Easton, 2005). 
In this example, this region of sequence was found to contain a structured region that 
when removed inhibited translation of M2 ORF-2 (P. Gould and A. Easton, personal 
communication). It was therefore decided to investigate if a structured region was 
present in this region of critical sequence for PVM M2 ORF-2. In vitro transcription 
reactions were therefore used to identify the presence of a large secondary structure 
through the production of premature termination products. Using this technique, a 
large stable RNA structure was identified during transcription of amplicons 
generated from the PVM reporter plasmid pPVMWC. This structure began inside the 
M2 ORF-1 sequence that was critical for translation of PVM M2 ORF-2. Mfold 
modeling software was used to characterise this structure by inputting this critical 
sequence for M2 ORF-2 translation. The software predicted a structure that consisted 
of three stem loops similar to the secondary structure critical for hRSV M2 ORF-2 
translation (P. Gould and A. Easton, personal communication).  
 
Although this structure was identified in the region critical for translation of M2 
ORF-2, it was still unknown whether this structure was a factor in ORF-2 translation. 
A set of mutations were therefore made in plasmids that used the same reporter 
system as used in other plasmids in this chapter to measure ORF-2 expression. These 
mutations were designed both to disrupt the structure and retain the predicted 
structure, in an attempt to investigate if this predicted structure was a factor in ORF-
2 translation. Although the plasmids that were designed to disrupt the structure had 
no effect on ORF-2 translation, translation of ORF-2 was inhibited for the plasmid 
designed to mutate key residues but retain the predicted structure. This plasmid had 
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six point mutations incorporated into this critical region located in the M2 ORF-1 
sequence.  
 
From these data, it is possible to conclude that PVM likely uses a similar mechanism 
to coupled translation in hRSV, where translation is reliant on an upstream structured 
region. It is likely that these point mutations that inhibited translation of ORF-2 
disrupted the actual secondary structure located in this region. It is therefore likely 
that the secondary structure predicted by Mfold is not accurate and the secondary 
structure identified using in vitro transcription has an alternate and unknown 
structure.  
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Chapter 7 
Discussion 
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7.1. Transcriptional profiles of bRSV and hRSV 
Using transcriptional profiles to measure viral mRNA abundance in hRSV and bRSV 
infected cells, it was observed that a large proportion of viral mRNAs in both viruses 
at both 4 and 8 hpi had relative mRNA abundances consistent with the polar gradient 
model of transcription. For example, between the mRNAs expressed from the N to 
the G gene in both viruses at both time points, with the exception of the hRSV P 
gene at 4 hpi, there was a progressive decrease in viral mRNA abundance in the 
same sequential order as that of the genes from the 3´ promoter. However, there were 
also examples where the abundance of some viral mRNAs did not follow the 
expected gradient. For example, an increase in mRNA abundance was seen in both 
viruses at both time points between the G to F and F and M2 genes with the 
exception of bRSV M2 gene at 4 hpi. The reason for this variation at 4 hpi is 
unknown. As the mRNA levels measured were those at steady state and the data did 
not indicate true transcription rates of the genes, it is likely that this divergence from 
the polar gradient is due to the mRNA half-life of viral mRNAs differing from one 
another. While there is currently no evidence to support differing half-lives between 
viral mRNAs (Pennica et al., 1979). However, in reports where a divergence from 
the polar gradient model was reported, it was considered that this may be due to 
differences in mRNA half-life (Aljabr et al., 2016; Krempl et al., 2002). For cellular 
mRNAs, half-lives can differ significantly and the rates of decay are dependent on 
multiple factors such as sequence and size of mRNAs (Yang et al., 2003). As the 
half-life for viral mRNAs is dictated by cellular decay pathways (Tycowski et al., 
2012), it is quite possible that the same factors have a similar influence on viral 
mRNA half-lives.  
 
The data also shows that mRNA abundance may be consistent with the polar 
gradient model at one time point but not another. For example between the NS2 and 
N genes at 8 hpi but not at 4 hpi in both viruses, there was an increase in mRNA 
abundance (4.8% increase in hRSV and 3.8% increase in bRSV). This suggests that 
the mRNA half-life changes during infection. In agreement with this, at 24 and 48 
hpi the M and G genes had the highest levels of mRNA abundance (Aljabr et al., 
2016) but at 4 and 8 hpi, the M mRNA was closer to the median mRNA abundance 
level and the G mRNA had the second lowest abundance at both time points. This 
was also seen with the NS1 gene, where the levels of mRNA were significantly 
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lower as a proportion of total mRNA at 24 and 48 hpi (Aljabr et al., 2016) compared 
to the levels at 4 and 8 hpi reported here (Section 3.4).  
 
These data suggest that if the half-life differs for each viral mRNA at different stages 
of infection, then control of viral protein expression is unlikely to occur based solely 
on mRNA abundance. Therefore, it is likely that translational regulation of virus 
mRNAs also plays a role in determining levels of protein. 
 
While transcriptional profiling provides evidence of the steady state levels of mRNA, 
it does not directly address the question of whether virus transcription in 
pneumoviruses follows the polar gradient model. To address this directly, it will be 
necessary to also investigate viral mRNA half-life and to look at the levels of nascent 
RNA at different times during infection. 
 
7.2. Translational profile of bRSV and hRSV 
It is clear that from translational efficiencies of the individual mRNAs, translational 
regulation plays a role in gene expression in both bRSV and hRSV. In both viruses, 
only the G mRNA was highly translated (upregulated) and the L mRNA poorly 
translated (downregulated) at both 4 and 8 hpi. The P mRNA was also translated 
efficiently in both viruses at all time points with the exception of hRSV P mRNA 
extracted at 4 hpi. For the SH mRNAs and M2 ORF-1 for bRSV and the NS1 and SH 
mRNAs for hRSV the translation efficiencies were regulated at both time points.  
 
Further evidence for the presence of translational regulation was seen for the hRSV 
SH mRNA at 8 hpi. The mRNA abundance for this mRNA was at very low levels of 
1.4% in contrast to 9.4% for the bRSV SH mRNA. However, the translational 
efficiency of the hRSV had a value of 6.57 (indicating upregulation), while the more 
abundant bRSV SH mRNA had a translational efficiency of 0.53 (indicating 
downregulation). This suggests that the level of the SH protein for these viruses is 
achieved by a balance between mRNA levels (which likely differs as a result of 
different stabilities), and translation efficiencies. In both viruses there was also 
evidence of changes in mRNA translation efficiencies for specific mRNAs at 
different time points. This is seen with the bRSV NS1 mRNA and the hRSV N and 
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NS2 mRNAs (Table 3.3). This may be a mechanism to control the levels of protein 
at different stages of infection due to changing demand for the protein. 
 
For the bRSV M2 ORF-1, regulation may occur due to the non-canonical mechanism 
used for translation M2 ORF-2 affecting translation of M2 ORF-1. This is 
unsurprising, since initiation of translation for M2 ORF-2 appears to take place 
inside M2 ORF-1, which is likely to disrupt translation of M2 ORF-1 (see later 
discussion).  
 
It is currently understood that regulation of translation primarily occurs at the 
initiation stage of translation (Fütterer et al., 1997; Jacks and Varmus, 1985; 
Tsukiyama-Kohara et al., 1992). It is likely, with the exception of the M2 mRNA, 
that both bRSV and hRSV regulate translation through a canonical initiation 
pathway. The precise factors determining translation efficiencies of mRNAs are not 
known. One possible factor is that the virus mRNAs compete for cellular resources 
present in limiting concentrations and that some mRNAs are more efficient at 
binding to these. An example of limiting resources may be specific initiation factors 
that become limiting in the face of the large increase in overall mRNA levels that 
occur during virus infection. This may also be affected by the different stages of 
infection where there is a change in cellular metabolism. For example, a decrease in 
the levels of eIF4F (containing eIF4A) at later stages of infection may decrease 
successful initiation of mRNAs with highly structured 5´ UTRs. Another possible 
factor is the codon usage. In this, mRNAs containing sequences for multiple rare 
codons are likely to have lower levels of translation due to a relative shortage of rare 
tRNAs. In this case, it is not clear if the translation efficiency would be likely to alter 
throughout infection. Further analysis of the sequence of each mRNA may clarify 
this. A specific factor relevant for pneumovirus mRNAs is that the viruses can 
produce polycistronic mRNAs and the proportion of each of these is specific for each 
gene junction and is different for different virus strains as has been reported for the P 
mRNA in the related measles virus (Section 1.6.3) (Liston and Briedis, 1995). This 
could indirectly affect translation, as translation of the downstream ORF is likely to 
be rare. The frequency of polycistronic mRNAs in pneumoviruses has not been 
established. 
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An important consideration is that the data acquired for bRSV was obtained from a 
single experiment and replicates are required to provide confidence for assessment of 
mRNAs where the differences in translation efficiencies were small. This will also 
provide additional repeats for transcriptional profile data of bRSV. In addition, it will 
be necessary to confirm the translational regulation for specific mRNAs using 
biochemical analyses. 
 
7.3. The mechanism of translation of bRSV M2 ORF-2 
The hRSV M2 ORF-2 has been shown to be translated using a novel process of 
coupled translation termination/initiation (Section 1.4.2). It was anticipated that the 
very closely related and highly homologous bRSV would use the same process and 
this was investigated using a reporter gene approach that was used to characterise the 
hRSV system. Initially it was shown that the AUG codon at position 563 located in 
the M2 ORF-1/ORF-2 overlap region was used primarily to initiate translation of the 
bRSV M2 ORF-2 (Section 4.4) though initiation could occur at 20-fold lower levels 
at the AUG codon at position 554 if the preferred AUG codon was mutated. If the 
AUG at codon 554 was also used as a result of leaky scanning (Jacks et al., 1988b) 
this would result in an M2-2 protein that contained an additional 3 amino terminal 
residues compared to the product initiated at the preferred AUG 563.  
 
While in principle ribosomal profiling data could be used to identify where 
ribosomes are initiating translation of bRSV M2 ORF-2, the levels of translation of 
M2 ORF-2 were extremely low making it difficult to distinguish initiating ribosomes 
in the M2 ORF-1/ORF-2 overlap region from elongating ribosomes translating M2 
ORF-1. It is possible that the levels of translation of M2 ORF-2 increase at later 
stages of infection as the requirement for M2-2 protein increases with the switch 
from viral transcription to replication (Bermingham and Collins, 1999). Ribosomal 
profiling of samples extracted between 12 to 15 hpi, when levels of translation of M2 
ORF-2 may be higher may prove more suitable for identification of the AUG codons 
used for translation.  
 
As described in Chapter 5 the Kozak sequence surrounding the M2 ORF-2 initiation 
codon was a factor in successful initiation. This is commonly seen in other non-
canonical scanning mechanisms (Racine et al., 2007; Wise et al., 2009) but not in 
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members of the Caliciviridae family that use a form of coupled translation to access 
an overlapping ORF (Luttermann and Meyers, 2014). This may also explain the 
preference for initiation at position 563 instead at position 554, as the preferred AUG 
codon has a stronger Kozak sequence. However mutation of the Kozak sequence at 
AUG 563 suggested that this was not the only factor in initiation site preference 
(Tikole and Sankararamakrishnan, 2008). Mutation of the Kozak sequence adjacent 
to the AUG at position 563 to introduce an optimal sequence reduced translation of 
M2 ORF-2. This suggests that the sequence surrounding the AUG codon is already 
optimal for translation of M2 ORF-2. 
 
The insertion of two separate artificial AUG codons for M2 ORF-2 translation led to 
a failure to initiate translation when both native start codons for M2 ORF-2 were 
mutated (Section 5.4). The Kozak sequences for these artificial codons were stronger 
than the Kozak sequence for the AUG codon at position 554. The failure of these 
optimised codons to initiate translation of ORF-2 suggests that the location of the 
codon may also be important for successful translation. It also suggests that the 
Kozak sequence is not an essential factor in the ribosome choosing the location of 
initiation of M2 ORF-2. Further experiments to establish whether the location of the 
AUG codon is a factor would involve moving the sequence of the preferred AUG 
codon including the surrounding Kozak sequence further downstream and would 
indicate if the position of this codon relative to some other region may be important. 
 
The finding that the Kozak sequence is not the sole factor in the site of initiation of 
translation of the M2 ORF-2 suggests that a scanning mechanism such as leaky 
scanning is not used to access ORF-2 as the ‘strength’ of the Kozak sequence is not a 
priority. This is also consistent with the data obtained from the plasmids containing 
the artificial start codons. The data suggests that the preference for the AUG codon at 
position 563 is based both on its location and on the nature of the upstream sequence 
with the latter acting in an unknown role. 
 
A key characteristic of coupled translation termination/initiation common to all 
examples, is that the upstream ORF termination codon is located sufficiently close to 
the initiation codon for the downstream ORF to allow reinitiation (Ahmadian et al., 
2000; Gould et al., 2014; Gould and Easton, 2007; Luttermann and Meyers, 2007). 
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Moving the terminating codon to increase this distance either significantly reduces or 
completely inhibits the translation of the second ORF. Mutating the bRSV M2 ORF-
1 stop codon and increasing the ORF-1/ORF-2 overlap region to 92 nts had no effect 
on translation of ORF-2 (Section 4.5). In these experiments the increased length of 
the bRSV M2 ORF-1/ORF-2 overlap region was significantly longer than the size of 
the M2 ORF-1/ORF-2 overlap region required to inhibit translation of M2 ORF-2 in 
other members of the Pneumoviridae family (Ahmadian et al., 2000; Gould and 
Easton, 2007). This indicates that bRSV does not use coupled translation to access 
the M2 ORF-2. Ribosomal profiling provided further evidence that initiation of 
translation of bRSV M2 ORF-2 was not achieved using coupled translation (Section 
4.6). In these data it was clear there were no significant examples of ribosomes 
stalling in a similar manner observed in hRSV (Phillip Gould and Andrew Easton, 
personal communication) or that the translation between the two ORFs were linked.  
 
The data reported here shows that bRSV is the first member of the 
Orthopneumovirus family that does not use the mechanism of coupled translation. 
While there was a report that the Metapneumovirus HMPV does not use coupled 
translation to access the M2 ORF-2, this was not proved conclusively. As described 
in Section 1.6.1, translation of the HMPV M2 ORF-2 was not inhibited when 
translation of M2 ORF-1 was prevented. This was interpreted to suggest that HMPV 
M2 ORF-2 is not reliant on translation of M2 ORF-1. However the key experiment 
of mutating the M2 ORF-1 termination codon and observing the effect on M2 ORF-2 
expression was not performed (Buchholz et al., 2005). Since preventing M2 ORF-1 
translation leaves open the possibility that with these mutants the M2 ORF-2 was 
accessed by leaky scanning, it remains possible that coupled translation is used for 
this mRNA. 
 
It is likely that a non-canonical mechanism is used to initiate translation of the bRSV 
M2 ORF-2. It is unlikely that leaky scanning is used, as a ribosome initiating 
translation at the preferred AUG codon at position 563 would have to bypass 14 
other potential initiation codons, 3 of which have similar strength Kozak sequences. 
Although the distance from the preferred start codon is not too far for leaky scanning 
to occur (Fütterer et al., 1997), the efficiency of leaky scanning decreases with 
distance. This is further supported by transfection and expression of ORF-2 from the 
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plasmid pbRSVWC14 (Section 5.6). With this plasmid, the ribosome would have to 
bypass a total of 22 codons and travel 1371 nts to reach the desired AUG codon. This 
is over 1.5 times the largest distance reported to be used by leaky scanning, making it 
extremely unlikely (Fütterer et al., 1997).  
 
The absence of a fusion protein in cells transfected with the plasmid pbRSVWC42 
suggests that programmed ribosomal frameshifting is not used (Section 5.2). There 
was also no evidence of a slippery sequence surrounding the site of initiation. 
Although it is important to note that in cases of -2 and +1 frameshifting, the slippery 
sequence appears to be case specific (Matsufuji et al., 1996; Olivier et al., 2008). 
However the majority of -2 and +1 mechanisms are still reliant on downstream 
structured regions in the vicinity of the slippery sequence (Ivanov and Atkins, 2007). 
In the creation of the reporter plasmids the sequence directly downstream of the 
initiation site for M2 ORF-2 was replaced with CAT coding sequence and the 
continued expression of the M2 ORF-2 in these plasmids indicates that such an 
essential slippery sequence is not required for M2 ORF-2 expression in bRSV. 
 
It is also unlikely that ribosomal shunting is used to translate M2 ORF-2 by a 
ribosome translating a short ORF in the 5´ UTR in order to retain certain initiation 
factors for a jump, as the M2 mRNA 5´UTR is only 9 nts long. Similarly if shunting 
occurred after termination of M2 ORF-1, mutating the ORF-1 stop codon thereby 
changing the donor site, also had no effect on translation, suggesting this mechanism 
is not used in the bRSV M2 mRNA. It has been shown for the late adenovirus 
mRNAs, that instead of the ribosome using initiation factors gained from translating 
a short ORF to bypass the 5´ UTR, the ribosome can utilise complementary 
sequences to the 3´ end of the 18S rRNA to facilitate the jump from the 5´ UTR to 
the internal initiation position (Yueh and Schneider, 2000). While a short sequence 
complementary to the 3´ end of the 18S rRNA was identified in the bRSV M2 ORF-
1, mutating this sequence to either improve or reduce the complementarity of this 
sequence had no effect on the translation of ORF-2. Finally, altering the M2 ORF-1 
sequence with the addition of 708 nts to ORF-1 and a new 5´ UTR in the reporter 
plasmid pbRSVWC14, did not reduce or eliminate translation of ORF-2 (Fig. 5.16). 
It is therefore unlikely that ribosomal shunting is used to initiate translation of M2 
ORF-2.  
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The use of chimeric reporter assays identified a region upstream of the M2 ORF-
1/ORF-2 overlap region that was critical for translation of M2 ORF-2 (Fig. 5.16). 
Studies with bicistronic reporter assays to test this critical region of sequence suggest 
that an internal initiation mechanism is likely to be used by bRSV for initiation of 
translation of M2 ORF-2 (Section 5.6). The sequence between position 210 and 563 
was able to facilitate internal translation when placed in the context of an unrelated 
ORF (Section 5.8). While a stable secondary structure is not always required for an 
IRES, and in some cases can be inhibitory (Filbin and Kieft, 2009), such regions are 
frequently identified in association with internal initiation processes. However, there 
was no evidence of a stable secondary structure in this region (Section 5.5.2.1). 
Further work is required to establish if the M2 IRES-like region loads the ribosome 
directly onto the AUG codon or requires the ribosome to scan a distance downstream 
(Jaafar et al., 2016). Further work is also required to ensure that plasmids used to test 
for internal translation contained no cryptic promoters. Although it is important to 
note that there is currently no evidence of T7 promoters acting as cryptic promoters 
when transfected into eukaryotic cells that have not been infected with vaccinia virus 
that expresses T7 RNA polymerase (Ray et al., 2006, Dhar et al., 2007).  
 
An unusual feature is the putative stem loop structure identified between the IRES-
like sequence and the initiation codon for M2 ORF-2, that reduces the efficiency of 
translation for M2 ORF-2 (Section 5.5.1.2). Structural predictions suggest that most 
of the M2 ORF-1/ORF-2 overlap region, including the preferred initiation codon for 
M2 ORF-2, is base paired in the stem of this structure. A point mutation inserted into 
this sequence designed to disrupt this structure without altering the Kozak sequence 
significantly improved ORF-2 expression. The increase in ORF-2 translation may 
result as a consequence of the ribosome not having to unwind the structure to access 
the preferred AUG codon for translation of ORF-2. This is consistent with studies 
showing that structured regions can inhibit successful initiation and require 
unwinding before efficient initiation can occur (Oppenheim and Yanofsky, 1980). To 
further characterise this inhibitory structure, additional mutations to further 
destabilise it, in conjunction with biochemical analyses, will clarify the role and 
potential function of this region. 
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7.4. Coupled translation termination/initiation for initiation of translation of 
PVM M2 ORF-2 
It has been shown previously that the PVM M2 ORF-2 is accessed by coupled 
translation (Gould and Easton, 2007). Using chimeric reporter plasmids based on the 
PVM M2 mRNA it was shown that a region of sequence upstream of the PVM M2 
ORF-1/ORF-2 overlap region between positions 229 and 332 was required for 
translation of ORF-2. When this region was removed, translation of M2 ORF-2 was 
reduced to basal levels similar to those observed when the M2 ORF-1 terminating 
stop codon was mutated (Gould and Easton, 2007) (Section 6.3). The progress of T7 
RNA polymerase was reduced during in vitro transcription across this region 
strongly suggesting that it contained a secondary structure as had been demonstrated 
for the hRSV M2 mRNA (Gould and Easton, 2005). The Mfold software predicted a 
secondary structure consisting of three stem loops that was similar to the structured 
region critical for hRSV M2 ORF-2 translation (P. Gould and A. Easton, personal 
communication). Mutations designed to alter the predicted structure led to complete 
inhibition of ORF-2 translation (Section 6.6). This is similar to the situation for 
hRSV M2 ORF-2 translation (Gould and Easton, 2005). 
 
This evidence combined with a highly similar mechanism of coupled translation 
reported in hRSV (reviewed in Section 1.4.2), makes it highly likely that the 
secondary structure in PVM acts in a similar mechanism to the hRSV structure 
(Section 1.4.2). The secondary structure in the hRSV M2 mRNA appears to be more 
stable than the structure in the PVM M2 mRNA and this may play a role in the 10 
fold difference in the levels of M2 ORF-2 expression between the two different 
viruses (Gould and Easton, 2007). However, several additional factors such as size of 
the M2 ORF-1/ORF-2 overlap region may also play a role and further investigation 
is required to define the reasons for the differences between the two virus systems. 
Such studies would involve additional mutational analysis within the region to 
disrupt and map the critical structure. Biochemical analysis such as SHAPE mapping 
would also further define the secondary structure. Ribosomal profiling would then be 
used to identify if the secondary structure is used by PVM in the same manner as in 
hRSV (P. Gould and A. Easton, personal communication). 
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7.5. Concluding remarks 
Current understanding of the control of gene expression in pneumoviruses is limited. 
The data presented here indicates that there are both transcriptional and translational 
regulatory factors that play a role in determining the final level of expression of gene 
products. It is also clear that although many similarities are shared between the 
closely related bRSV, PVM and hRSV, the mechanism of translation of M2 ORF-2 
differs between these viruses. While hRSV and PVM appear to use very similar 
processes to access and initiate translation of M2 ORF-2, a different mechanism is 
used for translation of bRSV M2 ORF-2. Translation of the bRSV M2 ORF-2 
requires an upstream sequence located within the M2-1 ORF, which is similar to 
PVM and hRSV. However for bRSV, this sequence appears to direct ribosomes to 
initiate translation internally within the M2 mRNA rather than to promote coupled 
translation termination/initiation that is seen in the other Orthopneumoviruses. 
Whilst the outcome of these different processes is the same with the expression of 
ORF-2, the data demonstrates that the viruses can achieve this by using different 
mechanisms. This raises fundamental questions about the evolutionary relationships 
of the viruses.   
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Appendix A 
Commands for scripts used to process raw next 
generation sequencing data generated from ribosomal 
profiling.  
	Scripts used to process raw sequencing data from libraries built using the technique 
of ribosomal profiling. Scripts are numbered in order of use. File containing raw 
sequencing data is initially downloaded from BaseSpace prior to being processed 
using Fastx_clipper. File when downloaded is in fastq format. 
 
1. Clipper to remove sequence of 5´ primer  
Script: Fastx_clipper 
 
 
./fastx_clipper -a AGATCGGAAGAGCACACGTCT -l 25 -c -n -v -Q33 -i P4.fastq -
o P4clipped.fastq 
 
A Script used. Must have ./ to designate that file is in folder 
A Sequence that will be removed  
-I –i= input  -o =output file. Must have – before  
A  Input and output file name must go after –i/-o respectively  
25 Minimum length of read recommended by illumina 
 
2. Trimmer to trim unwanted length of sequence  
Script: Fastx_trimmer 
 
./fastx_trimmer -Q33 -f 1 -i P4clipped.fastq >P4trimmed.fastq 
 
A Script used. Must have ./ to designate that scirpt is in folder 
-I –i= input >=output file  
A Input and output file name must go after –i/> respectively 
 
3. Building index genome  
Scrip: Bowtie-build 
 
First download genome from genbank in FASTA format. Rename and place in 
designated folder. 
 
./bowtie-build bRSV.fna bRSV 
 
A Script used. Must have ./ to designate that file is in folder 
A Name of input genome file in FASTA format  
A Output file name  
 
4. Bowtie alignment 
Script Bowtie 
 
To align sample ensure trimmed file is in the same folder/directory  
 
./bowtie -S brsvindex P4trimmed.fastq P4.sam 
t 
A Script used. Must have ./ to designate that file is in folder 
A Name of genome in index form, only use the file name that is used in bowtie build, 
the programme will use all the files produced  
A Input file name 
	A Output file name ensure the file name ends in .sam 
 
5. Turn aligned file into compatible file for IGV 
Script Samtools 
 
IGV, the viewing tool will only recognise a certain file type with a correct index 
attached.  
 
First .sam file needs to be converted into .bam file  
 
./samtools view -bS -o P4.bam P4.sam 
 
A Script used. Must have ./ to designate that file is in folder 
A –o output code 
A Output file must have .bam at end and must have –o before  
A Input file name from bowtie alignment 
 
Next turn .bam file into sorted file  
 
./samtools sort -o P4.sorted P4.bam 
A Script used. Must have ./ to designate that file is in folder 
A –o output code 
A Output file, must have .sorted at end and must have –o before  
A Input file name with .bam 
 
Finally an index must be created. This is for IGV to recognise the sorted file  
./samtools index -b P4.sorted P4.bam.bai 
 
A Script used. Must have ./ to designate that file is in folder 
A Input file must have .sorted at end  must have –o before  
A Output file name with .bam.bai The file must also have the same name before as 
the sorted file.  
 
In folder change the file names to the following: 
FileName.sorted    :change to:     FileName.bam 
FileName.bam       :change to:      FileNameunsorted.bam  
 
 
This is to ensure IGV does not recognize the unsorted version. 
 
6. Loading alignment in IGV 
First, load genome in the FASTA format. 
Next load aligned file. Choose the .sorted file that is renamed to .bam. 
 
7. WIG files  
Script WIG 
 
Used to view location of first nucleotide of each read aligned to genome 
./orfAnalysis2 -w -p 0.01 –pt 100 -g  brsv.rna_first -b P8.bam 
A Script used. Must have ./ to designate to look in that file  
	A Psuedo count, set between 0.01 and 0.3. Recommended to use 0.01 
A Output file that is used to compare to genome. Ensure just the file name ends  in 
.info 
-b Always put before input file 
A Input file should be the sorted version, that has been renamed to end in .bam. 
  
	 
 
 
 
 
Appendix B 
Additional figures.  
	 
 
 
 
	 
 
 
	 
 
Appendix B1: QC plot of reads from sequencing libraries created in Chapter 3 
QC plot of reads from sequencing libraries created in Chapter 3. Plot shows the quality of each 
nucleotide along unprocessed reads in each library. The software FastQC was used to test quality of 
sequencing reads. (A) FastQC plot from library hRSV4T. (B) hRSV8T. (C) hRSV4P. (D) hRSV8P. 
(E) bRSV4T. (F) bRSV8T, (G) bRSV4P 
 
 
 
Appendix B2:Sequencing of the plasmid pbRSVM2 
Sample of sanger sequencing from plasmid pbRSVM2 using GATC sequencing. Sequence ranges 
from position 1 to 150. 
	 
Appendix B3: eGFP protein expression for plasmids used to investigate if an internal initiation 
mechanism is used for initiation of translation of M2 ORF-2 
Levels of expression of eGFP protein expressed from plasmids individually transfected into HEp-2 
cells. Each repeat represents the average of three separate transfections of each plasmid. All 
experiments were performed during the same set of transfections. Results were normalised against the 
empty vector pBluescribe and are expressed as a percentage of the single plasmid transfection with the 
highest eGFP protein expression. Error bars indicate standard deviation. 
 
 
 
 
Appendix B4: Schematic of the gene transcript transcribed from the plasmid pWildCAT 
Schematic representation of the gene transcript transcribed from the hRSV plasmid pWildCAT used 
as control in in vitro transcription reactions. Including the two ORFs, ORF-1 (hRSV M2 ORF-1) and 
ORF-2  (hRSV M2 ORF-2/CAT ORF) which includes the ORF-1/ORF-2 overlap region  
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Appendix C 
List of oligonucleotides.  
	Δ560CF 
5´CAAGGTGACATAATTGTTAATGAACCAAATGAATAATCTAGAGAAAAA
AATC3´ 
Δ560CR 
5´GATTTTTTTCTCTAGATTATTCATTTAGTTCATTAACAATTATGTCACCT
TG3´ 
Δ550F 
5´GTAATAACCAAGGTGACATAATTATTAATGAACAAAATGAATAATC3´ 
Δ560GF 
5´CAAGGTGACATAATTGTTAATGAACGAAATGAATAATCTAGAGAAAAA
AATC3´ 
Δ560GR 
5´GATTTTTTTCTCTAGATTATTCATTTCGTTCATTAACAATTATGTCACCT
TG3´ 
Δ550R 
5´GATTATTCATTTTGTTCATTAATAATTATGTCACCTTGGTTATTAC3´ 
Δ560UF 
5´GATTTTTTTCTCTAGATTATTCATTTGGTTCATTAACAATTATGTCACCT3
´TG 
Δ560UR 
5´CAAGGTGACATAATTGTTAATGAACTAAATGAATAATCTAGAGAAAAA
AATC3´ 
5´AUGR  
5´AGATTCTCTAGATTATTCATTTTGTTCAGTAACAATTATG3´ 
3´AUGR 
5´AGATTCTCTAGATTATTCAGTTTGTTCATTAAC3´ 
AUG524F  
5´CAAGGTGACATAATTGTTACTGTTGTTAATGAATAATCTAGAGAAAAA
AATCACTG3´ 
AUG557F  
5´CAAGGTGACATAATTGTTACTGATGAAACTGAATAATCTAGAG3´ 
AUG524R  
5´CAGTGATTTTTTTCTCTAGATTATTCATTAACAACAGTAACAATTATGTC
ACCTTG3´ 
	AUG557R  
5´CTCTAGATTATTCAGTTTCATCAGTAACAATTATGTCACCTTG3´ 
AUGSeqSF 
5´CCAAGGTGACATAATTGTTACTGTTGTTAATGAATAATCTAGAGAAAA
AAATC3´ 
AUGSeqSR  
5´CTCTAGATTATTCAGTTTCATCAGTAACAATTATGTCACCTTG3´ 
bRSV120R2 
5´CAATAACATCATTTTCATCTTTGATTAGCAAAGAGGATATGCTGCAAGG
GTATTTTTCTG3´ 
bRSV120R1ST 
5´TGCAAGGGTATTTTTCTGGGAAAATAATAATGTTGGAGTTGTTCATTTT
GTTCATTAAC3´ 
bRSV120R1WC 
5´TGCAAGGGTATTTTTCTGGGAAAATAATAATGTTGGAGTTATTCATTTT
GTTCATTAAC3´ 
bRSV42  
5´AGATTCTCTAGAGAAAATAATAATGTTGGAG3´ 
bRSVCATF 
5´GTTGCCATCAAAAATCATGAGAACAAAATGAATAATCTAGAG3´ 
bRSVIRESF  
5´AGATTCGCATGCGTTGCTATGAGTAAAC3´ 
bRSVSTOP 
5´AGATTCTCTAGATTGTTCATTTTG3´ 
bRSVWTF 
5´GGGAAAGGTACCATGGGGCAAATATGTCACG3´ 
bRSVWTR 
5´AGATTCTCTAGATTATTCATTTTGTTCATTAACAATTAT3´ 
CAT120F1 
5´CTAAGTCATCAAAATGTTCTTGACTACTTACAATTTCATCTAGAGAAAA
AAATCACTG3´ 
CAT120F2 
5´ATATCCTCTTTGCTAATCAAAGATGAAAATGATGTTATTGTACTAAGTC
ATCAAAATG3´ 
	CATF 
5´GGGAAATCTAGAGAAAAAAATCACTG3´ 
CAT Hind III 
5´ATAATAAAGCTTTTACGCCCCGCCCTGCCAC3´ 
CATInt 
5´ACACGCCACATCTTGCG3´ 
CATR 
5´GGGAAAGCATGCTTACGCCCCGCCCTGCCACTC3´ 
DoubleR 
5´AGATTCTCTAGATTATTCAGTTTGTTCAGTAACAATTATG3´ 
eGFPIRESR 
5´GTTTACTCATAGCAACACAGGCATGCTTACTTGTACAGCTCGTCCATGC
CGAG3´ 
eGFP Sph I 
5´AATTAGCATGCTTGTACAGCTCGTCCATG3´ 
KozakF 
5´GTAATAACCAAGGTGACATAATTGTTAGCCGCCACCATGGATAATCTA
GAGAAAAAAATC3´ 
KozakR 
5´GATTTTTTTCTCTAGATTATCCATGGTGGCGGCTAACAATTATGTCACCT
TGGTTATTAC3´ 
KozakStopF  
5´GTAATAACCAAGGTGACATAATTGTTAGCCGCCACCATGGACAATCTA
GAGAAAAAAATC3´ 
KozakStopR  
5´GATTTTTTTCTCTAGATTGTCCATGGTGGCGGCTAACAATTATGTCACCT
TGGTTATTAC3´ 
M2 GTF 
5´GGGAAAGGTACCGGGGCAAATATGTCACGAAG3´ 
M2 GTR 
5´GGGAAAGCATGCTTTTAAATAACTATCTGTTAAG3´ 
pbRSV14F 
5´GAATTAGCATGCACGAAGAAATCCCTGCAAATATG3´ 
 
	pbRSV89F 
5´GAATTAGCATGCCTTTGAATGGCCTCCACATGC3´ 
pbRSV209F 
5´GAATTAGCATGCTAGAACAGAAGAATATGCATTG3´ 
pbRSV293F 
5´GAATTAGCATGCCTGTGTTGCTATGAGTAAAC3´ 
pbRSV380F 
5´GAATTAGCATGCGATAAGAATATATAACACAG3´ 
pbRSV527F 
5´GAATTAGCATGCTAATAACCAAGGTGACATAATTG3´ 
PVM6 F 
5´AATTAGCATGCGAGTGTGAGACCTTGCAAATTTG3´ 
PVM84 F 
5´AATTAGCATGCGGAATGGCCTTTGAAAACTC3´ 
PVM204 F 
5´AATTAGCATGCGACTGCTGAGTATGCCTTG3´ 
PVM370 F 
5´AATTAGCATGCTTACTTGAGAAGTTGCAAC3´ 
PVM424 F 
5´AATTAGCATGCGAGACAAATTATTCACATTC3´ 
PVM228 
5´AATTAGCATGCCATAGGTGTGCTGAAAAGTTAC3´ 
PVM306 
5´AATTAGCATGCATTGCAGAACTTGGATGTTGG3´ 
PstrucC F 
5´CAACATCACTAAATCAATACCTTCTGGCACTTTGATCACTGTATTGCAG
3´´ 
PstrucC R 
5´CTGCAATACAGTGATCAAAGTGCCAGAAGGTATTGATTTAGTGATGTTG
3´ 
PstrucGC F 
5´GTTACCTGGAAAAAAGTAACAAGATCAGTAAATCAATACCTTCTGGCA
CTTTGATCACTG3´ 
 
	PstrucGC R 
5´CAGTGATCAAAGTGCCAGAAGGTATTGATTTACTGATCTTGTTACTTTT
TTCCAGGTAAC3´ 
PstrucT F  
5´CATCACTAAATCAATATCTTTTGGCATTTTGATCACTGTATTGCAG3´ 
PstrucT R  
5´CTGCAATACAGTGATCAAAATGCCAAAAGATATTGATTTAGTGATG3´ 
RenLucF  
5´AGATTCGCATGCAACTTCTTAATTTACCAAAG3´ 
RenLucR 
5´CTCTAGATTATTCATTTTGTTCTCATGATTTTTGATGGCAAC3´ 
ShuntKF 
5´GGTAATAACAAGGTGACATAACACAAACCAAACAAAATGAATAACTCC
AAC3´ 
ShuntKR  
5´GTTGGAGTTATTCATTTTGTTTGGTTTGTGTTATGTCACCTTGTTATTAC
C3´ 
ShuntPF 
5´GTAATAACAAGGTGACATAATTGTTTATGGAAATTATGAATAATCTAG
AG3´ 
ShuntPR 
5´CTCTAGATTATTCATAATTTCCATAAACAATTATGTCACCTTGTTATTAC
3´ 
T3 down 
5´CATGATTACGCCAAGCTCG3´ 
T7 
5´TAATACGACTCACTATAG3´ 
T7-91 
5´GGCGAAAGGGGGATGTGCTG3´ 	
 
